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Abstract
Purpose: To contribute to advances in acquisition strategies for hyperpolarised 129Xe MRI of pulmonary
function via:
i) optimisation of 3D steady-state pulse sequences for imaging lung ventilation with 129Xe
ii) validation of 129Xe MR metrics of lung ventilation and microstructure against 3He equivalents
iii) experimental verification of the 129Xe chemical shift saturation recovery (CSSR) technique for eval-
uation of pulmonary gas exchange
iv) assessment of the reproducibility and experimental limitations of the CSSR technique
v) development of geometrical models of the alveoli for numerical analysis of 129Xe exchange dynamics
in human lungs and substantiation of CSSR data
Methods:
i) A numerical optimisation procedure for 3D balanced steady-state imaging of 129Xe gas was developed
and utilised to acquire lung ventilation images with naturally-abundant xenon
ii) MR-derived 129Xe and 3He ventilation volume percentage (VV%) and apparent diffusion coefficient
(ADC) measurements were compared in healthy volunteers, and patients with lung cancer and
chronic obstructive pulmonary disease (COPD)
iii) 129Xe CSSR was performed in healthy volunteers, and patients with systemic sclerosis (SSc), idio-
pathic pulmonary fibrosis (IPF)
iv) CSSR reproducibility studies were performed in patients with COPD and age-matched volunteers
v) Histology and micro-CT images were employed to derive representative models of lung microstruc-
ture for finite element analysis of 129Xe gas exchange
Results:
i) High quality images of pulmonary ventilation were obtained with optimised steady-state acquisitions
of both 129-enriched and naturally-abundant xenon
ii) 3He and 129Xe MR-derived VV% and ADC metrics were comparable in all subjects, and reproducible
in COPD patients
iii) 129Xe CSSR-derived septal thickness measurements were capable of distinguishing patients with IPF
and COPD from healthy volunteers
iv) 129Xe CSSR septal thickness values were reproducible in COPD patients and age-matched volunteers
v) 2D/3D image-based models (accounting for heterogeneity of lung microstructure) resulted in quali-
tatively similar 129Xe exchange dynamics as compared with CSSR data, exhibiting subtle differences
with 1D models
Conclusion: Hyperpolarised 129Xe shows promise for replacing 3He as a powerful MR contrast agent for
assessment of pulmonary function, and providing unprecedented sensitivity to gas exchange limitation.
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Chapter 1
Thesis overview
The principal goal of this thesis is to improve and validate existing techniques, and develop new method-
ologies for assessment of lung structure and function with hyperpolarised 129Xe MRI.
To set the scene and provide relevant background information for this thesis, Chapter 2 includes a gen-
eral overview of techniques for human lung imaging with proton and hyperpolarised gas MRI, along with
appropriate clinical applications.
The fundamentals of MRI physics and the requirements and strategies for hyperpolarised gas MRI
are presented in Chapter 3. The purpose of this chapter is multi-fold: (i) to review the key physical
principles underpinning MRI, and to discuss how the implementation of hyperpolarised gas MRI differs
to that of conventional 1H MRI; (ii) to establish the theoretical foundations upon which each subsequent
chapter of this thesis is based; (iii) along with Chapter 2, to provide an overview of methodology for
bringing persons new to the field of hyperpolarised gas MRI “up to speed”.
Following the introduction of the essential theory behind hyperpolarised gas MRI, this thesis is divided
into five chapters, each of which represent discrete but related pieces of original research.
Chapter 4 reports the optimisation of 3D SSFP acquisition strategies for enabling high quality, full
lung coverage imaging of lung ventilation with hyperpolarised 129Xe. Simulations of 129Xe 3D SSFP mag-
netisation dynamics and SNR are presented, which account for the B1 distribution of typical RF coils and
the intrinsic B0 homogeneity in the lungs. Images with sufficient quality to identify minor abnormalities
of lung function are shown to be obtainable using xenon in its relatively inexpensive naturally-abundant
form. The possibility of clinical implementation of same-breath hyperpolarised 129Xe and anatomical 1H
MRI is highlighted by the use of compressed sensing with 3D SSFP techniques.
Chapter 5 follows on from Chapter 4 and compares the applicability and sensitivity of 129Xe lung
MRI to that of 3He, for the purpose of assessing the feasibility of routine use of 129Xe in place of 3He. A
qualitative comparison of ventilation images acquired using the two nuclei is presented, and a statistical
analysis of quantitative measurements of lung ventilation and microstructure — namely; ventilated vol-
ume percentages, and apparent diffusion coefficients — derived from MRI of the two nuclei in a number
of different cohorts is reported, along with an appraisal of the reproducibility of each of these metrics in
patients with COPD.
Chapter 6 introduces the 129Xe chemical shift saturation recovery (CSSR) technique, which enables
evaluation of pulmonary gas exchange function and quantification of lung microstructural parameters. An
overview of the physiology and physics of gas exchange in the lungs is provided in this chapter, including
a summary of the existing analytical diffusion models of lung microstructure that have been utilised for
measuring lung function with 129Xe CSSR. The clinical potential of the technique is explored in subjects
with interstitial lung disease and healthy volunteers over a spectrum of ages. Chapter 7 explores the
the reproducibility of CSSR-derived metrics of lung microstructure and function in COPD patients and
age-matched healthy volunteers, and reviews the limitations, assumptions and general methodological
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considerations for implementation of the 129Xe CSSR technique in humans.
Following on from these experimental measurements of gas exchange dynamics, Chapter 8 describes
finite element simulations of the gas exchange process, using model gas exchange systems and realistic
geometries of lung microstructure derived from imaging methods such as histology and micro-CT. The
implications of these simulations for future MR imaging and spectroscopy studies with 129Xe are discussed.
In each of these chapters, the relevance and implications of the strategies established in this work are
discussed with respect to the fields of hyperpolarised gas lung MRI, and lung physiology. Chapter 9
summarises the findings of each of the individual projects, and reiterates the potential applications and
opportunities for clinical scalability of hyperpolarised 129Xe techniques. This final chapter also presents
some preliminary ongoing work pertaining to the implementation of methods for imaging of gas exchange
function with dissolved hyperpolarised 129Xe. The challenges and future perspectives of dissolved 129Xe
MR methods are discussed with reference to current clinical gold-standards and their limitations.
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Chapter 2
Introduction: 1H and multi-nuclear
MRI methods for structural and
functional assessment of the lungs
The purpose of this chapter is to provide an overview of existing methodologies for 1H and multi-nuclear
MR imaging of the lungs and their applications.
This chapter is based on the following publication: “MRI methods for structural and functional assess-
ment of the lungs: proton and multi-nuclear”. N. J. Stewart, J. M. Wild. European Respiratory Society
Monograph: Chapter 1, 70, 1-19 (2016). Author contributions statement: NJS and JMW; drafting and
revision of the manuscript.
Conventional magnetic resonance imaging (MRI) involves non-ionising radiofrequency radiation excita-
tion and detection of the nuclear spin free precession of protons (hydrogen nuclei, 1H) within the lungs.
Image contrast is provided by fundamental differences in the properties of tissues of interest, including
proton density and MR signal relaxation times. 1H MRI of the lungs is inherently challenging due to the
low proton density and the complex magnetic environment posed by the vast numbers of tissue and air
interfaces. Nevertheless, a variety of methods — both 1H and multi-nuclear, the latter employing inhaled
gases as contrast agents — have been developed to overcome these limitations and establish lung MRI as
an important clinical tool for assessment of both lung structure and several aspects of regional pulmonary
function, with high spatial and temporal resolutions.
In this chapter, an overview of proton and multi-nuclear MR imaging methodologies for the human
lung is presented, ranging from recognised clinical tools to recent technological advances. This work aims
to provide respiratory physiologists, imaging scientists and clinicians with an introduction to the funda-
mental principles of MR methods, and to highlight relevant clinical developments.
2.1 Proton lung MRI methods
The abundance of air-tissue interfaces in the lungs creates a challenging magnetic environment; the large
magnetic susceptibility difference between air and tissue gives rise to numerous local magnetic field in-
homogeneities. As a result, the transverse relaxation time (T ∗2 ) of
1H in lung parenchyma and blood is
extremely short [1], which makes MR signal acquisition challenging from a hardware perspective. This,
along with the presence of unavoidable respiratory and cardiac motions, necessitates rapid image acqui-
sition within a single breath-hold and/or accurate motion-triggering procedures.
Generally, a pulmonary 1H MRI protocol comprises various pulse sequences, each targeted to examine
specific aspects of the lung, including; structure or tissue density, ventilation, gas exchange and perfusion.
The clinical field strength of 1.5 T has historically been considered as an appropriate choice for lung MRI
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[2]; the greater magnetic field inhomogeneity at 3 T leads to faster signal losses [3] and the additional
signal-to-noise ratio (SNR) associated with higher field imaging of other organs (such as the brain) is less
easily realised in the lungs. Furthermore, whilst low-fields (≤ 0.5 T) offer longer relaxation times, signal
averaging is required to achieve sufficient SNR, lengthening the acquisition.
Figure 2.1: Anatomical and structural 1H MR imaging of the lungs of a subject with idiopathic pulmonary fibrosis
(IPF). (a) Spoiled gradient echo, (b) ultra-short echo time and (c) steady-state free precession images all highlight
peripheral and basal fibrosis in both lungs, and an apparent scar in the middle-right lung, as denoted by arrows.
Spoiled gradient echo (SPGR), single shot and segmented fast spin echo (FSE) and balanced steady-state
free precession (bSSFP) pulse sequences are the clinical workhorse methods for anatomical and structural
1H MRI of the thorax, examples of which are illustrated in Figure 2.1. The SPGR sequence comprises a
low flip angle radiofrequency (RF) pulse to excite 1H nuclei, followed by a frequency encoding magnetic
field gradient with a short echo time to overcome the rapid T ∗2 signal decay, and lastly a spoiler gradient,
which destroys any residual signal. 3D breath-hold SPGR acquisitions enable whole lung coverage imag-
ing, with image weighting dependent on the T ∗2 and a combination of proton density and the longitudinal
(T1) relaxation time. Although the lung parenchyma appears dark on SPGR images, they are suitable
for anatomical reference scans, lung volume measurements [4] and assessment of the mediastinum [5].
Furthermore, 3D SPGR sequences are commonly combined with fat saturation methods or gadolinium
contrast; the latter which reduces the T1 of the pulmonary blood vessels enabling identification of en-
hancement in nodules, inflammation in bronchiectactic airways and delineation of mediastinal tumours
[6]. Moreover, when combined with gadolinium contrast, these sequences allow visualisation of the pul-
monary blood vessels with MR angiography and perfusion MRI as outlined below.
bSSFP sequences also require short echo time image encoding, however the 1H magnetisation is re-
cycled rather than destroyed at the end of each encoding step, allowing the use of higher flip angles
when compared with SPGR, leading to increased SNR at the expense of increased specific absorption
rate (SAR) of patient heating by radiofrequency deposition i. By virtue of the inherent mixed T2 and T1
relaxation time contrast, bSSFP images provide “bright blood” signal, affording a clear depiction of the
pulmonary vessels and other long T2 fluids such as infiltrates and mucous in the lungs. The technique
is particularly suited to assessment of central pulmonary emboli (PE) [7] and is a suitable diagnostic
alternative to helical computed tomography (CT) [8] in subjects at risk to ionising radiation exposure or
MR contrast agents [9]. bSSFP imaging has shown utility for appraisal of bronchiectasis, mucus plugging
and atelectasis, with comparable diagnostic value to CT in cystic fibrosis (CF) patients [10], although
iSee Section 3.2.3 for a formal definition of SAR.
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currently inferior to CT in interstitial lung disease (ILD) [11]. For diseases characterised by significant
tissue loss or reduced blood volume (e.g. chronic obstructive pulmonary disease, COPD), morphological
MRI with SPGR or bSSFP sequences is inherently challenging and CT remains the first-line modality [9].
In addition to breath-hold structural imaging, bSSFP sequences are routinely applied for dynamic MRI of
free breathing subjects to evaluate respiratory cycle mechanics [12] and for quantitative lung volumetry
[4], which has been validated against conventional spirometry tests [13].
Spin echo sequences utilise trains of refocusing RF pulses to recover signal losses from magnetic field
inhomogeneities (T ∗2 decay), prior to image encoding. FSE images are weighted by the T2 relaxation
time (≥ T ∗2 ) and are well-suited to identification and evaluation of infiltrates, nodules and other fluids
with long T2 [14, 15]. Spin echo acquisitions are lengthier and more SAR intensive than gradient echo
acquisitions, and acceleration techniques such as single-shot encoding (e.g. single-shot FSE (SSFSE)),
half-Fourier encoding (e.g. half-Fourier single-shot turbo spin echo (HASTE)) or parallel imaging with
multiple RF receiver coils, are commonly employed to reduce scan time. SSFSE MRI is sensitive to pul-
monary oedema and bronchial wall thickening [16] and exhibits comparable efficacy to CT for detection
of pneumonia and pulmonary nodules [15, 17]. In pathologies characterised by fibrotic tissue (e.g. CF),
spin echo MRI has been demonstrated as essentially comparable to CT and chest x-ray techniques [18].
High-field respiratory- and cardiac-gated SSFSE MRI has been reported to perform at least comparably
to CT for evaluation of ILD [19], and segmented FSE methods employing motion compensation, e.g.
respiratory-gating, show great potential for high resolution imaging of multiple pathologies in the lungs
[20]. Whilst FSE acquisitions are slower than bSSFP, dynamic SSFSE MRI during free breathing can also
be utilised to study respiratory mechanics. Using this approach, abnormal respiratory motion has been
observed in emphysema subjects [21], and signal intensity changes between inspiratory and expiratory
images have been shown to correlate with pulmonary function testing [22].
Short tau inversion recovery (STIR) preparation sequences, employing an additional RF inversion
pulse prior to the standard RF excitation, can be combined with many of the aforementioned techniques
to saturate the potentially compounding signal from fat in the thorax, whilst simultaneously affording
valuable T1 and T2 contrast benefits from the lung parenchyma. Consequently, STIR sequences provide
good delineation of fluid-filled regions, in particular, lymph nodes [23], for which the method performs
comparably to fludeoxyglucose positron emission tomography (FDG-PET)/CT [24]. In a recent study,
a combination of STIR MRI and FDG-PET/CT was demonstrated to improve diagnostic capability for
N-staging in cancer patients [25]. Furthermore, turbo inversion recovery magnitude MRI has been shown
to be sensitive to segmental inflammatory lung oedema, corresponding to the severity of the regional
allergic reaction, as determined by the percentage of eosinophils in broncho-alveolar lavage fluid 24 hours
after segmental allergen challenge in patients with asthma [26].
To overcome the low MR signal from lung parenchyma and enhance the functionality of lung MRI, ex-
ogenous contrast agents are often introduced. Inhaled oxygen acts to decrease the parenchymal and
pulmonary blood T1, boosting the available MR signal and improving the delineation of ventilated lung
tissue. Oxygen-enhanced (OE) MRI is typically implemented via one of two methods: (i) acquisition
of IR-prepared, T1-weighted HASTE images at a number of different inversion times (TI — the time
between inversion and acquisition) [27, 28]; (ii) dynamic T1 mapping with a Look-Locker sequence [29],
5
Figure 2.2: Oxygen-enhanced MRI of the lung parenchyma. a) Look-Locker inversion recovery acquisition strategy
for obtaining a series of T1-weighted gradient echo images at different inversion times. This acquisition scheme is
repeated for the subject breathing normal air (21% oxygen) compared with pure (100%) oxygen. b) OE proton T1
maps of the lungs of a healthy subject (left) and a COPD subject (right). The healthy subject exhibits a generally
uniform T1 in the lungs, whilst abnormalities in the emphysematous lungs are highlighted by regions of reduced
T1 (diminished oxygen uptake).
wherein a series of fast, low flip angle gradient echo images are acquired in quick succession after a global
inversion pulse [30] (as illustrated in Figure 2.2). In both cases, acquisitions are performed alternately,
with the subject breathing room air (21% oxygen) or pure 100% oxygen. Data can be presented as O2
signal-enhancement maps or image intensities can be fitted on a pixel-wise basis to derive a lung T1
map. The functional information afforded by OE-MRI comprises a combination of ventilation, gas ex-
change and perfusion weighting. Assuming that signal enhancement maps predominantly reflect changes
in pulmonary ventilation [31, 32] allows for regional depiction of ventilation defects and quantification of
fractional ventilation (the fraction of gas turned over in one breathing cycle) from oxygen wash-in and
wash-out [33]. In comparison with quantitative CT, MR mapping of oxygen enhancement has been shown
to be capable of evaluating pulmonary functional loss in COPD [34]. Following oxygen’s diffusive exchange
across the air-blood barrier, OE-MRI can be used to assess gas exchange limitation (e.g. in ILD [35, 36]).
OE-MRI transfer metrics have been shown to provide comparable information to the whole lung transfer
factor of carbon monoxide (TL,CO), but on a regional basis, in subjects with emphysema and ILD [37, 38].
Furthermore, areas of reduced T1-enhancement on OE-MRI (“ventilation defects”) have been observed to
correspond with perfusion defects in CF patients [39].
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Although functionally sensitive, inherently safe and non-invasive, OE-MRI is limited by long scan times,
relatively poor spatial resolution and volume coverage and its relatively small T1 shortening / signal
enhancement effect. Gadolinium chelates are routinely employed as MR contrast agents to induce T1
shortening and signal enhancement in the pulmonary system and other organs [40, 41]. Dynamic contrast-
enhanced (DCE)-MRI of the lung typically refers to the process of tracking the first passage of gadolinium
through the pulmonary vascular circuit after intravenous contrast injection, providing unique information
about pulmonary perfusion with excellent spatial and temporal resolution [28]. Moreover, with timing
of the bolus, the arterial and venous enhancement of the pulmonary vessels can be separated to produce
high resolution MR angiograms [42] (examples shown in Figure 2.3). For these applications, a rapid 3D
gradient echo sequence is typically employed in combination with acceleration techniques such as parallel
imaging [43] and view sharing (e.g. time-resolved imaging of contrast kinetics (TRICKS) [44]). DCE per-
fusion imaging and MR angiography offer increased sensitivity compared with non-CE techniques, which
has been exploited for appraisal of pulmonary embolism [7, 42], where DCE-MRI and MR angiography
exhibit comparable or superior sensitivity versus nuclear scintigraphy [45, 46]. Additionally, regional
DCE-MRI perfusion abnormalities in emphysema patients have been observed to correlate with alveolar
destruction on CT [47]. The technique is appropriate for assessment of post-operative lung function, and
has been reported as a feasible non-ionising radiation alternative to the current clinical standard means of
evaluation of cancer resection surgery (nuclear scintigraphy) [48]. DCE-MRI is also pertinent for studying
perfusion impairment in vascular disease, for example pulmonary (arterial) hypertension (P(A)H) [49, 50],
and MR angiography screening for chronic thrombo-embolic PH (CTEPH) [51] presents an equally sen-
sitive technique to nuclear scintigraphy. In addition, MR angiograms are routinely used as replacements
for catheter pulmonary angiography in the diagnosis of PAH in selected specialised centres.
The dynamics of contrast uptake can be determined by placing regions of interest (ROIs) in different
areas of the lung and analysing the full time series of images, in order to yield quantitative perfusion data
from signal enhancement versus time curves (see Figure 2.4). Typically, one ROI is positioned at the pul-
monary artery to derive the arterial input function, by which to normalise the derived uptake dynamics.
Quantitative parametric maps of perfusion parameters can also be generated for regional quantification of
pulmonary blood volume (PBV), blood flow (PBF) and mean transit time (MTT) of blood through the
pulmonary circuit (MTT=PBV/PBF). A significant relationship has been observed between MTT (and
PBF) values and mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR)
from right heart catheter measurements, the clinical gold-standard metric for assessment of PAH [52].
Quantitative DCE perfusion MRI offers diagnostic value in patients with PAH, where a decreased PBF,
PBV and prolonged MTT have been measured in comparison to healthy subjects [49, 53]. Furthermore,
in patients with COPD, DCE-MRI parameters appear to correlate with global pulmonary function in-
cluding TL,CO [54], and in subjects with combined pulmonary fibrosis and emphysema, prolongation of
MTT exhibits a correlation with mPAP and PVR [55].
Proton MRI encompasses an array of methods for probing various aspects of pulmonary structure and
function that are now routinely used in clinical practice in specialist centres, focusing specifically on high
morbidity / high treatment cost diseases such as CF and PH, as a non-ionising radiation alternative to
CT. Development of the field of 1H lung MRI continues to be fruitful, with recent advances in ultra-short
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Figure 2.3: Contrast-enhanced MR angiograms of the pulmonary arteries of patients with different sub-types of
pulmonary hypertension: a) idiopathic PAH; b) PH with co-existing emphysema / COPD; c) PH in ILD; d)
thrombo-embolic PH; e) normal. Figure courtesy of Scott Nagle, University of Wisconsin.
Figure 2.4: a) Time series of DCE-MR images showing gadolinium bolus passage through the pulmonary vas-
culature (reproduced with permission from [56]). b) contrast-enhanced MR signal vs time curves for regions of
interest placed at the position of the pulmonary artery and the left atrium (reproduced with permission from [53];
note PTT equates to MTT, the mean pulmonary transit time of the contrast bolus). c) Two example slices of
peak DCE-MR signal (peak gadolinium concentration) maps acquired from the lungs of a subject with idiopathic
pulmonary fibrosis (same subject as in Figure 2.1).
echo time (UTE) sequences for accelerated imaging with improved visualisation of the lung parenchyma
and airway delineation [57]. The clinical potential of UTE in humans is promising; comparable efficacy to
CT for parenchymal assessment of patients with CF, lung cancer, ILD and emphysema has been recently
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reported [58]. In addition, Fourier decomposition (FD) MRI, where dynamic analysis of free breathing
imaging can be used to generate maps of lung regions modulated by ventilation and cardiac pulsatility,
thus providing surrogate maps of ventilation and perfusion from a single slice of the lung [59]. Like OE-
MRI, FD-MRI must be shown to be reproducible across centres and capable of providing volumetric lung
coverage in order to be considered diagnostically beneficial in a clinical setting [60].
2.2 Multi-nuclear lung MRI methods
Alongside the development of 1H lung MRI methods, MRI with the inhaled hyperpolarised noble gases
helium-3 (3He) and xenon-129 (129Xe) has become established as a versatile means of functional assess-
ment of pulmonary ventilation, structure and gas exchange. 3He and 129Xe are intrinsically biologically
safe and non-reactive, and possess similar nuclear spin properties to protons. Typical properties of these
isotopes relevant to lung MRI are summarised in Table 2.1, in comparison to 1H. Due to the low density
of the gases, signal enhancement is necessary to achieve sufficient SNR for in vivo MR applications. Hy-
perpolarisation of these nuclei, affording a factor of 105-106 increase in available MR signal, is possible via
collisional spin-exchange optical pumping [61] (or metastability-exchange optical pumping [62], 3He only).
A number of high-throughput commercial systems are available for polarisation of 3He (e.g. Polarean Inc,
Durham, NC) and 129Xe [63], and home-built 129Xe systems with low-cost components can now attain
comparable polarisation levels [64, 65].
Since the acquisition of the first images of pulmonary ventilation in human lungs with hyperpolarised
3He in 1996 [66, 67] and 129Xe in 1997 [68], inhaled noble gas MRI has rapidly evolved as a means to
provide excellent depiction of pulmonary ventilation and quantification of pulmonary function that is not
afforded by other methods [69, 70]. Ventilation MR imaging is typically performed under breath-hold
after inhalation of ≤ 1 L of hyperpolarised gas, using fast gradient echo or bSSFP sequences to acquire
a stack of 2D slices or a 3D volume [71], providing high resolution visualisation of the gas distribution in
the lungs, with image intensity proportional to gas density. In addition to breath-hold time constraints
to avoid respiratory motion, rapid acquisition and low excitation flip angles are imposed by the non-
renewable nature of the laser-induced hyperpolarisation.
Isotope 1H 3He 129Xe
Isotopic abundance (%) 99.99 1.4× 10−4 26.44 NA
80− 90 EN
Gyromagnetic ratio (MHz/T) 42.58 −32.44 −11.78
Self-diffusion coefficient (cm2.s-1) 2× 10−5 2.05 0.06
Cost (£/L) N/A ∼ 500 ∼ 20 NA
∼ 150 EN
Table 2.1: Properties of 1H, 3He and 129Xe relevant to lung MRI. (NA = natural-abundance xenon; EN = xenon
enriched with the 129 isotope.)
The majority of clinically-relevant lung imaging research with hyperpolarised gases to date has been per-
formed with 3He, exploiting its intrinsically higher gyromagnetic ratio compared with 129Xe (see Table 2.1)
and the fact that it has been historically easier to polarise to levels prerequisite for in vivo MRI. 3He ven-
tilation MRI has been implemented in multi-centre studies [72], is feasible at the clinical field strengths
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of both 1.5 T [73] and 3 T [74], and has shown clinical utility in a number of pulmonary pathologies,
particularly obstructive lung diseases in which ventilation heterogeneity presents as signal voids in the
image. Ventilation defect distribution has been comprehensively studied in patients with asthma [75, 76],
chronic obstructive pulmonary disease (COPD) [72, 77] and cystic fibrosis (CF) [78, 79]. Furthermore, the
technique has exhibited sensitivity to ventilation abnormalities in pulmonary embolism [80] and chronic
rejection of lung transplantation [81]. Dynamic ventilation MRI of inspiration has been facilitated by
rapid spiral [82] and radial [83] image encoding schemes to track the passage of gas through the major
airways and further evaluate flow restrictions in obstructive disease.
The availability of helium-3 is becoming increasingly regulated, as it is not naturally-abundant and
is solely generated as a by-product of tritium decay in the nuclear industry [84]. Xenon is considerably
cheaper and more readily-available; it is naturally-abundant in air (87 ppb), of which 26% comprises the
129Xe isotope, and the 129Xe fraction can be enriched to up to 80-90% by employing gas centrifuge tech-
niques. Hyperpolarised 129Xe is also a promising contrast agent for pulmonary ventilation imaging, with
little or no apparent loss in functional information compared with 3He [85–87]. A side-by-side comparison
of 3He and 129Xe ventilation images acquired from normal and abnormal lungs is presented in Figure 2.5.
Abnormalities in pulmonary ventilation in COPD have been observed on 3He and 129Xe MRI in a similar
manner [85, 86], and preliminary evidence suggests that 129Xe may be sensitive to smaller scale defects
[85, 88] by virtue of its low diffusion coefficient, which could be beneficial in early-stage disease detection.
Fuelled by recent advancements in polarisation technology [63–65] and pulse sequences, high-quality ven-
tilation imaging has now been realised using natural-abundance xenon [89] and low dosages of enriched
xenon [90], highlighting 129Xe as a commercially-scalable contrast agent for routine clinical studies.
The non-ionising radiation nature of hyperpolarised gas MRI is suitable for longitudinal studies of dis-
ease progression or treatment response. For example, the increase in prevalence of ventilation defects
in asthma patients after exercise and methacholine challenge [91], and the ventilation response to bron-
chodilator application in COPD and CF [92, 93], has been studied via multiple time-point 3He ventilation
imaging. Although xenon possesses anaesthetic properties [94], the low dosages used for lung MRI have
been reported to be safe and tolerable over several breath-holds in humans [95, 96], which is promising
for low-cost longitudinal screening of patients.
Hyperpolarised gas ventilation imaging can be combined with 1H DCE perfusion MRI in order to eval-
uate regional ventilation-perfusion matching [97]. The potential for pooled assessment of ventilation and
perfusion abnormalities is important in pulmonary embolism [80, 98], and the alteration of ventilation-
perfusion relationships has been studied with hyperpolarised 3He and 1H MRI in patients with PE and
post-lung transplant [97]. Furthermore, techniques and RF hardware for same-breath acquisition of hy-
perpolarised gas ventilation images and 1H anatomical images [99, 100] have been recently developed that
allow inherently co-registered, complementary structural and functional MR images to be obtained.
In addition to the visualisation of pulmonary ventilation, hyperpolarised gas MRI with 3He and 129Xe
permits quantitative evaluation of alveolar microstructure. Diffusion-weighted MRI enables measurement
of the apparent diffusion coefficient (ADC) of the hyperpolarised gas in the lungs. The 3He ADC is
reduced when compared to its free diffusion coefficient due to the restricting alveolar walls, however, in
the presence of tissue destruction (e.g. in emphysema), the ADC increases because the gas diffusion is
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Figure 2.5: Comparison of 3He and 129Xe MR
ventilation images of the lungs of a healthy
never-smoker (a), a healthy smoker (b), a pa-
tient with asthma (c) and a patient with COPD
(d). Progressively worse ventilation abnormali-
ties can be seen from b) to d), with mild, patchy
abnormalities in the smoker, more severe ob-
struction in the asthma subject and large re-
gions of completely unventilated lung in the
COPD subject. All images were acquired with
an optimised 3D SSFP sequence [89]. The slice
thickness and resolution for acquisitions a) and
b) were identical. 3He images for the asthma
and COPD subjects were acquired with a lower
slice thickness than 129Xe images, however, for
comparison, the 3He images in c) and d) repre-
sent reconstructions that mimic the same slice
thickness as the 129Xe images.
less restricted [101]. Various geometrical [102, 103] and phenomenological [104, 105] models have been
developed to relate observed ADC changes to quantitative physiological alterations in alveolar dimen-
sion or surface-area-to-volume ratio. Comprehensive 3He diffusion-weighted MRI studies of emphysema
patients [72, 106], asymptomatic smokers [107, 108] and asthma patients [109] have been performed to
assess regional variations in diffusion restriction across the lungs, and good correlations with both spirom-
etry [106, 110] and histology [111] have been reported. In addition, alterations in 3He ADC have been
mapped in the developing paediatric lung [112] and have been used as evidence of lung development
post-pneumonectomy treatment of adenocarcinoma [113] and alveolarisation in young adults [114].
Again, despite the predominant use of 3He in patient studies, hyperpolarised 129Xe ADC mapping is
likewise effective for assessment of COPD [115], and direct comparisons between diffusion-weighted MRI
of the two nuclei have highlighted agreement in the spatial distribution of ADC values, and correlations in
mean ADC values, in healthy volunteers, COPD patients and ex-smokers [85, 116]. Moreover, mean ADC
values were observed to correlate with TL,CO and mean Hounsfield units from CT [85, 116]. Figure 2.6
presents a comparison of 3He and 129Xe ADC maps acquired from healthy volunteers and COPD patients.
Although ventilation imaging and ADC mapping are undoubtedly the most well-established and widely-
applied hyperpolarised gas MRI techniques in a clinical setting, a number of additional experimental
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Figure 2.6: Example regional maps of the
apparent diffusion coefficient (ADC) of he-
lium (left) and xenon (right) in the lungs,
derived from diffusion-weighted hyperpolarised
gas MRI, using a 2D spoiled gradient echo se-
quence. a) One slice acquired from a healthy
subject — the mean global ADC values (± stan-
dard deviation) were 0.166 ± 0.064 cm2s-1 and
0.032 ± 0.018 cm2s-1 for 3He and 129Xe, re-
spectively. b) One slice acquired from a pa-
tient with severe COPD, in which clear un-
ventilated regions of the lung can be observed.
The mean ADCs were significantly increased to
0.594 ± 0.131 cm2s-1 and 0.090 ± 0.025 cm2s-1
for 3He and 129Xe, respectively.
techniques have been developed to further investigate specific aspects of lung function.
Multiple-breath ventilation imaging methods have been implemented to quantify lung ventilation via
metrics of ventilation heterogeneity or fractional ventilation (gas turnover per respiratory cycle). Origi-
nally demonstrated using multiple sequential imaging acquisitions after a variable number of inhalations of
hyperpolarised 3He to study gas wash-in in small animals [117, 118], the technique has subsequently been
modified to measure regional gas wash-out in humans to characterise ventilation heterogeneity [119, 120]
by acquiring multiple images after sequential exhalation-inspiration cycles of 3He. This technique provides
analogous quantitative information to the nitrogen wash-out pulmonary function test, but on a regional
rather than global scale, and preliminary evidence suggests its potential utility in the assessment of CF
[121]. In comparison to fractional ventilation imaging with 1H OE-MRI (e.g. [33]), multiple-breath hyper-
polarised gas imaging is potentially advantageous as a direct, quantitative regional measure of ventilation
rather than a measure that is only proportional to lung ventilation.
Following a similar acquisition strategy of repeated ventilation images separated by a specified time
gap, delayed ventilation of the small airways can be investigated [77, 122]; where apparently obstructed
regions of the lung start to fill during the breath-hold period and present as ventilated regions in images
acquired at a later time-point. The technique has been used to assess collateral ventilation pathways in
COPD [77]. Although delayed ventilation effects can also be highlighted indirectly by long-range MR
diffusion measurements [109], direct imaging methods may be preferred.
The dependence of the 3He longitudinal relaxation time (T1) on alveolar oxygen tension (i.e. partial
pressure, pO2) [123] can be exploited to infer alveolar pO2 from T1 changes over multiple MR acquisitions
during a breath-hold [124, 125]. The alveolar pO2 comprises information about ventilation, perfusion and
gas exchange, and hyperpolarised gas pO2 mapping MRI permits non-invasive regional quantification of
oxygen uptake. Substantial delays between acquired MR images are required to induce sufficient 3He
signal decay, necessitating long breath-holds, which can be partially overcome with 3D sequences [126] or
variable flip angle strategies and conservative image encoding schemes [127, 128]. To date, preliminary
studies in patients with COPD [122, 127] and post-lung transplant [128, 129] have shown that regional
pathological abnormalities in pO2 can be effectively detected. Nevertheless, the application of this method
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to obstructive lung disease is limited by collateral ventilation [122].
Phase contrast velocimetry (PCV) MRI offers a means to study gas flow in the lungs and major air-
ways by sensitising the MR acquisition to the hyperpolarised gas velocity [130, 131]. The method has
been validated via computational fluid dynamics modelling of the airways [132] and has important clinical
implications for particle deposition and drug delivery in the respiratory system. PCV MRI was recently
applied to examine gas flow oscillations in the human lungs induced by cardiac motion [133], and shows
potential for evaluation of pathological flow abnormalities in patients with obstructive lung disease.
Current developments of 129Xe lung MRI techniques utilise xenon’s diffusivity, solubility and MR proper-
ties to target the detection of dissolved 129Xe in the parenchyma and blood for the non-invasive assessment
of pulmonary gas exchange [134]. Xenon is mildly soluble in somatic tissues and blood [135], and the 129Xe
isotope displays unique NMR chemical shift signatures when dissolved in lung tissues and plasma (T/P),
and red blood cells (RBCs) [136, 137] (as illustrated in Figure 2.7a). As such, this “dissolved-phase”
129Xe can be detected separately from “gaseous-phase” 129Xe in the alveoli.
Dynamic 129Xe NMR spectroscopy, for example the chemical shift saturation recovery (CSSR) tech-
nique, permits studies of gas exchange dynamics [138], which can be analysed using mathematical models
of diffusion [138, 139] to quantify global changes in lung microstructure [140], e.g. in COPD [141], and to
detect alveolar septal thickening in ILD [142] (Figure 2.7b), both of which have been reported to correlate
significantly with the TL,CO metric [141, 142].
Direct imaging of dissolved-phase 129Xe in the lungs is challenging due to the very short T ∗2 relaxation
times and low concentration of dissolved xenon. One proposed method to separately image dissolved and
gaseous 129Xe is to exploit the large NMR chemical shift difference in their resonances to resolve the two
compartments in a single image [143]. Although a promising surrogate of ventilation (gaseous 129Xe) and
perfusion (dissolved 129Xe) in humans [143], this technique does not permit distinction of the T/P and
RBC components, and as such, the dissolved 129Xe signal is only partially comprised of signal from 129Xe
in the blood (i.e. it represents only a pseudo-perfusion measurement). A number of rapid acquisition
techniques with non-Cartesian image encoding schemes [144] have been introduced that exploit different
echo times [145, 146] to distinguish the dissolved 129Xe components, and yield RBC images that delin-
eate only 129Xe that has traversed the air-blood barrier into the pulmonary capillaries. These methods
have been employed to regionally visualise gas exchange impairment in patients with COPD and asthma
[141, 147] (e.g. Figure 2.7c) and regions of low 129Xe RBC signal have been reported to correlate visually
with fibrosis on CT in IPF patients [148].
In contrast to direct imaging of dissolved-phase 129Xe, an alternative technique has been proposed to
indirectly probe gas exchange function by studying the decay in the 129Xe gas signal following the ap-
plication of exchange-weighted radiofrequency pulses [149]. Entitled xenon polarisation transfer contrast
(XTC) MRI [149, 150], this method has been applied to map the alveolar surface-area-to-volume ratio in
the human lungs [151] and regionally depict gas exchange efficiency in the lungs of healthy volunteers and
COPD subjects, in attempt to quantify tissue loss due to emphysema [152, 153].
Exposure of hyperpolarised gas MRI to a broad clinical audience has historically been hindered by the
limited commercial availability of specialised hardware and the relative expense of the isotopes when
compared to other contrast agents. In recent years, fluorinated gas MRI, which exploits the non-zero
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Figure 2.7: MR of pulmonary gas exchange with hyperpolarised 129Xe. a) 129Xe NMR spectrum acquired from
the human lungs, exhibiting distinct peaks from 129Xe gas in the alveoli (G), 129Xe dissolved in tissues and blood
plasma (T/P) and in red blood cells (RBC). b) Alveolar septal thickness (ST) values estimated from 129Xe chemical
shift saturation recovery (CSSR) MR in healthy volunteers (HV, light blue), scleroderma patients (SSc, yellow)
and idiopathic pulmonary fibrosis patients (IPF, pink) (adapted from data in [142]). 129Xe CSSR is sufficiently
sensitive to detect interstitial tissue thickening in both diseases. c) Chemical shift imaging (CSI) of 129Xe in the
lungs of a healthy subject (H6), two patients with COPD (C3,4) and two with asthma (A2,4), depicted in the form
of maps of the ratio of signal intensities from each of the NMR peaks (reproduced with permission from [141]).
In patients, the gas exchange maps (RBC-to-GP and RBC-to-TP) were considerably more heterogeneous than in
healthy subjects, and the mean ratios were reduced in subjects with severe COPD.
nuclear spin of 19F, has emerged as a prospective alternative means to visualise pulmonary ventilation.
Fluorinated gases do not require hyperpolarisation, however the innate MR signal is typically low, neces-
sitating continuous breathing of a fluorinated gas mixture prior to breath-hold imaging for adequate SNR
to be realised (see e.g. [154]). Although the SNR and resolution of 19F lung MRI is presently inferior
to that of hyperpolarised 3He or 129Xe, the possibility of human application has been demonstrated in
healthy volunteers and patients with a variety of lung diseases using gradient echo sequences with an
inhaled perfluoropropane-oxygen mix [155], and subsequently UTE sequences have been reported to offer
enhanced SNR in healthy volunteers [156]. However, 19F gases are not soluble in biological substances
and thus cannot be utilised to probe pulmonary gas exchange.
The advent of low-cost 129Xe polarisers constructed from widely-available components, in combina-
tion with reductions in gas cost (afforded by naturally-abundant xenon [89] and unpolarised fluorine-19
[154] for example), are paving the way for improved dissemination of multi-nuclear MR methods in the
clinic. In particular, hyperpolarised 129Xe is emerging as a cost-effective contrast agent for high-quality
MR imaging of pulmonary ventilation. In Sheffield, we have recently established the technique as part
of clinical diagnostic referrals with a regulatory licence for manufacture of hyperpolarised 3He and 129Xe
gas for routine clinical lung imaging.
2.3 Conclusion
1H lung MRI is now an established non-ionising radiation alternative to CT for structural imaging of the
lung, and offers a range of techniques for quantitative investigation of diversified aspects of pulmonary
function that have considerable clinical value. MRI with hyperpolarised noble gases provides exquisite de-
piction of lung ventilation and presents a quantitative functional tool for assessment of lung microstructure
and gas exchange. Recent advances in MR pulse sequence acquisition strategies, polarisation technology
and image processing algorithms are promising for routine diagnostic lung imaging and clinical translation
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of these sensitive multi-nuclear lung MR imaging techniques.
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Chapter 3
Theory
This chapter provides an overview of the necessary background required to understand some of the con-
cepts introduced in the experimental chapters of this thesis. The chapter is divided into two main sections;
the first covering the morphometry and physiology of the lungs, and the second reviewing the fundamental
physics of magnetic resonance imaging and the specifics of hyperpolarised gas MRI.
3.1 Introduction to lung anatomy and physiology
This section describes the basic morphology of the lungs and the physiological basis of ventilation and
gas exchange. The content of this section approximately follows that of “What Makes a Good Lung?”, E.
R. Weibel, Swiss Med Weekly, (2009) [157], and the first three chapters of “Respiratory Physiology: The
Essentials (Ninth Edition)”, J. B. West, Lippincott Williams & Wilkins, (2012) [158].
3.1.1 Lung structure and function
The lungs are ideally suited to their primary function of facilitating exchange of oxygen from the air into
the bloodstream. There are three critical anatomical features of the lung for facilitating this gas exchange:
(i) the pulmonary airways (which transport inspired air to the alveoli); (ii) the gas exchange surface of the
alveoli (where inspired air traverses the blood-gas barrier from the alveoli into the pulmonary capillaries);
(iii) the pulmonary vascular system (which perfuses the alveoli and carries away the transferred gas). This
subsection provides an introduction to the morphometry of these three main features.
(i) The normal adult human tracheo-bronchial tract can be divided into 23 generations, which become
progressively smaller the deeper into the lung they penetrate. A resin cast of these airways is presented in
Figure 3.1, and approximate values for relevant morphological parameters as a function of depth are shown
in Figure 3.2. The trachea bifurcates into the left and right main bronchi, which in turn bifurcate, and
their products bifurcate, and so on and so forth. The first 14 generations from the trachea to the terminal
bronchioles — the deepest generation without alveoli — are known as the “conducting airways” (Z = 0-
14, Figure 3.2), whose function is to “conduct” the inspired gas to the alveolar regions for gas exchange.
Beyond the terminal bronchioles, the transitional bronchioles represent the bridge between the conducting
airways and the “acinar airways” (Z ′ 6= 0, Figure 3.2), which span the region from the respiratory bron-
chioles (where the first alveoli form), to the alveolar ducts and sacs (that have a complete lining of alveoli).
(ii) There are approximately 480 million alveoli in the human lungs (range: 274-790 million; coefficient of
variation: 37%) [161]. The geometry of the alveoli is tailored to maximise the available surface area for gas
exchange, resulting in a total surface area twice the size of a squash court. Each alveolar airspace spans
a diameter of approximately 250 microns and is lined with an extremely thin (∼ 1 µm) tissue barrier to
the pulmonary capillaries. Relevant morphometric data is summarised in Table 3.1.
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Figure 3.1: Resin cast of the human airway tree
and pulmonary blood vessels. Left: airways
only; right: airways, pulmonary arteries (red)
and veins (blue). Reproduced with permission
from [157].
Figure 3.2: Diagram of the airway generations in the Weibel model, with associated morphometric parameters.
Adapted with permission from [159], using data based on [160]. (σ denotes the typical cross-sectional area of
airways in a particular generation.)
The blood-gas barrier (i.e. tissue barrier) is composed of epithelial and endothelial layers separated by
an interstitial space and supported by basement membranes. 95% of the alveolar epithelium is comprised
of specialised, flat, Type I pneumocyte cells embedded in an elastin-collagen mesh, with the remaining
5% made up by cuboidal, Type II pneumocytes which secrete surfactants to modify the compliance of
the lung. On the other hand, the endothelium is principally composed of squamous cells. An electron
microscope image of a pulmonary capillary, showing high magnification of the blood-gas barrier, is shown
in Figure 3.3. It can be seen that the pulmonary capillaries are just wide enough to permit the passage
of red blood cells (approximately 7-10 microns in diameter [158]).
(iii) As a consequence of their extreme thinness, the pulmonary capillaries are inherently very fragile. The
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Morphometric Parameter Mean ± standard error
Alveolar surface area 130± 12 m2
Capillary surface area 115± 12 m2
Capillary volume 194± 30 mL
Alveolar diameter ∼ 250 µm
Tissue barrier harmonic thickness 0.62± 0.04 µm
Total barrier harmonic thickness 1.11± 0.1 µm
Table 3.1: Summary of lung morphometric data. Adapted with permission from [157], using data compiled from
[162], [163] and [164].
Figure 3.3: Electron microscope image of the
pulmonary capillary and blood-gas barrier in
the normal human lung. A: alveolus; C: capil-
lary; EP: epithelium; IS: interstitial space; EN:
endothelium; RBC: red blood cell. Reproduced
and annotated with permission from [165] (orig-
inally taken from [162]).
output of the right ventricle must be re-distributed from the pulmonary artery across the dense network
of capillaries that line the alveoli; hence, small changes in the pulmonary capillary blood pressure can
impact adversely on the alveolar microstructure. As quoted in Table 3.1, the capillary blood volume is
of the order of 200 mL, and on average, each RBC spends approximately 0.75 seconds in the pulmonary
capillaries (this is known as the RBC transit time). Capillary units are perfused in parallel, such that
blood of the same oxygen content is distributed to each unit.
3.1.2 Lung volumes and spirometry
The volume of inspired, expired and residual gas in the lungs at different points during normal (tidal)
breathing, and at the extremes of inspiration and expiration, is crucial information for describing the lung
structure and function, and provides reference points for quantitative measurements, for example from
pulmonary function tests and imaging examinations. Table 3.2 and Figure 3.4 give written and pictorial
descriptions, respectively, of the lung volumes that are important in routine clinical practice, and also
pertinent to the content of this thesis.
The term pulmonary function tests (PFTs) encompasses a range of measurement techniques that typically
involve patients breathing air or specific tracer gases in order to probe particular aspects of lung physiol-
ogy. Spirometry denotes the most commonly performed subset of PFTs, and includes the measurement
of FEV1, FVC, and the ratio of these two parameters, FEV1/FVC. In addition, spirometry can provide
information about VC and thus FEV1/VC. FEV1 and FVC are determined by measuring the volume of
gas exhaled by a patient as a function of time after forced exhalation from maximum inspiration. The
subject is instructed to inhale to maximum inspiration after a period of steady tidal breathing, then
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Lung volume / capacity Description
Tidal volume (TV) The peak-to-peak inspiratory-to-expiratory air vol-
ume during normal tidal breathing.
Inspiratory reserve volume (IRV) The additional volume of air beyond TV that can be
inspired when a subject inhales to their total lung ca-
pacity.
Expiratory reserve volume (ERV) The volume of air beyond TV that can be expired
when a subject exhales to their maximum capacity.
Residual volume (RV) The volume of the lungs remaining after a subject has
exhaled to their maximum capacity.
Forced expiratory volume in 1 second (FEV1) The volume of air that can be forcibly expired in 1
second ∗.
Total lung capacity (TLC) The total volume of air that can be contained in the
lungs.
Inspiratory capacity (IC) The total volume of air that can be inspired from tidal
exhalation.
Vital capacity (VC) The total volume of inspired air when TLC is achieved.
(VC = ERV + TV + IRV)
Forced vital capacity (FVC) The amount of air that can be forcibly exhaled from
TLC ∗.
Functional residual capacity (FRC) The volume of air remaining in the lungs after normal
tidal exhalation.
Table 3.2: Lung volume (top half) and capacity (bottom half) acronyms and their descriptions relevant for
spirometry applications. ∗: all volumes and capacities except FEV1 and FVC are shown graphically in Figure 3.4.
forcibly exhale to their full capacity, and then return to normal tidal breathing (this process is shown
diagrammatically in Figure 3.4). These fundamental measurements are used routinely in the diagnosis of
different pulmonary disorders (in particular COPD) and in distinguishing obstructive airway disease and
restrictive disease i.
The results of PFTs are generally reported in comparison to “predicted” values for a given pa-
tient, which are derived from empirical reference equations for normal, healthy subjects with equivalent
antrhopometric characteristics to the patient (e.g. sex, age, height, race). For example, COPD is typi-
cally classified in terms of %-predicted spirometry values as follows: mild (FEV1/FVC < 70% and FEV1
≥ 80%-predicted); moderate (FEV1/FVC < 70% and FEV1 < 80%-predicted); severe (FEV1 < 50%-
predicted) [166].
3.1.3 Ventilation and gas exchange
Ventilation defines the process by which air enters the lungs and fills the alveolar airspaces. The total
ventilation is the volume of gas inspired or expired from the lung per a certain time interval, or equiv-
alently, the product of the volume of inhaled or exhaled gas and the respiration frequency. This can be
divided into contributions from the conducting airways (also known as anatomic “dead space” because
they do not contribute to gas exchange) and from the acinar airways:
iMeasurements of additional lung volumes such as TLC, FRC and RV require the use of techniques other than spirometry,
for example body plethysmography, which will not be covered in this thesis.
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Figure 3.4: Diagram of lung volumes achieved during steady tidal breathing followed by forced inhalation and
exhalation, as would be measured by spirometry apparatus.
V˙T = VTn = V˙D + V˙A (3.1)
where V˙T , V˙D and V˙A are the total, dead space and alveolar ventilations, respectively, VT is the to-
tal volume of expired gas, and n is the breathing frequency (e.g. number of breaths per minute). It is
worth noting that the anatomic dead space considers only the volume of the conducting airways; however
in practice, there is additional “alveolar” dead space in the lungs resulting from non-perfused alveoli.
The anatomical and “physiological” dead space is approximately equivalent in normal subjects (since the
alveolar dead space is negligible; physiological = anatomical + alveolar), however in subjects with severe
disease, the physiological dead space can become significantly greater than the anatomical dead space.
The alveolar ventilation can be determined by re-arranging Equation 3.1 to V˙A = V˙E− V˙D and measuring
the expired ventilation, V˙E and appropriate dead space volumes.
Gas exchange defines the transfer of gas, typically oxygen, from the alveolar airspaces, across the blood-
gas barrier and into the pulmonary capillaries. This occurs by passive diffusion of the gas along a partial
pressure gradient through the barrier membrane. Efficient gas exchange is facilitated by matching the
alveolar ventilation and capillary perfusion, such that the optimum partial pressure gradient is created.
Exchange of oxygen across the alveolar-capillary membrane in normal, healthy subjects is limited by
the capillary perfusion; i.e. the rate at which oxygen transfers into the capillaries is constrained by the
rate at which oxygen is extracted from the capillary bed by blood flow (since the diffusion of oxygen across
the membrane itself is relatively fast). On the other hand, the uptake of gases such as carbon monoxide is
governed by the rate of diffusion of the gas across the membrane; i.e. the capillary perfusion is sufficiently
fast that the capillaries are not saturated with CO on the scale of the RBC transit time, because the
diffusion of the gas through the membrane is slow in comparison. The concept of diffusion-limited and
perfusion-limited gas exchange is introduced pictorially in Figure 3.5.
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Figure 3.5: Pulmonary capillary partial
pressure of N2O, O2 and CO through
the course of a capillary. Transfer of
N2O and O2 (in normal subjects) is
perfusion-limited, whilst transfer of CO
is diffusion-limited. Reproduced with
permission from [158].
The ability of the lungs to exchange gas in this manner can be quantified by performing a pulmonary
function test to determine what is known as the diffusing capacity of the lung for carbon monoxide
(DL,CO) in the US, or the transfer factor of the lung for carbon monoxide (TL,CO) in Europe. Both terms
have the same physiological meaning, but the measurement units are different: DL,CO is measured in
mL/min/mmHg, whilst TL,CO is measured in mmol/min/kPa
ii. Carbon monoxide is chosen because its
uptake in the pulmonary capillaries is highly diffusion-limited, as illustrated in Figure 3.5. The physio-
logical basis of the measurement is described in the following.
From Fick’s law, the rate of diffusion of gas across the membrane separating the alveoli from the
capillaries, V˙ , is dependent on the surface area, A, and thickness, x, of the membrane, the diffusion co-
efficient of the gas in that medium, D, and difference in partial pressure of the gas between the two media:
V˙ =
AD (PA − Pc)
x
(3.2)
where PA and Pc are the gas pressures in the alveoli and capillaries, respectively. It can be therefore
seen that the rate of gas exchange in the lungs is controlled principally by the alveolar morphometry. The
diffusing capacity of the gas across the alveolar-capillary membrane, DL, is defined as:
DL =
AD
x
=
V˙
PA − Pc (3.3)
For CO, the partial pressure in the capillary is regarded as negligible, because CO transfer across the
alveolar-capillary membrane is diffusion-limited, and as such, the associated partial pressure increase in
the capillary over time is small. Thus, the diffusion capacity of the lung for carbon monoxide is related by:
iiThe following conversion can be applied between the two sets of units: DL,CO ≈ 2.986× TL,CO.
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DL,CO =
V˙CO
PA,CO
(3.4)
DL,CO is generally expressed as the product of two quantities, namely the CO transfer coefficient (KCO)
and the alveolar volume of the lung containing CO (VA), which are the output of the standard PFT for
deriving DL,CO, as discussed below:
DL,CO = KCOVA (3.5)
where KCO is the CO uptake (change in concentration [CO]) per unit time, t, per unit volume, per
unit driving pressure:
KCO =
∆ [CO]
PA,CO∆t
(3.6)
These equations are only valid during breath-hold, and can be used to infer DL,CO with a single breath
technique [167], by recording the CO concentration decay over time. A volume of gas containing a non-
negligible concentration of CO is inhaled until TLC is reached, breath-hold is maintained for a period of
a few seconds whilst CO transfers into the bloodstream, and then the gas is expired. The concentration
of CO in the inspired and expired gas is recorded by an infrared analyser, and VA is inferred from the
concentration of the tracer gas with which the CO is mixed (usually helium):
VA = VI
FI,He
FA,He
(3.7)
where VI is the inspired volume of helium, and FI,He and FA,He are the fractional concentrations of
helium in inspired and expired gas, respectively.
In the above, the diffusion capacity is only considered to be governed by diffusive transport of CO across
the alveolar-capillary membrane. However, in practice, it is also influenced by the finite reaction rate
of CO with haemoglobin. As formulated by Roughton and Forster [168], these two contributions can be
separated by analogy with two conductances in series:
1
DL,CO
=
1
DM,CO
+
1
θCOVc
(3.8)
whereDM,CO is the “membrane conductivity”, θCO is the rate of reaction between CO and haemoglobin,
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and Vc is the volume of haemoglobin in the capillary blood.
Whilst both these factors must be considered in the explanation of pathological alterations to DL,CO,
it is notable for the later sections of this thesis that xenon does not react with haemoglobin and hence
in an equivalent analysis of the xenon diffusion capacity, the second term in Equation 3.8 is not required
[169, 170]. Furthermore, xenon is perfusion-limited [171], and therefore exhibits similar behaviour to N2O
as shown in Figure 3.5. This behaviour is discussed further in reference to techniques for quantifying
diffusion limitation with hyperpolarised 129Xe MRI in Chapter 6.
3.2 Fundamentals of magnetic resonance imaging
This section describes the fundamental physics of MRI, providing the required theoretical basis for un-
derstanding the spectroscopy and imaging techniques employed in the subsequent sections of this thesis.
The content of this section is derived from a number of seminal MRI textbooks and adopts a combination
of semi-classical and quantum approaches for describing the motion of spins. For further information, we
refer the reader to [172–180].
3.2.1 Nuclear spins in a magnetic field
Quantum mechanical introduction
Spin angular momentum is an intrinsic property of protons, neutrons, electrons and whole nuclei. Spin
is quantised, with fermions such as protons, neutrons and electrons each possessing a spin of 12 . Nuclei
with an even number of neutrons and an even number of protons have zero total nuclear spin, and are
unsuitable for NMR. Odd-odd nuclei (nuclei with an odd number of neutrons and odd number of protons)
have a positive integer value of nuclear spin, and both odd-even and even-odd nuclei have half integral
spin. Conventional MRI exploits the endogenous spin- 12
1H nuclei in the human body, which consist of a
single proton.
An electron possesses both spin angular momentum S and orbital angular momentum L, with a total
angular momentum J = L+ S. On the other hand, the orbital angular momentum of a nucleus is negli-
gible, and only the nuclear spin, I, contributes to its total angular momentum. Nuclei with non-zero spin
have an associated magnetic moment, µ, defined by:
µ = γI (3.9)
where the constant of proportionality, γ, is a scalar quantity known as the gyromagnetic ratio iii. The
nuclear spin I is not just a vector quantity, but a quantum mechanical operator. As such, the nuclear
spin can be “observed” by considering its component, m, along a particular axis. For convenience, here
we choose to project the spin angular momentum along the z axis, and denote m ≡ mz. Generally termed
the spin angular momentum quantum number, m can take 2I + 1 values (where I is the absolute value of
the nuclear spin) in the range: −I, −I+1, · · ·, I−1, I, corresponding to 2I+1 different quantum mechan-
iiiµ and I are co-linear by definition. It is worth noting that nuclei can have a negative γ, resulting in an oppositely-
orientated magnetic moment and spin.
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ical states, which are degenerate in energy in the absence of a magnetic field. In practice, a nucleus does
not inhabit one specific state; rather it exists in a linear superposition of all 2I+1 states, |ψ〉, described by:
|ψ〉 =
∑
m
am |m〉 (3.10)
where am are the amplitudes associated with the 2I + 1 “basis states”, |m〉. When observing the spin
angular momentum along the z axis, the spin angular momentum quantum number is an eigenvalue of
the eigenstates |m〉, which adhere to the following equation:
Iz |m〉 = m |m〉 (3.11)
where Iz is the nuclear spin angular momentum operator for the z axis.
When placed in a magnetic field, B0, the degeneracy between the nuclear states is lifted; the states be-
come divided in energy according to the Zeeman Hamiltonian, H:
H = −γh¯B0Iz (3.12)
which has “eigen-energies”:
E = γh¯B0m (3.13)
where B0 = |B0|. These equations arise from the definition of the interaction energy of a magnetic
moment in a magnetic field, E = −µ ·B0. The reduced Plank’s constant, h¯, is the fundamental unit of
energy for a quantised system. The energy level diagram for the most simplistic spin- 12 system is shown
in Figure 3.6. The two energy states correspond, for a nucleus with positive gyromagnetic ratio, to
∣∣− 12〉,
at an energy of γh¯B0/2, and
∣∣ 1
2
〉
, at an energy of −γh¯B0/2, with an energy difference of ∆E = γh¯B0.
By convention,
∣∣− 12〉 is usually referred to as the “spin-down state”, and ∣∣ 12〉 as the “spin-up state”,
corresponding to spins being aligned anti-parallel and parallel to the magnetic field, respectively. (Note:
for a nucleus with negative gyromagnetic ratio, the states are reversed in energy, i.e. the spin-up (
∣∣ 1
2
〉
)
state is at higher energy.) From this point onwards, we will consider only spin- 12 systems.
Although it has been noted above that the wave function of a fundamental particle or nucleus comprises
a linear combination of its basis states, it is helpful for the description of the nuclear magnetic resonance
phenomenon to consider that each particle or nucleus can inhabit one of the two states at any given time;
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Figure 3.6: Energy level diagram for a spin- 1
2
(two spin-state)
nucleus in a magnetic field. For a nucleus with positive gy-
romagnetic ratio, |β〉 ≡ ∣∣− 1
2
〉
; |α〉 ≡ ∣∣ 1
2
〉
. ∆E = γh¯B0, and
h¯ = h
2pi
, where h = 6.63× 10−34 Js is Planck’s constant.
indeed, when a spin is “observed”, it exhibits distinct energies corresponding to one of the two states,
rather than a continuum of energies in between. The NMR phenomenon then relies upon inducing tran-
sitions between the two nuclear states, which is possible by applying a time-dependent “perturbation”
with an angular frequency of ω0, and an energy described by the Planck equation:
∆E = h¯ω0 (3.14)
In NMR, this time-dependent perturbation is an alternating magnetic field, which can be related by
a perturbation Hamiltonian, Hp, for example along the x axis:
Hp,x = −γh¯B1,xIxcos (ω0t) (3.15)
where Ix and B1,x are the x components of the spin angular momentum operator and applied alter-
nating field, respectively, and t is time. As a consequence of the construction of Ix, this perturbation
Hamiltonian can only induce transitions between states m and m′ where m′ = m± 1, i.e. two states that
are adjacent in energy. Thus, by combining Equations 3.13 and 3.14, we arrive at:
ω0 = −γB0 (3.16)
This is the Larmor equation that underpins the angular frequency of a perturbation required to induce
a resonant transition between the two ground states of a spin- 12 nucleus, as a function of γ, an intrinsic
property of the nucleus, and B0, a fundamental property of the NMR system. By convention, the nega-
tive sign in Equation 3.16 indicates that positive-γ nuclei will exhibit a negative Larmor frequency and
a negative-γ species will have a positive Larmor frequency. The same equation results from a classical
treatment of the motion of spins in a magnetic field, as discussed in the following subsection.
Semi-Classical description of spins in a magnetic field
In order to move from a description of the energy levels of a single nuclear spin to arrive at a macroscopic
description of magnetisation, we must consider an ensemble of spins, and their propensity to inhabit one
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of the two spin states. In the presence of a magnetic field, spins exhibit a slight preference to align with
the field rather than against it, i.e. to inhabit the slightly lower energy
∣∣ 1
2
〉
state as shown in Figure 3.6.
The relative populations of the two states, P|± 12 〉 (which can also be thought of as the relative probabilities
of inhabiting either state), are well defined by the Boltzmann distribution:
P|± 12 〉 =
N|± 12 〉
N
=
exp (±γh¯B0/2kBT )
exp (−γh¯B0/2kBT ) + exp (γh¯B0/2kBT ) (3.17)
where N|± 12 〉 is the number of nuclei in a given state and N is the total number of nuclei in the system;
kB = 1.38 × 10−23 J.K-1, the Boltzmann constant, T is the temperature of the system. The population
difference between the two states is known as the polarisation, P , of the sample:
P = P| 12 〉 − P|− 12 〉 = tanh
(
∆E
2kBT
)
≈ γh¯B0
2kBT
(3.18)
where the approximation tanh (x) ≈ x at small x is justified by the fact that in general, the thermal
energy of a spin system is far greater than the energy difference between the two spin states. As an
example, for 1H at 1.5 T and room temperature (293 K), the polarisation P ≈ 5×10−6. From this result,
the macroscopic magnetisation (per unit volume) of a spin ensemble in a magnetic field of strength B0,
caused by the population difference between the two states, can be determined by:
M0 = N
(
P| 12 〉 − P|− 12 〉
)
µ ≈ N γ
2h¯2B0
4kBT
(3.19)
where N is the number of spins per unit volume, and the magnetic moment operator µ = γh¯I, such
that µ = γh¯/2.
Continuing the semi-classical treatment, the following concerns the semi-classical approach of describing
the motion of spins in a static magnetic field, B0, which for simplicity, we can consider to be pointing in
the z direction, i.e. B0 = B0kˆ, where kˆ is the unit vector of the z axis. In many textbooks H0 = H0kˆ is
used to define the applied magnetic field. However, when considering a macroscopic sample of spins, the
magnetic susceptibility becomes important, and hence is it appropriate to consider the magnetic induc-
tion, B0 rather than the applied magnetic field:
B0 = µ0 (1 + χ)H0 (3.20)
Here, µ0 = 4pi × 10−7N.A-2 is the permeability of free space and χ is the magnetic susceptibility of the
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sample (i.e. the propensity of the material to develop a magnetic moment iv).
In the presence of a magnetic field, a nuclear spin will experience a torque, τ , governed by the cross
product of its magnetic moment and the applied magnetic field, which acts to align the spin with the
magnetic field:
τ =
dI
dt
= µ×B0 (3.21)
where the definition of torque is the rate of change of angular momentum. Equivalently, for a spin
ensemble, the net magnetisation vector, M , resulting from the average of the individual magnetisation
vectors associated with the spins in the ensemble, experiences a torque. Since µ = γI, and the magneti-
sation is the magnetic moment per unit volume, we can write:
dM
dt
= γM ×B0 (3.22)
which, for B0 = B0kˆ, can be decomposed into the following:
dMx
dt
= γMyB0 (3.23)
dMy
dt
= −γMxB0 (3.24)
dMz
dt
= 0 (3.25)
In its “equilibrium state”, the net magnetisation vector points along z with an initial magnitude of
M0, given by Equation 3.19. However, if the magnetisation is displaced from the z axis by an an-
gle of α in the direction of the y axis, the above equations can be solved with the initial condition
M (t = 0) = 0ˆi +M0sin (α) jˆ +M0cos (α) kˆ, to yield:
Mx (t) = M0sin (α) sin (ω0t) (3.26)
My (t) = M0sin (α) cos (ω0t) (3.27)
Mz (t) = M0cos (α) (3.28)
ivOn a macroscopic scale, most materials do not naturally exhibit a magnetic moment; instead µ is typically induced
according to µind =
1
µ0
V χB0, where V is the volume of the object.
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These equations describe the precessional motion of the net magnetisation vector with angular frequency
ω0 about the z axis after being perturbed by an angle of α in the direction of the y axis, as shown picto-
rially in Figure 3.7a. The Larmor equation (Equation 3.16) is typically written with a negative sign, such
that the direction of precession is “negative” for positive-γ nuclei, i.e. clockwise if the spin is observed in
a direction opposite to the magnetic field, and “positive” for negative-γ nuclei, i.e. anti-clockwise. The
displacement angle α is known as the flip angle in NMR.
Figure 3.7: Coordinate representations of spin excitation and precession (a), and the rotating reference frame
(b). In both cases, the static magnetic field is applied along the z axis. In a), α denotes the angle by which
spins are displaced from the z axis towards the y axis. After time t, the net magnetisation vector has precessed
by an angular distance of ω0t with respect to its position at t = 0. (Note: a chemical species with a negative
gyromagnetic ratio exhibits precessional motion in the opposite direction with respect to B0 compared to that of
a positive gyromagnetic ratio species.) In b), the coordinate system x′, y′, z is shown to be rotating about the
z axis at a frequency of −ωr. In this rotating frame, both the B1 and B0 fields are stationary, and are aligned
along the x′ and z axes, respectively. Both diagrams are adapted with permission from [176].
In practice, the perturbation of the magnetisation vector from its rest position is typically achieved by
applying an oscillating magnetic field, B1, in a direction perpendicular to the B0 field, and which is
rotating with an angular frequency ωr:
B1 (t) = B1cos (ωrt) iˆ−B1sin (ωrt) jˆ (3.29)
By substituting B = B0 +B1 for B0 in Equation 3.22, the following expressions can be obtained for the
three components of magnetisation:
dMx
dt
= γ [MyB0 +MzB1sin (ωrt)] (3.30)
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dMy
dt
= γ [MzB1cos (ωrt)−MxB0] (3.31)
dMz
dt
= −γ [MxB1sin (ωrt) +MyB1cos (ωrt)] (3.32)
which can be solved by inspection to yield:
Mx (t) = M0sin (ωrt) sin (ω0t) (3.33)
My (t) = M0sin (ωrt) cos (ω0t) (3.34)
Mz (t) = M0cos (ωrt) (3.35)
where ωr = γB1 is the angular frequency associated with the rotating magnetic field. Comparing to
Equations 3.26 to 3.28, we arrive at an expression for the flip angle in terms of the B1 field:
α = ωrt = γB1t (3.36)
Equations 3.33 to 3.35 dictate that in the presence of both static and rotating magnetic fields, the magneti-
sation simultaneously precesses about both. Visualisation of this motion is complicated in the conventional
laboratory frame, and therefore it is appropriate to transform the problem to a coordinate system that
rotates with an angular frequency of −ωr about the z axis, such that both the B1 and B0 fields appear
stationary. This coordinate system, designated by x′, y′ and z, is known as the rotating frame, and is
illustrated in Figure 3.7b.
Writing the full form of the angular frequency of the rotating frame as Ω = 0ˆi + 0ˆj − ωrkˆ, the time
derivative of the magnetisation can be separated into two components:
dM
dt
=
δM
δt
+ Ω×M (3.37)
where δMδt is the rate of change of M with time as viewed from the rotating frame. Combining this
with Equation 3.22, we obtain:
δM
δt
= γM ×
(
B +
Ω
γ
)
(3.38)
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where the term in brackets can be denoted as the effective field, Beff = B1ˆi +
(
B0 − ωrγ
)
kˆ. If
ωr
γ = B0, Beff = B1ˆi, and the net magnetisation vector precesses around the B1 field. Otherwise, the
effective longitudinal (z) field is non-zero, and Equation 3.38 dictates that the magnetisation will precess
about an effective field that is offset from the B1 axis.
3.2.2 Relaxation and the Bloch equations
After perturbation from equilibrium — e.g. caused by the application of an oscillating magnetic field —
the net nuclear magnetisation vector does not precess indefinitely around the effective field, but instead
is restored to its equilibrium state (parallel to the direction of B0) over time by the process of “spin-
lattice” (or “longitudinal”) relaxation. This process is analogous to the damping of a pendulum caused
by air resistance or friction, and represents the energy lost by the spin system via collisional, rotational or
electromagnetic interactions with the “lattice” of surrounding nuclei, atoms and molecules. Spin-lattice
relaxation denotes the growth/re-growth of magnetisation in the longitudinal (z) direction according to
the following expression:
dMz
dt
= − (Mz −M0)
T1
(3.39)
where Mz = Mz (t) and T1, the spin-lattice relaxation time, represents the characteristic time-scale of
spin-lattice relaxation. This equation has a solution of the form of an exponential growth function, with
T1 as the exponential time constant:
Mz (t) = Mz (0) exp
(
− t
T1
)
+M0
(
1− exp
(
− t
T1
))
(3.40)
As such, for an initial longitudinal magnetisation Mz (0) = 0, e.g. resulting from a perturbation of flip
angle 90◦, the T1 represents the time after which approximately 63% of M0 is recovered along the z
direction.
Whenever spin-lattice relaxation is present in a system, an accompanying relaxation process describing
the damping of the transverse (x and y) components of magnetisation is also present. This process is
known as “spin-spin” or “transverse” relaxation and arises from a combination of indirect energy exchange
with the lattice (as in T1 decay), and additional direct mechanisms, which cause the characteristic relax-
ation time for spin-spin relaxation, T2 to be less than or equal to T1. Spin-spin relaxation is governed by
the rate equation:
dMxy
dt
=
−Mxy
T2
(3.41)
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which has a solution of the form of a decaying exponential, where the exponential time constant T2 in
this case defines the time after which the transverse magnetisation has decayed to approximately 37% of
its initial value.
Mxy (t) = Mxy (0) exp
(
− t
T2
)
(3.42)
Equations 3.39 and 3.41 can be combined with the equation for torque in the rotating frame (Equa-
tion 3.38) in order to derive the Bloch equations in the rotating frame:
dMx
dt
= γMy
(
B0 − ωr
γ
)
− Mx
T2
(3.43)
dMy
dt
= γMzB1 − γMx
(
B0 − ωr
γ
)
− My
T2
(3.44)
dMz
dt
= −γMyB1 − Mz −M0
T1
(3.45)
These relationships describe the general form of the dynamics of a spin system in the presence of a static
magnetic field B0 and an oscillating magnetic field B1 along the x axis, and are a critical reference point
for many NMR applications. An example solution to these equations can be derived for the most simple
case where the magnetisation has been perturbed by 90◦ from the z axis and lies entirely along the y
axis at time t = 0 (i.e. Mz (0) = Mx (0) = 0, My = M0). Also assuming that there is no oscillating field
applied after this initial displacement, i.e. B1 = 0, the Bloch equations can be solved by the following
functions:
Mx (t) = M0exp
(−t
T2
)
sin (ω′t) (3.46)
My (t) = M0exp
(−t
T2
)
cos (ω′t) (3.47)
Mz (t) = M0
[
1− exp
(−t
T1
)]
(3.48)
where ω′ = ω0 − ωr.
Mechanisms of relaxation and Chemical shift
As mentioned in the previous subsection, spin-lattice relaxation is not only responsible for the return of
the net magnetisation vector to thermal equilibrium, but also for the establishment of the net magneti-
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sation vector, or net magnetic moment, in the first place. Consider a spin ensemble with an isotropic
distribution of spin, and hence magnetic moment, orientations. Instantaneously switching on a magnetic
field will cause the spins to precess about the magnetic field direction. Molecular motions, including trans-
lations and rotations, cause rapid fluctuations of the local magnetic fields associated with each nucleus and
electron. The field experienced by a given nucleus at a particular time is the summed effect of the applied
field and the neighbouring fields, thus, each nucleus experiences a field with a slightly different magnitude
and orientation at any given instant. These fluctuating fields break the isotropy of the distribution of
nuclear spin orientations.
In other words, over time, each nucleus experiences many different microscopic fields, which cause
the angle between the spin and the external field to change. This process is not isotropic because the
thermal dynamics of the system dictate that the spins have a slight preference to align with the external
field, as this is the state of lowest energy. Eventually, the spin ensemble establishes a thermal equilibrium
with a net distribution of spins aligned parallel to the external field v. The exact same processes act
to re-establish a thermal equilibrium magnetisation if the net magnetisation is perturbed, e.g. by the
application of a rotating magnetic field as discussed earlier.
In thermal equilibrium, the summation over all spins with different precession angles averages to yield
zero transverse component of the net magnetisation vector. Then, on perturbation from equilibrium, the
transverse component becomes non-zero and the net magnetisation precesses about the z axis in the same
manner as the individual spins. However, the resulting transverse component of the net magnetisation
vector decays to zero over time because small fluctuations in the magnetic fields experienced by each
nucleus lead to differences in phase between the precession of different nuclei. Hence, the spins in the
ensemble lose coherence with each other and the net magnetisation diminishes to zero. This process is
known as spin-spin relaxation.
As stated in the previous section, it is often written that T2 ≤ T1 since all processes that induce spin-
lattice relaxation will also lead to spin-spin relaxation (and additional mechanisms can induce the latter
whilst not influencing the former) vi. Before summarising the exact mechanisms of relaxation, since many
relaxation processes are driven by molecular motion, it is appropriate to introduce the concept of molec-
ular correlation time τc, which is the average time taken for a given molecule to rotate by one radian.
This parameter is a characteristic of a particular type of molecule, and exhibits a strong influence on the
relaxation times, as shown in Figure 3.8.
Slow motion (i.e. long correlation time) is typical of large, complex molecules such as polymers or pro-
teins. On the other hand, small molecules exhibit fast molecular “tumbling” (τc is sometimes called the
molecular tumbling rate), and for these molecules, T1 and T2 values can be of a similar magnitude. The
x-axis in Figure 3.8 can be interpreted as the molecular size or the resistance to motion / viscosity. The
minimum T1 for a given nucleus, i.e. the fastest rate of recovery of longitudinal magnetisation, occurs at
a correlation time τc =
1
ω0
. In other words, molecular motions are most effective at inducing longitudinal
vThough this equilibrium state is stable, the thermal motions continue and the orientation of individual spins continues
to change, whilst the established net magnetisation remains fixed.
viAlthough this is often the case, the theoretical limit is actually T2 ≤ 2T1 [174, 181], and experimental evidence has
shown that T2 can indeed be greater than T1 in certain situations [182].
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Figure 3.8: Logarithmic plot of the relationship be-
tween T1 and T2 relaxation times and the molecular
correlation time, τC . Adapted with permission from
[172].
relaxation when they occur at a rate equal to that of the Larmor frequency.
Relaxation can result from a number of different mechanisms, some of which are briefly listed in the
following:
i) Dipole-dipole: this is the direct coupling between the dipole of a nucleus and another dipole, either
on the same molecule, or on a different molecule. This can occur between any two dipoles, includ-
ing those generated by an isolated electron or proton, or a nucleus with non-zero spin. Molecular
tumbling induces fluctuating fields at each dipole, and both spin-lattice and spin-spin relaxation
can occur to differing degrees depending on the rate of molecular tumbling compared to the Larmor
frequency. The magnitude of the dipole-dipole effect on the relaxation rate is inversely proportional
to the distance between the dipoles raised to the power of six, and thus, dipole-dipole coupling is
most effective at relaxing nuclei that are bonded together.
ii) Chemical shift anisotropy: as discussed in the Aside below, the external applied field induces cur-
rents in the electron clouds of the molecules containing the nuclear spins. These currents in-turn
generate an additional magnetic field, which alters the magnetic field experienced by a given nucleus.
This process is known as the chemical shift effect. When anisotropy in chemical shift is present,
local differences in the induced magnetic fields lead to relaxation. Molecular tumbling causes the
orientation and magnitude of these induced magnetic fields to change as a function of time; how-
ever, if the tumbling rate is rapid, asymmetries can average out and hence relaxation by chemical
shift anisotropy can be alleviated. The magnitude of this effect is proportional to the square of the
magnetic field strength.
iii) Scalar (J)-coupling: the indirect interaction of two nuclei lying on the same molecule, mediated by
shared bonding electrons. This effect is independent of magnetic field strength.
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iv) Spin rotation: the interaction of nuclear spins with the local magnetic fields generated by the circular
motion of electrons in a rotating molecule. The magnitude of this effect is dependent on the fre-
quency of molecular collisions. This mechanism typically governs the observed relaxation behaviour
of gases at high temperatures.
v) Electric quadrupole coupling: for nuclei with spin > 12 , which have a non-spherical (oblate/prolate)
nuclear charge distributions, this is the interaction between nuclei and local electric field gradients
in the surrounding electron clouds. This process does not occur for spin- 12 nuclei which exhibit a
spherically-symmetric nuclear charge distribution.
vi) Molecular translation: the movement of nuclear spins from one environment to another on the time-
scale of the NMR experiment, e.g. by flow or diffusion, can cause a precessional phase shift between
nuclei, and consequentially, a loss of transverse magnetisation coherence, i.e. spin-spin relaxation.
This typically occurs when spins pass through susceptibility gradients, and the magnitude of this
effect is dependent on the square of the field gradient and the time required for the spin to pass
through the gradient.
vii) Chemical exchange: the movement of a spin from one chemical / molecular environment to another
with a different chemical shift (and hence Larmor frequency). This process causes spin-spin relax-
ation via a loss in transverse magnetisation coherence. The magnitude of this effect is proportional
to the square of the applied magnetic field and is strongly influenced by the exchange rate, which
varies between molecules.
Most of these mechanisms pertain to interactions between the internal electric and magnetic fields of the
spin sample. When analysing the internal energy of the spin system, it is appropriate to consider the
contribution of each of these mechanisms to the internal Hamiltonian of the system, Hint. Figure 3.9
provides an overview of the approximate relative contribution of each mechanism to the internal Hamil-
tonian, and hence its propensity for inducing relaxation, and furthermore summarises the organisation of
the interactions - i.e. whether they can occur for a single spin, or two or more spins.
Aside: Chemical Shift
In order to understand the chemical shift anisotropy effect, it is necessary to introduce the concept of
chemical shift. In addition, this concept is pre-requisite knowledge for the understanding of 129Xe NMR
of pulmonary gas exchange, as presented in Chapter 6.
The magnetic field experienced by a particular nucleus is dependent on its chemical environment. The
action of an applied magnetic field tends to produce currents in the electron cloud of each molecule, and
in response, the electron cloud generates an “induced” magnetic field that acts to oppose the applied field
(by virtue of Lenz’s law), and “shield” the nucleus, such that it experiences a local field:
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Figure 3.9: Organisation and relative magnitude of internal spin interaction terms, i.e. contributions to the internal
Hamiltonian Hint. (Electric quadrupolar moments are not present in spin-
1
2
nuclei.) Reproduced with permission
from [179].
Bloc = B0 +Binduced = B0 (1− σ) (3.49)
where the induced field Binduced is linearly-dependent on the applied field, and σ is the shielding
tensor. The shielding tensor is a 3 × 3 matrix, representing the fact that the orientation of the induced
field may differ from that of the applied field, depending on the orientation of the molecule in question.
In general, a set of axes can be found such that the shielding tensor, and the corresponding chemical
shift tensor δ = −σ, can be diagonalised such that all off-diagonal elements become zero. The chemical
shift can be then reported as a single number, δiso, which represents the average value over all different
orientations of the induced field:
δiso =
1
3
(δxx + δyy + δzz) (3.50)
where δxx,yy,zz are the three diagonal elements of the diagonalised chemical shift tensor. From the
above relationships, it can be seen that an increase in shielding, or a corresponding decrease in chemical
shift, implies a reduction of the local magnetic field strength and hence a corresponding reduction in the
Larmor frequency of a given nucleus.
In actuality, for a solute nucleus within a solvent, a number of mechanisms contribute to the shielding
of the nucleus, and hence the resulting chemical shift, including: the bulk susceptibility of the medium,
the anisotropy of the molecular susceptibility, van der Waals forces between the solute and solvent, and
polar effects caused by the interaction of solvent and solute electron clouds (see e.g. [183]). This discus-
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sion is beyond the scope of this thesis, but is an important consideration when analysing the origin of a
measured chemical shift.
Note: chemical shift values are conventionally quoted in parts per million with respect to the resonance
frequency of the nuclei of interest in a standard chemical environment. For 1H nuclei, this reference point
is either tetramethylsilane (TMS) in organic solvents or sodium 2,2-dimethyl-2-silapentane-5-sulfonic acid
(DSS) in aqueous solutions. As encountered in later chapters, 129Xe chemical shifts are conventionally
quoted with respect to the Larmor frequency of 129Xe in the gaseous-phase.
3.2.3 Free induction decay, and spin and gradient echoes: Principles of NMR
detection
Description of a free induction decay
This subsection concerns the detection of an NMR signal. As introduced in previous subsections, energy
must be input to a spin system in order to perturb its thermal equilibrium state, i.e. to displace the
net magnetisation vector from alignment with the external magnetic field. In NMR, this perturbation is
achieved by applying a secondary, smaller, magnetic field that is rotating with a frequency equal to the
Larmor frequency of spins precessing about the static magnetic field. This Larmor frequency lies in the
radiofrequency (RF) part of the electromagnetic spectrum, and the application of the rotating magnetic
field is often termed as RF excitation. It may therefore be thought that it would be possible to detect
the RF energy subsequently emitted by a nucleus. However, the RF energy released by a single nucleus
is insufficient for detection, and furthermore, nuclei within a sample emit RF energy in all directions.
Various theories exist to explain NMR detection using a quantum mechanical framework; the most popu-
lar paradigm being that NMR detection relies on coherent spontaneous emission from a sample of nuclei
[184], whilst opposition to this paradigm includes the explanation of NMR detection by the exchange of
virtual photons [185]. These theories are beyond the scope of this work, and for simplicity, the detection
of an NMR signal is considered as follows by adopting a semi-classical approach.
The precession of magnetisation in the plane transverse to that of the external field will induce an
oscillating current in a coil of wire that has its winding axis also positioned transverse to that of the
external field. This is a consequence of Faraday’s law of induction, which states that the electromotive
force, E induced in a coil of wire with N turns is directly proportional to the rate of change of magnetic
flux ΦB :
E = −N dΦB
dt
(3.51)
where the negative sign arises from Lenz’s law that the direction of the induced electromotive force
opposes that of the changing magnetic flux. The magnetic flux through a surface is defined as the integral
of the magnetic field (a.k.a. flux density) normal to the surface: ΦB =
∫∫
S
B · nˆdA. The electromotive
force is the line integral of the electric field over the boundary of the surface: E = ∮ E · dl. These rela-
tionships can be used in combination with Stokes’ theorem — that the line integral of a function F along
the boundary of a surface is equivalent to the surface integral of the curl of that function normal to the
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surface — to relate Equation 3.51 to the following Maxwell equation:
∇×E = −∂B
∂t
(3.52)
This fundamental equation states that an electric field is always associated with an alternating magnetic
field; it is this electric field that induces motion of the electrons within the wiring of the coil. The current
induced in the coil oscillates with a frequency equal to the Larmor frequency, and has a decaying ampli-
tude. This signal is known as the free induction decay (FID), and has a rate of decay governed by the T2
and the effects of spatial inhomogeneity of the external magnetic field B0; two contributions which are
combined in the definition of the T ∗2 relaxation time:
1
T ∗2
=
1
T2
+
1
T ′2
(3.53)
where T ′2 is the relaxation time associated with B0 inhomogeneity (
1
T ′2
= γ∆B0,i, where ∆B0,i ex-
presses the spatial variation in the amplitude of the external field).
Typical Larmor frequencies in MRI at standard clinical field strengths are of the order of tens of MHz
and above, too high for accurate conversion of the analogue current signal into digital form. Instead, the
oscillation frequency is down-converted with respect to a reference frequency, ωref , such that the resulting
FID oscillates with a frequency ∆ω = ω0−ωref . Two output signals are generated by the NMR receiver,
chosen to be 90◦ out of phase with each other in order to represent orthogonal phases of the magnetisation,
i.e. the real and imaginary components of a complex FID. (In effect, this is equivalent to detecting Mx
and My.) This procedure allows the distinction of Larmor frequencies that are greater than and lower
than ωref , which would not be possible by analysis of a single output signal
vii. Note: if ∆ω = 0, there is
no oscillatory component to the FID.
Following RF excitation viii of a certain flip angle (as introduced in Section 3.2.1), the complex FID
signal (as discussed in the Aside below, this is directly proportional to the net magnetisation) can be
written as follows:
S (t) = S0exp (i∆ωt) exp
(
− 1
T ∗2
)
(3.54)
which can be decomposed into its real and imaginary components by expanding the exponential:
viiThis can be understood by considering the Fourier transform of the cosine and sine functions; the cosine function is
even, and its Fourier transform gives two peaks of equal amplitude in the frequency domain at ±ω, whilst the sine function
is odd, such that its Fourier transform gives two peaks at ±ω but with oppositely-signed amplitudes. The two signals must
be summed together to leave only one single peak at +ω (separate analysis of one signal or the other would not permit
distinction of the peak at +ω from that at −ω).
viiiFrom this point onwards, “RF excitation” will be used interchangeably with the term “RF pulse”, which corresponds
to a displacement of the net magnetisation vector by the application of a magnetic field rotating at a frequency in the RF
range of the electromagnetic spectrum.
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Sreal (t) = S0cos (∆ωt) exp
(
− 1
T ∗2
)
(3.55)
Simag (t) = S0sin (∆ωt) exp
(
− 1
T ∗2
)
(3.56)
where S0 is the signal at time t = 0, and i =
√−1. In practice, there will be an additional exp (iφr)
term in Equation 3.54 to account for the absolute receiver phase, φr (which means that Sreal and Simag
do not correspond exactly to Sy and Sx), however, for the present analysis, we can consider that the
receiver phase is zero or has been accounted for in post-processing of the FID signal. The time domain
FID can be converted into the frequency domain by a Fourier transformation:
F [f (t)] = F (ω) =
∫ ∞
−∞
f (t) exp (−iωt) dt (3.57)
where F is the Fourier transform operation, f (t) and F (ω) are the time-domain and frequency-domain
representations of a signal, respectively. The underlying principle of the Fourier transform is that any
time-domain signal can be decomposed into a summation of a series of sinusoidal waveforms, each with
different frequencies and amplitudes. The operation in Equation 3.57 thus links the two representations
of a given signal. Taking the Fourier transform of the complex time-domain signal in Equation 3.54, we
can obtain the real and imaginary components of the NMR spectrum, which is the frequency domain
representation of the FID and exhibits the fundamental frequency of the oscillating signal (∆ω):
Re {F [S (t)]} = S0T
∗
2
1 + (ω −∆ω)2 T ∗22
(3.58)
Im {F [S (t)]} = − S0 (ω −∆ω)T
∗2
2
1 + (ω −∆ω)2 T ∗22
(3.59)
These functions describe the absorption Lorentzian (real) and dispersion Lorentzian (imaginary), respec-
tively. The maximum height of the absorption spectrum occurs at ∆ω = 0, and its full width at half
maximum (FWHM) in units of Hz is 1piT∗2
. The real and imaginary parts of an FID and the corresponding
NMR spectrum are illustrated graphically in Figure 3.10.
Note: in practice, the NMR signal may comprise a number of different components with different
frequencies. A general FID consisting of m components, with corresponding amplitudes am, transverse
relaxation times, T ∗2,m, and frequencies ∆ωm can be written as follows:
S (t) =
∑
m
amexp (i∆ωmt) exp
(
− 1
T ∗2,m
)
(3.60)
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where the amplitudes am can be considered to encompass a phase offset φm for each component:
am = |am| exp {iφm}. The same procedure applies for analysing the individual components of the fre-
quency representation of an NMR spectrum; i.e. a signal with multiple components is comprised of a
summation of complex Lorentzian terms.
Figure 3.10: Left: real and imaginary parts of the free induction decay (FID), and right: the corresponding real
(absorption) and imaginary (dispersion) parts of the complex NMR spectrum resulting from a complex Fourier
transformation of the FID. The FWHM of the absorption and positive and negative peak separation of the
dispersion spectrum are both equal to 1
piT∗2
.
Aside: SNR of an NMR experiment
In the above discussion, the direct proportionality of S0 and M0 was introduced. The origin for this, and
consideration of the experimental factors governing the available NMR signal, and also the noise associ-
ated with NMR measurements, was reported by Hoult and Richards [186]. Here, we review the salient
points of their work, to provide an expression for the signal to noise ratio of an NMR experiment.
From Equation 3.51, it is known that the electromotive force induced in a receiver coil is governed by
the rate of change of magnetic field in a direction perpendicular to the surface of a sample. Equivalently,
the field produced by a coil through which a current is flowing is given by the same equation. For a sample
of magnetisation M within the effective region of the coil, the infinitesimal magnetic moment normal to
an area dA of the sample, dµ = InˆdA, for current I, can be combined with the definition of magnetisation
M = dµ
dV
to yield, for a coil with one turn:
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E = −dΦB
dt
= −
∫∫
S
dB1
dt
· nˆdA =
∫
sample
∂
∂t
{
B1
I
·M
}
dV (3.61)
which shows that the electromotive force induced in the coil can be derived if the B1 of the coil is
known at all points in the sample. Assuming that the magnetisation of the sample has been excited by a
flip angle of 90◦ such that all magnetisation lies in the transverse plane:
E = ω0K
(
B1
I
)
xy
M0VScos (ω0t) (3.62)
where VS is the volume of the sample, and K is an integration constant incorporating the inhomo-
geneity of the B1 field. The magnetisation M0 is given by the earlier Equation 3.19. The noise of an
NMR measurement can be estimated by the thermal (Johnson) noise associated with the resistance, R,
of the coil:
Vrms =
√
4kBTcR∆f (3.63)
where kB is Boltzmann’s constant, Tc is the temperature of the coil and ∆f is the bandwidth over
which the noise is measured. (Note: in practice, the thermal noise associated with a human subject in
MRI can sometimes be greater than the thermal noise of the coil, so it is not always appropriate to model
the noise in this way.)
Equations 3.62 and 3.63 can be combined with an analytical expression for the coil resistance to arrive
at a relationship for the signal-to-noise ratio as a function of experimental parameters and constants (this
equation is not derived in full here, see e.g. [186] or [172]). Interestingly, the resulting equation shows that
the only experimentally variable quantities governing the SNR are those of the coil geometry, temperature
and material properties, and also the noise figure of the electronics used to amplify the signal. (The design
of coils for radiofrequency transmission and detection is not covered in this thesis; the reader is referred to
[187].) Additionally, the SNR is found to be dependent on the gyromagnetic ratio (i.e. Larmor frequency)
raised to the power of 74 .
This relationship is applicable for situations where the Johnson noise of the coil is the dominant source
of noise. However, at clinical field strengths, the noise of the NMR experiment is typically dominated by
the thermal noise of the sample rather than coil noise [188]. In this case, the SNR is found to be directly
proportional to the gyromagnetic ratio [189]. Note however, for the case of a hyperpolarised sample, the
magnetisation is not governed by the Boltzmann distribution (Equations 3.18 and 3.19) [190].
Chemical exchange broadening of an NMR spectrum
Chemical exchange was briefly introduced in Section 3.2.2 as a mechanism for inducing spin-spin relax-
ation. It pertains to the exchange of nuclear spins between two or more different chemical environments
which have a distinct chemical shift associated with them. The corresponding frequency difference induces
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a phase difference between spins that results in a loss of coherence and hence a decay in the transverse
component of the net magnetisation. As described above, the width of the absorption peak of an NMR
spectrum is inversely proportional to the T ∗2 relaxation time. Therefore, an increase in the rate of chem-
ical exchange of a given nuclear species will lead to a reduction of the effective T ∗2 and a concomitant
broadening of the absorption spectrum.
This fact becomes important when attempting to distinguish two or more components of an NMR
spectrum pertaining to the Larmor frequency of a given species in two or more chemical environments
that are undergoing chemical exchange. The simplest situation that can be considered is two pools of
spins a and b with angular frequencies ωa and ωb and chemical shifts δa and δb, with an equal probability
for a spin to inhabit each pool. The rate of exchange k between pools is equivalent in the forward and
backward directions:
a
k
⇀↽
k
b (3.64)
The appearance of the NMR spectrum depends upon the exchange rate k in comparison to the chemical
shift (or frequency) difference between the two pools δa − δb. If k = 0, there is no exchange between the
two pools and the NMR spectrum exhibits two peaks at δa and δb with a width defined by the T
∗
2 in the
absence of exchange. As the rate of chemical exchange is increased, the peaks begin to broaden (termed
“slow exchange”) and then merge together when k ∼ δa − δb (“intermediate exchange” or “coalescence”).
If the exchange rate is increased past the coalescence point — where only a single resonance peak, centred
at the average frequency of the two compartments, is observed — the single peak becomes narrower,
because the spins exchange so quickly that they inhabit each pool for an insufficient time to develop a
significant phase difference (termed as “fast exchange” and “motional narrowing” of the spectrum). A
summary of example NMR spectra that would be produced in each of these situations is presented in
Figure 3.11.
Figure 3.11: The NMR appearance of chemical exchange between two equally-populated pools of nuclear spins,
as a function of exchange rate, k (increasing k from left to right).
In many cases, the rates of the forward and backward reactions may be unequal, for example due to an
asymmetric energy barrier pertaining to the occurrence of the chemical reaction. In this case:
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a
ka⇀↽
kb
b (3.65)
where ka and kb describe the rates of the forward and backward reaction, respectively, and the frac-
tional populations of the two pools will be given by:
Pa =
kb
ka + kb
(3.66)
Pb =
ka
ka + kb
(3.67)
As for the case of a symmetric reaction, the exchange dynamics for an asymmetric reaction can be classi-
fied into slow, intermediate and fast regimes, which are defined by k  δa−δb, k ∼ δa−δb and k  δa−δb,
respectively, where k = ka + kb. The peak shapes are broadened in a similar manner to the symmetric
reaction, and furthermore, in the intermediate and fast regimes, the peaks coalesce to a single peak at a
chemical shift that is the average of the individual chemical shifts, weighted by the fractional populations
of the two pools:
δobs = Paδa + Pbδb ≡ δa +Kδb
1 +K
(3.68)
where K = kakb , the equilibrium rate constant. Although it will not be covered further in this thesis, the
reader is referred to the work of McConnell [191], who combined the rate equations for two-site chemical
exchange with the Bloch equations in order to describe the influence of chemical exchange processes on
the magnetisation dynamics.
Formation of spin and gradient echoes
In practice, the FID introduced in the previous subsection is rarely detected for use in the formation
of MR images ix. Instead, “echoes” are generated by means of radiofrequency pulses or magnetic field
gradients; these echoes appear as additional NMR signals after the FID. It is these signal echoes that are
most commonly detected and used to construct MR images.
A “spin echo” (SE) can be formed by the application of a 180◦ RF “inversion” pulse, some time after
an initial 90◦ RF excitation pulse. After the 90◦ pulse, spins dephase according to T ∗2 relaxation. The 180
◦
pulse inverts (i.e. reverses) the phase angles of the individual spins, and as such the spin ensemble returns
to phase synchrony after a total time equal to twice the separation of the two RF pulses, generating an
echo signal. The time between the centre of the 90◦ RF pulse and the centre of the echo is termed the
“echo time” or TE. The process of forming a spin echo is illustrated in Figure 3.12.
It is worth noting that spin echoes can be formed with flip angle combinations other than 90◦ and
ixHowever, FID detection is routinely employed in a number of NMR spectroscopic techniques, and in rapid imaging
techniques where the species of interest exhibits a very short transverse relaxation time.
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180◦, although this combination provides the maximum attainable echo signal intensity. In addition, we
note that it is possible to apply multiple 180◦ inversion pulses arranged in a “train” after the original RF
pulse (i.e. with a constant time spacing between them) in order to produce a train of echoes of dimin-
ishing intensity. This procedure is advantageous for rapid imaging applications, as discussed further in
Section 3.2.5.
Figure 3.12: Pictorial description of the formation of a spin echo. Initially the net magnetisation vector lies along
the positive z direction. (i) The application of a 90◦ radiofrequency pulse along the x axis tips the magnetisation
into the x-y plane such that it instantaneously lies along the y axis. A free induction decay (FID) is generated by
precession of the magnetisation in the transverse plane. (ii) Spins precess at different frequencies and lose phase
coherence (the amplitude of the FID decays according to T ∗2 ). (iii) The application of a 180
◦ radiofrequency pulse
along the y axis inverts the phase of the individual magnetisation vectors about the y axis. (iv) As such, the
original phase dispersion is reversed. (v) After a time equal to twice the separation of the two RF pulses, an echo
signal is formed as the spins return to perfect phase. (Note: the rate of decay of the FID and echo have been
accentuated with respect to the magnetisation dynamics for illustration purposes.) Adapted with permission from
[172].
The intensity of an FID is diminished over time according to the rate of transverse relaxation including
inhomogeneities in the static magnetic field T ∗2 . Since the inhomogeneity of the B0 field may be assumed
to be static in time, the associated induced decay (at a rate 1
T
′
2
) is reversible. The application of the 180◦
pulse to invert the phase of the spins effectively reverses the effects of the static magnetic field inhomo-
geneity, such that the intensity of the echo signal is governed by the T2 relaxation time rather than the
T ∗2 . The spin-spin relaxation mechanisms encompassed in T2 are intrinsic to the nuclei of interest in a
given molecular environment, and cannot be reversed. Furthermore, any diffusional motion of the spins
in the time between the two RF pulses will lead to additional dephasing due to spins sampling different
magnetic field environments that cannot be reversed by the spin echo procedure. These effects can be
summarised to describe the signal of a spin echo, SSE with respect to the initial signal at time t = 0, S0,
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in the following equation:
SSE = S0exp
[
−TE
T2
− 2
3
γ2∆B20,iD
(
TE
2
)3]
≈ S0exp
(
−TE
T2
)
(3.69)
where, D is the apparent diffusion coefficient of the nuclei of interest and, as before, ∆B0,i represents
the gradient (in T.m-1) of the external magnetic field associated with inhomogeneities. Generally, the
influence of diffusion on spin dephasing is described by the b-value equation: St = S0exp (−bD), where b
is a term depending on the square of the gyromagnetic ratio, and the nature of the gradient in magnetic
field through which a spin is diffusing. The behaviour of diffusion within magnetic field gradients will be
discussed further in Section 3.2.5. For now, it is sufficient to note that the expression in Equation 3.69
represents a simplification of the form of b for a perfect linear gradient. For the purposes of this discussion,
we note that if the diffusion coefficient is sufficiently small, and TE  T2, the second term can be safely
neglected such that the signal dependence is solely governed by the initial signal at time t = 0 and the T2
relaxation time.
A “gradient echo” (sometimes “gradient-recalled echo”, GRE) relies on the application of magnetic field
gradients in place of a 180◦ RF pulse in order to generate an echo signal. A simple linear gradient in
magnetic field as a function of position causes phase dispersion because spins at different spatial positions
along the direction of the gradient experience a different effective magnetic field, and hence acquire a
different Larmor frequency. The phase dispersion in the presence of a magnetic field gradient occurs on
a much faster timescale than would occur by conventional transverse relaxation processes, thus, rapid
signal loss results. A gradient echo can be generated by switching on two magnetic field gradients in
quick succession on the same axis but with opposite polarity, following an initial RF excitation of flip
angle α (typically less than 90◦, as discussed in Section 3.2.5). Firstly, after the RF pulse, a negative
polarity gradient is employed to rapidly induce a phase dispersion. Then, a second gradient with positive
polarity is used to reverse the phase dispersion caused by the first gradient. As a result, a gradient echo
is produced at a time TE when the area of the second gradient is equal to the area of the first gradient.
Note: the first gradient is often termed the “dephasing gradient” and the second gradient the “rephasing
gradient”. (Note: an equivalent result is obtained by applying a positive gradient followed by a negative
gradient.) The process of forming a gradient echo is illustrated in Figure 3.13.
The positive and negative gradient lobes do not reverse the loss in phase coherence due to magnetic field
inhomogeneities, and, as such, the signal intensity of a gradient echo is governed by T ∗2 rather than T2.
In other words, only the spin dephasing that was induced by the first gradient is accounted for by the
second gradient; all other dephasing effects occur as normal. Thus, the GRE signal intensity is described
by:
SGRE = S0exp
(
− t
T ∗2
)
(3.70)
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Figure 3.13: Pictorial description of the formation of a gradient echo. Initially the net magnetisation vector lies
along the positive z direction. (i) The application of a radiofrequency pulse of flip angle α along the x axis tips
the magnetisation into the x-y plane such that it instantaneously lies along the y axis. A free induction decay
(FID) is generated by precession of the magnetisation in the transverse plane. (ii) A negative magnetic field
gradient is applied to rapidly create a phase dispersion between spins. (iii) The magnetic field gradient direction
is reversed, and the phase dispersion created by the first gradient is reversed. (iv) After a time such that the total
area of the applied negative and positive gradients is equal (hatched regions), an echo signal is formed as the spins
return to perfect phase. (Note: the rate of decay of the FID and echo have been accentuated with respect to the
magnetisation dynamics for illustration purposes.)
Due to the inherent rapid forced dephasing of spins by the magnetic field gradients, and the lack of re-
quirement for a second RF pulse, the process of generation of a gradient echo can be significantly faster
than that of a spin echo. In addition, if the flip angle used in a gradient echo sequence is significantly less
than 90◦, the time between subsequent iterations of the simple gradient echo “pulse sequence” shown in
Figure 3.13 can be considerably shorter than that of the SE pulse sequence x. (Note: pulse sequences will
be introduced in the next subsection.) As a result, the time associated with the complete acquisition of
a GRE image can be far less than that of a SE image.
xFor high flip angles, a short inter-pulse repetition time may be unfeasible due to: (i) the T1 of the nuclei; (ii) the high
amount of radiofrequency power deposited in the sample (typically a patient) at a fast rate. The limits of safe RF power
deposition are set by the specific absorption rate (SAR), which is the rate of energy absorption by a tissue measured in
W.kg-1, defined mathematically as: SAR = 1
V
∫
tissue
σ(r)|E(r)|2
ρ(r)
dr, where V is the volume of the tissue sample, σ (r), ρ (r)
and E (r) are the electrical conductivity, density of the sample and the electric field in the sample as a function of position,
r. In practice, the SAR can be related to the magnetic field strength, flip angle and RF duty cycle (i.e. repetition time) as
follows: SAR ∝ B20α2TR.
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3.2.4 k-space and spatial encoding
Magnetic field gradients
Until this point, this chapter has focussed on the treatment of individual spins or spin systems, and the
acquisition of single NMR signals from a sample. This subsection is concerned with the processes of
“encoding” acquired NMR signals in order to attribute the origin of different signals to different spatial
locations, and the “reconstruction” of this encoded information in order to form an image. Image en-
coding is typically implemented through a combination of three techniques: “frequency encoding” (or
“read-out”), “phase encoding”, and “slice selection”. Each of these methods will be considered individu-
ally in the following discussion. In the following, and the remainder of this thesis, the convention of x as
the frequency encoding gradient direction, y as the phase encoding gradient direction and z as the slice
selection gradient direction (or the second phase encoding gradient direction for 3D sequences) will be
adopted.
Each of these three processes requires the application of magnetic field gradients, which have been
introduced in the previous subsection, but have not been described mathematically as yet. For the fol-
lowing discussion, it is appropriate to define a magnetic field gradient in one of the x, y or z directions,
Gx,y,z, typically measured in mT.m
-1, by:
Gx,y,z =
∂Bz
∂x, y, z
(3.71)
Thus, each gradient corresponds to a variation in magnetic field as a function of position in x, y or z
which adds to (or subtracts from) the external (static) magnetic field, chosen here to lie in the z direction,
B0 = B0kˆ. Taking the x direction as an example, the magnetic field experienced by a nucleus in the
presence of a constant amplitude gradient Gx varies linearly with x, according to:
Bz (x) = B0 +Gxx (3.72)
and correspondingly, the Larmor frequency will vary with position according to:
ω0 (x) = γ (B0 +Gxx) (3.73)
A pictorial description of the effects of a linear magnetic field gradient is presented in Figure 3.14.
In principle, magnetic field gradients cannot be instantaneously switched on or off. When turning on a
gradient, a finite “ramp time” is required, during which the gradient increases in amplitude from zero until
its target maximum amplitude. An equivalent ramp period is necessitated when the gradient is switching
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Figure 3.14: The effect of a magnetic field gradient
on the magnetic field experienced by a nucleus, and
hence on the Larmor frequency it exhibits. Adapted
with permission from [175].
off. Hence, the strength of a magnetic field gradient as a function of time traces out a trapezoidal shape;
thus, in the following subsections, gradients will be represented by trapezoidal shapes on pulse sequence
timing diagrams.
k-space formalism and discrete sampling
In order to establish a mathematical basis upon which to explain methods for encoding the spatial lo-
cations of spins by the application of magnetic field gradients, it is appropriate to return to the Bloch
equation description of the magnetisation as a function of time, in the presence of an arbitrary magnetic
field gradient G (t) = Gx (t) iˆ + Gy (t) jˆ + Gz (t) kˆ. The vector Bloch equation in the rotating frame can
be written:
dM
dt
= γM ×B −
(
Mxˆi +My jˆ
)
T2
− (Mz −M0)
T1
kˆ (3.74)
where B = B1,xˆi + B1,y jˆ +
[(
B0 − ωrγ
)
+G (t) · r
]
kˆ. Assuming that the transmission frequency
ωr is equal to the Larmor frequency associated with the B0 field, the Bloch equations can be written in
matrix form, and separated into components associated with precession, relaxation and recovery as follows:

M˙x
M˙y
M˙z
 =

0 γG · r −γB1,y
−γG · r 0 γB1,x
γB1,y −γB1,x 0

︸ ︷︷ ︸
Precession

Mx
My
Mz
+

− 1T2 0 0
0 − 1T2 0
0 0 − 1T1

︸ ︷︷ ︸
Relaxation

Mx
My
Mz
+

0
0
1
T1

︸ ︷︷ ︸
Recovery
M0 (3.75)
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where M˙x,y,z =
dMx,y,z
dt
. If we consider the situation immediately after the initial RF excitation pulse,
B1,x,y = 0, the precession and relaxation terms can be combined as follows:

M˙x
M˙y
M˙z
 =

− 1T2 γG · r 0
−γG · r − 1T2 0
0 0 − 1T1


Mx
My
Mz

︸ ︷︷ ︸
Precession & Relaxation
+

0
0
1
T1

︸ ︷︷ ︸
Recovery
M0 (3.76)
This equation can be decoupled into two equations describing the rate of change of the longitudinal, Mz,
and transverse, Mxy = Mx + iMy, magnetisations. The Mz part of the equation does not contain a G · r
term, and hence has already been solved (see Equation 3.40). The Bloch equation for the rate of change
of transverse magnetisation becomes:
M˙xy =
(
− 1
T2
− iγG · r
)
Mxy (3.77)
which is a homogeneous differential equation that can be solved with an integrating factor I(t) =
exp
[∫ t
0
1
T2
+ (iγG · r) dt′
]
to yield:
Mxy (r, t) = Mxy (r, 0)︸ ︷︷ ︸
Sample
exp
(
− t
T2
)
︸ ︷︷ ︸
Relaxation
exp
(
−iγr ·
∫ t
0
G (t′) dt′
)
︸ ︷︷ ︸
Spatial Encoding
(3.78)
The spatial encoding component is conventionally described using a three dimensional “spatial frequency
vector”, or “k-space vector”, k, which has units of inverse metres:
k (t) =
γ
2pi
∫ t
0
G (t′) dt′ (3.79)
such that the transverse magnetisation can be written:
Mxy (r, t) = Mxy (r, 0) exp
(
− t
T2
)
exp (−i2pik (t) · r) (3.80)
The MR signal is directly proportional to the volume integral of the transverse magnetisation across the
sample as introduced in the previous subsection, and hence we can write:
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S (t) =
∫
sample
Mxy (r, 0) exp
(
− t
T2
)
exp (−i2pik (t) · r) d3r (3.81)
Finally, this equation can be re-written by noticing that the signal S (t) is exactly equivalent to the Fourier
transform of Mxy (r, 0), evaluated at k (t) in the limit T2 →∞:
S (t) = F {Mxy (r, 0)} |k=k(t)= F [k (t)] (3.82)
These equations are fundamental to understanding the principles of spatial encoding in MRI. From Equa-
tion 3.82, it can be seen that the distribution of the initial transverse magnetisation as a function of
position (i.e. the target object) can be determined by acquiring MR signals as a function of spatial
frequency, k (t), and taking an inverse Fourier transform of the result. As discussed previously (c.f. Equa-
tion 3.57) we recall that any signal can be represented by a summation of a series of sinusoidal waveforms
with different frequencies. Whilst Equation 3.57 considers the decomposition of a time-domain signal into
its respective frequency components, here the spatial frequency vector k (t) has been introduced as a fre-
quency representation of a signal in the spatial domain. k (t) has units of m-1 and effectively describes the
number (or energy) of spatial frequencies which compose the target image Mxy (r, 0). A spatial frequency
can be understood as the frequency with which the brightness of an image varies with position; the “DC”
spatial frequency k = 0 describes the average brightness of the overall image. Thus, any image can be
decomposed into a summation of signals with different spatial frequencies and amplitudes.
This leads to the concept of “k-space”, or spatial frequency space. Any two-dimensional image with
spatial axes x and y can be described by a two-dimensional k-space comprising the two spatial frequency
dimensions kx and ky, as illustrated in Figure 3.15.
Figure 3.15: Example two-dimensional k-space (left) and corresponding MR image (right). It can be clearly seen
that the majority of the energy in k-space is concentrated at the origin, where k is close to zero. Adapted with
permission from [180].
The relative brightness of a particular pixel in this two-dimensional k-space denotes the relative contribu-
tion of the (2D) spatial frequency vector defined by that pixel (k = kxˆi + ky jˆ) to the overall image. The
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2D k-space and image representations of a signal are related by the 2D Fourier transform:
F (kx, ky) =
∫ ∞
−∞
∫ ∞
−∞
f (x, y) exp [−i2pi (kxx+ kyy)] dxdy (3.83)
thus, comparing to Equation 3.82:
S (t) =
∫ ∞
−∞
∫ ∞
−∞
Mxy (x, y, t = 0) exp [−i2pi (kxx+ kyy)] dxdy (3.84)
The k-space vector, k (t) relates the trajectory through k-space that is traced out when magnetic field
gradients are switched on. The rate of change of the k-space vector, k˙, describes the velocity with which
k-space is traversed, which is governed by the amplitude of the applied gradients. The double time deriva-
tive of the k-space vector, k¨, is the acceleration associated with the k-space traversal, determined by G˙,
the rate of change of the gradient field. G˙ is also known as the “slew rate”, and defines the minimum
ramp time required for a gradient to reach its maximum amplitude. It is worth noting that, by definition
of Equation 3.79, for nuclei with positive and negative values of γ, the direction of k-space traversal is
opposite.
In the following subsections, the various strategies for traversing k-space and obtaining spatial fre-
quency information in order to reconstruct an image of the magnetisation distribution of an object of
interest are introduced. Firstly, however, the concept of discrete sampling of k-space will be discussed.
F [k (t)] in Equation 3.82 (or F (k), assuming k is one-dimensional for simplicity) is a smooth, continuous
function. Measurement of a purely continuous function would in principle require an infinite number of
measurements to be taken along the variable dimension of that function (i.e. k). In practice, the function
can only be sampled with a finite number of measurement points, with a discretised “sampling interval”
(∆k) in between sampling points.
Discrete sampling in k-space can be considered by multiplying F (k) with the comb function:
comb (k) =
∞∑
n=−∞
δ (k − n∆k) ≡ 1
∆k
comb
(
k
∆k
)
(3.85)
where δ represents the Dirac delta function, which is defined by:
∫ ∞
−∞
F (k) δ (x− a) dx = F (a) (3.86)
The sampling process can thus be described by a sampling function Q (k):
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Q (k) =
1
∆k
comb
(
k
∆k
)
F (k) (3.87)
This process is shown diagrammatically in Figure 3.16a, where Q (k) precisely defines the values of F (k)
at a finite number of points with spacing ∆k.
In k-space, samples are acquired symmetrically about (kx, ky) = (0, 0). There exists a minimum
sampling rate, (proposed separately by Shannon and Nyquist) in order to ensure that F (k) is correctly
represented by the discrete function Q (k), equal to two times the maximum frequency contained within
the continuous function of interest. This condition is depicted in Figure 3.16b for an example of a single
frequency sinusoidal function. In the top plot, the sine wave is sampled at a sampling rate RQ  NS ,
where NS is the Shannon / Nyquist sampling rate, whilst in the bottom plot, the function is sampled
at a rate RQ  NS . As a result, the top sampling function gives a correct representation of the signal
F (k), whilst the bottom sampling function gives an incorrect (“aliased”) representation of the sine wave
F (k) as a constant (dashed line). The origin of the Shannon / Nyquist criterion can be understood by
realising that adding one additional sampling point to the bottom sampling function (in the middle of the
negative lobe of the sine function) will allow a correct representation of F (k) to be obtained with Q (k);
if this additional point was added, the sampling rate would be twice the frequency of the sine wave.
Figure 3.16: a) Pictorial representation of the discrete sampling of an arbitrary k-space function, F (k), with a
sampling function Q (k), as described mathematically by Equation 3.87. b) Illustration of the Shannon / Nyquist
sampling criterion, and how sampling at an insufficient rate can lead to an incorrect representation of the measured
signal.
At this point, it is useful to think about the two-dimensional representation of a discretised k-space. It
is important to note that by definition, the Fourier transform operates on continuous functions, but a
discretised form can be derived in order to numerically relate the discretised k-space and image space
representations of a signal, in which the continuous integrals are replaced with discrete summations over
a finite number of values. Conventionally the fast Fourier transform (FFT) (see e.g. [192]), an algorithm
for computing the discrete Fourier transform (DFT), is employed for rapid reconstruction of images from
acquired k-space data. A pictorial representation of a two-dimensional discretised k-space and correspond-
ing image space is shown in Figure 3.17.
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Figure 3.17: Discretised representation of a 2D k-space (left) and 2D image space (right), linked by the two-
dimensional Fourier transform (FT). kx,y,max is the maximum k-space vector in the x or y directions for a k-space
centred at the origin. Lx,y is the maximum spatial extent in the x or y direction, also known as the field-of-view
(FOV) of the image. ∆kx,y and ∆x, y are the spacings between discretised sampling points in k-space and image
space, respectively.
The properties of the FT provide some important relationships between the quantities defined in Fig-
ure 3.17. Firstly, the spatial separation between sampling points in the spatial domain, ∆x, y, also known
as the resolution of the image, is inversely related to the maximal extent of k-space sampled. In the x
direction:
∆x =
1
2kx,max
=
1
Nk,x∆kx
(3.88)
where the number of sampling points in the kx direction, Nk,x =
2kx,max
∆kx
. Reciprocally, the separation
between adjacent k-space sampling points is inversely proportional to the maximum spatial extent in
image space (the FOV):
∆kx =
1
Lx
=
1
Nx∆x
(3.89)
where the number of sampling points in the x direction of image space, Nx =
Lx
∆x . Equivalent equations
exist for y and ky. It can therefore be seen that the spatial resolution and field-of-view of the image are
controlled by the maximum k-space extent and k-space sampling rate, respectively.
In practice, if the function describing the object extends beyond Lx or Ly, then the portion of the function
that overlaps is aliased (or “wrapped”) back on to the opposite end of the field-of-view. In an image, this
is equivalent to a portion of the object extending past the field-of-view in one direction being mapped back
on to the other side of the image. This artefact can be understood by considering the scaling properties of
the Fourier transform, and employing the convolution theorem, to derive the sampling function in image
space (x in 1D) from Equation 3.87. The result is that the sampling function in image space is defined
52
by the convolution of a comb function and the spatial function to be sampled f (x) = F [F (k)]:
q (x) = 2kx,maxcomb (∆kxx) ∗ f (x) (3.90)
where ∗ is the convolution operator. Thus, by consequence of the convolution with the comb function,
the function f (x) is replicated in image space, with consecutive occurrences of f (x) separated by 1∆k .
Therefore, if ∆kx ≤ 1Rx (where Rx is the extent of f (x)), consecutive occurrences of f (x) do not interfere
with each other, and only one occurrence is contained within Lx. However, if ∆kx >
1
Rx
, the adjacent
occurrences of f (x) will overlap to some degree xi, producing an aliased signal within the field-of-view.
Note: another artefact that should be considered when applying a Fourier transform to a sampling func-
tion is the Gibbs’ or truncation artefact. That is, it is impossible to sample an infinite extent of k-space
and hence certain high spatial frequency data cannot be acquired. Sampling therefore effectively results
in “chopping off” the ends of an infinite k-space, which presents as a “ringing” (alternation of bright and
dark bands) in image space, most prominently at high-contrast boundaries in the image (which require a
large number of spatial frequencies to be represented correctly).
Frequency encoding (read-out)
The following subsections explain the processes employed for spatial encoding in three dimensions. As
mentioned at the beginning of Section 3.2.4, frequency and phase encoding will be introduced to describe
spatial encoding within a 2D plane — with the convention of frequency encoding for traversing in the kx
direction and phase encoding for traversing in ky — and slice selection will be introduced for the purpose
of localisation of signals to a given slice in the z direction.
Frequency encoding is the general term denoting the association of a particular Larmor frequency with
a certain spatial location by the application of a magnetic field gradient, where the frequency is linearly
proportional to the spin location along the gradient direction. If the transverse magnetisation of an object
is sampled as a function of time during the application of a constant amplitude gradient, the resulting
sampled data traces out equally-spaced points in kx. This is the process of acquiring frequency-encoded
data.
In practice, a magnetic field gradient is not just instantaneously switched on as soon as an FID has
been generated by an RF pulse. In standard, Cartesian sampling with a gradient echo sequence (as de-
scribed later), a negative gradient is first applied, which, according to Equation 3.79, is associated with a
negative k-space vector. Typically, this “prewinder” or “prephasing” gradient is associated with a k-space
vector k = −kx,max, and, as discussed in Section 3.2.3, serves a dual purpose of dephasing spins in order
to generate an echo when the subsequent positive gradient is applied xii. After the negative gradient, a
positive “read-out” gradient is applied which leads to the traversal of kx from −kx,max to +kx,max. The
generated echo exhibits peak signal intensity where the total area under the read-out gradient is equal
xiThe left part of the immediate right copy of f (x) will be included into the right hand side of the field-of-view, and
vice-versa.
xiiFor SE sequences, the prephasing gradient has positive polarity and is positioned prior to the 180◦ inversion pulse.
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Figure 3.18: Depiction of a frequency encod-
ing gradient on the pulse sequence timing di-
agram. The RF axis shows a rectangular ra-
diofrequency pulse used to generate transverse
magnetisation Mxy. Gx represents the ampli-
tude of the frequency encoding gradient as a
function of time, which is played out after the
initial RF pulse. DAQ denotes the position of
the data acquisition window.
to that of the prephasing gradient. Hence, the echo is conventionally centred at kx = 0. Normally, data
is only acquired during the plateau region of the positive gradient, such that kx is traversed with an
equal spacing between sampling points. An inverse Fourier transform of the frequency-encoded k-space
data thus yields the spatial distribution of signal along the x direction. The typical implementation of
a frequency encoding gradient as a function of time is shown on a pulse sequence timing diagram, along
with the corresponding data acquisition positioning, in Figure 3.18.
Equation 3.73 relates the angular frequency as a function of position x, in the presence of a gradient Gx.
In the rotating frame, the γB0 term can be removed to yield:
ω (x) = γGxx (3.91)
The phase accumulated by a precessing spin in the presence of a magnetic field gradient Gx between time
t′ = 0 and t′ = t is therefore:
φ (x) =
∫ t
0
ωdt′ = γ
∫ t
0
Gx (t
′)x (t′) dt′ = 2pixkx (3.92)
where kx is the one-dimensional k-space vector. From Equation 3.81, it can be seen that in one
dimension, the NMR signal in the presence of a gradient Gx as above can be written as a summation
over all spin isochromats j xiii, in terms of their acquired phase φx,j and weighted by their spin density ρx,j :
S (t) =
n∑
j=1
ρx,jexp (−iφx,j) ≈
∫ ∞
−∞
ρ (x) exp (−iφ (x)) dx (3.93)
In order to mathematically describe the effects of the prephasing and read-out gradients, we can define
the duration of the prephasing gradient as tp and the timing of the echo relative to the start of the
xiiiA spin isochromat is a group of spins exhibiting the same precessional frequency.
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read-out gradient as te, and introduce the corresponding k-space vectors kx,p and kx,r, and phases φp and
φr. Then, since the direction of the phase dispersion created by the two gradients is opposite, we can write:
S (t) =
∫ ∞
−∞
ρ (x) exp [−i (φr (x)− φp (x))] dx (3.94)
where −i (φr (x)− φp (x)) = −i2pix (kx,r (t)− kx,p (t)). At a time te from the start of the read-out
gradient, kx,p = kx,r, the phase dispersion term is zero and an echo is formed. At this point, the areas of
the two gradients Gx,r and Gx,p are equal, i.e.:
∫ te
0
Gx,rdt
′ = ±
∫ tp
0
Gx,pdt
′ (3.95)
where the ± indicates that the prephasing gradient may be of positive or negative amplitude for SE
or GRE sequences, respectively.
The total read-out gradient duration is determined by the ramp time and the acquisition time, Tacq,
which is equal to the length of the gradient plateau. In order to symmetrically sample k-space, te =
Tacq
2
(for a hypothetical ramp time of zero). Tacq is the product of the number of sampling points Nx and the
sampling time (a.k.a. dwell time, ∆t):
Tacq = Nx∆t =
Nx
2∆ν
(3.96)
where the bandwidth of the receiver is ±∆ν. By definition of the k-space vector for a constant gradi-
ent, the spacing in kx corresponding to a dwell time ∆t is:
∆kx =
γ
2pi
Gx∆t (3.97)
Thus, comparing to Equation 3.89, ∆kx =
1
Nx∆x
, the amplitude of the read-out gradient, Gx, is found to
be inversely related to the field-of-view Lx = Nx∆x, as follows:
Gx =
4pi∆ν
γLx
(3.98)
Hence, at fixed receiver bandwidth, stronger gradients are required to achieve a smaller field-of-view.
Furthermore, Equation 3.98 dictates that nuclei with low γ require the use of more powerful gradients to
achieve a given field-of-view compared with high γ nuclei.
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In order to reduce the echo time (e.g. for species with short T2 or T
∗
2 values, or for alleviating susceptibil-
ity artefacts), kx can be sampled asymmetrically. Practically, the area of the prephasing gradient can be
reduced such that fewer values in the negative kx direction are sampled, and correspondingly, the position
of the echo is shifted earlier in the data acquisition read-out. This is known as a partial-echo read-out.
Utilising the symmetry of the Fourier transform (conjugate symmetry) to synthesize the missing data in
the −kx direction, it is possible to reconstruct images as if a complete data-set was acquired. Note: in
principle, in the absence of phase errors (i.e. introduced due to variations in precession frequency across
the object of interest), MR images would be real-valued and could be reconstructed from exactly half
the number of k-space samples required for complete symmetric sampling of kx. However, in reality,
algorithms such as the homodyne reconstruction algorithm [193] require a small portion of k-space in the
−kx direction to be acquired such that the resulting small amount of symmetrical k-space data can be
used to evaluate phase errors prior to synthesizing the missing data.
It is worth noting that frequency encoding can be implemented along any of the three principal axes,
and also at arbitrary angles from the kx axis, e.g. by simultaneously playing out magnetic field gradients
in the x and y directions with amplitudes of Gx = Gmaxcos (β) and Gy = Gmaxsin (β). As such, radial
“spokes” can be traversed through the k-space centre, as discussed briefly in Section 3.2.5.
Slice selection
Slice selection pertains to the localised RF excitation of a specific section of the sample of interest, as
opposed to the sample as a whole. Slice selection is a special case of frequency encoding in which a
frequency-selective RF pulse is applied at the same time as a magnetic field gradient (termed the “slice
selection gradient”).
The simplest example of a frequency-selective RF pulse is a sinc-shaped pulse; a B1 field with an am-
plitude that varies according to sinc (t) = sin(t)t . This pulse has a rectangular-shaped frequency profile;
F [sinc ( t2)] = rect (ω), where rect (ω) =
1, if |ω| ≤ 120, otherwise . It has been introduced that a magnetic field
gradient can be used to assign a frequency variation as a function of spatial position. Thus, if a sinc RF
pulse is played out at the same instant as a magnetic field gradient, then the range of frequencies excited
by the RF pulse, ∆f , will correspond to a certain spatial extent, ∆z. This spatial extent is known as the
thickness of the “slice”.
The direction along which the slice selection gradient is applied is the normal to the plane of the
resulting slice xiv. For example, if we assume that the slice selection gradient is applied along the z axis,
and that this axis corresponds to the cranial-caudal axis of a subject, then an axial slice of the body would
be excited by the RF pulse.
A pictorial description of the slice selection process is provided in Figure 3.19, and the positioning of
the slice selection gradient with respect to the pulse sequence timing diagram is shown in Figure 3.20.
The selective RF pulse is only played out during the plateau of the slice selection gradient xv, and hence
xivThis originates from the fact that the frequency shift associated with a given gradient is proportional to the dot product
of the gradient and the spin position.
xvBecause of this, the z component of G in Equation 3.81 can be taken out of the k-space vector integral, and as such,
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Figure 3.19: Left: time domain representation of a slice selection gradient of amplitude Gz along the z axis,
and corresponding frequency-selective (sinc) radiofrequency pulse. Right: frequency domain representation of
the radiofrequency excitation and the accompanying magnetic field gradient. Right bottom: the spatial domain
depicting the resulting slice of thickness ∆z. Adapted with permission from [178] and [175].
the change in Larmor frequency with position is given by (c.f. Equation 3.91):
f (z) =
γ
2pi
Gzz (3.99)
If the desired slice is centred at the isocentre of the B0 field, then the slice must span a frequency range
∆f with frequencies at the edge of the slice given by f0± ∆f2 . Depending on the strength of the gradient,
this range of frequencies is associated with a spatial extent ∆z:
∆z =
2pi∆f
γGz
(3.100)
∆z thus describes the thickness of a slice excited by an RF pulse with a bandwidth BWRF = ∆f . There-
the Fourier transformation reduces to a two-dimensional problem in x and y, as shown in Figure 3.15.
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Figure 3.20: Depiction of a slice selection gradi-
ent on the pulse sequence timing diagram. The
RF axis depicts a truncated sinc pulse, played
out at the same time as the slice selection gradi-
ent on the Gz axis. Gx represents the frequency
encoding gradient, and DAQ denotes the posi-
tion of the data acquisition window.
fore, the slice thickness can be controlled by the strength of the slice selection gradient and the bandwidth
of the radiofrequency pulse.
In order to excite a slice of spins situated at a position δz away from the isocentre, the transmission
frequency of the RF pulse must be shifted from f0 by a factor δf :
δf =
γ
2pi
Gzδz (3.101)
where the gradient amplitude Gz remains unchanged from a slice located at isocentre. In practice,
most MR imaging scans acquire a set of slices (at a number of frequency offsets) in a given gradient direc-
tion in order to obtain a set of images over a particular volume of the sample. Slices are either acquired
sequentially (i.e. k-space is encoded in its entirety for one slice, then the next slice, and so on) or in an
interleaved fashion (for each encoded point in k-space, all slices are acquired before moving to the next
point in k-space).
Slice selection gradients can be applied on axes other than z in order to localise the RF excitation to
slices in one of the other anatomical planes (sagittal or coronal). Furthermore, it is possible to apply two or
more slice selection gradients on different axes in order to localise excitations to slices at an oblique angle
to one of the principal axes. For example, gradients of amplitude Gx = GSScos (ξ) and Gy = GSSsin (ξ)
can be employed to obtain a slice at an angle ξ from the x axis (where GSS is the amplitude of the slice
selection gradient defined by the desired slice thickness in Equation 3.100).
It is not practically feasible to obtain a perfectly rectangular slice profile. A true sinc function has limits
that extend to ±∞, however, practicality, safety and time constraints enforce that sinc pulses be trun-
cated / apodised for realistic MRI applications, such that the number of sidelobes of the pulse is restricted.
The Fourier transform of the truncated sinc function is not a perfect rect function; instead there is some
rippling and fall-off of the excitation profile at the edges of the slice, and hence excitation of some spins
outside of the desired slice profile results. For many in vivo MR imaging applications, sinc pulses are
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not used; instead, tailored Shinnar La Roux [194] or Gaussian pulses are commonly employed to achieve
better excitation profiles, although trade-offs between the RF pulse width, SAR, and desired slice profile
are still required. Shinnar La Roux algorithms offer a means to solve the Bloch equations numerically,
which become non-linear for B1,xy > 0 (i.e. the problem has no general analytical solution unlike in the
previous subsection).
In addition to inadequacies in the RF excitation profile, inhomogeneity or non-uniformity of the slice
selection gradient itself could result in a modulation of the slice profile from the ideal rectangular shape.
Furthermore, if the sample of interest comprises spins with different chemical shifts, the slice positions of
these chemically-different species will be offset from each other, causing potential misinterpretation of the
spatial position of a given species.
Note: the action of the slice selection gradient produces some phase dispersion along the gradient axis
during the application of the RF pulse. In order to reverse this phase dispersion, the slice selection gra-
dient is usually immediately followed by a slice rephasing gradient, which has opposite polarity to the
slice selection gradient (shown as a negative triangle after the slice selection trapezoid in Figure 3.20).
Conventionally, the slice rephasing gradient has a total area equal to half the area of the slice selection
gradient, assuming that the centres of the RF pulse and the slice selection gradient are aligned. Con-
ceptually, it can be imagined that the RF pulse acts instantaneously at the centre of the slice selection
gradient, such that excited spins accumulate a position-dependent phase in the second half of the slice
selection gradient, which must be corrected by the rephasing gradient.
Phase encoding
It is not possible to assign a unique frequency to every point in a two dimensional slice by simultaneously
applying frequency encoding gradients in two dimensions (there will always be two or more points that
have the same assigned frequency). In order to encode spatial signals in y (or spatial frequencies in ky),
an alternative technique known as phase encoding can be employed.
As shown by Equation 3.92, spins accrue a phase according to their spatial location in the presence
of a magnetic field gradient. Where frequency and phase encoding differ is that when the magnetic field
gradient is switched off, the spins return to precessing with a common resonance frequency (i.e. frequency
encoding is turned off); however, the phase differences induced by the gradient remain. In other words,
the phase dispersion induced by the gradient is permanent (or, until it is reversed by another gradient),
whilst the frequency dispersion is transient and only occurs during the time when the gradient is non-zero.
Phase encoding is implemented in practice by switching on a phase encoding gradient (e.g. along the ky
direction) for a certain length of time following the RF pulse, and then switching it off, and subsequently
playing out the normal frequency encoding gradient to resolve the spatial distribution of signals in x.
However, one phase encoding gradient can only be used to resolve one phase component (i.e. one
step in ky), rather than the full range of kx probed by a single frequency encoding gradient amplitude.
This is because, whilst the Fourier transform can distinguish between individual frequency components, it
cannot distinguish between different phase shifts for spins resonating at the same fundamental frequency
xvi. This problem is resolved by repeating the acquisition for a number of different amplitudes of the
xviThis can be understood by taking an example of the summation of two sinusoids oscillating at the same frequency but
with different phase offsets; the summation results in a sinusoid that oscillates at the same basic frequency as the individual
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Figure 3.21: Depiction of a phase encoding gra-
dient on the pulse sequence timing diagram.
The RF axis depicts a truncated sinc pulse,
simultaneously applied with the slice selection
gradient on the Gz axis. Gx represents the fre-
quency encoding gradient, and DAQ denotes
the position of the data acquisition window. Gy
depicts the conventional means of displaying a
phase encoding gradient as a number of differ-
ent gradient amplitudes on top of each other.
This depiction is chosen to represent the fact
that acquisition of the whole of the 2D k-space
kxy requires the sampling of a number of differ-
ent phase encode gradient amplitudes. For each
new phase encoding gradient (each new “repe-
tition” of the sequence), the slice selection and
frequency encoding gradient amplitudes remain
constant.
phase encoding gradient; each different amplitude introduces a distinct relative phase shift. As such, Ny
phase encoding gradient amplitudes can be used to distinguish Ny phase components (i.e. Ny steps in
the ky direction). The total time required to encode a complete 2D k-space is therefore defined by the
product NyTR, where TR represents the “repetition time”; the time required for acquisition of one line
of k-space.
The resulting phase encoded signals in ky can be converted into a corresponding spatial distribution
in y by a 1D Fourier transform. In practice, frequency encoding and phase encoding are unravelled simul-
taneously by the 2D Fourier transform (Equation 3.83). The relative positioning of the phase encoding
gradient is shown in the pulse sequence timing diagram in Figure 3.21.
The mathematical basis for describing the phase accrued during a gradient has already been introduced;
a phase encoding gradient in the y direction can be considered by transforming x→ y in Equation 3.92.
The maximum area of the phase encoding gradient — required to acquire the k-space line corresponding
to ky,max — can be derived as follows.
Usually, Ny phase encodes are acquired symmetrically about ky = 0, with one acquisition correspond-
ing to ky = 0, such that ky,max =
1
2 (Ny − 1) ∆ky. According to Equation 3.89, the spacing of subsequent
phase encoding steps in k-space is given by ∆ky =
1
Ly
= 1Ny∆y . Thus, the maximum area of the phase
encoding gradient is:
Ay,max =
∫ t
0
Gy (t
′) dt′ =
2pi
γ
ky,max =
pi (Ny − 1)
γLy
(3.102)
sinusoids, but with a single phase shift that is the average of the two individual phase shifts. Hence, the two phases cannot
be resolved by a Fourier transform; only one averaged phase value would be apparent.
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The duration of the phase encoding gradients is typically minimised in order to reduce the time required
for one repetition of the pulse sequence; as such, the maximum phase encoding gradient area Ay,max will
generally result from applying a gradient of maximum amplitude and slew rate.
Similar principles to those discussed previously for asymmetric / partial echo sampling in the frequency
encoding direction can be applied in the phase encoding direction. By exploiting the conjugate symmetry
of the Fourier transform in the ky direction, it is possible to reconstruct an image from data acquired with
just over half the number of phase encodes required to obtain a fully-sampled, symmetric k-space (where
the “just over” lines are required to correct for phase errors). This technique is termed “half-Fourier”
encoding. The major advantage of reducing the number of acquired phase encoding samples is that the
overall scan time required to encode the entire k-space reduces by the same factor. Note: partial echo
sampling cannot be combined with half Fourier encoding, because only acquiring only ∼ 14 of the fully-
sampled k-space data is insufficient to exploit conjugate symmetry properties to synthesize the missing
data.
Phase encoding can in principle be applied in any number of spatial dimensions. In fact, the frequency
encoding gradient could be replaced by a series of phase encoding gradients, although in practice this is
rarely done as it necessitates that the total scan time increases by a factor of Nx. However, for certain
applications, phase encoding can be applied in the z direction to replace slice selection (known as “slice
encoding”). Pulse sequences with phase encoding in two dimensions (y and z) are generally classified
as 3D sequences, because they require the introduction of a third k-space dimension, kz. On the other
hand, pulse sequences with one-dimensional phase encoding in y and slice selection in z are termed 2D
slice-selective sequences, because the k-space representation is two-dimensional.
Acquisition of a 3D volume with a 3D sequence requires a lengthier scan time by a factor of Nz in
comparison to the acquisition of each 2D slice. If 2D slices are acquired sequentially, then the number of
acquisitions required to obtain Nz slices is equal to Nz, and hence if the TR is the same for the 2D and
3D sequences, the total scan time is the same. However, in practice, multiple slices can often be acquired
in an interleaved manner within one TR, such that the number of acquisitions required to sample all slices
is < Nz, and therefore a 2D sequence would be completed faster than a corresponding 3D sequence with
equal TR.
In addition, the SNR of 2D and 3D acquisitions can be compared. The SNR of an MR acquisition is
proportional to the product of the three pixel dimensions and the square root of the total time required
to sample the complete data-set. Hence, for a 3D sequence:
SNR3D ∝ ∆x∆y∆z
√
NyNzNSATacq (3.103)
where NSA represents the number of spectral averages, which is the number of times that each k-space
point (or image pixel) is sampled, and Tacq is length of time for which the data acquisition window is
open. The SNR of a 2D slice-selective sequence is similarly related by:
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SNR2D ∝ ∆x∆y∆z
√
NyNSATacq (3.104)
Thus SNR3DSNR2D =
√
Nz. However, if interleaved acquisition of 2D slices is possible, this permits a comparable
or equivalent SNR to an analogous 3D sequence to be obtained.
Finally, 2D slice-selective acquisitions are limited by imperfect slice profiles as discussed in the previous
subsection; generally, 3D phase-encoded acquisitions produce better-resolved “slices”. Furthermore, the
minimum resolution (i.e. slice thickness) that can be obtained in 3D acquisitions in typically lower than
that of 2D acquisitions within standard hardware and timing limitations; as shown by Equation 3.100,
2D slice thicknesses are limited by the maximum achievable gradient amplitude and RF bandwidth. Nev-
ertheless, 3D sequences introduce the possibility of Gibbs’ artefacts in the z direction which are not
encountered in 2D slice-selective acquisitions. Since Gibbs’ artefacts are alleviated by reducing the slice
thickness, in reality, 3D sequences are only used in place of 2D sequences when the desired slice thickness
is less than a certain threshold value.
3.2.5 MR imaging sequences
Gradient echo and subclasses
The most basic gradient echo imaging sequence is composed of each of the individual spatial encoding
components discussed above: an RF pulse with simultaneously-applied slice selection gradient; a phase
encoding gradient; and a frequency encoding gradient. The relevant pulse sequence timing diagram has
been presented in Figure 3.21.
Gradient echo sequences employ small flip angle RF pulses (α < 90◦), allowing a short repetition time
(TR) between subsequent phase encoding steps. By virtue of the fact that the TR of a GRE sequence is
usually much less than the spin-lattice relaxation time, T1, there is insufficient time within one repetition
for the longitudinal magnetisation to fully recover. After a few RF pulses have been applied to the sys-
tem with a fixed repetition time between them, a “steady-state” or “dynamic equilibrium” is reached; as
such, the proportion of longitudinal magnetisation excited per repetition is equivalent to the proportion
recovered by spin-lattice relaxation in one repetition.
In addition, if TR < T2, some transverse magnetisation remains at the end of each repetition. This
residual transverse magnetisation is conventionally dealt with in one of two ways: “spoiling” (i.e. elim-
inating) the residual transverse magnetisation; or “rewinding” (i.e. preserving) it for use in the next
iteration of the sequence.
Firstly, spoiled gradient echo (SPGR, a.k.a fast low angle shot (FLASH)) sequences denote a classifica-
tion of pulse sequence in which the transverse magnetisation is destroyed at the end of each sequence
repetition. This magnetisation spoiling can be implemented by: a) selecting TR & 5T2, such that the
transverse magnetisation has naturally decayed away to zero by the end of the repetition; b) applying
“spoiler” magnetic field gradients after the frequency encoding gradient in order to dephase residual mag-
netisation; c) varying the phase of the RF excitation pulse between acquisitions in order to accentuate the
natural dephasing process. In practice, the first method is not routinely used because it negates the speed
advantage of SPGR sequences as compared to other approaches. The most effective technique for spoiling
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Figure 3.22: Pulse sequence timing diagram for
a typical two-dimensional spoiled gradient echo
(SPGR) pulse sequence. RF: radiofrequency
excitation axis; Gx: frequency encoding gradi-
ent axis; Gy: phase encoding gradient axis; Gz:
slice selection (and spoiler) gradient axis; DAQ:
data acquisition axis. One instance of this tim-
ing diagram (with one phase encoding gradient
amplitude) represents one repetition, of length
TR.
with magnetic field gradients is to use a spoiler gradient amplitude that varies in a pseudo-random fashion
from acquisition to acquisition. However, gradient spoiling is inherently spatially-nonuniform, and RF
spoiling, by varying the phase of each RF pulse in a pseudo-random manner (or according to a specific
cyclical schedule) often provides better, spatially-uniform results xvii. The pulse sequence timing diagram
for a typical 2D SPGR sequence is shown in Figure 3.22.
By considering the propagation of longitudinal and transverse magnetisation between successive sequence
repetitions after steady-state has been reached, an expression for the steady-state signal of a perfectly-
spoiled SPGR sequence can be derived as:
SSPGR ∝
sin (α)
(
1− exp
(
−TRT1
))
exp
(
−TET∗2
)
1− cos (α) exp
(
−TRT1
) (3.105)
where the constant of proportionality will be related to the spin density, ρ. The RF excitation flip
angle that provides the maximum signal intensity can hence be derived by differentiating Equation 3.105
with respect to α, to obtain the result:
αE = arccos
[
exp
(
−TR
T1
)]
(3.106)
xviiA spatially-uniform result is only achieved if a phase encoding rewinder gradient is used to ensure that the total gradient
area on each axis does not vary between repetitions.
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where αE is often termed the Ernst angle (see [195]). Note: in the limit that TR  T1, αE → 90◦,
however, in most applications, TR < T1, so the Ernst angle will be less than 90
◦.
Equation 3.105 can be analysed to determine the conditions required for different image contrast to be
obtained. The contrast of an SPGR image will depend upon a combination of the T1, T
∗
2 , and spin density,
according to the flip angle and pulse sequence timing settings. At long echo times, the image contrast
is dominated by T ∗2 relaxation (the image is said to be “T
∗
2 -weighted”). At low flip angles, cos (α) → 1,
such that the 1− exp
(
−TRT1
)
terms in the numerator and denominator of Equation 3.105 cancel and the
image contrast is dominated by the spin density. T1-weighted images can be obtained by increasing the
flip angle and/or decreasing the TR.
The second approach to dealing with residual transverse magnetisation present at the end of a given
acquisition is to recycle it and utilise it in subsequent acquisitions. “Rewound” GRE sequences (such
as gradient recalled acquisition in the steady-state (GRASS), a.k.a. fast imaging with steady precession
(FISP)) have an additional phase “rewinder” gradient at the end of the repetition to re-phase the trans-
verse magnetisation and enforce consistency in the phase gradient area between repetitions; this ensures
that spins are phase coherent. As a result, this leads to the formation of a steady-state transverse mag-
netisation after a few repetitions, in addition to an analogous steady-state longitudinal magnetisation that
is observed with SPGR sequences. This concept is illustrated in Figure 3.23.
Figure 3.23: Formation of a steady-state transverse magnetisation. a) Any two successive RF pulses with an inter-
pulse spacing TR produce an echo at a time 2TR. Thus, each subsequent RF pulse in a train will be immediately
preceded by the formation of an echo from the previous RF pulse pair, and immediately succeeded by the FID
generated by the current pulse itself. If TR T2, the transverse magnetisation decays to zero between successive
RF pulses. b) However, if TR < T2, the subsequent FID and echo signals will overlap, such that a steady-state
transverse magnetisation is generated for each acquisition. Adapted with permission from [180].
The development of a steady-state transverse magnetisation requires a number of conditions to be met:
(i) fundamentally, TR must be less than T2, otherwise the transverse magnetisation would die away nat-
urally before the next RF pulse; (ii) gradient-induced phase shifts must be consistent between cycles (i.e.
a phase rewinder gradient is needed); (iii) field inhomogeneities (causing a variation of phase across the
object) must be constant (i.e. static) throughout the complete acquisition.
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Figure 3.24: Pulse sequence timing diagram of
a typical two-dimensional balanced steady-state
free precession (bSSFP) pulse sequence. RF: ra-
diofrequency excitation axis; Gx: frequency en-
coding gradient axis; Gy: phase encoding gradi-
ent axis; Gz: slice selection gradient axis; DAQ:
data acquisition axis.
As shown in Figure 3.23, after steady-state is reached, the transverse magnetisation is made up of an
FID-like signal that forms immediately after each RF pulse, and an echo-like signal that forms immediately
prior to that RF pulse, resulting from previous combination(s) of RF pulses xviii. In most steady-state
pulse sequences, the phase of the RF pulse is alternated, because this leads to more efficient restoration of
longitudinal magnetisation and hence a higher steady-state signal than if the RF pulse was always applied
in the same direction.
Balanced steady-state free precession (bSSFP, a.k.a True FISP) sequences are rewound GRE sequences
in which the gradients on all three axes are completely balanced, such that the time integral of the gradi-
ents along each axis is zero. As a result, the peaks of the FID- and echo-like signals occur at exactly the
same instance in time (the centre of the TR). As with conventional rewound GRE sequences, alternation
of the sign of the RF pulse (changing the phase of the pulse by ±180◦ each repetition) is routinely imple-
mented to yield an optimum steady-state signal.
The signal dependence of a bSSFP sequence can be derived in the same manner as that of a spoiled
GRE sequence, and leads to the following result (assuming that the sign of the RF pulse alternates each
repetition):
SSSFP ∝
sin (α)
[
1− exp
(
−TRT1
)]
exp
(
−TET2
)
1− cos (α) exp
(
−TRT1
)
− exp
(
−TRT2
) [
exp
(
−TRT1
)
− cos (α)
] (3.107)
where again, there will be a constant of proportionality related to the spin density, ρ. T ∗2 is replaced
with T2 to represent the transverse magnetisation decay prior to the echo time, which is valid if TE =
TR
2
xviiiFISP acquisitions sample the FID-like signal, and an equivalent and opposite acquisition-type (known as PSIF) exists
which samples the echo-like signal.
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(otherwise, if the echo position is shifted from the centre of the repetition, the signal will be influenced
somewhat by T ′2). This T2 dependence can be thought of as originating from the fact that the echo-like
signals arise from a combination of spin echo- and stimulated echo-type contributions xix. For further
details, the reader is referred to [196].
bSSFP sequences are acutely sensitive to inhomogeneity in the main magnetic field B0. If the phase
accumulated per TR due to field inhomogeneities is equivalent to 180◦, then the effect of RF phase alterna-
tion is completely opposed. Associated signal losses appear as dark bands in the image, characteristically
associated with regions of high susceptibility difference, or poor B0 homogeneity. Since the phase accrued
in a given repetition depends upon the sequence TR, very short TR values are typically chosen for bSSFP
sequences in order to minimise the prevalence of these “banding” artefacts. Equation 3.107 can be simpli-
fied for TR T1, T2 by expanding the exponentials as a Taylor series (i.e. exp
(
− TRT1,2
)
≈ 1− TRT1,2 ), to yield:
SSSFP ∝
sin (α) exp
(
−TET2
)
(
T1
T2
)
[1− cos (α)] + 1 + cos (α)
(3.108)
which has a maximum signal at αE = arccos
(
T1−T2
T1+T2
)
. This equation dictates that the bSSFP signal
is essentially independent of TR if TR is short; the signal varies only as a function of flip angle and the
ratio T2T1 . In particular, for a flip angle of 90
◦, Equation 3.108 simplifies further to:
SSSFP ∝
T2exp
(
−TET2
)
T1 + T2
(3.109)
which becomes 12exp
(
−TET2
)
if T2 ≈ T1, and T2T1 exp
(
−TET2
)
if T2  T1.
In most cases, bSSFP images exhibit a mixture of T1 and T2 weighting; as seen in Equation 3.108, the
bSSFP contrast can be defined by the ratio T2T1 , particularly for the case of high flip angles (c.f. GRASS
sequences, which inherently exhibit some T ∗2 weighting). As such, fluids, which have long T2 values, appear
bright on bSSFP images. Although not routinely employed, the use of low flip angles leads to increased
spin density weighting. In addition to magnetic field inhomogeneities, bSSFP sequences are particularly
sensitive to motion and flow which can destroy the coherence in transverse magnetisation built up between
subsequent acquisitions.
3D balanced steady-state sequences, and the process of simulating the magnetisation dynamics for 3D
bSSFP imaging with hyperpolarised gases, form the substance of Chapter 4 of this thesis.
Spin echo and subclasses
Standard single-echo spin echo (SE) sequences employ a 90◦ RF excitation pulse, followed by a 180◦ refo-
cusing pulse, and the aforementioned spatial encoding gradients, as illustrated in Figure 3.25. Whilst for
xixStimulated echoes form from three consecutively-applied RF pulses; the first pulse generates transverse magnetisation,
which is converted to longitudinal magnetisation by the second pulse, and then refocussed by the third to generate an echo
signal.
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Figure 3.25: Pulse sequence timing dia-
gram for a typical two-dimensional spin
echo (SE) pulse sequence. RF: radiofre-
quency excitation axis; Gx: frequency
encoding gradient axis; Gy: phase en-
coding gradient axis; Gz: slice selec-
tion gradient axis; DAQ: data acquisi-
tion axis.
gradient echo sequences, the prephasing lobe of the frequency encoding gradient has a negative polarity
and is positioned immediately before the part of the frequency encoding gradient where data acquisition is
performed, in spin echo sequences, the prephasing lobe has positive polarity and is positioned prior to the
180◦ pulse, because the echo is RF-induced rather than gradient-induced. The position of the resulting
echo is determined by when the area under the frequency encoding lobe is equal to that of the prephasing
lobe. Conventionally, the time at which the gradient areas are equal is designed to be the same as the time
at which the RF spin echo would be formed in the absence of imaging gradients; if these two times are not
equivalent the echo intensity will be reduced by a factor exp
(
− toffT∗2
)
, where toff is the time difference
between the position of the RF- and gradient-induced echoes.
By considering the propagation of longitudinal and transverse magnetisation during one instance of a spin
echo sequence, an expression for the signal of a SE sequence (assuming flip angles of 90◦ and 180◦) can
be obtained:
SNRSE ∝
[
1− 2exp
(
−
(
TR− TE2
)
T1
)
+ exp
(
−TR
T1
)]
exp
(
−TE
T2
)
(3.110)
where all symbols have their previously-defined meanings. In the case TE  TR, this equation sim-
plifies to:
SNRSE ∝
[
1− exp
(
−TR
T1
)]
exp
(
−TE
T2
)
(3.111)
A full form of Equation 3.110 can be derived for arbitrary flip angles of the excitation and inversion RF
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pulses; indeed, it is readily seen from the full form that the maximum signal is obtained with flip angles
of 90◦ and 180◦ for the two pulses, respectively.
The timing parameters of a spin echo sequence can be tailored to produce image weighting dominated
by T2, T1 or spin density, depending on the desired application. As can be seen from Equations 3.110
and 3.111, at short echo and repetition times, T1-weighted images will be obtained, whilst long TE and
TR values lead to T2-weighted images. Spin density weighting can be achieved at an intermediate situa-
tion of long TR and short TE (note: as before, the proportionality constant in Equations 3.110 and 3.111
is directly related to the spin density).
Provided that sufficient transverse magnetisation remains at the end of each sequence repetition, one
or more additional echoes may be generated by subsequent 180◦ RF pulses. As such, additional images
can be acquired, each with a different T2 weighting
xx. Of particular interest, dual-echo sequences usually
involve the acquisition of one image with a short TE and one with a long TE, which will be weighted by
proton density and T2, respectively.
SE sequences are characteristically slower than GRE sequences, especially when T2 or spin density con-
trast is needed. In practice, normally both the excitation pulse and refocusing pulse are slice selective,
such that multiple slices can be excited in an interleaved manner within one repetition time. In addition,
species with sufficiently long T2 relaxation times afford the possibility of multiple k-space lines to be
acquired within a single TR, by generating multiple echoes with different phase encodings.
Fast spin echo (FSE, a.k.a. turbo spin echo, TSE, or rapid acquisition with relaxation enhancement,
RARE) sequences involve the acquisition of multiple phase encoding lines per TR by acquiring multiple
echoes with different phase encoding gradients applied just prior to each echo. In order to preserve signal
coherence and traverse k in the same direction for each consecutive echo, a phase rewinding gradient must
be applied after each acquisition. The phase of the 180◦ RF pulses is typically shifted by 90◦ with respect
to the initial excitation pulse in order to correct for phase errors that can be introduced by diffusion
effects, imperfect 180◦ pulses and/or inhomogeneity of the B1 field. A schematic of a typical FSE pulse
sequence is shown in Figure 3.26.
The major benefit of FSE-based approaches is that the total scan time required for a FSE sequence
is reduced by a factor equal to the echo train length (ETL; the number of echoes acquired per TR) as
compared with a conventional SE sequence. These time saving benefits are often crucial for practical
applications where T2-weighted images are desired (long TR, long TE needed). In addition, as with stan-
dard SE sequences, 2D FSE approaches permit interleaving of multiple slice acquisitions per TR, whilst
3D FSE sequences involve phase encoding along one dimension using the echo train and phase encoding
in the other dimension is conventionally performed step-wise after each TR.
In a similar manner to standard SE sequences, FSE sequences can be designed to obtain images with T1,
T2 or spin density contrast by accordingly altering the TE and TR. However, the definition of TE must
be considered differently in a FSE sequence as compared to a conventional SE sequence. As a result of
the different phase encoding steps being applied for different echoes, different lines of k-space are acquired
at distinct values of TE (where TE is the time difference between the initial excitation pulse and the
xxIn these multi-echo sequences, the same phase encoding gradient applies to all subsequent echoes, unlike in the case of
FSE sequences, as discussed below.
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Figure 3.26: Pulse sequence timing diagram of a typical two-dimensional fast spin echo (FSE) pulse sequence. RF:
radiofrequency excitation axis; Gx: frequency encoding gradient axis; Gy: phase encoding gradient axis; Gz: slice
selection gradient axis; DAQ: data acquisition axis.
centre of each echo). In practice, the effective echo time defining the overall image contrast is the time
associated with the acquisition of the central line(s) of k-space. Therefore, a cluster of central k-space
lines acquired with TE values close to the TE of a conventional SE sequence chosen for a specific image
contrast weighting will yield a FSE image with comparable contrast to that SE image. Note: in addition
to the effective echo time, the ETL is a critical determinant of FSE image contrast. For example, increas-
ing the ETL will lead to stronger T2 weighting.
Furthermore, dual-echo FSE sequences can be employed to obtain two images at different effective
echo times, weighted by spin density and T2. A common means of implementing dual-echo FSE is view-
sharing, where the central lines of k-space are acquired at both early and late effective TE values in the
echo train; the k-space lines associated with higher spatial frequencies are shared between the two images,
whilst the differing central lines provide a distinct contrast.
Trajectories for traversing k-space
In addition to the choice of pulse sequence and associated pulse sequence parameters, the manner in which
k-space is traversed is an important factor that has a bearing on acquisition speed, image contrast and
SNR. A number of both simple and complex k-space traversal approaches have been developed for specific
applications, as briefly introduced below. A summary of some of the most common k-space acquisition
trajectories is presented in Figure 3.27.
Conventionally, spin echo and gradient echo sequences employ a sequential (a.k.a. linear) trajectory
for filling k-space points on a Cartesian grid. In sequential sampling, k-space lines are acquired in order
from one edge (ky,max) to the opposite edge (−ky,max) or vice-versa, such that the central line (k = 0) is
acquired approximately halfway through the scan. In single echo sequences, one line is acquired per RF
excitation pulse, whilst in multi-echo sequences, a number of k-space lines can be acquired after only one
RF excitation.
It is sometimes advantageous to acquire the central line of k-space at the beginning of the acquisition
rather than halfway through. Centric encoding is a Cartesian sampling method similar to sequential
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sampling, in which the order of acquired k-space lines is altered such that k-space is filled from the
centre-out, rather than from one end to the other. This is achieved by consecutively switching between
positive and negative phase encoding gradient amplitudes. Centric ordering is often employed in dynamic
contrast-enhanced MRI with gadolinium contrast injection, to exploit the fact that the majority of the
image contrast is dominated by the central k-space lines. Additionally, signals arising late in the scan can
be suppressed using centric encoding schemes, because only the extremities of k-space will be sampled at
that stage.
Echo planar imaging is an extreme example of fast encoding of k-space in which the entire k-space is
encoded after one RF pulse. Typically, EPI follows a sequential Cartesian-type pattern, but the frequency
encode gradient switches from positive to negative amplitudes such that each subsequent k-space line is
acquired in the opposite direction. “Blipped” phase encoding gradients are typically applied after each
line of k-space has been acquired, in order to add to the phase dispersion of the previous phase encoding
gradient and therefore advance to the next k-space line. This results in a snake-like trajectory across
k-space.
Figure 3.27: Summary of typical Cartesian and non-Cartesian trajectories for k-space traversal. (For Cartesian
acquisitions, numbers indicate the order in which the k-space lines are acquired.)
Non-Cartesian methods of k-space sampling are classified as those which acquire points that do not lie
on the standard Cartesian grid of equally-spaced points in kx and ky. A variety of techniques exist for
encoding k-space by tracing different shapes in two or three dimensions. Although other methods are
available, images are commonly reconstructed by a procedure is known as “gridding”, which involves con-
sidering the contribution of each acquired data-point to each point on a standard Cartesian grid, and then
mapping the non-Cartesian data-points onto the Cartesian grid such that a regular Fourier transform can
be performed to obtain the desired image.
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One of the most popular non-Cartesian sampling methods is radial encoding, where frequency encod-
ing (read-out) gradients are simultaneously applied in the x and y (and z) directions with amplitudes
governed by the trigonometric functions, in order to encode points tracing a circle (or sphere) in two-
dimensional (or three-dimensional) k-space by sampling along radial “spokes” passing through the k-space
origin. Radial acquisitions negate the need for phase encoding gradients and thus allow minimisation of
the echo time, either by rapidly forming an echo with two gradients of opposite polarity, or by directly
sampling the free induction decay with a unipolar gradient immediately after the RF excitation pulse.
This permits imaging of species with extremely short T2 values, such as protons in bone or tendons.
Additionally, radial sequences are intrinsically robust to motion artefacts because the centre of k-space is
sampled by all radial spokes; though the relatively reduced sampling density of the periphery of k-space
can lead to image blurring.
An alternative non-Cartesian k-space sampling method is spiral encoding, which involves the applica-
tion of time-oscillating gradients along x and y in order to trace a spiral pattern through k-space. As with
radial acquisition strategies, spiral k-space trajectories remove the need for phase encoding gradients by
simultaneously encoding multiple points in kx and ky. Spiral trajectories are typically implemented in a
single-shot or multiple-interleaved manner, and afford considerably improved efficiency for encoding the
whole of k-space as compared to Cartesian sequences. Nevertheless, any variations in Larmor frequency
(off-resonance) across the sample due to B0 inhomogeneity and/or susceptibility artefacts can severely
impact the application of spiral trajectories by inducing image blurring.
Motion encoding sequences: Diffusion and flow
Standard spin echo and gradient echo sequences can be modified to provided contrast weighting governed
by the diffusion behaviour of the species of interest. This is achieved by the addition of two magnetic
field gradients of equal area (known as “diffusion gradients”) to the standard sequence. SE sequences
achieve diffusion weighting by applying both diffusion gradients with positive polarity in between the slice
selection pulse and the data acquisition, at either side of the 180◦ inversion pulse. The simplest imple-
mentation is sometimes referred to as a Stejskal-Tanner sequence [197]. In the case of GRE sequences,
the two diffusion gradients have opposite polarity and do not straddle any other pulses or gradients. A
characteristic pulse sequence timing diagram for a diffusion weighted (DW)-SPGR sequence is presented
in Figure 3.28.
According to Equation 3.92, spins precessing in the transverse plane accrue a certain phase in the
presence of any magnetic field gradient. The spatial position of a diffusing spin changes over time in a
random fashion; as such, a random phase is accrued. The principle of the two diffusion gradients is such
that, for spatially-fixed spins, the phase dispersion induced by the first gradient is reversed by the second
gradient (which has an equivalent area), whilst the spins that have diffused in a random manner during
the gradients will not be re-phased. Thus, MR signal is lost as a result of diffusion in the presence of these
gradients. As shown below, this signal loss presents itself in a similar manner to standard transverse re-
laxation processes; therefore, the applied diffusion weighting must be sufficient for diffusion-related signal
losses to dominate the MR signal behaviour over T2 or T
∗
2 relaxation in the case of SE or GRE sequences,
respectively.
The Einstein relationship for the mean square displacement of a spin diffusing for a time, t in one direc-
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Figure 3.28: Pulse sequence timing di-
agram of a 2D spoiled gradient echo
(SPGR) pulse sequence with bi-polar
diffusion gradients added to the slice
(Gz) axis for diffusion sensitisation.
RF: radiofrequency excitation axis; Gx:
frequency encoding gradient axis; Gy:
phase encoding gradient axis; Gz: slice
selection gradient axis; DAQ: data ac-
quisition axis.
tion, x is given by
〈
x2
〉
= 2Dt, where D is the diffusion coefficient. In three dimensions, this becomes〈
|r|2
〉
= 6Dt (assuming the diffusion coefficient is isotropic). In this subsection, diffusion gradients are
considered to be applied on one direction only (chosen to be the z axis by convention), and hence diffusion
along this axis only will contribute to measured MR signal losses.
For the sake of clarity, we note again that the phase accrued in the presence of an arbitrary magnetic
field gradient (originally described in Equation 3.92 for a gradient in the x direction) is:
∆φ (r) =
∫ t
0
ω (t′) dt′ = γ
∫ t
0
G (t′) · r (t′) dt′ (3.112)
where, in the case of a diffusing spin, r (t′) is not constant in time. The ensemble average of the phase
modulation of transverse magnetisation induced by diffusion in the presence of an arbitrary magnetic field
gradient is given by:
〈exp (i∆φ (r))〉 =
∫ ∞
−∞
P (∆φ) exp (i∆φ) d∆φ (3.113)
where ∆φ is as defined in Equation 3.112, and P (∆φ) is the probability density function describing
the spread of ∆φ values. In most diffusion-weighted MRI applications, P (∆φ) is assumed to follow a
Gaussian / normal distribution, which yields 〈exp (i∆φ (r))〉 = exp
(
−〈∆φ〉2
)
. This dictates that the loss
in MR signal according to molecular diffusion follows an exponential relationship with diffusion coefficient,
such that:
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S = S0exp
(
−〈∆φ〉2
)
= S0exp (−bD) (3.114)
where b is defined as the b-value of a pair of diffusion gradients, measured in s.m-2, and S0 is the
MR signal in the absence of diffusion. The b-value is governed by the properties of the applied diffusion
gradients, and controls the strength of the diffusion weighting (i.e. it is analogous to TE determining the
T2 contrast of an image). Assuming a Gaussian phase distribution, the b value can be formally defined
as:
b = γ2
∫ TE
0
[∫ t
0
G (t′) dt′
]2
dt = (2pi)
2
∫ TE
0
k (t) · k (t) dt (3.115)
where the second equality defines b in terms of the k-space vector (c.f. Equation 3.79). The b-value
is thus solely determined by the diffusion gradient waveforms and the gyromagnetic ratio of the species
of interest. For many standard gradient waveform designs, the b-value can be analytically derived in
terms of parameters describing the timing and amplitude of the diffusion gradients. As an example, for
a gradient echo sequence, assuming perfectly rectangular diffusion gradients (i.e. τ = 0 in Figure 3.28,
which is practically impossible), the b-value is given by:
b = 2γ2G2
δ2
3
(3.116)
It can therefore be seen that the degree of diffusion weighting can be controlled by: the amplitude of the
diffusion gradients (G); the length of the plateau region of each diffusion lobe (δ); the length of the ramp
region of each diffusion lobe (τ , assumed to be zero in this simplified case); and the separation of the two
lobes (∆ = δ + τ , measured from centre-to-centre or from leading edge to leading edge is the “effective”
diffusion time), as defined pictorially in Figure 3.28.
It is worth noting that the diffusion-weighted signal equation (Equation 3.114) can be equivalently
derived from a modified version of the Bloch equations that include a term for the diffusion coefficient,
D. For completeness, in one dimension:
dMx
dt
= γMy
(
B0 − ωr
γ
)
− Mx
T2
+∇ ·D · ∇Mx (3.117)
where the term containing the diffusion coefficient is of exactly the same form as that of the standard
diffusion equation; a fundamental result of Fick’s laws, this conventionally describes the time-dependent
concentration of a diffusing species. Equation 3.117 is known as the Bloch-Torrey equation and its gener-
alised, 3D form is relevant for more complex situations of three-dimensional diffusion-weighted imaging,
e.g. diffusion tensor imaging (DTI), where the diffusion behaviour is directionally-dependent (i.e. D is a
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3D matrix).
In practice, the apparent diffusion coefficient, ADC, is used in place of D in the above analysis. The ADC
is the measured or effective diffusion coefficient of the species of interest in a particular medium, which
is often less than the “free” or “self” diffusion coefficient of the species. For instance, in the lungs, the
diffusion of gas is restricted by the walls of the alveoli, and as such, the MR-observed diffusion coefficient
of gases such as helium and xenon, the nuclei of interest in the experimental sections of this thesis, is
significantly reduced as compared to the free diffusion coefficient, as introduced in Section 2.2.
Whilst any diffusion-weighted SE or GRE sequence can be utilised to obtain diffusion-weighted images,
two or more acquisitions with different diffusion weightings offers the possibility of quantifying the ADC
of a particular species in each voxel (in this case, the ADC can be defined as the mean diffusion coefficient
observed in a given voxel). Typically, maps of the ADC parameter can be derived by interleaving the
acquisition of k-space lines with the application of diffusion gradients associated with at least two different
b-values (usually including b = 0). On a voxel-by-voxel basis, the ADC can be determined by fitting the
natural logarithm of the signal intensities of images associated with different b values according to Equa-
tion 3.114. Measuring the apparent diffusion coefficient is a powerful means of assessing molecular motion
in a particular environment, and hence gleaning information about the length scales by which diffusion is
restricted (e.g. the dimensions of the alveoli which confine gas molecules, as discussed in Section 2.2).
In a similar manner to diffusion sensitisation of MR sequences, bi-polar gradients can also be utilised to
encode information about the velocity of spins that are flowing in a particular direction. Again, motion
in each direction is considered separately by applying gradients along each of the three principal axes.
Whilst diffusional motion is spatially-random by nature, flow motion is regarded as coherent motion of
particles along a single direction. Thus, constant velocity flow in the x direction can be treated by re-
placing r (t′)→ x (t′) = x′0 + vxt′ in Equation 3.112, which results in a total accumulated phase after the
bi-polar gradients that is linearly proportional to the flow velocity vx in the gradient direction.
Analogous to the b-value of diffusion-weighted imaging, the “strength” of velocity encoding of an image
can be defined by a parameter venc, which is the flow velocity that would result in an accumulated phase
shift of pi. Although its exact mathematical formalism is beyond the scope of this review, venc is related to
the strength and separation of the bi-polar gradients, and determines the range of flow velocities that will
be highlighted in a given velocity-encoded acquisition. It is worth noting that in principle, information
about higher orders of motion, including acceleration, can be revealed by applying particular combinations
of gradients (with more than two lobes) prior to the acquisition.
Finally, it should be noted that whilst flow encoding schemes are designed to reveal specific aspects of
flow motion, there are a number of ways in which flow motion can affect standard MR imaging sequences
(that do not possess flow encoding gradients). For example, flow enhancement can be observed in im-
ages where a slow-flowing component enters the imaging volume during the acquisition; the spins in this
component are excited by fewer MR pulses and are hence associated with a higher signal than the spins
localised to the imaging volume. This principle, known as time-of-flight, can be exploited to obtain non-
contrast-enhanced MR angiograms. Similarly, signal losses in SE sequences can result from fast-flowing
species that are subjected to the initial RF excitation but then flow out of the imaging volume before the
inversion pulse is applied. Furthermore, phase errors will be introduced by flow motion during imaging
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gradients, or in the presence of an inhomogeneous B0 field (since a phase difference will be accrued by
moving spins according to the same principles applied for velocity encoding).
3.2.6 Specifics of hyperpolarised gas lung MRI
Many of the customised approaches employed for optimised hyperpolarised gas imaging of the lungs were
introduced in Chapter 2. In this subsection, considerations for hyperpolarised gas MR implementation
from the perspectives of polarisation hardware and pulse sequence design are discussed with reference to
the aforementioned acquisition techniques. Additionally, a summary of the NMR-relevant properties of
129Xe — the nucleus which is the focus of the experimental chapters of this thesis — is presented.
Spin-exchange optical pumping
Due to the intrinsically low spin density of gases as compared to protons in the body, the bulk magneti-
sation produced by the spin- 12 gaseous isotopes
3He and 129Xe according to the Boltzmann equation (see
Equations 3.17 to 3.19) at standard clinical field strengths is insufficient for MR imaging applications. For
example, Figure 3.29a shows the averaged NMR spectrum produced after 25 acquisitions from a 129Xe
thermal phantom consisting of 18 mL 129-enriched xenon (86% 129Xe at Boltzmann polarisation) and
10 mL oxygen (for T1 shortening as discussed in the following subsection), with a flip angle of 90
◦ and
TR & 5T1 to allow full recovery of longitudinal magnetisation between subsequent excitations.
“Hyperpolarised” describes the status of a species in which the effective nuclear polarisation has been
increased far beyond the thermal equilibrium conditions set out by Equations 3.17 and 3.18. In other
words, it can be imagined that the probability of a nucleus inhabiting the lower energy state (for a spin- 12
system) greatly exceeds that of inhabiting the higher energy state. Attainable polarisation values are typ-
ically many orders of magnitude greater than the equivalent thermal (Boltzmann) polarisation; in fact,
the techniques discussed below can be used to obtain polarisation values of tens of percent (i.e. P ∼ 10−1;
c.f. the estimate of P ≈ 5 × 10−6 for the 1H Boltzmann polarisation at 1.5 T and 298 K presented in
Section 3.2.1).
Figure 3.29b shows a single NMR spectrum acquired from a 10 mL sample comprising 3% 129-enriched
(hyperpolarised) xenon, with a flip angle of 10◦.
In order to quantify the observed polarisation, Pobs,Xe, of a sample of hyperpolarised
129Xe gas, the signal
intensities of NMR acquisitions from a hyperpolarised sample (Shp) and a thermally-polarised sample (St)
can be compared, as follows [65]:
Pobs,Xe =
Shp
St
sin(αt)
sin(αhp)
At
Ahp
Vt
Vhp
PB (3.118)
where α denotes the flip angle, A is the relative fraction of the 129Xe isotope within each sample,
and V is the volume of xenon gas within the coil active volume. PB is the Boltzmann polarisation (see
Equation 3.17).
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Figure 3.29: Representative 129Xe gas NMR
spectra and corresponding FIDs (insets) ob-
tained from a) 25 averaged acquisitions of a
thermally-polarised sample and b) a single ac-
quisition of a hyperpolarised sample.
The most-commonly employed technique for generating hyperpolarised 3He and 129Xe is spin-exchange
optical pumping (SEOP) [61]. Others methods have been demonstrated for 129Xe, such as low tempera-
ture “brute force” approaches [198] and Dynamic Nuclear Polarisation (DNP) [199, 200]. Metastability-
exchange optical pumping (MEOP) [62] has been employed in a number of applications for hyperpolari-
sation of 3He, but is not practically feasible for 129Xe. The fundamentals of SEOP only are reviewed in
this subsection, with a focus on special considerations for 129Xe.
SEOP is fundamentally a two-stage process, comprising an optical pumping (OP) stage and a spin-
exchange (SE) stage. In summary: firstly, alkali metal atoms (typically rubidium) are optically pumped
with resonant laser light in order to polarise the valence electron spins; second, the induced polarisation
is transferred between the alkali metal electrons and the noble gas nuclei by spin-exchange processes.
Alkali metals are suited to acting as an intermediate in the SEOP process, by virtue of their simplified
electronic structure and efficient absorption of laser light. In its ground state, the single valence electron
of an alkali metal atom occupies the 2S 1
2
sublevel. In the presence of a magnetic field, Zeeman splitting of
the ground and excited (2P 1
2
) states produces two states with spin angular momentum quantum number
m = ± 12 in each sublevel, and two states in m = ± 32 in the P sublevel xxi. A valence electron in one
of the ground states can be excited by light at a wavelength equal to the energy of separation between
the ground and excited states. Then, the excited state electron can relax into one of the ground states.
By tuning the polarisation of the laser light, an ensemble-averaged accumulation of electrons in a desired
ground state quantum level (i.e. an electron polarisation) can be achieved.
For the case of rubidium, a laser wavelength of 794.77 nm corresponds to the D1 resonance (transition
between the 52S 1
2
and 52P 1
2
states). Driving this transition with left-circularly polarised photons (σ+) at
794.77 nm results in the transfer of +1 unit of angular momentum to the electron, inducing a change in
the spin angular momentum quantum number of the electron by one unit, ∆m = +1. A schematic of this
process is shown in Figure 3.30.
Sometimes termed “collisional” spin-exchange, the process of transferring polarisation from alkali metal
xxiThe S sublevel corresponds to states with orbital angular momentum of the electron l = 0, whilst the P sublevel
corresponds to l = 1.
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Figure 3.30: Diagram of optical pump-
ing of the electronic states of rubid-
ium by interaction with resonant σ+
laser light. “Collisional mixing” denotes
the process by which the rate of de-
excitation from excited state to either
ground state is equalised. Adapted with
permission from [61]. Copyrighted by
the American Physical Society.
electrons to noble gas nuclei fundamentally involves collisions between the two species. Spin-exchange of
3He occurs predominantly via binary collisions between rubidium and helium atoms. The helium electron
cloud is tightly-bound, and characteristically unreactive; hence the probability of spin-exchange interac-
tions is relatively low and necessitates that SEOP be performed over the order of many hours [201] to
attain saturation of the nuclear polarisation.
In the case of 129Xe, the electron cloud is much larger and consequently the probability of spin-exchange
is increased. However, correspondingly, the probability of Rb-Xe collisions that can destroy the induced
rubidium polarisation (a process known as “spin destruction”) is also increased. For these reasons, optical
pumping cells — in which the noble gas of interest is contained along with a few mg of rubidium (which is
vaporised prior to optical pumping) — comprise different gas concentrations for helium and xenon exper-
iments. For helium, OP cells are usually filled with 100% 3He, whilst for 129Xe, a gas mixture containing
approximately 1−3% xenon is typically used in order to ameliorate the destruction of Rb polarisation via
Rb-Xe collisions [202]. The gas mixture in the xenon OP cell is balanced by “buffer” gases (typically a
mixture of N2 and
4He). In addition to simply making up the gas concentration in the cell, nitrogen also
serves the purpose of quenching potential radiative transitions of excited-state Rb electrons; the excess
energy is instead converted to rotational and vibrational motion of the nitrogen molecules.
In most cases, both 3He and 129Xe OP cells are pressurised to more than one atmosphere, in order to
broaden the intrinsically narrow Rb D1 resonance. For xenon, the operating pressure becomes important
in terms of the mechanism governing the spin-exchange interaction: at high pressures, spin-exchange is
dominated by Rb-Xe binary collisions, whereas at low pressures, the formation of temporary Rb-Xe van
der Waals molecules is significant xxii.
In the high cell pressure, low xenon concentration regime, the ∼ litre quantities of polarised 129Xe
required for lung imaging are typically obtained by operating the polariser in “continuous flow” over
a period of minutes to hours xxiii. This process involves continuously flowing the OP cell gas mixture
through the cell at a sufficiently low flow rate that the 129Xe nuclei are adequately polarised during the
time in which they reside in the cell. Upon exiting the OP cell, xenon is cryogenically separated from the
xxiiIt is beneficial to operate 129Xe polarisers at low pressures in order to suppress collisional destruction of Rb polarisation;
however, this necessitates the use of extremely narrow-linewidth lasers and large, complex optical pumping cells in order to
counteract the lack of pressure-broadening of the Rb D1 resonance, and overcome the low xenon concentration, respectively
[63, 203].
xxiiiSince for SEOP of 3He, the 3He itself usually constitutes ∼ 100% of the gas mixture contained within the optical cell,
no continuous flow accumulation process is required; instead, batches of hyperpolarised 3He can be extracted directly from
the OP cell after a saturation polarisation has been reached.
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buffer gases as it passes through glassware submersed in liquid nitrogen and housed within a permanent
magnetic field (to preserve the 129Xe polarisation). Xenon solidifies within the glassware at liquid nitrogen
temperatures (see Section 3.2.6), whilst the buffer gases do not and can be safely extracted and discarded.
The gas flow persists over a period of tens of minutes and, once a sufficient quantity of xenon has
been accumulated in the frozen state, the xenon “ice” can be sublimated into gaseous form by immersing
the glassware in warm water. The resulting hyperpolarised xenon gas is typically transferred to a plastic
(Tedlar) bag, to which a mouthpiece can be affixed in order to administer the gas to a patient. The
freezing and subsequent thawing of xenon does not result in significant 129Xe polarisation losses [204],
and as such, litre quantities of 129Xe gas with nuclear polarisations of the order of tens of percent can be
routinely obtained using this method [65, 202, 205].
The 129Xe continuous flow SEOP process can be described mathematically as follows. Upon exiting the
OP cell, the polarisation of 129Xe, P cellXe , is governed by [65, 202]:
P cellXe (tres) =
γSE
γSE + ΓXe
〈PRb〉 (1− exp (− (γSE + ΓXe) tres)) (3.119)
where γSE is the spin-exchange rate dictating the transfer of spin polarisation between rubidium elec-
trons and 129Xe nuclei, ΓXe is the rate constant of
129Xe polarisation loss (by a number of relaxation
mechanisms as discussed in the following subsection), and 〈PRb〉 is the ensemble-averaged rubidium po-
larisation in the OP cell. During passage through the cell, the xenon polarisation builds-up according to
an exponential relationship as a function of residency time in the cell, tres. The rubidium polarisation as
a function of position along the laser axis z, can be written:
PRb (z) =
γopt (z)
γopt (z) + ΓRb
(3.120)
where γopt (z) is the position-dependent optical pumping rate for rubidium electrons, and ΓRb is the
rate of rubidium spin polarisation destruction, governed by the rate of binary collisions and van der Waals
molecule formation with xenon. The optical pumping rate can be defined as a function of frequency, ν,
as the integral of the product of laser photon flux, Φ (ν, z), and the photon absorption cross section, σs (ν):
γopt (ν, z) =
∫
Φ (ν, z)σs (ν) dν (3.121)
Finally, the theoretical spin-exchange rate γtheorySE can be decomposed into a summation of terms related
to van der Waals (vdW ) molecule formation and binary collisions (BC):
γtheorySE = γ
vdW
SE + γ
BC
SE =
(
κvdWSE + κ
BC
SE
)
[Rb] (3.122)
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Figure 3.31: Contour plot of 129Xe polarisa-
tion as a function of gas flow rate and total
accumulated volume (for an upgraded version
of the polariser presented in [65], and employed
in Chapter 4 of this thesis).
where the κSE terms represent spin-exchange cross sections related to van der Waals molecule forma-
tion and binary collisions, and [Rb] is the concentration of rubidium in the OP cell.
Although Equation 3.119 provides a theoretical prediction of the polarisation of 129Xe immediately af-
ter it exits the OP cell, the polarisation of 129Xe after cryogenic accumulation, P accXe (tres, ta), is affected
by spin-lattice relaxation of 129Xe in the frozen state, which occurs with a characteristic time constant T1,f :
P accXe (tres, ta) = P
cell
Xe (tres)
T1,f
ta
(
1− exp
(
− ta
T1,f
))
(3.123)
where ta is the length of time for which xenon is accumulated in the cryogenic glassware. These
equations relate that for a fixed experimental set-up (including gas and rubidium concentrations, OP
cell volume, laser flux, etc.) the polarisation of 129Xe in the gaseous form at the end of the polarisation
procedure is determined by the 129Xe residency time tres in the OP cell, and the accumulation time in
the cryogenic glassware, ta. The former is inversely proportional to the gas flow rate, and the latter
depends on the flow rate and the intended gas volume. Therefore, experimental parameters should be
chosen accordingly to achieve the best compromise between the desired 129Xe polarisation, total xenon
volume, and the total accumulation time. Figure 3.31 shows a contour plot of some of these parameters
for the upgraded version of the polariser in [65] (and also described in Chapter 4 of this thesis).
The polariser utilised in the experimental chapters of this thesis has been previously described in [206]
and [65] and is shown schematically in Figure 3.32a. The apparatus consists of: a glass OP cell housed
within a ceramic oven (for vaporisation of rubidium); a Helmholtz coil pair, for producing the static B0
field (i.e. for Zeeman splitting of electronic and nuclear energy states); spiral glassware submerged in
liquid nitrogen (for accumulation of frozen hyperpolarised xenon). In all experiments, the OP cell was
filled with a gas mixture of 3% Xe, 10% N2 and 87%
4He, at a cell temperature of 100◦C and pressurised
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to 2 bars.
During the course of this work, improvements were made to the laser hardware used to generate the
circularly polarised light for Rb optical pumping (see details in Section 4.4.1); hence, certain experiments
were performed with different laser characteristics and resulting 129Xe polarisations. The original form
of the laser hardware, comprising an external cavity diode laser and a number of optical elements to
shape the laser beam onto the cell, is shown in Figure 3.32. In each chapter of this thesis, the type of
laser hardware employed is detailed explicitly, and any modifications to the above operating scheme are
discussed.
Figure 3.32: a) Schematic diagram of the “continuous flow” 129Xe polariser used in this thesis, including the
original laser hardware and optical apparatus: (1) laser diode array; (2) half-wave plate, for rotation of the plane
of linear polarisation from the laser; (3) polarisation beam splitter, with 1
3
transmission down the laser axis, and 2
3
reflection down the cell axis; (4) holographic grating, for narrowing of the laser beam and tuning of the operating
wavelength; (5) quarter-wave plate, for conversion of linear to circular light polarisation; (6) Helmholtz B0 coils;
(7) temperature-controlled oven; (8) glass OP cell. b) Photograph of the polariser.
Considerations for hyperpolarised gas MRI
This subsection concerns the unique properties of hyperpolarised gases that govern their NMR behaviour.
These properties therefore dictate the applicable MR acquisition strategies for 3He and 129Xe, and are
considered on a point-by-point basis in the below discussion.
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(i) The induced hyperpolarisation is non-renewable. Upon excitation by a radiofrequency pulse, the lon-
gitudinal magnetisation of hyperpolarised gas nuclei recovers by spin-lattice relaxation to the thermal
(Boltzmann) polarisation. As discussed in the previous subsection, the Boltzmann polarisation is nor-
mally many orders of magnitude lower than the induced hyperpolarisation, and is insufficient for MRI
applications. Thus, the induced hyperpolarisation of a nuclear spin ensemble can be considered to decay
according to its spin-lattice relaxation time. As such, high flip angles are impractical for hyperpolarised
gas MR imaging (e.g. whilst a 90◦ RF pulse will lead to a high initial transverse magnetisation, it will
leave no longitudinal magnetisation remaining for subsequent excitations) xxiv.
In practice, hyperpolarised gas MR images of the lungs are typically acquired using low flip angle
SPGR pulse sequences, as discussed in Section 2.2. By considering the propagation of transverse and
longitudinal magnetisation at different points in a spoiled gradient echo sequence — and considering the
spin-lattice relaxation term to be represented by an exponential decay rather than an exponential recovery
term — the transverse magnetisation of a hyperpolarised species as a function of RF pulse number, n,
can be written as (see e.g. [207]):
Mxy (n) = M0exp
[
− (n− 1) TR
T1
]
sin (αn)
n−1∏
j=1
cos (αj) (3.124)
where α is the RF excitation flip angle, M0 is the initial longitudinal magnetisation at the start of the
sequence, TR is the repetition time between RF pulses, and T1 is the longitudinal relaxation time. This
equation permits the flip angle to vary in an arbitrary fashion during the acquisition; however, in most
regular applications, a constant flip angle is used, such that the above equation reduces to:
Mxy (n) = M0sin (α) cos
n−1 (α) exp
[
− (n− 1) TR
T1
]
(3.125)
Thus, the rate of decay of hyperpolarised gas magnetisation during an SPGR acquisition is governed solely
by the excitation flip angle and the number of RF pulses required to encode the image (for a fixed TR
and T1). For a 2D sequence with no image acceleration, the required number of RF pulses is equal to the
number of phase encodes in the ky direction, Ny. In order to maximise the signal in a sequentially-ordered
2D SPGR hyperpolarised gas acquisition, the transverse magnetisation for n =
Ny
2 should be maximised.
Thus, the optimum flip angle can be derived by differentiating Equation 3.125 with respect to α [208]:
αopt = arctan
 1√
Ny
2 − 1
 (3.126)
The decay in longitudinal magnetisation of a hyperpolarised species as a function of the RF pulse number
xxivHigh flip angles are also difficult to achieve in the thorax, particularly for 129Xe, which has an almost four-fold lower
gyromagnetic ratio than 1H. Consequently, fast spin echo techniques are impractical for hyperpolarised gas lung MR imaging.
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is known as the “k-space filter”. Compared to MR imaging of thermally-polarised nuclei such as 1H —
where constant flip angle RF excitation results in a steady-state longitudinal magnetisation being reached
after a few RF pulses, leading to a flat k-space filter — constant flip angle, sequential MR acquisitions
of hyperpolarised nuclei magnetisation result in a smoothly decaying k-space filter, which leads to image
blurring according to the distinct signal weightings associated with different k-space lines. Centrically-
ordered k-space acquisitions can be utilised to obtain images with a greater signal-to-noise ratio at the
expense of increased blurring due to the high weighting of the centre of k-space and relatively low weight-
ing of points at large ky values; in this case, the k-space filter is approximately symmetric about
Ny
2 .
Optimal image sharpness can be obtained by varying the flip angle throughout the acquisition procedure
according to [207]:
αn = arctan
(
1√
Ny − n
)
(3.127)
where αNy = 90
◦. As mentioned in the previous footnote, limitations imposed by RF coil hardware
constrain the use of high flip angles, which is one reason for the lack of widespread uptake of variable flip
angle SPGR imaging of hyperpolarised gases. In practice, a good compromise between complexity of im-
plementation, and sharpness and SNR of the resulting image, can be achieved by employing a constant flip
angle approach that results in a longitudinal magnetisation at the end of the acquisition of ≈ 0.2−0.3M0.
(ii) The effective flip angle of customised RF coil designs is not typically known in advance. The excitation
flip angle in standard 1H MR applications is typically calibrated and optimised by built-in software for
most MRI scanners. However, for hyperpolarised MRI with custom-built radiofrequency coils, the flip
angle must be characterised when the coil is loaded by the subject of interest. The mean flip angle of an
RF coil can be calculated by measuring the MR signal decay during the course of an imaging acquisition
in which the phase encoding gradients are nulled; i.e. a sequence comprising an RF pulse, a frequency
encoding gradient and a spoiler gradient only. The decay in echo signal intensity then follows the form
of Equation 3.125 as a function of RF pulse number. Unless the T1 of the hyperpolarised species is well-
known, it is appropriate to use a sequence with a short TR such that T1 relaxation can be considered
negligible. Therefore, the average flip angle can be determined by fitting the signal decay with a function
∝ cosn−1 (α).
Whilst this procedure yields the average flip angle of a given RF coil across the whole of the thorax, it
is possible to extend this approach to an imaging experiment in order to obtain a quantitative map of the
flip angle distribution, as described in Section 4.3.3. The design of customised RF coils for hyperpolarised
gas lung imaging applications requires a compromise to be made between: the flexibility and filling factor
of the coil for imaging subjects of variable size; the range of achievable flip angles necessitated by particu-
lar pulse sequences / applications; the required homogeneity of the resulting flip angle across the thorax.
(iii) Spin-lattice relaxation of hyperpolarised gas nuclei is dominated by paramagnetic molecular oxygen.
As introduced briefly in Section 2.2, the T1 of hyperpolarised gas nuclei changes with the molecular oxygen
content of the gas mixture. In fact, the inverse of the relaxation time (i.e. the relaxation rate) is directly
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proportional to the partial pressure of molecular oxygen, pO2 [123, 209]:
1
T1
= B (T ) pO2 (3.128)
where B(T ) is a temperature-dependent coefficient. Molecular oxygen is paramagnetic by virtue of
possessing a free-radical pair and hence a permanent dipole. In the lungs, the dipole-dipole coupling
interaction with residual O2 typically dominates the relaxation behaviour of
3He or 129Xe, resulting in a
T1 of ∼ 20 s for both nuclei. This places strict limits on the MR acquisition time and necessitates that
the hyperpolarised gas be inhaled only immediately before the scan is commenced.
Furthermore, all stages of the process prior to the patient inhaling the hyperpolarised gas — includ-
ing the SEOP procedure and the transfer of gas to the patient — must be performed under controlled,
low-oxygen conditions xxv.
Although minimisation of the spin-lattice relaxation induced by molecular oxygen is of utmost impor-
tance, there are additional factors to consider that contribute to the relaxation rate of hyperpolarised gas
nuclei both during and after the SEOP process (ΓXe in Equation 3.119), as follows.
(a) During SEOP: intermolecular dipole-dipole collisions in 3He [210]; spin-rotation interactions be-
tween 129Xe molecules [211]; cross-relaxation of 129Xe with the isotope 131Xe [212]; binary collisions [213];
and the formation of Xe-Xe van der Waals molecules [214], all contribute to longitudinal relaxation.
(b): During and post-SEOP: surface (“wall”) relaxation is often the ultimate limiting factor for longi-
tudinal relaxation, although T1 values of the order of hours can be achieved for hyperpolarised
129Xe in
a Tedlar bag in a homogeneous storage field [215]; relaxation in the presence of field gradients, e.g. the
fringe-field of the polariser and scanner magnets, can reduce T1 values from hours to minutes [216].
(iv) Respiratory motion necessitates MRI at breath-hold. Respiratory motion occurs over a time-period of
the order of seconds and can severely affect MR images that are acquired on this time-scale. Although a
number of MR motion recording and correction strategies have been developed, the most feasible practical
solution for minimisation of respiratory motion effects is to perform hyperpolarised gas imaging whilst
the subject maintains a breath-hold manoeuvre. In addition, breath-holding ensures that only a nominal
amount of molecular oxygen can enter the lungs during the scan process. Conventionally, the procedure
of preparing for a hyperpolarised gas scan involves instructing a patient to inhale a bag containing hyper-
polarised gas from a given lung inflation level, e.g. FRC, after a period of relaxed, tidal breathing.
Coincidentally, the typical breath-hold time achievable by human subjects is similar to the T1 of
3He
and 129Xe in the lungs, and therefore both place a comparable constraint on total scan duration.
(v) Gases are highly diffusive. Both helium and xenon gas exhibit a free diffusion coefficient many orders
of magnitude larger than the mean diffusion coefficient of protons in bodily tissues: D0,He ∼ 2 cm2.s-1
[217]; D0,Xe ∼ 0.06 cm2.s-1 [218]; D0,water ∼ 2 × 10−5 cm2.s-1 [219]. In healthy lungs, the apparent
xxvThe entire SEOP system must be free of paramagnetic impurities, and also water vapour, with which rubidium reacts
violently. In practice, optical cells are prepared under closed vacuum and pressurised using an inert-gas glove box.
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diffusion coefficient of helium is reduced compared to the free diffusion value, whilst the xenon ADC is
comparable to its free diffusion coefficient (due to a combination of effects from dilution of the gas in air
and diffusion restriction by the alveolar walls): DHe ∼ 0.2 cm2.s-1 [101, 106] and DXe ∼ 0.04 cm2.s-1
[115, 220]. Under these conditions, gas diffusion during imaging gradients induces transverse relaxation
in a similar manner to T2 relaxation as described previously; according to Equation 3.114 for diffusion-
weighted MRI. Thus, the effective b-value of the phase encoding, slice selection and frequency encoding
gradients must be considered when designing a hyperpolarised gas imaging pulse sequence and assessing
the apparent T ∗2 of the gas. In 2D SPGR applications, diffusion effects are slight, but non-negligible, and
frequency encoding gradients usually exhibit the largest b-values for concern [208]. However, in bSSFP
acquisitions, diffusion during imaging gradients can lead to appreciable reductions in the effective T2.
This issue is discussed further in Chapter 4.
(vi) The magnetic field is inhomogeneous across the thorax. The susceptibility difference between the
lung parenchymal tissue (which is diamagnetic) and the air (containing residual molecular oxygen which
is paramagnetic) means that fluctuations in the static magnetic field B0 experienced by each nucleus can
be prominent in the lungs due to the presence of numerous air-tissue interfaces. The associated variation
in Larmor frequency presents as phase errors and extremely low T ∗2 values in the lung tissue (∼ 1-2 ms
for 1H, as introduced in Chapter 2). As a result, 1H MR imaging of the lungs results in images with poor
signal-to-noise, where the lungs appear dark against the rest of the anatomy of the thorax. Nevertheless,
the transverse relaxation times of 3He and 129Xe gas (& 25 ms) are sufficient for SNR advantages to be
gleaned with balanced steady-state acquisition strategies, as discussed in Chapter 4.
Despite the reasonable T ∗2 values of hyperpolarised gases, the complexity of the lung anatomy —
particularly in close proximity to the vessels, and at the boundaries between air and tissue at the lung
periphery and notably at the diaphragm — can lead to significant susceptibility artefacts on GRE images
[82, 221], and the possibility of banding artefacts in balanced sequences [222]. Careful consideration of
the mean Larmor frequency across the chest, in addition to knowledge of the 3D B0 distribution in the
imaging volume of interest, is critical to minimising the effects of these variations in magnetic susceptibil-
ity. (The latter can be calculated from an interleaved imaging acquisition with two or more TE values,
according to the procedure explained in Section 4.3.3.)
Fundamental properties of 129Xe
Xenon is a noble gas atom with atomic number Z = 54 and a molecular weight of 131 a.m.u. Chem-
ically inert, it exists monatomically, with nine stable isotopes, of which only 129Xe and 131Xe have a
non-zero nuclear spin quantum number, as required for NMR detection. Table 3.3 lists some of the NMR-
relevant properties for 129Xe and 131Xe, in comparison with 3He and 1H (see also Table 2.1 in Section 2.2).
As illustrated in Table 3.3, the gyromagnetic ratios of both 129Xe and 131Xe nuclei nuclei are significantly
smaller than those of 3He and 1H. As a result of its relatively larger gyromagnetic ratio (and historically
greater attainable SEOP-induced polarisation), 3He has typically been employed as the noble gas nu-
cleus of choice for human lung MR imaging applications. However, the availability of 3He is diminishing
and its cost has greatly increased since the advent of its regulation by the US government [84]. On the
other hand, xenon occurs naturally in air, at a concentration of 0.087 ppm [227]. Also, 129Xe possesses
84
Property 1H 3He 129Xe 131Xe
Nuclear spin, I 12
1
2
1
2
3
2
Magnetic moment, µµN 4.84 −3.69 −0.78 0.69
Quadrupole moment, Q (barn) 0 0 0 −0.114
Gyromagnetic ratio, γ (MHz.T-1) 42.58 −32.44 −11.78 3.49
Self diffusion coefficient, D0 (cm
2.s-1) 2× 10−5 2.00 0.06
Diffusion coefficient in air, Da (cm
2.s-1) 0.86 0.14
Table 3.3: Table of NMR-relevant properties of 129Xe and 131Xe, in comparison to 3He and 1H. Data from
[223, 224], except the quadrupole moment of 131Xe [225], self diffusion coefficients (see references in the previous
subsection) and diffusion coefficients in air [226]. (See previous subsection for values of the 3He and 129Xe diffusion
coefficients in human lungs.) The relative natural abundances of the isotopes 129Xe and 131Xe are 26.44% and
21.18%, respectively. µN is the nuclear (Bohr) magneton.
Figure 3.33: The phase diagram of xenon, re-
produced from [230], based upon data from
[231]. The triple point (t.p.) at 161.3 K and
81.6 kPa is clearly identifiable.
additional properties — including a non-negligible solubility in various compounds, and a chemical shift
modulation dependent upon its molecular environment — that can be exploited in a number of ways to
enable functional NMR studies that cannot be performed with 3He (see e.g. Chapters 6 to 8).
As discussed in the previous subsection, both 3He and 129Xe are highly diffusive, which permits quan-
tification of lung microstructural dimensions by diffusion-weighted MR acquisitions (see Sections 2.2, 3.2.5
and 5.2). Of note, the xenon self diffusion coefficient and diffusion coefficient in air are substantially smaller
that the matching helium diffusion coefficients, which offers the possibility of probing smaller length-scale
structures with 129Xe as opposed to 3He diffusion-weighted MRI.
The non-zero quadrupole moment (see Section 3.2.2) of the 131Xe nucleus gives rise to rapid spin-
lattice relaxation, with a relaxation time constant on the same timescale as typical NMR experiments
(even in perfectly evacuated systems, T1 values are of the order of seconds to minutes [228]). Nevertheless,
additional sensitivity to surface interactions and high magnetic fields is obtainable with NMR of spin- 32
131Xe versus spin- 12
129Xe (see e.g. [229]).
Figure 3.33 depicts the xenon phase diagram, which highlights the fact that all three physical states are
accessible under moderate physical conditions, and hence NMR experiments can be performed on 129Xe
or 131Xe in any of those phases. Of particular relevance for SEOP (see Section 3.2.6), xenon will readily
deposit or solidify at pressures of ≤ 1 bar and liquid nitrogen temperatures (77 K).
The large electron cloud of xenon (108 pm, calculated [232]) is easily distorted / “polarised” by neigh-
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bouring molecules. As such, xenon is a highly sensitive probe of its local chemical environment, and is
readily soluble in a number of polar and non-polar solvents. Xenon’s ready solubility in somatic solvents
has facilitated its routine clinical use as a general anaesthetic for many years [233, 234]; inhaled concen-
trations of 71% xenon yield general anesthesia in 50% of patients [235].
The acute sensitivity of the xenon atom to its chemical environment is highlighted by the broad NMR
chemical shift range exhibited by 129Xe; ∼ 250 ppm when dissolved in various liquids [236] (and up to 7500
ppm when present in molecules with electronegative fluorine or oxygen partners [227]), in comparison to
only 0.8 ppm for 3He [237] xxvi. Table 3.4 provides a summary of values of the Ostwald solubility of xenon
in a number of biologically-relevant substances, and the corresponding NMR chemical shift of 129Xe (in
comparison to the gaseous-phase 129Xe resonance at 0 ppm). (For a review of the chemical shifts of xenon
dissolved in liquid hydrocarbons, see e.g. [238].)
Solvent Ostwald Solubility Coefficient Chemical Shift (ppm)
Distilled Water 0.083 [239] 190 [240]
0.083 [241]
Saline 0.093 [242] 194 [243]
(0.9% NaCl) 0.078 [239]
Olive Oil 1.83 [244] 198 [236]
1.79 [241]
Adipose Tissue 1.715 [244] 191† [245]
Blood Plasma 0.103 [242] 194 [240]
0.091 [241] 192 [136]
0.094 [244] 197 [246]
Erythrocytes 0.20 [242] 216 [240]
(RBCs) 0.19 [241] 216 [136]
0.27 [244] 222 [246]
PFOB 1.20 [247] 106 [247]
Table 3.4: Xenon Ostwald solubility coefficients and corresponding 129Xe chemical shifts in somatic substances.
Chemical shift data is expressed in parts per million (ppm) offset from the gaseous-phase 129Xe resonance (0 ppm).
PFOB: perfluorooctyl bromide emulsion, a substance employed as a blood substitute. †: rat adipose tissue.
Upon inhalation, xenon gas fills the alveolar airspaces and diffuses through the lung parenchymal tissue
and into the capillary bed. As shown in Table 3.4, 129Xe exhibits two distinct resonances when dissolved
in blood; pertaining to 129Xe dissolved in blood plasma (P) and red blood cells (RBCs), which are shifted
downfield by ∼ 196 ppm and 218 ppm on average, respectively from the position of the gaseous-phase
129Xe resonance. The chemical shift of 129Xe dissolved in lung parenchymal tissue is identical to that of
blood plasma, and hence the two environments contribute to a single, combined resonance in vivo (known
as the tissue/plasma, or T/P resonance).
The large frequency separation of dissolved- and gaseous-phase 129Xe allows selective RF excitation,
and hence independent investigation, of the two phases, even at fields as low as 0.2 T [248]. However,
the available MR signal from 129Xe dissolved in the T/P and RBC compartments in vivo is significantly
reduced compared with the gaseous-phase 129Xe signal, by virtue of the relatively low solubility of xenon
xxviHelium is also characteristically insoluble in most substances.
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in parenchymal tissues and blood, and the small fraction of the total lung volume that is occupied by the
dissolved-phase compartments.
Figure 3.34 depicts an example NMR spectrum of hyperpolarised 129Xe obtained from the human
lungs, exhibiting all three resonances.
Figure 3.34: NMR spectrum of hyperpolarised
129Xe in the human lungs. The resonance
of 129Xe in the gaseous-phase (G) is conven-
tionally placed at 0 ppm. Two spectrally-
separated resonances arising from 129Xe dis-
solved in parenchymal tissues and blood plasma
(T/P) and red blood cells (RBCs) can be ob-
served at approximately 196 ppm and 218 ppm
downfield from the gas resonance, respectively.
This spectrum was obtained by applying a 90◦
Gaussian RF pulse centred in between the two
dissolved-phase resonances, which produced an
off-resonant . 1◦ excitation of the gaseous-
phase 129Xe magnetisation.
Xenon atoms dissolved in whole blood undergo continuous chemical exchange between the plasma and
RBCs; i.e. rather than permanently binding to RBCs, xenon atoms tend to “hop” on and off. The
rate of chemical exchange of xenon between the two compartments is quantified by an exchange constant
of approximately 12 ms [136]. In addition, passive diffusive exchange of xenon between the airspaces,
parenchymal tissues and capillaries, occurs on a similar timescale (see Chapters 6 and 8). As a result,
the dissolved-phase 129Xe resonances are exchange-broadened, and the effective transverse relaxation time
constant, T ∗2 , of
129Xe in these dissolved-phase compartments is very short (∼ 1-2 ms [249, 250] xxvii).
As discussed in Section 2.2, these short relaxation times constrain the feasibility of MR imaging of
129Xe dissolved in the lung tissues and blood. Nevertheless, provided that the gaseous 129Xe magnetisation
is not strongly excited by selective RF pulses applied to dissolved 129Xe, there exists a large reservoir of
available magnetisation in the gaseous-phase, from which 129Xe spins continuously diffuse into the blood
and tissues during the imaging TR to replenish the dissolved-phase 129Xe signal.
The longitudinal relaxation time constant, T1, of
129Xe gas is of the order of hours when stored in a
polymeric Tedlar bag [215]; however, upon inhalation into the lungs, it is reduced to approximately 20-30
s [134, 252] (due to the presence of residual paramagnetic oxygen molecules, as mentioned in the previous
subsection).
When dissolved in whole blood, the 129Xe T1 relaxation time is of the order of a few seconds, and has
been observed to increase in a non-linear manner with the oxygenation of the blood. Average T1 values
for 129Xe in whole blood have been reported as follows: ∼ 3-4 s in deoxygenated blood [246, 253, 254] and
a wide range of values in oxygenated blood, from 5.7 s [246] to 13 s [254]. The most up-to-date report
has been recently published by our group, which quotes a T1 of 2.2 s in deoxygenated blood (oxygen
saturation, sO2=0.06) and 7.8 s in completely oxygenated blood (sO2=1.00) [255].
Thus, the T1 relaxation times of
129Xe dissolved in arterial blood are comparable to the blood circula-
xxviiBy comparison, the T ∗2 of
129Xe gas in the lungs has been reported to be 50 and 25 ms, in fully-inflated and partially-
inflated lungs, respectively at 1.5 T [251].
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tion time from the lungs to the brain in humans [256], and are hence sufficient for detection of 129Xe NMR
signal in tissues distal to the lungs, such as the heart [257], kidneys [258] and brain [68, 259]. Furthermore,
the T1 relaxation times of
129Xe dissolved in the brain are adequate for further preservation of 129Xe MR
signal; T1 ≈ 14 s and 8 s in grey and white matter, respectively [260].
In addition, blood oxygenation has a significant impact on the chemical shift of the 129Xe RBC resonance
(whilst the plasma resonance is unaffected). In a similar manner to the relaxation time, the 129Xe RBC
chemical shift has been observed to increase in a non-linear fashion as a function of blood oxygenation
[261]. The most recent measurements of this effect, reported by our group, suggest a ∼ 5 ppm change in
129Xe RBC chemical shift can be observed over the full range of blood oxygenation values [262].
It is currently believed that the physical mechanisms underpinning the relaxation and chemical shift
behaviour with blood oxygenation are the same [262]; they are thought to be governed by changes in the
conformational state and xenon binding site locations of haemoglobin with oxygenation. In light of these
observations, hyperpolarised 129Xe has excellent potential as a non-invasive probe of blood oxygenation
in the pulmonary system, and possibly also other, distal tissues.
The rate of exchange of xenon between lung tissue and blood is governed by the diffusion coefficient of
xenon in those environments. The diffusion coefficient of xenon dissolved in human blood and tissues
is not well known (see Section 7.4), and NMR measurements with standard diffusion-sensitising pulse
sequences are challenging, due to the inherently short, exchange-weighted, transverse relaxation times of
129Xe dissolved in these media as discussed above. Wolber et al have presented a spin echo train spectro-
scopic technique for quantification of the diffusion constant of xenon in vitro in water, PFOB and benzene
samples using hyperpolarised 129Xe [263], yielding values of DXe,PFOB = (4.5± 0.6)× 10−5 cm2.s-1 and
DXe,water = (2.2± 0.4)× 10−5 cm2.s-1. However, in blood, the rapid chemical exchange between plasma
and RBCs means that the echo trains cannot be refocused. To this end, pulsed-gradient spin echo tech-
niques have been employed to study the diffusion of 129Xe in plasma (DXe,plasma = 1.0 × 10−5 cm2.s-1)
[264]. As reviewed in Section 7.4, only one in vivo measurement of the average xenon diffusion coefficient
in lung tissues and blood has been performed to date; Ruppert et al presented a combined dissolved-
phase 129Xe diffusion coefficient derived from exchange-weighted spectroscopic measurements in rabbits
of 3.3× 10−6 cm2.s-1 [265]. Determining distinct xenon diffusion constants for human tissues and RBCs
in vivo is experimentally challenging, as is the preparation and measurement of tissue or RBC samples
in vitro that adequately mimic the in vivo functional status. Hence, no reports of the xenon diffusion
constant in tissue samples or RBCs have been published to date.
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Chapter 4
129Xe ventilation imaging with 3D
balanced steady-state free precession
(bSSFP)
4.1 Introduction
As described in previous chapters, hyperpolarised noble gas lung MRI with 3He and 129Xe can overcome
many of the constraints of existing clinical gold-standard methods for diagnosing pulmonary disease, in-
cluding: the lack of regional information offered by pulmonary function testing; the ionising radiation
associated with computed tomography; and the low spatial resolution of nuclear scintigraphy. 3He has
made the initial impact in clinical lung imaging research [69], most likely due to two factors; firstly it
has historically been easier to polarise 3He to higher levels in the volumes required for lung MRI, and
secondly the larger gyromagnetic ratio of 3He when compared with 129Xe (see Section 3.2.3 for details on
the relationship between signal-to-noise ratio and gyromagnetic ratio). 3He MRI has been implemented in
multi-centre studies [72] and has demonstrated clinical utility, with sensitivity to early disease processes, in
numerous pulmonary pathologies [75, 77, 78]. Preliminary studies have shown that hyperpolarised 129Xe
is also promising for pulmonary ventilation imaging, with image quality similar to that of 3He [85, 86, 100].
Furthermore, 129Xe possesses additional functional sensitivity [134] as a tracer of gas exchange and lung
perfusion, based on its non-negligible solubility and broad range of NMR chemical shift in tissue and blood.
Although 3He enjoys intrinsic MR signal advantages over 129Xe, it is generated exclusively as a by-product
of tritium decay and is difficult to obtain in the quantities needed for widespread clinical dissemination
[84]. On the other hand, xenon is naturally-abundant in air (87 ppb, of which 26% comprises spin- 12
129Xe). The proportion of 129Xe can be enriched to ∼80-90% by gas centrifuge techniques, however this
requires significant additional investment. Although xenon is substantially cheaper than 3He, gas doses
delivered to patients for inhalation have typically been ≥ 3 times higher for enriched xenon (hereafter de-
noted EN129Xe) (i.e. up to 1 L [95]) than for 3He (up to ∼300-400 mL [86]), in order to obtain lung images
of sufficient SNR for clinical interpretation. The reason for this is two-fold: the achievable polarisation of
129Xe has historically been lower; and the gyromagnetic ratio is only 13 that of
3He. Naturally-abundant
xenon gas (26% 129Xe, hereafter denoted NAXe) is significantly cheaper than both EN129Xe and 3He,
but has not been well-explored for imaging in humans due to SNR limitations imposed by the 3-fold
lower proportion of spin- 12
129Xe nuclei [248]. However, with recent developments in gas polarisation
technology, promoting the utilisation of high power, narrow-linewidth lasers and mid-low cell pressures
[63–65], polarisation of 129Xe to levels previously achieved with 3He can now be realised. Furthermore,
continued advances in pulse sequence optimisation have shown that improved image SNR can be obtained
in hyperpolarised gas lung imaging by using steady-state free precession (SSFP) [222, 266, 267] rather
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than conventional spoiled gradient echo (SPGR) sequences [71, 207].
In this chapter, the application of 3D SSFP sequences for high-quality MR imaging of pulmonary venti-
lation with 129Xe is presented. The theoretical background of this acquisition method is introduced, and
the results of an optimisation of sequence parameters by numerical simulations of the 3D SSFP signal, and
in vivo measurement of k-space filters, is reported. The possibility of clinical translation of the technique
is assessed by evaluating the feasibility of lung MR imaging with NAXe at 1.5 T and 3 T. Further image
acceleration with compressed sensing techniques is reported for the purpose of enabling same-breath ac-
quisition of 129Xe ventilation images and 1H anatomical images. The quality of 129Xe images produced
highlights the potential of xenon as a cost-effective contrast agent for clinical MR imaging of pulmonary
ventilation.
Part of this chapter is based on the following publication: “Feasibility of Human Lung Ventilation
Imaging using Highly Polarized Naturally-Abundant Xenon and Optimized 3D SSFP”. N. J. Stewart,
G. Norquay, P. D. Griffiths, J. M. Wild. Magnetic Resonance in Medicine, 74, 346-352 (2015). Author
contributions statement (for all parts of the chapter other than Section 4.5): study design, NJS, GN,
JMW; acquisition of data, NJS, GN; analysis of data, NJS; preparation of manuscript, NJS, GN, PDG,
JMW. Author contributions statement for Section 4.5: this section of work was completed in collaboration
with Guilhem Collier, who performed all CS simulations, and contributed to all stages of study design,
data acquisition and analysis.
4.2 Theory: 2D SPGR vs 3D SSFP
The purpose of this section is to review the fundamental theoretical description of 2D SPGR and 3D
SSFP pulse sequences, and the manner in which the dynamics of the hyperpolarised gas magnetisation
differs between the two approaches.
4.2.1 2D SPGR
As discussed in Section 2.2, 2D spoiled gradient echo (SPGR) sequences have been typically employed as
the workhorse approach for lung ventilation imaging with hyperpolarised gases, with reproducible results
demonstrated at a number of different centres [68, 71, 86, 87]. In Sheffield, after establishing effective
protocols for 3He ventilation imaging with SPGR sequences, the first in vivo 129Xe images were reported
using 2D, slice-selective SPGR sequences [251].
Replicating the results shown in Section 3.2.6, the dynamics of the magnetisation of hyperpolarised gas
nuclei during an SPGR acquisition is expressed by the following equation (see Equation 3.124):
Mxy (n) = M0exp
[
− (n− 1) TR
T1
]
sin (αn)
n−1∏
j=1
cos (αj) (4.1)
where α is the radiofrequency excitation flip angle, M0 is the initial magnetisation at the start of the
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sequence, n is the RF pulse number, TR is the repetition time and T1 is the longitudinal relaxation time
for the nuclei of interest. This equation intrinsically accounts for a variable excitation flip angle during
the acquisition. However, for the case of a constant flip angle, and assuming that TR T1, Equation 4.1
reduces to (c.f. Equation 3.125):
Mxy (n) = M0sin (α) cos
n−1 (α) (4.2)
As explained previously, the magnetisation of hyperpolarised gas is non-renewable; once excited, it recov-
ers to its thermal equilibrium value. Thus the rate of decay of magnetisation during an SPGR acquisition
is dictated by the excitation flip angle and the number of RF pulses required to encode the image, the
latter which is equal to the number of phase encodes for a 2D slice-selective sequence, or the product of
the number of y and z phase encodes (Ny ×Nz) for a 3D sequence.
A diagram of a typical SPGR sequence is depicted in Figure 3.22. The presence of a spoiler gradient
destroys residual magnetisation after the read-out, minimising the sequence TR and enabling rapid ac-
quisition of many slices during a single breath-hold. A relatively low flip angle . 10◦ is used for 2D
slice-selective imaging in order to preserve magnetisation throughout the full acquisition process. As
such, these sequences are often referred to as “fast low-angle shot” (or “FLASH”) sequences.
3D SPGR sequences, with phase-encoding on the z-axis as opposed to slice-encoding, afford full cov-
erage images of the lungs to be obtained. It has been demonstrated that 3D SPGR sequences can offer
a SNR benefit over 2D SPGR sequences of a factor of ∼1.5 for hyperpolarised 3He applications [71].
Intrinsically, each spin receives an increased number of RF pulses in a 3D sequence due to the additional
z phase-encoding. This results in a SNR increase by a factor of
√
Nz, where Nz is the number of z
phase encodes, although in practice, much of this SNR discrepancy can be recovered by interleaving of
2D multi-slice sequences. Note: by virtue of the increase in total number of RF pulses, the excitation flip
angle in a 3D sequence must be considerably reduced compared with that of a 2D sequence.
4.2.2 3D SSFP
Due to the absence of refocusing RF pulses or balanced gradients, SPGR sequences are constrained by T ∗2
decay and associated susceptibility artefacts. However, as a consequence of the relatively long T ∗2 values
of 129Xe and 3He when compared with the sequence repetition time — at 1.5 T, T ∗2,Xe ∼ 25 and 52 ms (in
partially- and fully-inflated lungs, respectively) [251] and T ∗2,He ∼ 27 ms [268] i — a significant proportion
of hyperpolarised noble gas magnetisation remains at the end of each encoding step that is destroyed by
the spoiling process and hence cannot contribute to the signal in subsequent encoding steps. The utilisa-
tion of steady-state free precession (SSFP) sequences enables this magnetisation to be recycled, resulting
in an overall improvement in SNR compared with SPGR sequences for hyperpolarised gas applications
[222].
A schematic of a 2D balanced SSFP sequence is depicted in Figure 3.24. The 3D form of the se-
quence offers a minimal echo time by permitting removing of the slice selection gradient, using of a hard
iAt 3 T, T ∗2,Xe ∼ 18 and 24 ms in partially- and fully-inflated lungs, respectively.
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radiofrequency pulse of short duration, and implementing phase encoding along the z direction for three-
dimensional imaging. Balancing the phase encoding gradients ensures that the magnetisation coherence
is preserved between excitations.
For SSFP of thermally-polarised 1H nuclei, a true steady-state magnetisation is achieved and the trans-
verse relaxation time can be approximated by the Carr-Purcell-Meiboom-Gill (CPMG) T2 [269].
In the absence of imaging gradients, it has been shown that a pseudo steady-state can be achieved
in a 3He gas phantom with an effective T2 ∼ 1 s (see Figure 4.1). However, in the presence of magnetic
field gradients, gas diffusion during the acquisition causes dephasing of spins, which reduces the effective
T2. As such, the MR signal continuously decays over the course of the image acquisition, as presented in
Section 4.3.1 (see e.g. Figure 4.2). For a 3D SSFP sequence with a hard radiofrequency (RF) pulse, the
dominant gradient in terms of diffusional attenuation of MR signal is the read-out gradient. The effective
T2, T2,eff , is modified as follows:
T2,eff (τ) =
τ
b (τ)D + τT2,CPMG
(4.3)
where τ is the time for which diffusion occurs (in the case of the read-out gradient this becomes the
echo time, TE); b (τ) is the b-value of the read gradient; D is the hyperpolarised gas diffusion coefficient,
taken to be D0 = 0.062 cm
2.s-1 [226], the xenon self-diffusion coefficient, in the following work.
Figure 4.1: Normalised MR signal decay in the
absence of imaging gradients for a 2D SSFP ex-
periment (128 phase encodes) compared with
2D SPGR equivalents for a 3He gas syringe
phantom (D = 0.9 × 10−4 cm2.s-1). Figure re-
produced from Figure 2 of reference [222], with
permission from the publisher.
The gradual rate of signal decay in SSFP compared with SPGR sequences permits the use of considerably
higher flip angles in the former. Higher flip angles, in combination with the low TR, and associated high
RF duty cycle, may however place restrictions on the flip angle and repetition time in order to maintain
safe RF deposition to human subjects. This is a particularly important consideration for SSFP sequences
with 129Xe because its relatively low gyromagnetic ratio necessitates increased RF power to achieve the
same flip angle as for a nucleus with a greater gyromagnetic ratio (see Equation 3.36).
Furthermore, steady-state sequences are acutely sensitive to B0 field inhomogeneity, manifesting as
banding artefacts (regions of low signal) where the resonance frequency is significantly offset from the
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Larmor frequency. This issue is discussed in detail in Section 4.3.3. Finally, by virtue of the excitation of
the entire 3D volume of spins for each phase-encoding step, and the associated longer image acquisition
times, 3D sequences are less robust to motion artefacts than 2D sequences. Since hyperpolarised gas
images are typically acquired at breath-hold, respiratory motion can often be mitigated, however, cardiac
motion can induce artefacts such as ghosting. Nevertheless, resulting “ghosts” usually appear outside
the lungs and thus can be removed by careful masking of the lung cavity, for example with the aid of
simultaneously-acquired 1H anatomical scans.
4.3 3D SSFP sequence optimisation: Simulation of signal dy-
namics
The purpose of this section was to optimise the 3D SSFP pulse sequence for hyperpolarised 129Xe lung
imaging applications, in order to evaluate 129Xe as a cost-effective alternative to 3He for clinical applica-
tions in humans.
4.3.1 Theoretical background
The signal-to-noise ratio of a 3D SSFP experiment depends fundamentally on sequence parameters, in-
cluding: echo/repetition time (TE/TR); read-out bandwidth (BW ); the associated b-value of the read
gradient; the (sine of the) flip angle (α); the voxel size or resolution in three-dimensions; the field-of-view
(FOV). In addition, the following factors external to the sequence must be considered: B0 inhomogeneity
and the resulting distribution of off-resonance frequencies across the chest; the diffusion coefficient of the
gas of interest in the alveolar spaces, D; the transverse and longitudinal relaxation times, T1, T2, T
∗
2 ; the
polarisation of the hyperpolarised gas, i.e. PXe.
With this knowledge, it is possible to simulate the 129Xe magnetisation during the course of a 3D SSFP
acquisition using a matrix product operator approach. This involves the propagation of the matrix form of
the Bloch equations for each encoding step in the acquisition. The theory underpinning this approach has
been detailed previously for 1H [270] and 3He [222, 266] applications, and considers the combined effects
of excitation flip angle, off-resonance (B0) inhomogeneity, and pulse sequence parameters, as follows.
The magnetisation at encoding step n+ 1, Mn+1, can be described by the multiplication of the mag-
netisation at the previous encoding step, Mn, by a propagation matrix, A:
Mn+1 = AMn +B (4.4)
The term B is related to the recovery of magnetisation and is hence zero for hyperpolarised gas nuclei,
because the T1 decay acts to return the polarisation to its thermal equilibrium state, in which detection
by in vivo imaging methods is not feasible. The propagation matrix comprises the product of a series of
matrices describing the rotation, free precession and relaxation of magnetisation during a single encoding
step:
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A = PTECTERpi (n)RαPTR−TECTR−TE (4.5)
where Pτ represents the free precession of magnetisation:
Pτ =

cos (2pi∆f0τ) sin (2pi∆f0τ) 0
−sin (2pi∆f0τ) cos (2pi∆f0τ) 0
0 0 1
 (4.6)
Here, τ is the time for which free precession occurs and ∆f0 is the difference between the resonance
frequency and the 129Xe gas Larmor frequency. This matrix becomes the identity matrix if spins are
assumed to be resonating at the Larmor frequency.
The matrix Cτ accounts for relaxation in the transverse and longitudinal planes:
Cτ =

exp (−τ/T2 (τ)) 0 0
0 exp (−τ/T2 (τ)) 0
0 0 exp (−τ/T1)
 (4.7)
where T2 and T1 are the transverse and longitudinal relaxation rates, respectively. As shown in Equa-
tion 4.5, one instance of the sequence can be divided into two periods of free precession and relaxation
where τ takes the values TE and TR− TE, respectively.
Rα is the 3D rotation matrix, shown below for the case of excitation by a flip angle α about the x-axis.
Rα =

1 0 0
0 cos(α) sin(α)
0 −sin(α) cos(α)
 (4.8)
Finally, Rpi represents the rotation matrix evaluated at a flip angle of pi or −pi radians, depending on
the RF pulse number n. This accounts for magnetisation phase cycling between successive excitations.
4.3.2 Methods
Full details of the hardware relating to the MR scanner, radiofrequency coils, and 129Xe polarisation
apparatus employed in this work are described in Section 4.4.1.
To maximise the available SNR from a 3D SSFP experiment, the global 129Xe magnetisation vector was
simulated using the matrix form of the Bloch equations for different experimental conditions. The matrix
product operator approach was utilised to predict the longitudinal magnetisation dynamics (so-called “k-
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space filters”) imposed by the 3D SSFP 129Xe magnetisation evolution, for various receiver bandwidths
and flip angle settings, in order to compare with in vivo experiments. The 3D SSFP image SNR was mod-
elled as a function of bandwidth and flip angle, by normalising the simulated transverse magnetisation,
Mxy, at the centre of k-space (i.e. signal) by the square root of the bandwidth (i.e. noise).
In these initial simulations, a range of T2,CPMG values between 300 ms and 25 ms (the
129Xe T ∗2 in
partially-inflated human lungs at 1.5 T [251]) was used. The T2,CPMG of
129Xe at 1.5 T or 3 T has not
been reported, though measurements at low-field (0.2 T) in humans [248], and high-field (4.7 T) in rats
[271] have suggested a value of ∼ 300 ms in the lungs. However, the field dependence of T2,CPMG is
not known, and measurement of this parameter is challenging in the lungs with xenon due to the finite
inter-echo times attainable and diffusion of the gas causing incomplete magnetisation refocusing. Thus,
it is appropriate to perform simulations over a range of T2,CPMG values and assess the value at which
optimum agreement is observed between simulated and experimental data.
The longitudinal relaxation time of 129Xe in human lungs was taken to be T1 = 20 s [134]. It is
worth noting that the effect of diffusional dephasing due to applied imaging gradients on the T2,eff is
lesser for 129Xe compared with 3He [222], due to the ∼ 10-fold lower diffusion coefficient, and the fact
that the gradient b-value scales with the square of the gyromagnetic ratio (see Equations 3.115 and 3.116).
To provide a measured reference with which to compare simulated magnetisation responses, k-space filters
were acquired from the lungs of a healthy smoker (male, 28 years) in vivo at 1.5 T. This was done by
nulling the y and z phase-encoding gradients of a 3D SSFP sequence and recording the 129Xe frequency-
encoded read-out as a function of RF pulse number, for different flip angle and bandwidth settings, using
the experimental set-up described in Section 4.4.1. For each flip angle or bandwidth setting, the subject
inhaled 200 mL of a 50:50 EN129Xe:N2 mixture from a 1 L bag and maintained breath-hold for 8-22
seconds, whilst k-space filters were acquired ii.
The effect of off-resonance due to inaccurate centre frequency estimation or local B0 inhomogeneity upon
the 3D SSFP k-space filters and SNR was also simulated. Typically, the mean (global) resonance fre-
quency of 129Xe gas in the lungs is calibrated prior to imaging in order to maximise the available signal
throughout the acquisition. However, local variations in resonance frequency, due to susceptibility dif-
ferences and/or B0 inhomogeneity, can cause variability in signal intensity across the image. In order to
simulate this effect for 3D SSFP acquisitions, maps of ∆f0, the off-resonance frequency, were acquired in
a healthy subject (male, 33 years). A dual-interleaved 3D SPGR sequence with two different echo times
was employed with the following parameters: field-of-view (FOV), 40 cm; phase FOV, 1; 16 effective
coronal slices (z phase encodes) with no slice gap; in-plane resolution, 32 × 32 (12.5 mm in-plane pixel
dimension); effective slice thickness, 18 mm in the anterior-posterior direction; flip angle, ∼ 3◦; hard
RF pulse; TE1/TR1 = 1.4/3.2 ms; TE2/TR2 = 4.6/6.4 ms; bandwidth, ±8 kHz; breath-hold, 5 s. The
subject exhaled to functional residual capacity and inhaled 500 mL of hyperpolarised EN129Xe gas, mixed
with 500 mL nitrogen gas, from a 1 L Tedlar bag prior to image acquisition.
From the resulting ∆f0 maps, assuming a constant flip angle and a number of RF pulses corresponding
to the target image dimensions for an in vivo imaging experiment (see Section 4.4.1), the 3D SSFP SNR
iiThe lowest achievable bandwidth for the experimental set-up described in Section 4.4.1 was ±2 kHz, however this
required an unfeasibly long breath-hold of ≈ 39 s, and as such this data-set could not be acquired.
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was modelled on a regional basis for each resonance frequency of each pixel within the lung mask. Thus,
a 3D map of the effects of off-resonance on 3D SSFP SNR was generated.
In a similar fashion, to predict the spatial variations in 3D SSFP signal resulting from flip angle (B1)
inhomogeneity across the lungs generated by the flexible transmit-receive coil used for 129Xe ventilation
imaging (see Section 4.4.1), B1 maps were obtained from the same healthy volunteer. Three successive 3D
SPGR acquisitions with minimal time-gap between were acquired with the following sequence parameters:
FOV and resolution as above; flip angle, ∼ 4◦; hard RF pulse; TE/TR = 1.4/3.2 ms; bandwidth, ±8 kHz;
breath-hold, ∼ 5 s. Gas delivery was performed as above.
From the resulting flip angle (α) maps, the B1 amplitude was scaled up to achieve the target flip
angle for an in vivo imaging experiment (see Section 4.4.1), assuming a linear performance of the RF
hardware with current in the coil. Assuming that all spins were on resonance, and a number of RF pulses
corresponding to the target image dimensions, the 3D SSFP SNR was modelled on a regional basis for
each flip angle of each pixel within the lung mask. Thus, a 3D map of the effects of flip angle on 3D SSFP
SNR was generated.
4.3.3 Results
Experimentally-measured k-space filters
Figure 4.2: In vivo measured k-space filters for 3D SSFP with 129Xe at different flip angle and bandwidth settings
at 1.5 T. The normalised 129Xe MR signal intensity — during the course of a sequence in which the y and z phase
encoding gradients have been nulled — is plotted for 3D matrix sizes of 96× 24 and 78× 24 (Ny ×Nz) in the left
and right graphs, respectively. (The right-hand graph shows k-space filters acquired with α = 10◦. The left-hand
plot shows k-space filters acquired at a fixed bandwidth of ±8 kHz, and includes a simulated k-space filter for a
3D SPGR experiment of the same matrix size, derived using Equation 4.2.)
Figure 4.2 depicts experimentally-measured k-space filters for a 3D SSFP sequence with pixel dimensions
as implemented in Section 4.4.1. In all cases, the signal decay was considerably more gradual than that of
a SPGR acquisition with an equivalent flip angle. As expected, the decay in hyperpolarised 129Xe signal
over the course of the experiment was steeper for low bandwidths, due to increased dephasing of magneti-
sation in the presence of lengthier read-out gradients. These data can be utilised to determine suitable
bandwidth and flip angle settings for a 3D SSFP imaging experiment. A typical guideline adopted in
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hyperpolarised gas ventilation imaging in order to attain reasonable SNR without introducing significant
image blurring is to choose a k-space filter that results in a final magnetisation value of ≈ 13M0 (see
Section 3.2.6).
Global signal simulations (assuming on-resonance)
Simulated 129Xe 3D SSFP k-space filters (for various bandwidths at a fixed flip angle of α = 10◦) are
presented in Figure 4.3. The measured in vivo decay of 129Xe longitudinal magnetisation (Figure 4.2) was
considerably faster than the simulated decay using T2,CPMG = 300 ms (which was measured previously
under different experimental conditions [248, 271]); in fact, the best agreement between simulation and
experiment (at 1.5 T) was found at a value of T2,CPMG = 80 ms
iii, for which case the simulated k-space
filters are plotted in Figure 4.3.
Figure 4.3: Simulated k-space filters depicting
the decay in longitudinal magnetisation, Mz,
of hyperpolarised 129Xe during a 3D SSFP ac-
quisition at 1.5 T, for different imaging band-
widths at a fixed flip angle of α = 10◦, assum-
ing that all spins resonate at the same (Larmor)
frequency.
Simulation results for 3D SSFP SNR (as a function of imaging bandwidth and flip angle) for 78 and 24
phase encodes in the y and z dimensions, respectively, and T2,CPMG = 80 ms, are shown in Figure 4.4.
The available MR signal increases with bandwidth, however, the Johnson (shot) noise also scales as the
square root of the bandwidth, resulting in a simulated optimum SNR at a bandwidth of ±8 kHz. These
SNR simulations highlight that for 3D SSFP of 129Xe, the SNR is relatively robust and tolerant to varia-
tions in flip angle setting; with an optimum flip angle of 9.5◦ and a predicted SNR penalty of 20-25% for
using flip angles of 5◦ or 15◦.
Global signal simulations (of off-resonance effects)
Steady-state acquisition strategies are acutely sensitive to off-resonance, which presents as characteristic
“banding” artefacts in the image; periodic nulls in the SSFP signal as a function of ∆f0 result in dark
bands of low signal intensity that can obscure the image interpretation and potentially be misdiagnosed
as ventilation defects (see e.g. [272]). The B0 field exhibits considerable inhomogeneity across the lungs,
which is hampered by the large susceptibility differences at the air-tissue interfaces [221], as discussed
iiiIt was assumed that the more rapid magnetisation decay measured in vivo resulted from a T2,CPMG value of 300
ms being inappropriate under these experimental conditions. However, in practice, other factors may contribute to this
discrepancy; for example inhomogeneity in flip angle or B0, as is discussed in subsequent subsections.
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Figure 4.4: Simulated SNR for hyperpolarised
129Xe 3D SSFP, normalised to the maximum
predicted value (at a bandwidth of ± 8 kHz), as
a function of excitation flip angle and imaging
bandwidth, assuming that all spins resonate at
the same (Larmor) frequency.
in Chapter 2. In particular, this can lead to substantial signal drop-off, distortion or blurring near the
diaphragm in hyperpolarised gas images [82, 221]. Furthermore, B0 inhomogeneity is elevated at increased
field strength, as evidenced by the reduction in T ∗2 measured for
129Xe at 3 T compared with 1.5 T [251],
which implies that increased artefact severity may be observed at 3 T compared with 1.5 T.
Figure 4.5: a) Example banding artefact (white
arrow) due to significant off-resonance near the
diaphragm in a selected 129Xe 3D SSFP lung
image slice. In certain cases, these artefacts
could potentially be misinterpreted as true ven-
tilation abnormalities (e.g. the blue arrow
shows an artefact caused due to a bifid rib in
another example slice). Images in a) were ac-
quired after calibrating the transmit and receive
frequencies to the average (global) measured
resonance frequency in the lungs. b) Images
obtained without calibrating the mean trans-
mit and receive frequencies. In this extreme
case, the receive frequency was ≈ 70 Hz differ-
ent from the average measured resonance fre-
quency.
As illustrated in Figure 4.5a, non-negligible signal nulling due to off-resonance can often be seen in cer-
tain slices of a 129Xe 3D SSFP acquisition, even when the global resonance frequency is well-calibrated.
Although banding artefacts are typically most-prevalent in a similar position in each scan — at the base
of the lungs, close to the diaphragm (see the following subsection) — it is possible that these defects could
be confused for actual abnormalities in pulmonary ventilation function. Poor estimation or calibration
of the mean (global) resonance frequency of the target nucleus can result in almost complete loss of the
available signal across the whole of the lungs; as illustrated in Figure 4.5b, where the regions of high and
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low intensity are reversed with respect to Figure 4.5a.
Figure 4.6 demonstrates how imperfect calibration of the transmit and receive frequency with respect
to the measured resonance frequency of 129Xe in the lungs can severely impact on the available signal
during a 3D SSFP acquisition. Increasing the degree of off-resonance results in more rapid signal decay
and an amplification and elongation of the oscillatory behaviour of the longitudinal magnetisation at the
beginning of the acquisition iv. However, further increasing ∆f0 past a certain value leads to the oppo-
site behaviour, i.e. less steep k-space filtering and a smoothing of the oscillatory behaviour, such that
for ∆f0 ≈ 160 Hz, an approximately equivalent k-space filter to that for ∆f0 = 0 Hz can be observed.
Indeed, the effects of off-resonance on magnetisation are periodic, as shown in Figure 4.7, and hence in
Figure 4.6 the appearance of the k-space filter for ∆f0 = 240 Hz appears similar to that for ∆f0 = 80 Hz.
Figure 4.6: Simulated k-space filters depicting
the decay in longitudinal magnetisation, Mz, of
hyperpolarised 129Xe during a 3D SSFP acqui-
sition, for a fixed flip angle of α = 10◦ and a
fixed bandwidth of ±8 kHz, with variable fre-
quency offsets (∆f0).
These observations hence suggest that there should be an off-resonance frequency value between 0 and
160 Hz that induces a maximal rate of signal decay and most severe initial oscillatory behaviour. This
is confirmed by the SNR simulations depicted in Figure 4.7, where periodic nulls in the 3D SSFP signal
can be observed as a function of off-resonance frequency in the voxel of interest. The null position is
common to signal simulations for different flip angle settings, although the width of the null region, and
the amplitude of the predicted signal at non-null frequencies is significantly influenced by the choice of α.
In particular, it is noteworthy that the maximum on-resonance (∆f0 = 0 Hz) signal is greater for a flip
angle close to the optimum value (10◦) as compared to that at a setting of 5◦.
Regional signal simulations with B0 and B1 mapping
To further characterise the effects of flip angle and off-resonance on the 3D SSFP signal on a regional
basis, B1 and B0 maps were obtained using the acquisition strategies described in Section 4.3.2.
Firstly, B1 / flip angle maps were calculated using the first two of three successive 3D SPGR acqui-
sitions. For each pixel in the image domain, the signal intensities from the two acquisitions S1,2 and the
number of RF pulses between the two acquisitions were utilised to derive the effective flip angle at that
ivSome oscillatory behaviour was present in all simulated and measured k-space filters, representing the regime prior to
reaching steady-state.
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Figure 4.7: Simulated SNR for hyperpolarised
129Xe 3D SSFP, for a fixed bandwidth of ±8
kHz at different flip angles, as a function of fre-
quency offset (∆f0).
particular pixel location:
α = arccos
(
S2
S1
) 1
NyNz
(4.9)
where α is the flip angle and Ny and Nz are the number of phase encodes in the y and z directions,
respectively. The SPGR acquisitions must be performed with a high-enough target flip angle such that
sufficient signal decay is induced between successive acquisitions; for very low flip angles, inaccuracies
in the derived flip angle map can arise from relatively small differences in S2 and S1. Nevertheless, the
maximum flip angle is also constrained by the need to retain signal for a minimum of two complete ac-
quisitions. These considerations are especially important in 3D flip angle mapping when compared with
2D mapping, because all image voxels are excited by each RF pulse.
The flip angle for the flexible transmit-receive vest coil used for 129Xe ventilation imaging at 1.5 T (de-
scribed in Section 4.4.1) was found to be generally homogeneous across the 3D volume of the lungs, as
shown in Figure 4.8. In the most posterior slices, a higher flip angle was observed in the left lung, par-
ticularly the inferior region. In addition, the flip angle in the apex of the lungs was slightly lower than
that of the central and inferior lungs, especially in the central slices in the anterior-posterior direction.
However, overall, the inhomogeneity was less than 50%, with differences of ∼ 2-3◦ across the lungs in
the central slices and ∼ 5◦ in the most anterior and posterior slices, for an input flip angle of 10◦. The
mean ± standard deviation of the flip angle over the whole 3D volume was α = (4.29± 0.68)◦ for the
input flip angle of 4◦, which was scaled up to an input of 10◦, resulting in a mean ± standard deviation
of (10.74± 1.7)◦, assuming linearity of the RF hardware chain.
Resulting simulations of the distribution of 129Xe 3D SSFP SNR using these flip angle maps indicated
that the 3D SSFP acquisition is robust to variations in flip angle of the order of a few degrees (supporting
the simulations presented in Figure 4.4). As illustrated in Figure 4.9, the 3D SSFP signal was found to be
largely uniform across central and anterior slices, with a small degree of drop-off in regions of particularly
high flip angle in the most posterior slices.
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Figure 4.8: 3D flip angle maps for a flexible transmit-receive RF coil tuned to the hyperpolarised 129Xe resonance
frequency at 1.5 T. Original maps were acquired with an input flip angle of 4◦, as calibrated from the measurement
of the rate of global signal decay from a pulse-acquire-spoil sequence with short TR, as introduced in Section 3.2.6.
Displayed maps have been scaled to an input value of flip angle of 10◦, assuming linearity of the RF hardware
chain. The mean ± standard deviation of α from these maps was (10.74± 1.7)◦.
Figure 4.9: Simulated distribution of 3D SSFP SNR for a matrix size of 78× 24 phase encoding steps in the y and
z directions, respectively, derived using the 3D flip angle maps for 129Xe at 1.5 T shown in Figure 4.8.
B0 / ∆f0 maps were determined from a two-interleaved 3D SPGR sequence with different TE settings
for each interleave. For each voxel, of location r, the accumulated phase difference between the two in-
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terleaves can be related as follows:
∆φ (r) = φTE2 (r)− φTE1 (r) = −γ∆B0 (χ (r)) ∆TE (4.10)
where φTEm (r) is the phase of the particular voxel for interleave m and χ (r) is the local magnetic sus-
ceptibility in the voxel at position r. This equation can be derived using the Larmor equation ω = 2piγB0
and the definition of angular frequency as the rate of change of phase with time, ∆ω = ∆φ∆TE , and can be
rearranged to yield:
∆f0 (r) = −γ∆B0 (χ (r)) = ∆φ (r)
2pi∆TE
(4.11)
This equation can be utilised to derive the off-resonance frequency for each pixel in a 3D multi-
interleave acquisition by evaluating the phase angles of each voxel in the two interleaves.
Figure 4.10: 3D ∆f0 maps obtained using hyperpolarised
129Xe at 1.5 T. The mean ± standard deviation of ∆f0
from these maps was (15.15± 13.26) Hz.
The off-resonance frequency, ∆f0, was observed to be homogeneously distributed across the lungs, with
slightly higher values in the right lung compared to the left lung, as illustrated in Figure 4.10. The excep-
tion to this observed homogeneity was that high values of ∆f0 of up to 80 Hz were detected localised to
the basal region of the lungs, near the diaphragm. The mean ± standard deviation of the off-resonance
frequency over the whole 3D volume was ∆f0 = (15.15± 13.26) Hz.
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Resulting simulations of the distribution of 129Xe 3D SSFP SNR using acquired ∆f0 maps exhibited
a relatively uniform distribution of signal across the majority of the lungs, with no significant devia-
tions between anterior or posterior slices and central slices or between left and right lungs, as shown in
Figure 4.11. However, regions of significantly lower signal intensity near the diaphragm (corresponding
spatially to regions of high off-resonance in Figure 4.10) were noticeable in a non-negligible number of
slices. Moreover, these regions of low signal intensity correspond to the locations of the banding artefacts
typically detected in 129Xe ventilation imaging, as shown in Figure 4.5.
Figure 4.11: Simulated distribution of 3D SSFP SNR for a matrix size of 78 × 24 phase encoding steps in the y
and z directions, respectively, derived using the 3D ∆f0 maps for
129Xe at 1.5 T shown in Figure 4.10.
4.4 Feasibility of human lung ventilation imaging using highly
polarised naturally-abundant xenon
The purpose of this section was to evaluate the potential for high quality MRI of pulmonary ventilation
using naturally-abundant xenon (NAXe) gas with 3D SSFP pulse sequences optimised according to the
methods and findings presented in Section 4.3.
4.4.1 Methods
Study subjects
Three volunteers were recruited for ventilation imaging with naturally-abundant xenon (NAXe): (a)
healthy smoker, male, 28 years (HS); (b) healthy never-smoker, female, 32 years (HN1); (c) healthy never-
smoker, male, 28 years (HN2). All subjects showed normal spirometry and ≥ 95% oxygen saturation on
room air. Each volunteer provided written informed consent for this study, which was approved by the
UK National Research Ethics Committee.
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Hardware requirements
MR ventilation imaging of NAXe, EN129Xe and 3He was performed on a 1.5 T clinical whole-body MRI
scanner — GE Signa HDx (60 cm bore, GE Healthcare, Milwaukee, WI). NAXe MRI was also performed
at 3 T — Philips Ingenia (70 cm bore, Philips, Best, The Netherlands). Custom-built, flexible, quadrature
vest coils (CMRS, Brookfield, WI) were used to transmit and receive MR signals at the Larmor frequency
of 129Xe; 17.7 MHz (1.5 T) and 35.3 MHz (3 T), and of 3He; 48.6 MHz (1.5 T). Xenon gas (The Linde
Group, UK) was supplied in pre-mixed cylinders of 3% Xe, 10% N2 and 87% He, with a
129Xe content of
26% (NAXe) or 86% (EN129Xe). Helium-3 gas (Linde) was supplied in high purity (99.99% 3He).
129Xe was polarised by Rb-129Xe collisional spin-exchange optical pumping [61] using a home-built (UK
regulatory-approved) polariser constructed from widely-available components. In prior work, this po-
lariser was fitted with an external-cavity diode laser (ECDL), comprising a 30 W, 795 nm laser diode
bar externally-tuned by a holographic Bragg grating (2400 lines/mm), and enabled attainment of 129Xe
polarisations of the order of 10-15% under “continuous-flow” operation [65]. This system was recently
upgraded by fitting a 795 nm laser diode array with integrated volume holographic grating (BrightLase®-
Ultra-200; QPC, Sylmar, CA) providing 50 W of power incident on the optical cell containing the Rb
and Xe. An optical train with solid fibre (see e.g. [64]) was coupled to the diode to minimize light loss and
improve beam homogeneity along the length of the optical cell compared to the ECDL. These factors have
facilitated routine attainment of high 129Xe polarisations (∼ 25% for doses ≤ 1 L) under continuous-flow
operation [273]. For all 129Xe imaging experiments subsequently reported in this chapter, the 3% Xe gas
mixture was continuously flowed, at 0.35-0.4 sL/min, through the optical cell in a direction counter to
the incident laser light. Polarised xenon was cryogenically separated from the helium and nitrogen buffer
gases via a liquid nitrogen trap at the cell output. Accumulation of a 1 L dose of pure xenon required a
total flow time of ∼ 80 minutes (flow time ≈ dosage / (flow rate × Xe fraction)).
3He was polarised in an optical cell containing 99.99% 3He by Rb-3He collisional spin-exchange under
batch-mode operation, using a prototype commercial system (MITI, Durham, NC) over a period of ∼
14 hours. Doses of pure polarised 3He were extracted directly from the optical cell, with no cryogenic
accumulation required.
Image acquisition
Prior to all image acquisitions, the Larmor frequency and effective flip angle of 129Xe nuclei were cali-
brated. For centre frequency calibration, a high resolution 129Xe spectrum was acquired from the lungs of
each subject after inhalation of a 3% xenon mixture from a 1 L Tedlar bag (Jensen Inert Products, Coral
Springs, FL). Subjects maintained breath-hold for ∼ 5 s, and the excitation flip angle was determined by
fitting the decay of the hyperpolarised 129Xe signal from a series of pulse-acquire-spoil acquisitions from
the whole lungs with an inter-pulse TR of 50 ms. An equivalent procedure was carried out for 3He using
a 5% 3He:95% N2 gas mixture.
The following optimised 3D SSFP sequence parameters (see Section 4.3) were used for ventilation imaging
with NAXe at 1.5 T: field-of-view (FOV), 40 cm; phase FOV, 0.8 or 1.0; 20-24 effective coronal slices
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with no gap; in-plane resolution, 96 × 96 (4.2 mm pixel dimension); effective slice thickness, 10 mm in
the anterior-posterior direction; flip angle, 10◦; hard RF pulse; TE/TR = 2.1/6.4 ms (“balanced” SSFP
with asymmetric echo); bandwidth, ±8 kHz; breath-hold, 11-15 sec. Each subject exhaled to functional
residual capacity and inhaled 1 L of NAXe gas (∼ 25% polarisation) from a Tedlar bag prior to image
acquisition.
In one subject (HN2), same-breath (back-to-back) NAXe and 1H structural MR was performed at 1.5
T, similar to previous work performed with 3He or EN129Xe [100, 274]. The subject maintained breath-
hold for ∼ 16 sec after inhalation of 1 L NAXe; a 12 sec NAXe acquisition was followed by a 2 sec 1H
scan, with a small time delay in between due to software limitations. The structural 1H scan covered
the entire thorax (phase FOV, 1): 3D spoiled gradient echo sequence; TE/TR = 0.6/1.9 ms; bandwidth,
±83.3 kHz; flip angle = 5◦; identical pixel geometry as NAXe scan.
For comparison with NAXe imaging results, the same 3D SSFP imaging was performed on subjects HN1
and HS at 1.5 T using 400 mL EN129Xe mixed with 600 mL nitrogen, and identical imaging parameters as
above. In addition, hyperpolarised 3He 3D SSFP was performed at 1.5 T using a gas mixture of 200 mL
3He (25% polarisation) and 800 mL nitrogen. The following imaging parameters were modified for 3He
scans: TE/TR = 0.6/1.9 ms; bandwidth, ±83.3 kHz; breath-hold, 5 sec. EN129Xe and 3He images were
acquired subsequent to NAXe images, however, subjects exited the MR scanner for ∼ 1 hour between
scans to allow for continuous-flow accumulation of hyperpolarised 129Xe and switching of RF hardware,
respectively. Subjects were instructed to exhale to the same lung inflation level prior to inhalation of each
gas dose, to ensure comparable lung volumes for each data-set.
Lastly, to evaluate the feasibility of naturally-abundant xenon MRI at 3 T, subject HN2 was scanned
using a 3D SSFP pulse sequence with the following parameters: voxel size, 4.2× 4.2× 8 mm3, the latter
corresponding to the anterior-posterior direction; flip angle, 12◦; TE/TR = 1.5/4.7 ms; bandwidth, ±8.5
kHz; breath-hold, 8 sec. As above, the subject inhaled 1 L of NAXe prior to image acquisition.
For comparison of SNR between MR acquisitions with NAXe, EN129Xe and 3He, regions of interest (ROIs)
were placed in the upper right lobe of the lung and at the base of the image (outside the lungs) for each
slice. SNR was calculated as the ratio of mean signal in the first ROI to the standard deviation of the
signal in the second ROI.
4.4.2 Results
All of the NAXe images acquired from the three subjects at 1.5 T were of high quality, with mean SNRs of
between 25 and 40 (examples shown in Figure 4.12). The spatial resolution and SNR achieved permitted
identification of minor ventilation abnormalities in the healthy smoker’s lungs (white arrows, Figure 4.12).
A direct comparison of lung MR imaging with 200 mL 3He, 400 mL EN129Xe and 1 L NAXe is depicted
for subject HS in Figure 4.13. The average SNR values over all acquired slices were 40 ± 8, 36 ± 4 and
31± 5, respectively for the three doses.
At 3 T, the NAXe image SNR was considerably improved for subject HN2 when compared with 1.5 T,
even with the reduced voxel size (see Figure 4.14). The average slice SNR at 3 T was 40± 10 compared
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Figure 4.12: Selected coronal 3D SSFP image slices (10 mm thick) acquired from a healthy smoker (HS) and a
healthy never-smoker (HN1) after inhalation of 1 L of naturally-abundant hyperpolarised xenon at 1.5 T. White
arrows indicate minor ventilation defects (signal voids) identifiable in the lungs of the healthy smoker. The mean
SNR (average over all acquired slices) was 31± 5 and 33± 2 for subjects HS and HN1, respectively.
with 26± 6 at 1.5 T for this subject (c.f. T ∗2 ∼ 18 ms and 25 ms in partially-inflated lungs at 3 T and 1.5
T, respectively [251]). A small abnormality in the NAXe images was identified in the upper right lung of
this subject (white oval, Figure 4.14). This was previously associated with the impingement of a bifid rib
prior to carrying out this work. The NAXe image SNR at 1.5 T was also sufficient to identify this defect.
The results of same-breath 1H and NAXe MR at 1.5 T, depicted in Figure 4.15, confirmed that this void
in the hyperpolarised gas images was indeed recognisable from the co-registered proton images as a bifid
rib.
Particularly noticeable in Figure 4.15, pertaining to the false colour scale, it can be observed that in a
number of central and posterior slices, the NAXe signal intensity is lower in the apices of the lungs. This
effect can also be identified in Figures 4.12 and 4.14 for NAXe (or EN129Xe), although to a lesser extent
than in Figure 4.15. This finding is in agreement with the 129Xe flip angle maps presented in Figure 4.8,
and may result from the radiofrequency coil being placed in a more inferior position on subject HN2
compared with HS, HN1, or the subject for which the flip angle maps were acquired.
4.5 Compressed sensing for same-breath 3D 129Xe ventilation
imaging and 1H anatomical imaging
The purpose of this section was to assess the applicability of compressed sensing for acceleration of 129Xe
3D SSFP image acquisition, in order to reduce the required breath-hold duration for volumetric imaging
of patients with lung disease, and to facilitate same-breath acquisition of 129Xe ventilation images and
1H anatomical images. Author contribution statement: this work was completed in collaboration with
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Figure 4.13: Comparative coronal MR image
slices from a healthy smoker (HS) after inhala-
tion of a) 200 mL hyperpolarised 3He, b) 400
mL enriched xenon (86% hyperpolarised 129Xe)
and c) 1 L naturally-abundant xenon (26% hy-
perpolarised 129Xe), acquired at 1.5 T using an
optimised 3D SSFP sequence. The mean SNR
of 3He, EN129Xe and NAXe images attained
from this subject was 41± 8, 36± 4 and 31± 5,
respectively. Slice locations were not perfectly
identical due to the fact that the three scans
were not performed in a single session (see Sec-
tion 4.4.1).
Figure 4.14: 3D SSFP data-set from a healthy never-smoker subject (HN2), acquired using 1 L of naturally-
abundant xenon at 3 T. The average SNR over all acquired slices was 40 ± 10. The white oval indicates a small
“ventilation abnormality” that was identified for this subject, which is believed to be present due to a bifid rib,
rather than impaired ventilation function.
Guilhem Collier, who performed all CS simulations, and contributed to all stages of study design, data
acquisition and analysis.
4.5.1 Theoretical background
Image compression algorithms rely on the fact that images contain a considerable amount of redundant
information that can be removed in order to minimise the file size of the image whilst preserving image
quality and features. Compressed sensing (CS) has been developed as a means to acquire only the nec-
essary (non-redundant) information and reconstruct signals from data that would otherwise remain from
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Figure 4.15: Example images from same-breath proton and naturally-abundant xenon MR acquisition for a healthy
never-smoker (HN2) at 1.5 T. NAXe ventilation images (magenta) are overlaid directly on 1H (greyscale) structural
images; no image registration was performed. The mean SNR of the NAXe ventilation images was 26 ± 6. The
white oval indicates a bifid rib, which is clearly confirmed by the 1H image as a structural abnormality in the
thorax, external to the lung itself.
the compression process [275, 276]. The CS approach has been adapted for MRI applications by exploiting
the intrinsic sparsity of MR images [277]. CS implementation requires that three fundamental conditions
be fulfilled: (i) the target image must be sparse / compressible (i.e. should have a large number of zero
coefficients) in a given “transform domain”; (ii) data must be undersampled in a random, variable density
manner in order to ensure that artefacts in the transform domain are incoherent (“noise-like”) whilst
preserving the energy distribution of MR images in k-space; (iii) reconstruction must be performed by a
non-linear method, in order to ensure both sparsity of the image, and consistency between reconstructed
and acquired data. The first condition is intrinsically satisfied in MRI, and the second condition can be
implemented by careful choice of undersampling patterns as illustrated in Figure 4.16. Hence, randomly
undersampled images can be reconstructed by solving the following non-linear optimisation:
argmin
I
{‖FuI − y‖2l2 + λ‖ψI‖l1 + λTV TV (I)} (4.12)
where: Fu is the undersampled Fourier transform (i.e. the Fourier transform evaluated at only the
spatial frequencies defined by the undersampling pattern); I is the image to be reconstructed; y is the
acquired undersampled data; ψ is the sparsifying transform that translates the original data to the chosen
sparse transform domain; λ and λTV are regularisation parameters that weight the optimisation in order
to balance sparsity and data consistency. TV represents the total variation, which is the sum (l1 norm) of
the variations between neighbouring pixels over the image, and aids the reconstruction process by imposing
sparsity in finite differences simultaneously to sparsity in the transform domain. The lp norm is defined as:
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‖x‖lp = p
√∑
i
|xi|p where p ∈ Ò (4.13)
Hyperpolarised gas MR images are intrinsically sparse, and CS-based approaches have been tailored for hy-
perpolarised gas applications in order to reduce acquisition times and facilitate the attainment of multiple
aspects of pulmonary function within a single breath-hold; for example, to enable high resolution ventila-
tion imaging and apparent diffusion coefficient (ADC) mapping with 3He [278] and multiple-interleaved
acquisition of 3He ADC maps, B1 maps and T
∗
2 maps in a single breath-hold [279]. Recently, same-
breath acquisition of isotropic resolution 3D SSFP 3He images and anatomical 1H data-sets has been
demonstrated using compressed sensing [280]. In addition, a CS-based technique has been implemented
to permit phase contrast velocimetry MRI of the upper airways in order to quantify 3He and 129Xe gas
flow during free breathing [131].
4.5.2 Methodology and preliminary results
In order to simulate the effects of random undersampling and compressed sensing reconstruction, a fully-
sampled EN129Xe 3D SSFP data-set was acquired from a healthy smoker using sequence parameters
slightly modified from the 3D SSFP implementation described in Section 4.4.1. The number of phase
encodes in the z direction was increased from 24 to 32, in order to improve the reliability of random
undersampling in that dimension. Correspondingly, the pixel dimension in the z direction was reduced to
7.5 mm, such that the voxel resolution was 4.2× 4.2× 7.5 mm3 in three dimensions. Additional sequence
parameters were as follows: FOV and flip angle as in Section 4.4.1; phase FOV, 0.8; TE/TR = 3.6/7.9
ms; bandwidth, ±8 kHz; breath-hold, 18 sec. The subject exhaled to functional residual capacity and
inhaled a gas mixture of 500 mL EN129Xe and 500 mL N2 from a 1 L Tedlar bag prior to image acquisition.
Figure 4.16: Undersampling patterns for 3D SSFP compressed sensing acquisition with 129Xe, for acceleration
factors (AF) of between 2 and 5. (White pixel: data-point will be acquired; dark pixel: data-point will not be
acquired.)
“Undersampling patterns” were generated by selecting points, in a pseudo-random fashion, in the y and z
phase encoding directions that should not be acquired, whilst ensuring that the central region of k-space
was not severely undersampled as to compromise consistency of undersampled and fully-sampled data.
This so-called variable density random undersampling was implemented by employing a sampling density
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that scales as a power law with the distance of each pixel from the k-space origin v.
Figure 4.16 depicts optimised sampling patterns for different acceleration factors (AF) between 2 and
5, indicating the factor by which the total number of phase encodes to be acquired is reduced (or equiva-
lently, the factor by which the total scan time is shortened). As illustrated in Figure 4.16, increasing the
degree of undersampling leads to the acquisition of significantly fewer high spatial frequency components
(or correspondingly, less acquired k-space points near the periphery of k-space), whilst almost all low
frequency components (data-points in the central regions of k-space) would still be acquired.
Figure 4.17: a) Representative slice from CS-reconstructed images obtained from retrospective undersampling
of the k-space of the original fully-sampled data-set, using the sampling patterns depicted in Figure 4.16, for
acceleration factors (AF) of between 2 and 5. b) Difference images representing the pixel intensity difference
between the original image and each of the simulated CS-reconstructed images (for AF = 2 to 5; first panel of b)
shows the original image).
The k-space of the acquired fully-sampled data-set was retrospectively undersampled in order to simu-
late the effects of the undersampling patterns. For each designed pattern, retrospectively-undersampled
images were reconstructed using the non-linear optimisation in Equation 4.12. Figure 4.17 shows an ex-
ample slice from the original fully-sampled data-set (reconstructed by the conventional discrete Fourier
transform), and the equivalent slice reconstructed from retrospectively-undersampled images at each ac-
celeration factor between 2 and 5, for the optimum sampling patterns shown in Figure 4.16. The effect of
the CS reconstruction was noticeable as additional blurring and smoothing of small details in the images,
which intensified with increasing AF.
In order to quantify the differences between the original images and the CS-reconstructions of the
retrospectively-undersampled k-spaces, the mean absolute error (MAE) metric was evaluated on a pixel-
by-pixel basis for a region of interest covering the full lungs.
vUndersampling patterns were generated for a number of different parameters by varying the order of the power law and
also the effective radius of the central disk of fully-sampled points in k-space. For each case, a number of randomly-ordered
patterns were generated, and the closest representation of a truly random pattern was used in subsequent simulations.
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MAE =
∑Ny
j=1
∑Nz
k=1|CSj,k − FSj,k|
NyNz
(4.14)
where CS and FS denote CS-reconstructed and original (fully-sampled) images, respectively, and Ny
and Nz are the number of phase encodes in the y and z directions, respectively. MAE analysis was per-
formed for all generated undersampling patterns, and the optimum patterns (displayed in Figure 4.16)
were chosen as those which provided the minimum MAE value. The MAE for the chosen undersampling
patterns is plotted as a function of AF in Figure 4.18. The MAE is 0 by definition for the fully-sampled
image, and was observed to steadily increase with AF, appearing to approach a plateau value at the
highest AF values.
Figure 4.18: Mean absolute error (MAE) as a
function of acceleration factor (AF) for CS sim-
ulations of the fully-sampled 129Xe 3D SSFP
acquisition, as shown in Figure 4.17.
Considering the data presented in Figures 4.17 and 4.18, an acceleration factor of 3 was chosen as a suitable
compromise for CS-based acquisitions; affording a significant reduction in scan time whilst preserving the
major details of the image, and adding only an acceptably low level of blurring during the reconstruction
process. The associated AF = 3 undersampling pattern was employed to obtain prospective CS 3D SSFP
data-sets in two healthy subjects (one healthy smoker, HS, as above; one healthy never-smoker, male, 45
years, HN3). Sequence parameters were equivalent to those of the fully-sampled acquisition, except: the
flip angle was increased to 11◦ (the optimum value resulting from SSFP signal simulations, reflecting the
3-fold reduction in number of RF pulses); breath-hold time was reduced to 6 sec; EN129Xe volume, 600
mL (mixed with 400 mL nitrogen).
Reconstructed undersampled images were of a good quality, with high SNR and no significant identifi-
able losses in image details due to excessive blurring. The complete CS-reconstructed data-set from HN3
is shown in Figure 4.19.
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Figure 4.19: Prospective CS data-set obtained using 3D SSFP with 600 mL EN129Xe in a healthy subject (HN3).
Acceleration factor = 3; voxel size = 4.2 × 4.2 × 7.5 mm3, the latter corresponding to the anterior-posterior
dimension.
4.6 Discussion & Conclusions
3D SSFP simulations
This work highlights the benefits of 3D SSFP-based acquisition strategies for full-lung coverage, high
quality lung ventilation imaging with hyperpolarised 129Xe. The ideal bandwidth and flip angle settings
for a target resolution of 4.2× 4.2× 10 mm3 at 1.5 T have been derived by comparing in vivo measured
and numerically-simulated k-space filters in order to estimate the T2,CPMG of
129Xe at 1.5 T. Both global
and regional simulations, the latter utilising the measured spatial flip angle maps of a flexible transmit-
receive vest coil, have demonstrated that 3D SSFP approaches are robust to imperfect calibration of RF
excitation flip angle, and minor variations in the flip angle across the lungs, respectively.
The constraints imposed on 3D SSFP imaging by off-resonance and associated banding artefacts have
been explored by numerical simulations of the SNR on a global and regional basis, the latter using B0
maps measured for 129Xe in the lungs. Regions of high off-resonance frequency, and associated banding
artefacts, have been observed to be localised to the diaphragm region. Recognition of these artefacts may
be improved in future by communicating their prevalence and typical appearance to the image analyst.
Unlike the excitation flip angle, it is crucial to ensure that the transmit/receive frequency is carefully
calibrated to be equivalent to the Larmor frequency of 129Xe in the lungs of each subject to be scanned;
it has been shown here that poor images may result if this condition is not precisely met.
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The simulation strategies developed in this work permit the “correction” of 3D SSFP signal intensity
using B1 and B0 maps. Same-breath acquisition of B1 and B0 maps is feasible within a single breath-
hold using interleaved sequences, which can be accelerated by the implementation of techniques such as
compressed sensing [279]. In future work, it may be feasible to obtain B1 and B0 maps in a separate
breath to 3D SSFP images, simulate the expected SNR from these maps, and then retrospectively correct
the signal distribution of the 3D SSFP data-set. This method would intrinsically account for flip angle
and off-resonance frequency variations across the lungs and result in an image weighted predominantly
by the 129Xe gas distribution (i.e. ventilation), however would be limited by the accuracy of the image
registration techniques used to compare and analyse the separate-breath images.
Since the publication of the paper regarding some of the preliminary work described here, an additional
factor associated with the simulation procedure has been identified. The current simulation strategy fun-
damentally assumes that the SSFP sequence is fully balanced and that the generated echo is positioned
in the centre of the acquisition window. Although the gradients employed in Sections 4.3 and 4.4 were
balanced such that the total gradient area along each axis was zero, a minimum TE, asymmetric read-out
echo was used to enable the shortest possible scan time. As introduced in Section 3.2.5, the SSFP MR
signal is governed by T2 (with little T
∗
2 contribution) only if the echo is positioned at the centre of the
acquisition window; i.e. the use of an asymmetric echo leads to some weighting according to T ∗2
vi.
The effect of employing a symmetric echo as opposed to an asymmetric echo is presently under in-
vestigation, in order to evaluate the possibility of further improving the image quality with the use of
a perfectly symmetric echo, and to determine to what extent our estimate of T2,CPMG is affected by
dephasing due to background B0 inhomogeneity. As a preliminary experiment, following the procedures
described in Section 4.3.2, k-space filters were acquired from the lungs of a healthy smoker in vivo using
a modified 3D SSFP sequence with an asymmetric echo (TE = 2.1 ms) and a symmetric echo (TE = 3.6
ms) (other parameters: 8 kHz bandwidth, 10◦ flip angle). The resulting k-space filters are depicted in
Figure 4.20.
Figure 4.20: Measured k-space filters depicting
the decay in longitudinal magnetisation, Mz,
of hyperpolarised 129Xe during 3D SSFP with
asymmetric (min TE) and symmetric (min-full
TE) echoes.
viNevertheless, in practice, for a spin ensemble in which random (Brownian) diffusion is present, magnetic field inhomo-
geneities will induce additional signal decay even for a symmetric echo, because the phase losses associated with the random
diffusion of spins through an inhomogeneous field cannot be refocussed within the finite inter-echo time.
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The observed difference in signal decay behaviour between the two echo types is non-negligible, but ap-
pears to be less than the differences seen between bandwidth settings (as shown in Figure 4.3). Therefore,
from Figure 4.4, it can be concluded that the difference in optimum flip angle and achievable SNR associ-
ated with using symmetric versus asymmetric echoes is relatively minor. Nevertheless, in future work, the
simulations presented in Figures 4.3 and 4.4 will be repeated for the case of a perfectly symmetric echo,
in order to further investigate the achievable image SNR, and to derive a more accurate estimate of the
intrinsic T2,CPMG. This will be coupled with the employment of a variable flip angle 3D SSFP scheme
for 129Xe, as demonstrated previously in 2D with 3He [266], in order to further improve image SNR and
reduce blurring associated with ky and kz filtering.
3D SSFP imaging
With improved 129Xe polarisations and pulse sequence optimisation procedures, we have demonstrated
full-lung coverage MRI with naturally-abundant hyperpolarised xenon using 3D SSFP, of a similar quality
to recent studies with EN129Xe [86, 87, 281]. Scans were completed within a moderate breath-hold (≤ 16
sec), with sufficient resolution (4.2 × 4.2 × 8/10 mm3) to allow recognition of subtle abnormalities in
pulmonary ventilation, comparable to those expected in early-stage lung disease. At 1.5 T, the mean 3D
SSFP image SNR for NAXe was moderately variable between subjects, likely due to differences in lung
size, completeness of exhalation to functional residual capacity (and residual oxygen content in the lungs
[209]), and fluctuations in 129Xe polarisation. Nevertheless, the SNR for any individual slice over all sub-
jects was ≥ 18.5, which should be sufficient for radiological interpretation and automated segmentation.
A minor ventilation defect in the right middle lobe of the healthy smoker’s lungs was clearly depicted on
both EN129Xe and NAXe scans, although arguably less noticeable on 3He images (Figure 4.13). This can
be attributed to the different diffusion coefficients of the two gases; we note that Kirby et al. observed a
higher ventilation defect percentage for 129Xe than 3He in subjects with chronic obstructive pulmonary
disease [85]. Although the xenon diffusion coefficient will be partially increased in the presence of nitrogen,
there is no current literature evidence that 129Xe ventilation defect presentation is significantly altered by
the concentration of xenon within the inhaled mixture. Despite accurate calibration of the 129Xe Larmor
frequency, slight banding artefacts associated with B0 inhomogeneity were observed in ≤ 5 slices per
subject, typically appearing as dark bands near the diaphragm. These artefacts were easily identified
and did not inhibit the identification of true ventilation defects. Although the magnetic susceptibility
and correspondingly B0 inhomogeneity increases with field strength, there was no observation of more
prominent banding at 3 T compared with 1.5 T.
NAXe MR is particularly promising at 3 T, wherein the increased SNR compared with 1.5 T — likely
arising from a combination of differences in Larmor frequency, field inhomogeneity, coil sensitivity and the
“system” (e.g. the transmission line and receiver noise figure) at the two field strengths — reflects previous
observations with spoiled gradient echo imaging [251]. This SNR benefit, coupled with the possibility of
using receiver array coils rather than standard transmit-receive designs as employed here, may facilitate
NAXe lung imaging with 3D isotropic resolutions in future. In addition, the feasibility of same-breath
1H and NAXe MRI is encouraging for obtaining complementary structure-function information from the
lungs without necessitating multiple scans crossing different modalities. However, the breath-hold of ∼ 16
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sec could be shortened for clinical purposes, e.g. via compressed sensing techniques, as introduced in
Section 4.5.2.
Preliminary results of compressed sensing with EN129Xe have demonstrated the feasibility of three-
fold undersampling for high quality 129Xe ventilation imaging in a breath-hold  10 sec, with superior
resolution in the anterior-posterior direction compared with the NAXe and EN129Xe images presented at
1.5 T in Section 4.4.2. Simulations of the undersampling effects and CS reconstruction, in combination
with prospectively-acquired images in healthy volunteers, highlight the promise of rapid ventilation imag-
ing in a clinically-achievable breath-hold with 129Xe. Expected additional blurring introduced during the
CS reconstruction was not easily noticed in images obtained at an acceleration factor of 3, and no other
ancillary artefacts could be observed on prospectively-acquired undersampled images. The advancement
of CS acquisition and reconstruction strategies is ongoing work; for example, current work focusses on the
implementation of elliptical encoding with undersampling in the y and z phase encoding dimensions to
enhance achievable image SNR and support the CS reconstruction process. These improvements should
enable routine implementation of 129Xe 3D SSFP with CS in clinical studies with same-breath 1H scans
to provide complementary anatomical information. Same-breath acquisition provides better-matched 1H
and hyperpolarised gas lung volumes than separate-breath acquisition [282], simplifying or mitigating
image registration and improving the fidelity of quantitative assessment of ventilation defects, e.g. by
calculation of ventilated volume.
Perspectives of NAXe MRI
The comparable SNR of lung images acquired with 200 mL 3He, 400 mL EN129Xe and 1 L NAXe is
promising for more widespread viable diagnostic lung MRI with naturally-abundant xenon, or reduced
doses of enriched xenon. Taking recent cost estimates provided to our group and others, the relative cost
of gas for the scans in Figure 4.13 could range from approximately 6:2.5:1 to as high as 20:8:1 for 3He,
EN129Xe and NAXe, respectively (assuming that 3He is purchased under controlled release). For many
groups the cost benefits of NAXe could be considerably greater; for example, recently, other institutions
have delivered 300-400 mL of 3He [86] or up to 1 L of EN129Xe [87, 95] for lung imaging purposes, com-
pared to the modest doses we have shown to be sufficient for high SNR, though the pulse sequences and
attainable gas polarisations used in those studies differed from this study.
The implications of the achievable economic benefits with naturally-abundant xenon MRI are multi-fold:
not only in the realisation of repeated screening of patients with lung disease, but also for longitudinal
studies of disease progression and treatment efficacy. Although litre doses of NAXe may not be suffi-
cient for performing techniques with a particularly high SNR requirement — such as dissolved 129Xe
MR spectroscopy [140] or chemical shift imaging [147] where T ∗2 decay is rapid [249, 250] and available
signal is severely constrained — one can envisage the potential of NAXe as the mainstay gas for future
routine clinical ventilation imaging applications. Our findings are encouraging for NAXe fulfilling the
requirements imposed by the increasingly limited availability of 3He, and are timely and relevant to the
hyperpolarised gas MRI field as a whole. In particular, NAXe should provide an inexpensive testing plat-
form for development of hyperpolarised gas MR methods and offer additional opportunities for exposure
of these techniques to the wider clinical audience.
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In addition, further technological developments are permitting the production of hyperpolarised 129Xe
in large concentrations for “on-demand” delivery [65, 283]. Although this polarisation technology is cur-
rently only in-place at a few sites globally, the advent of lower-cost polarisers utilising high power lasers
[64] is likely to attract attention from lung clinicians and MR scientists and promote increased application
of hyperpolarised 129Xe MRI. Indeed, our group in Sheffield is now undertaking clinical radiology referrals
for diagnostic hyperpolarised gas imaging with 3He and 129Xe, made feasible in part due to the technical
advancements and economic benefits demonstrated in this work.
Conclusions
In this work, the potential of high quality clinical imaging of pulmonary ventilation with naturally-
abundant and enriched 129Xe at both of the clinically-relevant MRI field strengths (1.5 T and 3 T) has
been demonstrated.
3D steady-state acquisition strategies have been optimised for full-lung coverage ventilation imaging
with 129Xe by simulating the SNR for different combinations of sequence parameters and accounting for
the B1 and B0 distributions across the thorax. These results should improve the distinction of banding
artefacts and true ventilation abnormalities in 129Xe ventilation images, and may permit the correction
of the signal distribution of acquired 3D SSFP images in future.
By exploiting these optimisations in pulse sequence acquisition strategy, in combination with recent
advances in polarisation technology, high quality lung MR images with litre quantities of inhaled NAXe
gas have been acquired using standard transmit-receive RF coil designs, with no loss of functional informa-
tion compared to hyperpolarised 3He MRI. At a fraction of the cost per scan of 3He, commercially-realistic
diagnostic, longitudinal and treatment efficacy studies may now be envisaged.
Furthermore, the applicability of compressed sensing reconstruction techniques for rapid undersampled
acquisition of 129Xe ventilation images should expedite the routine attainment of co-registered functional
and structural information via facilitating same-breath hyperpolarised gas and proton MR imaging. Con-
tinued improvements in this field should allow 129Xe to fill the gaps imposed by the decline in availability
of 3He.
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Chapter 5
Comparison of 3He and 129Xe MRI
for evaluation of lung microstructure
and ventilation at 1.5 T
5.1 Introduction
To date, a large proportion of hyperpolarised gas lung MRI methodological development studies and
clinically-relevant patient examinations have been performed using 3He gas. Despite this, recent years
have seen an upsurge in the application of 129Xe for lung MRI [284], encouraging an increased number of
patient studies of both lung ventilation [85, 87, 89, 95] and microstructure [115, 116] with this naturally-
abundant isotope. The resurgence in the use of 129Xe for lung imaging purposes is attributable to both
the decline in availability and consequentially rising cost of 3He [84], and developments in the field of
gas polarisation technology [63–65], which are helping to bridge the gap in image quality imposed by the
difference in gyromagnetic ratio between 129Xe and 3He and its contribution to image SNR.
In the past few years, a number of comparative studies of the relative sensitivity of 3He and 129Xe
methods for assessment of lung ventilation function and microstructural changes have been reported —
particularly by the group at Robarts Research Institute — in healthy subjects and patients with chronic
obstructive pulmonary disease [85, 88], asthma [86] and former smokers [116]. Generally, pulmonary ven-
tilation and microstructural information of similar quality and equivalent pathological significance has
been obtained from MRI of the two nuclei. In addition, small animal studies have been performed to
evaluate quantitative measurements of ventilated lung volume with 3He and 129Xe [285], and to compare
apparent diffusion coefficient measurements derived from both nuclei to histological results [286], with
promising results in both cases for the use of 129Xe as an alternative to 3He.
To date, studies comparing 3He and 129Xe ventilation and diffusion-weighted MRI of the lungs in
humans have been carried out at the field strength of 3 T (by the Robarts group). As such, possible
differences in the implementation of, and quantitative information resulting from, these methods at the
more clinically-relevant field strength of 1.5 T have not been examined.
In previous work, the most often presented quantitative metric of hyperpolarised gas ventilation imag-
ing has been the ventilation volume percentage (VV%), or conversely, the ventilation defect percentage
(VDP), which represents the total percentage of the lung volume that is ventilated by the hyperpolarised
gas, or the volume that is not ventilated, respectively. The 3He VV% metric has been demonstrated to
be highly reproducible at 3 T in COPD patients [74, 287], although the one-week variability was found to
be considerably higher than the same-day reproducibility. Additionally, good same-day reproducibility in
3He VV% has been reported in a potentially challenging population of paediatric cystic fibrosis patients
[288], whilst preliminary evidence has suggested that one-week changes in pulmonary function in adult
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CF patients could be identified by the high precision of 3He VDP compared with PFT results [289]. More-
over, the results of a multiple-site study of ventilation defect prevalence in subjects with exercise-induced
bronchoconstriction are promising for translation of hyperpolarised 3He ventilation imaging to a wider
clinical audience [290].
However, the same-day or week-to-week variability in quantitative measurements of lung ventilation
volume or defect prevalence derived from 129Xe MRI has not been determined. Driehuys et al. [95] and
Shukla et al. [96] have both reported the successful delivery of multiple doses of 129Xe for ventilation
imaging on the same day or on repeated days to subjects with a variety of pulmonary conditions, however,
the purpose of those studies was to assess the safety and tolerability of repeated 129Xe MRI, and as such,
quantitative evaluation of lung ventilation and its reproducibility was not achieved.
In a similar manner to the VV% or VDP indices, clinical hyperpolarised gas diffusion-weighted MRI
studies to date have typically reported the global mean 3He or 129Xe ADC value as a biomarker of overall
change in lung microstructure due to disease. Comprehensive investigations of the same-session [291] and
multiple-day [292] reproducibility of derived global mean 3He ADC values have revealed a high intra-
individual reproducibility in healthy subjects and patients with emphysema, and in addition, an acute
sensitivity of 3He ADC to changes in lung volume. Furthermore, investigations at 3 T have highlighted
a superior reproducibility of 3He ADC values when compared to VDP values in patients with COPD
[74, 287].
To the best of our knowledge, same- or multiple-day variability in 129Xe ADC measurements has not
been adequately assessed in healthy subjects or patient cohorts. Furthermore, to date, comparisons of
3He and 129Xe ventilation imaging and ADC mapping in humans have been limited to single session scan
results with no 129Xe reproducibility data available. Thus, the relative sensitivity of the two gases to
pulmonary functional changes probed by the two different techniques has not been fully explored.
The purpose of this chapter is to evaluate the sensitivity and reproducibility of 129Xe quantitative venti-
lation imaging and ADC mapping MRI of the lungs relative to 3He-based methods. This work presents
the results of a study at 1.5 T in which 3He and 129Xe MR images of lung ventilation were obtained
from patients with lung cancer and COPD, and ADC mapping with both nuclei was performed in healthy
volunteers and COPD patients. The multiple time-point reproducibility of the derived 3He and 129Xe
ventilation volume percentages and global mean ADC values is assessed in comparison to the same-day
and weekly variability of pulmonary function test results in COPD patients. Thus, the potential for
129Xe fulfilling the role of 3He as a clinically scalable inhaled contrast agent for functional and structural
assessment of the lungs is discussed.
Although the contents of this chapter have not been prepared as a manuscript, preliminary results have
been published in the form of a conference abstract (see Section 11.1), and it is planned that a publication
based on this chapter will be written in the near future. The co-authors of this chapter are: HF. Chan, P.
J. C. Hughes, G. J. Collier, F. C. Horn, G. Norquay, J. Parra-Robles, D. P. Yates, P. Collini, R. Lawson,
H. Marshall, and J. M. Wild. Author contributions statement: study design, DPY, PC, RL, HM, JMW;
acquisition of data, NJS, HFC, PJCH, GJC, FCH, GN, JPR, HM; analysis of data, NJS, HFC, PJCH,
GJC, JPR; drafting of chapter, NJS, JMW.
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5.2 Methods
Ten healthy volunteers with no history of smoking or respiratory disorders (6 male, 4 female; mean age
= 42± 4 years), five patients with COPD (2 male, 3 female; mean age = 67± 7 years), and six patients
with non-small cell lung cancer (2 male, 4 female; mean age = 69± 6 years) were recruited for this study,
which was approved by the National Research Ethics Committee. Patient characteristics and pulmonary
function test results are summarised in Table 5.1. Subjects with a resting oxygen saturation of < 90%,
unstable cardiac disease, or — in the case of lung cancer patients — co-morbid conditions that precluded
radiotherapy treatment, were excluded from the recruitment process.
All subjects underwent MRI at 1.5 T (GE HDx, GE Healthcare, Milwaukee, WI). Flexible radiofre-
quency coils were employed for transmission and reception of MR signals at the Larmor frequencies of
3He and 129Xe, as described in the previous chapter (see Section 4.4.1). Similarly, identical procedures to
those outlined in Section 4.4.1 were used for spin-exchange optical pumping of the two gases. In the case
of both nuclei, the polarisation achieved prior to inhalation of the gas dose was ∼ 25%.
Demographics PFT Parameters
Patient Age FEV1 CV FEV1/FVC CV TLCO CV
(Sex) (%-pred) (%) (%-pred) (%) (%-pred) (%)
HV1 49 (M) 94 — 78.5 — 102 —
HV2 36 (F) 98 — 82.3 — —  —
HV3 43 (M) 103 — 79.45 — 85 —
HV4 51 (M) 106 — 77.97 — —  —
HV5 43 (M) 107 — 79.49 — 102 —
HV6 48 (F) 123 — 80.01 — 110 —
HV7 42 (M) 111 — 79.61 — 103 —
HV8 44 (F) 98 — 80.75 — 67 —
HV9 32 (F) 89 — 82.94 — 72 —
HV10 35 (M) 107 — 80.91 — 101 —
LC1 68 (F) — — — — — —
LC2 76 (M) — — — — — —
LC3 62 (M) — — — — — —
LC4 72 (F) — — — — — —
LC5 72 (F) — — — — — —
LC6 62 (F) — — — — — —
COPD1 64 (F) 31.5± 0.7 2 33.2± 0.6 2 33.2± 2.1 6
COPD2 67 (F) 45.4± 1.6 4 49.8± 0.7 1 98.4± 3.8 4
COPD3 71 (M) 31.0± 1.3 4 27.6± 1.1 4 13.6± 2.2 16
COPD4 76 (M) 43.5± 2.1 5 32.5± 0.8 3 29.6± 2.0 7
COPD5 59 (F) 38.6± 2.5 6 42.8± 0.8 2 38.0± 4.1 11
Table 5.1: Patient demographics and pulmonary function test (PFT) results for the 3He-129Xe VV% and ADC
comparison study. HV: healthy volunteer; LC: lung cancer patient; COPD: chronic obstructive pulmonary disease
patient. FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; TLCO = diffusing capacity
of carbon monoxide; CV = coefficient of variation (i.e. the ratio of the standard deviation to the mean of repeated
measurements, expressed as a percentage); %-pred = PFTs expressed as a percentage of a predicted value, based
on the subject’s age, height, and other demographic factors. : TLCO data was unavailable from two subjects of
the healthy volunteer cohort.
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Patients with lung cancer and COPD underwent 3D steady-state free precession (SSFP) imaging of lung
ventilation at breath-hold with both 3He and 129Xe. 1H images of the thorax were acquired for anatomical
reference and lung volumetry in the same-breath as 3He scans, and in a separate breath-hold to 129Xe
scans. Ventilation volume percentages (VV%) were calculated from the resulting hyperpolarised gas and
corresponding 1H anatomical images as described previously [282].
Immediately prior to 3D SSFP imaging, the Larmor frequencies of 3He or 129Xe were calibrated in
the lungs of each subject, in order to minimise off-resonance effects associated with the steady-state pulse
sequence. As outlined in Section 4.4.1, a small dose of either 3He or 129Xe was mixed with medical grade
nitrogen and inhaled by the subject, and the Larmor frequency in the lungs of the subject was calibrated
from a high resolution spectral acquisition. Unlike in Section 4.4.1, calculation of the RF excitation flip
angle setting by NMR was not required; the flip angle for each nucleus was derived from the patient’s
weight based on look-up plots of RF power values obtained from previous subjects shown in Figure 5.1.
Figure 5.1: Calibration graphs for estimating the instruction amplitude (ia rf1) required for achieving a 10◦ flip
angle for 3D SSFP ventilation imaging with 129Xe (left) and 3He (right) from the patient’s weight. The instruction
amplitude is a GE scanner operator parameter that, to a good approximation, scales linearly with the excitation
flip angle induced by the coil.
3D SSFP sequence parameters were similar to those detailed in [282] and [89] for 3He and 129Xe, re-
spectively. For 3He: field-of-view (FOV), 40 cm; phase FOV, 0.8; ≈ 48 effective coronal slices with
no gap; in-plane matrix, 100 × 100 (4.0 mm pixel dimension); effective slice thickness, 5 mm in the
anterior-posterior direction; flip angle, 9◦; hard RF pulse; TE/TR = 0.6/1.9 ms; bandwidth, ±83.3 kHz;
breath-hold, 9 sec. Each subject exhaled to functional residual capacity and inhaled a mixture of 200 mL
3He gas and 800 mL N2 from a 1 L Tedlar bag prior to image acquisition.
For 129Xe, sequence parameters were comparable to those described in Section 4.4.1: FOV, 40 cm;
phase FOV, 0.8; ≈ 24 effective coronal slices with no gap; in-plane matrix, 100 × 100 (4.0 mm pixel
dimension); effective slice thickness, 10 mm in the anterior-posterior direction; flip angle, 9◦; hard RF
pulse; TE/TR = 2.2/6.7 ms; bandwidth, ±8 kHz; breath-hold, 14 sec. Each subject exhaled to functional
residual capacity and inhaled a mixture of 600 mL of EN129Xe gas and 400 mL N2 from a 1 L Tedlar
bag prior to image acquisition. Note: the 129Xe polariser apparatus used was the “upgraded” system
described in Section 4.4.1.
In both cases, 1H anatomical images were designed to have exactly the same positioning and resolution
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Figure 5.2: Representative 3He and 129Xe MR
ventilation images of the lungs of a healthy
never-smoker (a), a patient with COPD (b) and
a patient with lung cancer (c). The slice thick-
ness and in-plane resolution for the 3He and
129Xe acquisitions in a) was identical, whilst
3He images in b) and c) were acquired with half
the slice thickness of the 129Xe images (see body
text).
as the matching hyperpolarised gas images in three dimensions, but with a phase FOV of 1.0, and the
following prescription: 3D spoiled gradient echo sequence; TE/TR = 0.6/1.9 ms; bandwidth, ±83.3 kHz;
flip angle = 5◦. Example 3He and 129Xe images from the two patient cohorts are shown in Figure 5.2,
along with images previously obtained from a healthy subject for visual comparison.
Healthy volunteers and COPD patients underwent multi-slice 2D 3He and 129Xe diffusion-weighted lung
MRI. Maps of the apparent diffusion coefficient (ADC) of each gas in the lungs were generated by eval-
uating the mono-exponential diffusion-weighted signal equation (Equation 3.114) on a pixel-wise basis,
using the pixel intensities from the first two interleaves of a multiple b-value acquisition.
2D spoiled gradient echo pulse sequences with diffusion weighting on the z (slice) axis were employed
in both cases. Parameters for 3He acquisitions were comparable to those described in [293]: FOV, 40
cm; phase FOV, 0.75; 5 coronal slices with thickness, 15 mm and inter-slice gap, 10 mm; in-plane matrix,
64 × 64 (6.25 mm pixel dimension); flip angle, 4.8◦; sinc RF pulse; TE/TR = 4.8/10.0 ms; bandwidth,
±31.25 kHz; breath-hold, 16 sec. Diffusion weighting was applied using bi-polar gradient waveforms as
follows: diffusion time ∆ = 1.6 ms, ramp time τ = 0.3 ms, plateau time δ = 1.0 ms (see Figure 3.28);
separation of lobes = 0 ms; number of diffusion-weighted interleaves, 6; maximum gradient amplitude,
31.6 mT.m-1; first two interleaves, b = 0 and b = 1.6 s.cm-2. Each subject exhaled to functional residual
capacity and inhaled a mixture of 300 mL 3He gas and 700 mL N2 from a 1 L Tedlar bag prior to image
acquisition.
129Xe scans were performed with equivalent FOV, slice thickness and slice gap, but one less slice was
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Figure 5.3: Representative example 3He and
129Xe single slice ADC maps obtained from a
COPD patient. The slice thickness and slice
gap for the 3He and 129Xe ADC acquisitions
was equivalent, but the in-plane phase-encoding
pixel dimension of the two acquisitions was
slightly different (see main body text).
Figure 5.4: Scan schedule for assessment of
reproducibility of 3He and 129Xe MR-derived
VV% and ADC values. Two scans were per-
formed on the first day, one on the second day,
and one two weeks after the first scan date.
acquired overall (totally 4 slices), other parameters were as follows: in-plane matrix, 64× 48 (6.25× 8.33
mm2 pixel dimensions); flip angle, 6.7◦; sinc RF pulse; TE/TR = 12.5/27.0 ms; bandwidth, ±2 kHz;
breath-hold, 16 sec. In order to achieve approximately equivalent diffusion weighting as for 3He within
a reasonable breath-hold (i.e. a similar degree of signal attenuation), bi-polar gradient waveforms were
applied as follows: diffusion time ∆ = 5.0 ms (ramp time τ = 0.3 ms, plateau time = 3.0 ms); separation of
lobes = 1.4 ms; number of diffusion-weighted interleaves, 4; maximum gradient amplitude, 32.2 mT.m-1;
first two interleaves, b = 0 and b = 8.0 s.cm-2. Each subject exhaled to functional residual capacity and
inhaled a mixture of 600 mL 129Xe gas and 400 mL N2 from a 1 L Tedlar bag prior to image acquisition.
Examples of 3He and 129Xe ADC maps acquired from a COPD subject are depicted in Figure 5.3.
One of these examples is shown side-by-side with ADC maps obtained from a healthy subject in Figure 2.6.
The complete imaging protocol (3He and 129Xe ventilation and diffusion-weighted MR imaging) was re-
peated in the COPD patients on three additional scan sessions (1: on the same day as the first session
(session 0), 2: on the following day, 3: two weeks after session 0, as illustrated in Figure 5.4) in order
to assess the reproducibility of 3He and 129Xe MR-derived metrics of ventilated volume percentage and
apparent diffusion coefficient.
Pulmonary function tests (PFTs) — including the diffusing capacity of carbon monoxide (TLCO),
forced expiratory volume in 1 second (FEV1), and the ratio of FEV1 to forced vital capacity (FVC)
(FEV1/FVC) — were performed by each COPD patient, once on the same day as each MR scan session
(i.e. three times in total). Healthy volunteers carried out equivalent PFTs on the same day as diffusion-
weighted MRI scans. Lung cancer patients did not undergo pulmonary function testing as a part of this
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study.
Estimates of VV% and ADC derived from 3He and 129Xe MRI were compared in order to appraise the
relative functional sensitivity of the two gases to ventilation abnormalities associated with pulmonary
tumours and/or obstructive lung disease, and microstructural changes associated with emphysematous
tissue destruction or otherwise. MRI-derived measurements were also compared and correlated against
PFT results i. Where reproducibility data was available, the coefficient of variation (CV) of each MR
or PFT parameter was calculated as the ratio of the standard deviation to the mean of the repeated
measurements, expressed as a percentage.
5.3 Results & Discussion
In one healthy subject (HV9), the signal-to-noise ratio (SNR) of the obtained 129Xe diffusion-weighted
images exhibited insufficient SNR for accurate calculation of the xenon ADC across the lungs. From
the COPD patient cohort, one 3He ADC data-set, one 129Xe ADC data-set, one 3He VV% data-set and
two 129Xe VV% data-sets (each out of a total of 20 data-sets for each nucleus) were either not acquired
successfully or the image SNR was not satisfactory. Aside from these instances, all recorded data was of
sufficient SNR for quantitative VV% or ADC analysis (i.e. for 3He, 95% of both ADC and VV% data
was acceptable, and for 129Xe, 95% of ADC data, and 90% of VV% data, was acceptable).
Figure 5.5: Full data-set of 3He and 129Xe MR ventilation images overlaid on anatomical 1H images for a lung
cancer patient.
Considerable ventilation abnormalities were observed in patients with lung cancer, with most patients
exhibiting a patchy distribution of ventilated airspaces and typically one or more large defect(s) which
corresponded visually to the location of a malignancy on structural 1H lung MR images. In COPD sub-
jects, severe ventilation defects were detected, and in some cases, entire lobes of the lungs were seen to
be completely unventilated. The mean 3He VV% in lung cancer patients (84.0± 7.9%) was significantly
larger than that of COPD patients (71.8± 8.2%) at the P < 0.05 level. Whilst the 129Xe VV% appeared
to also suggest a trend of higher values in lung cancer patients (74.6± 15.2%) when compared to COPD
patients (59.8 ± 10.4%), there was no statistically-significant difference in the mean values (P = 0.099).
Example 3He and 129Xe ventilation images of the lungs of a patient with lung cancer and a patient with
iFor the purpose of correlations between parameters derived from the two gases, the mean values (± standard deviation)
of repeated measurements in COPD patients were used to represent a single data-point for each patient.
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Figure 5.6: Full 3He and 129Xe ADC data-sets obtained from a healthy subject and a COPD patient.
COPD are shown in Figure 5.2, in comparison to corresponding images obtained from a healthy subject.
Representative data-sets of all acquired 3He and 129Xe ventilation images overlaid on anatomical 1H im-
ages for a subject with lung cancer are depicted in Figure 5.5. It is worth noting that the signal-to-noise
ratio of individual 3He and 129Xe images was comparable in most subjects, which results from a balance
of factors, including: the 3-fold larger 129Xe dosage; the approximately 3-fold smaller 129Xe gyromagnetic
ratio (see Section 3.2.3); and differences in acquisition parameters (e.g. bandwidth, slice thickness), gas
polarisation and scanner noise.
Derived VV% values were observed to be larger on average for 3He than 129Xe (P = 0.001) images,
as calculated by comparing the mean values across all subjects. Similarly, assessing values within the
patient groups of COPD patients and lung cancer patients, significant differences between VV% values
derived from 3He and 129Xe MRI were found (P = 0.004 and P = 0.050, respectively). The overall
greater ventilated volume percentages resulting from 3He compared to 129Xe scans may be explained by
the significantly lower diffusion coefficient of 129Xe, and therefore its reduced ability to penetrate partial
obstructions. As reported previously at 3 T [85, 86], and mentioned in Section 4.6, an increased proportion
of ventilation defects, or correspondingly, a reduction in ventilated volume, is not unexpected due to the
Brownian diffusion behaviour of xenon as compared to helium. This effect was noticeable on a regional
basis in a number of patients studied here, where a slightly patchier presentation of ventilation defects,
or, conversely, marginally larger defects, were observed on 129Xe images (e.g. Figure 5.2c). Rather than
a limitation, situations can be envisaged in which this trend is useful; for example, in the assessment of
early-stage obstructive disease, 129Xe may exhibit a greater sensitivity to obstructions on a smaller length
scale than can be detected with 3He. Further validation of quantitative ventilation imaging of 129Xe
compared with 3He in patients with different forms of lung disease over multiple centres and at multiple
time-points is the next step in clinical evaluation of 129Xe MR.
Representative example slice 3He and 129Xe ADC maps obtained from a COPD patient are depicted in
Figure 5.3, and examples of all slices acquired from 3He and 129Xe ADC acquisitions of a healthy subject
and a COPD patient are shown in Figure 5.6. Mean ADC values derived from both nuclei were signifi-
cantly elevated in COPD patients when compared to healthy volunteers (P = 0.013 in both cases): mean
± standard deviation of 3He ADC was 0.43 ± 0.13 cm2.s-1 in COPD patients, and 0.19 ± 0.02 cm2.s-1
in healthy volunteers; mean ± standard deviation of 129Xe ADC was 0.072 ± 0.019 cm2.s-1 in COPD
patients, and 0.038 ± 0.003 cm2.s-1 in healthy volunteers. (Note: in the case of the COPD patients, the
mean ± standard deviation represents the mean and standard deviation of the intra-subject mean values.)
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This observation is in agreement with previous reports of emphysematous tissue destruction leading to
less restricted diffusion, as measured with both 3He [101, 108] and 129Xe [85, 115].
The diffusion coefficient of xenon in air is almost an order of magnitude lower than that of helium
in air, and as such, the ADCs of the two gases as measured in the alveoli are significantly different.
As discussed above, the reduced diffusion coefficient of 129Xe could offer the possibility of investigating
smaller microstructural changes than is possible with 3He. However, the low diffusion coefficient of xenon
also constrains the maximum achievable diffusion length scales within a given breath-hold (mean diffusion
length in 1D: 〈x¯〉 = √2Dt). As such, “long-range” diffusion measurements (based on mass transport and
longitudinal magnetisation, rather than phase dispersion of transverse magnetisation) for the evaluation
of complex diffusion pathways in the peripheral airways (see e.g. [109, 294]), may be unfeasible with 129Xe
in pure xenon or xenon-nitrogen mixtures. On the other hand, longer effective 129Xe diffusion lengths
may be enabled by mixing xenon with lighter gases such as 4He.
Comparison Spearman’s correlation P-value
coefficient (r)
3He ADC vs 129Xe ADC 0.982 < 0.001∗∗
3He ADC vs TLCO −0.967 < 0.001∗∗
3He ADC vs FEV1 −0.883 < 0.001∗∗
3He ADC vs FEV1/FVC −0.851 < 0.001∗∗
129Xe ADC vs TLCO −0.942 < 0.001∗∗
129Xe ADC vs FEV1 −0.833 < 0.001∗∗
129Xe ADC vs FEV1/FVC −0.859 < 0.001∗∗
3He VV vs 129Xe VV 0.845 0.001∗
3He VV vs TLCO 0.700 0.188
3He VV vs FEV1 0.800 0.104
3He VV vs FEV1/FVC 0.900 0.037
∗
129Xe VV vs TLCO 0.300 0.624
129Xe VV vs FEV1 0.500 0.391
129Xe VV vs FEV1/FVC 0.600 0.285
Table 5.2: Summary of correlations between MRI-derived 3He and 129Xe VV% and ADC measurements and
PFTs in a population of healthy volunteers and patients with lung cancer and COPD. ∗ indicates correlations at
the statistical significance level of P < 0.05, and ∗∗ indicates correlations at the statistical significance level of
P < 0.001. (Correlations of VV% with PFTs are quoted for COPD patients only.)
A summary of the correlation statistics between MR metrics and pulmonary function tests is presented in
Table 5.2. A statistically-significant positive correlation between 3He and 129Xe VV% values was identified
(Figure 5.7a: Spearman’s correlation coefficient r = 0.845, P = 0.001). Thus, although the mean derived
VV% was characteristically higher for 3He than 129Xe, the measurements were clearly related, implying
that equivalent functional information was probed in both cases. This finding was corroborated by a
Bland-Altman plot (see Figure 5.7b), which exhibits data scattered around a positively-biased mean dif-
ference between VV% values extracted from MRI of the two nuclei. Although the data appears scattered,
there is preliminary evidence of a trend toward better-matched 3He and 129Xe VV% values at mean VV%s
of close to 100%. The VV% correlation statistics could be further investigated by recruiting additional
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subjects; in particular, the inclusion of healthy volunteer data would widen the range of data-points in
Figure 5.7a, since most healthy volunteers would be expected to exhibit VV% values ≈ 100%.
Statistical comparisons and correlations between 3He or 129Xe VV% values and PFT results were
limited by the fact that PFTs were not performed by the lung cancer patients; as such, correlations were
determined for COPD subjects only. When evaluating the correlation of the intra-subject mean VV%
values and mean PFTs, only 3He VV% presented a statistically-significant correlation with FEV1/FVC
at the P < 0.05 level. The lack of correlation between 3He or 129Xe VV% and other PFTs is attributable
to the low number of data-points (n=5) and the absence of comparative data from another subject group,
e.g. healthy volunteers.
In prior work, the ventilation defect count per slice from 3He MRI was found to correlate significantly
with FEV1/FVC [295], and in a number of recent studies, VV% values or VDPs associated with both
3He
and 129Xe have been reported to correlate significantly with both FEV1 [85, 110] and FEV1/FVC [296].
Figure 5.7: a) Correlation between 3He and 129Xe VV% values in patients with lung cancer and COPD, with
associated Spearman’s correlation coefficient (r) and P value of statistical significance. The solid line represents
a linear fit to the data and error bars represent the standard deviation of all repeated scans for each COPD
patient. b) Bland-Altman analysis of the differences between 3He and 129Xe VV% values in these patients. Solid
lines indicate the mean difference between 3He and 129Xe VV%, and dashed lines represent plus and minus two
standard deviations from the mean difference, for each cohort.
A strong positive correlation between mean 3He and 129Xe ADC values was determined in healthy volun-
teers and COPD patients (Figure 5.8: Spearman’s r = 0.982, P < 0.001). As expected, by virtue of the
difference in diffusion coefficient between the two gases, the mean ADC values were almost an order of
magnitude lower for 129Xe than 3He, and hence Bland-Altman analysis was not appropriate.
On a regional basis, the effect of the reduced diffusion coefficient and lower overall ventilated volume
was typically noticeable as correspondingly larger defects on 129Xe ADC maps. However, as depicted in
Figures 5.3 and 5.6, slight discrepancies in slice position between 3He and 129Xe slice ADC maps were
observed, presumably arising due to the replacement of RF hardware and re-positioning of the patients
between scans. This suggested that the defect presentation was similar in some slices for the two nuclei,
or even that less significant defects were identifiable in 129Xe images (i.e. opposite to the general trend in
VV%). Whilst the 3D SSFP ventilation imaging acquisition was immediately followed by a separate- or
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Figure 5.8: Correlation between mean 3He and
129Xe ADC values in healthy volunteers and pa-
tients with COPD, with associated Spearman’s
correlation coefficient (r) and P value of statis-
tical significance. The solid line represents a
linear fit to the data and error bars represent
the standard deviation of all repeated scans for
each COPD subject.
same-breath 1H anatomical image, the DW-MR images were not obtained with accompanying 1H images,
which may limit the regional assessment of ADC maps, in terms of matching slice positions between nu-
clei. In future work, the application of compressed sensing for acceleration of DW-MRI [297] may permit
the acquisition of same-breath diffusion-weighted hyperpolarised gas images and 1H images in order to
mitigate these potential issues.
Mean ADC values derived from both nuclei exhibited significant correlations with PFTs, as summarised
in Table 5.2. In particular, correlations with the diffusing capacity of the lung for carbon monoxide, TLCO,
were highly significant, with Spearman’s r and P values of r = −0.967 and P < 0.001, and r = −0.942 and
P < 0.001 for 3He and 129Xe respectively. The TLCO metric has previously been reported by a number
of groups to be the most appropriate pulmonary function test against which to compare ADC values
[85, 107, 115, 298]. This is likely because, although the TLCO metric quantifies gas exchange function
whilst the ADC probes gas diffusion within the alveoli, both measurements fundamentally depend on the
surface-area-to-volume ratio of the alveolar airspace.
In COPD patients, a good visual agreement in the presentation of both 3He and 129Xe ADC maps was
observed as a function of scan time-point, as illustrated in Figure 5.9. Mean 3He and 129Xe ADC values
were found to be highly reproducible, with mean coefficient of variation (CV) values of less than 3% in
both cases. These CV values are comparable to those of FEV1 and FEV1/FVC, and considerably less
than those of the TLCO parameter, as measured in the COPD patient cohort (summarised in Table 5.3).
In addition, the CVs of both 3He and 129Xe ADCs were less than the previously reported same-session
/ same-day variability in FEV1 [299] and TLCO [300], and furthermore, were substantially lower than
measured long-term variability in TLCO (∼ 9% [301]). Moreover, the multi-day CV values of both 3He
and 129Xe ADC values presented in Table 5.3 were less than those reported by Diaz et al. in healthy
subjects, COPD patients and patients with alpha-1 antitrypsin deficiency at 1.5 T [292], and comparable
to CV values quoted by Parraga and colleagues for volunteers and COPD patients at 3 T [74].
Likewise, both 3He and 129Xe ventilation images appeared visually similar at each of the four scan
time-points, as shown in Figure5.10. However, CV values of 3He and 129Xe VV% measures were notice-
ably greater than those of the corresponding ADC values. In particular, the mean CV of 129Xe VV% was
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13.01%, which is larger than that derived for TLCO. The more than two-fold lower mean CV of
3He VV%
when compared with 129Xe VV% is likely attributable to difficulties associated with the manual segmen-
tation of 129Xe ventilation images and registration to the anatomical 1H images, which were acquired in
a separate breath (rather than the same breath in the case of 3He). Nevertheless, the CV of 129Xe VV%
is severely biased by the fact that one subject exhibited an outlying CV of 25%, whilst the CV value in
all other subjects was of the order of 10%. As mentioned in Section 4.5, it is hoped that improvement in
compressed sensing based acquisition strategies will help to facilitate same-breath 129Xe ventilation and
anatomical 1H imaging to alleviate potential issues with image processing, which in turn should lead to a
reduction in the CV of derived 129Xe VV% values. Nevertheless, the 3He and 129Xe VV% CV values in
COPD patients presented here were of a similar order to the week-to-week variability in FEV1 and TLCO
as reported earlier [299]. In addition, 3He VV% and 129Xe VV% reproducibility was comparable to that
previously reported in paediatric CF patients between two sessions on the same day [288], and the mean
3He (but not 129Xe) VV% CV was comparable to that of earlier studies in elderly healthy volunteers [302].
Finally, it is worth noting that an improved reproducibility between same-day scans when compared to
scans separated by one-week has been observed for 3He VDP by other groups in healthy volunteers and
COPD patients [74, 287]. Although the subject numbers in the present study are limited, in future work
it may be statistically feasible to distinguish same-day from two-week reproducibility and therefore better
identify the potential sources of variability between the different scan sessions. Data regarding day-to-day
and week-to-week reproducibility is critical for understanding the natural physiological variability in VV%
and ADC values in patients, and is necessary to further validate these metrics as outcome measures in
longitudinal studies (e.g. for assessment of disease progression or treatment response).
Figure 5.9: Representative 3He and 129Xe ADC maps acquired at each of the four scan time-points from a COPD
patient. Global mean ADC values (ADCglob) are quoted underneath each respective set of maps.
To our knowledge, this study presents the first comparative results of 3He and 129Xe MR ventilation
imaging in subjects with lung cancer. The analogous functional information attainable with 129Xe may
facilitate its use as a cost-effective alternative to 3He for radiation therapy planning applications [303].
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Figure 5.10: Selected 3He and 129Xe ventilation image slices acquired at each of the four scan time-points from
a COPD patient. Calculated ventilated volume percentages (VV%) are quoted underneath each respective set of
maps.
The lack of ionising radiation dosage associated with hyperpolarised 129Xe MRI may thus present a suit-
able substitute for 4D-CT in subjects with lung function dominated by the presence of a tumour [304].
This work also details the first comprehensive study of the relative sensitivity of 3He and 129Xe ventilation
and diffusion-weighted MR imaging at 1.5 T, indicating that 129Xe-based techniques should be feasible for
implementation at most clinical sites globally, with the requirements of only specialised RF and polariser
hardware. The findings reported herein support the growing extent of literature demonstrating that 129Xe
is close to readiness for replacing 3He for functional lung imaging applications in patients.
Further work is currently in progress to evaluate compressed sensing reconstruction techniques for
acquiring undersampled 129Xe ventilation images and facilitating routine same-breath 1H imaging for im-
proving the accuracy of ventilation volumetry. Analysis of the multiple b-value diffusion-weighted data
acquired in the present work is also underway to quantify alveolar microstructural dimensions from both
3He and 129Xe data. 3D multiple b-value diffusion-weighted acquisition strategies with CS are under devel-
opment for whole lung morphometric analysis using diffusion models of lung microstructural dimensions
[297]. If successfully implemented with 129Xe, multiple b-value acquisitions can be tailored to provide
equivalent information about acinar airway geometry as has been previously presented with 3He [305].
Furthermore, dynamic assessment of hyperpolarised gas wash-out over multiple breath-holds for quan-
tification of fractional ventilation (the volume of gas turned-over per breath) has been recently explored
with 129Xe, with promising results exploiting the additional SNR available from SSFP acquisitions strate-
gies [306]. Additionally, Collier et al. have reported sufficient SNR for phase-contrast flow velocimetry of
the upper airways with 129Xe in addition to 3He gas [131]. In summary, previously unfeasible acquisition
methods are becoming readily translatable to 129Xe, and the potential for novel functional applications
to be realised is exciting for the hyperpolarised gas MRI community [134].
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Parameter CV (mean %) CV (range %)
3He ADC 2.98 1.48− 5.61
129Xe ADC 2.77 1.68− 5.88
3He VV% 4.56 2.31− 8.86
129Xe VV% 13.01 9.64− 25.24
FEV1 4.22 2.16− 6.35
FEV1/FVC 2.35 1.49− 3.80
TLCO 8.73 3.91− 16.15
Table 5.3: Reproducibility of MRI-derived 3He and 129Xe VV% and ADC measurements and PFTs in COPD
patients, presented as inter-subject means and ranges of coefficient of variation (CV) values.
5.4 Conclusions
Preliminary experimental validation of hyperpolarised 3He and 129Xe MR ventilation imaging and ADC
mapping has been demonstrated at 1.5 T in healthy volunteers and patients with lung cancer and COPD.
Mean ADC values derived from both nuclei exhibited excellent agreement with each other and significant
correlations with pulmonary function test results in volunteers and COPD patients, whilst 3He and 129Xe
ventilated volume percentages correlated significantly with each other and showed a positive bias towards
increased VV% for 3He compared with 129Xe in lung cancer and COPD patients. ADC and VV% metrics
derived from both nuclei showed good reproducibility in the COPD patient cohort. These findings should
help pave the way towards increased use of 129Xe as a more readily-available, cost-effective alternative to
3He for future quantitative clinical MR imaging studies of lung ventilation and microstructure.
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Chapter 6
Experimental validation of the
hyperpolarised 129Xe chemical shift
saturation recovery technique
6.1 Introduction
An overview of the background literature underpinning the experimental work in this chapter has been
introduced already in Section 2.2. Here, a brief summary is provided, along with further specifics about
the 129Xe chemical shift saturation recovery technique.
129Xe possesses attractive properties for in vivo functional studies of the lungs; for example its solubility in
somatic substances, including parenchymal tissues and blood [233]. Also, since the xenon electron cloud is
highly polarisable, 129Xe exhibits a wide range of NMR chemical shifts in different chemical environments
[236]. Of particular importance for lung studies are the resonances of 129Xe dissolved in parenchymal
tissues and blood plasma (T/P) and 129Xe dissolved in red blood cells (RBCs) – collectively termed
“dissolved-phase” 129Xe. These are well separated from the “gaseous-phase” 129Xe resonance, situated at
197 ppm and 217 ppm downfield, respectively. Since xenon is chemically inert and is not metabolised in
the body, the NMR signal measured from this dissolved-phase 129Xe in vivo is governed by diffusive uptake
from the lung airspaces and perfusion in the capillaries, allowing quantitative mathematical modelling of
the gas exchange process from 129Xe NMR data.
These properties have been explored in several studies of pulmonary gas exchange function with dif-
ferent MR pulse sequence strategies, as follows. Direct imaging techniques [143, 144, 147] have been used,
wherein the gaseous and dissolved 129Xe resonances from the lungs are imaged simultaneously to provide
complementary information about pulmonary ventilation and perfusion. The xenon polarisation transfer
contrast (XTC) method [149–151] uses the relatively weak signal from dissolved-phase 129Xe to modulate
(relatively higher SNR) gaseous 129Xe images via diffusional exchange in between image acquisitions. The
chemical shift saturation recovery (CSSR) spectroscopy method [248, 265, 307] allows investigation of gas
exchange dynamics by monitoring the time-dependent build-up of dissolved 129Xe magnetisation in the
T/P and RBC compartments following selective saturation. XTC has been recently extended to allow
acquisition of gas exchange contrast images at multiple exchange times (multiple-exchange time XTC,
or MXTC) [152, 153], however, unlike CSSR, this method has not been shown to provide separation
between the two dissolved-phase 129Xe compartments. The ability of the CSSR spectroscopic technique
to yield dynamic information about both dissolved 129Xe compartments simultaneously is thus a unique
advantage over alternative techniques. The dynamics of xenon exchange in the lungs measured by 129Xe
CSSR can be modelled with standard diffusion equations [138, 307] in order to estimate parameters of
lung function and microstructure, including the alveolar septal thickness, the RBC transit time through
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the capillary bed, and the alveolar surface-area-to-volume ratio. To date, this methodology has been
applied in preliminary studies in humans, where it has been shown to provide clinically-relevant metrics
of gas exchange impairment [138, 140], enabling estimation of interstitial (septal) tissue thickening in
interstitial lung disease (ILD) [138], and inflammation in chronic obstructive pulmonary disease (COPD)
[141]. In addition, it has been utilised to examine lung function in small animals with a number of models
of different lung diseases [145, 308–311].
Figure 6.1: Example CT images of normal and IPF lungs. a) Representative slices from whole-lung inspiratory
CT of a normal subject and a patient with IPF. b) Representative µ-CT sections from normal and IPF lungs.
The CSSR technique is particularly suited to quantification of gas exchange impairment in interstitial-
type lung pathologies, such as idiopathic pulmonary fibrosis (IPF), a condition characterised by fibrosis of
parenchymal tissues [312, 313]. IPF is the most prevalent form of ILD and carries a very poor prognosis.
Also of significant clinical interest is systemic sclerosis (a.k.a. scleroderma, SSc), a rare connective-tissue
disease in which respiratory problems are the most common cause of death; SSc is characterised by a
combination of contributions from alveolar, interstitial and pulmonary-vascular components [314, 315].
Assessment of the causes of symptomatic limitation in these patients is challenging: pulmonary function
tests including measurement of the diffusing capacity (transfer factor) of carbon monoxide (TL,CO) are
frequently reduced, but TL,CO provides no information as to the underlying mechanism causing the ab-
normality of gas exchange. High-resolution CT can be used to assess the extent of structural lung disease
but is challenging in IPF; in particular, the derivation of useful quantitative metrics is limited by a mul-
titude of co-factors that contribute to attenuation [316]. Example CT and µ-CT images of IPF lungs are
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shown in Figure 6.1, in which key features such as honeycombing, reticulation and traction bronchiectasis
can be seen in comparison to normal subjects. The heterogeneity of the disease is also clearly depicted.
Interestingly in SSc patients, a reduced TL,CO is frequently observed in patients with apparently normal
CT scans. Therefore, the development of novel techniques is required for both disease groups in order
to quantify the functional consequences of structural changes in the lung impacting on gas exchange and
also to assess the efficacy of potential treatments.
The purpose of this work was to demonstrate the practicality of the 129Xe CSSR method for non-invasive
quantification of lung microstructure, gas exchange dynamics and pulmonary-vascular function in healthy
normal subjects and patients with SSc and IPF. For 129Xe CSSR to be accepted as a clinical tool for
routine application, experimental substantiation with existing gold-standard clinical methods is needed.
Here, we compare 129Xe CSSR-derived parameters with TL,CO measurements and quantitative indices
derived from dynamic contrast-enhanced (DCE)-MRI [43, 55]. Current quantitative models of diffusive
exchange of xenon in the lungs [138, 139, 309] are reviewed and their application to in vivo data is ap-
praised in order to determine the most appropriate and informative model for future clinical use. In
addition, the relationship between alterations to inter-alveolar septal structure and intra-alveolar shape
and size is assessed by comparing the results of 129Xe CSSR to those of 3He ADC mapping.
Part of this chapter is based on the following publication: “Experimental validation of the hyperpolar-
ized 129Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial
lung disease”. N. J. Stewart, G. Leung, G. Norquay, H. Marshall, J. Parra-Robles, P. S. Murphy, R. F.
Schulte, C. Elliot, R. Condliffe, P. D. Griffiths, D. G. Kiely, M. K. Whyte, J. Wolber, J. M. Wild. Mag-
netic Resonance in Medicine, 74, 196-207 (2015). Author contributions statement: study design, NJS,
GL, HM, PSM, CE, RC, DGK, MKW, JMW; acquisition of data, NJS, GL, GN, HM, JPR, RFS; analy-
sis of data, NJS, GL; preparation of manuscript, NJS, GL, GN, HM, JPR, PDG, DGK, MKW, JW, JMW.
6.2 Methods
Study subjects
Four subjects with SSc and four with IPF were recruited for this preliminary study. Inclusion criteria
included: patients aged 35-85 years; confirmed diagnosis of IPF or SSc (determined from current clinically-
accepted guidelines at the Royal Hallamshire Hospital, Sheffield, UK); resting oxygen saturation of ≥ 90%
on room air, as measured by pulse-oximetry. Patients receiving targeted drug therapies were excluded.
Ten healthy volunteers aged 23-74 years, with no history of respiratory or connective-tissue disease,
were also recruited. The study protocol and recruitment procedure were approved by the National Re-
search Ethics Committee (UK). Pulmonary function tests (including whole-lung transfer factor, TL,CO,
forced expiratory volume in one second, FEV1, and forced vital capacity, FVC) were performed on all
subjects and blood samples were taken from all patients by conventional venipuncture. The results of
these tests are summarised in Table 6.1.
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CSSR spectroscopy
All hyperpolarised 129Xe spectroscopy experiments were performed on a 1.5 T whole-body MRI scan-
ner (GE Healthcare, Milwaukee, WI), with a flexible transmit-receive vest coil (Clinical MR Solutions,
Brookfield, WI) tuned to the 129Xe Larmor frequency (17.66 MHz at 1.5 T). 129Xe was polarised by
spin-exchange optical pumping (SEOP), using a “freeze-out” accumulation procedure and a home-built
xenon polariser [65] with an external-cavity diode laser (see Section 3.2.6 and the ECDL system described
in Section 4.4.1 for further details).
Specially-designed radiofrequency (RF) pulses were employed for excitation of 129Xe nuclei in all ex-
periments. A 14-element, pulse-width modulated, binomial-composite RF pulse (of 1.13 ms duration) was
designed according to the procedures described in [317]; this pulse provided extremely selective excitation
of dissolved-phase 129Xe. When centred on the 129Xe gas resonance, the excitation profile of the “bal-
anced” form of the binomial pulse (in which the total area of positive and negative elements was equal)
yielded an on-resonant excitation of almost zero and a maximum RF power deposition at a frequency
∼ 3500 Hz (200 ppm at 1.5 T) downfield from the centre frequency. Thus, for CSSR applications, near-
perfect saturation of dissolved-phase 129Xe (flip angle ≈ 90◦) in the lung could be attained whilst a small,
repeatable excitation of gaseous 129Xe (flip angle ∼ 1◦) was ensured by adding a single positive element
(of length 0.02 ms) to the end of the RF pulse [317].
Figure 6.2: The CSSR pulse sequence, as implemented in this work. Pulse-width modulated binomial RF pulses
(amplitude modulated pulses shown for display purposes) can produce 90◦ excitations of dissolved-phase 129Xe
with minimal on-resonance excitation of gaseous 129Xe. These RF pulses were used for both saturation and
excitation of 129Xe NMR signal (generated free induction decays are shown in grey). The inter-pulse delay time
(TR) was varied between values of 20 ms and 1000 ms, in order to quantify the dynamics of xenon exchange in the
lungs. Each TR sweep was repeated three times to estimate the same-breath variability in the CSSR measurement.
Prior to CSSR, in order to calibrate the RF excitation flip angle and gaseous 129Xe centre frequency,
subjects inhaled 1 L of gas extracted directly from the OP cell of the polariser (3% xenon, 30 − 40%
polarisation) from a Tedlar bag (Jensen, Coral Springs, FL). A simple pulse-acquire sequence was utilised
for this purpose, with thirty RF pulses and an inter-pulse delay time (TR) of 30 ms ( T1 of 129Xe gas
in the lungs [134, 252]), leading to a breath-hold of less than one second. The bandwidth was 12 kHz and
the centre frequency was chosen such that the RF pulse excitation profile was maximal at the 129Xe gas
frequency. The normalised decay in 129Xe gas signal from pulse-to-pulse was fitted to a function of the
form cosn−1 (α), where α denotes the flip angle and n the RF pulse number.
The calibrated RF pulse amplitude was then used to determine the settings required for a 90◦ ex-
citation of dissolved 129Xe for CSSR experiments. Prior to each CSSR acquisition, the subject exhaled
to functional residual capacity (FRC) and then inhaled a 50:50 mixture of cryogenically-accumulated,
isotopically-enriched xenon gas (10− 15% nuclear polarisation) and nitrogen gas from a 1 L Tedlar bag.
The saturation recovery technique involves varying the time allowed for gas exchange (in this work, ≡ TR)
after each successive saturation pulse, in order to sensitise the NMR acquisition to gas exchange, as il-
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lustrated in Figure 6.2. 25 different TRs were used in the range 20 ms to 1 s; these were sequentially
swept through in three repeated cycles during a single breath-hold to obtain average signal values for
each TR and to estimate the uncertainty in each measurement (standard deviation of each point). Ad-
ditional pulse sequence parameters: 12 kHz receiver bandwidth; 64 spectral points; total breath-hold, 15 s.
CSSR data analysis
CSSR “xenon-uptake curves” were generated by evaluating F (t), the ratio of dissolved 129Xe signal inten-
sity at time t = TR to gaseous 129Xe signal intensity at t = 0 (the start of the TR), for each repetition.
Signal intensities of each chemical shift compartment were calculated by integration of the respective
NMR peaks in the magnitude spectra. The first acquired free induction decay (FID) was discarded since
it was associated with an unknown exchange time during inhalation. The signal intensities from each of
the three consecutive TR sweeps were first normalised by the 129Xe gas peak and corrected for differences
in flip angle experienced by gaseous and dissolved-phase 129Xe and then finally, the signals were averaged
to represent the mean result. The combined signal from 129Xe in T/P and RBC compartments (i.e. total
dissolved 129Xe) was fitted with the model of Patz et al [138, 248, 307], and individual xenon-uptake curves
for 129Xe in T/P and RBCs were fitted with the models of Ma˚nsson et al [309], and Chang (also known
as MOXE; the model of xenon exchange) [139], using non-linear least squares fitting routines developed
in Matlab (MathWorks, Natick, MA).
A complete mathematical description of each model can be found in the respective papers cited above;
however, the principal results are reviewed below and a diagrammatic summary of the underlying geo-
metrical model assumed for each is provided in Figure 6.3.
The Patz et al model [138] is based on the solution of the diffusion equation for xenon in the alveolar
septum (a slab of thickness d, comprising tissue and capillaries) surrounded by alveolar space on both
sides. The boundary conditions for the solution of this problem are defined as follows: at time t = 0,
the gaseous 129Xe longitudinal magnetisation Mg (x, 0) = M0, and the magnetisation of
129Xe dissolved
in the septal compartment Md (x, 0) = 0, since it has been saturated. After a diffusion time, t, for which
gas exchange can occur, the gaseous magnetisation is approximately unchanged Mg(x, t) = M0 (due to
the relatively low Ostwald solubility of xenon in tissue, λ), and the dissolved 129Xe magnetisation at the
boundaries of the septum is Md(0, t) = Md(d, t) = λMg (since it is assumed that there is another airspace
situated at the opposite side of the septum). This system is analogous to a heated metal bar with a fixed
temperature at either end and has a solution derived via the separation of variables method [318]:
Md(x, t) = λMg
{
1−
∑
n=odd
(
4
pin
)
sin
(npix
d
)
exp
(
−
[npi
d
]2
Dt
)}
(6.1)
where D denotes the dissolved-phase diffusion coefficient of xenon (i.e. the average of DT and DB), d
is the septal thickness (as defined in Figure 6.3), λ is the Ostwald solubility of xenon in lung tissue, and
the summation over n represents the contribution of different diffusion “modes” i. The fraction of the
iAs the order of the summation (n) increases, the relative weight of the exponential terms is significantly decreased.
Hence, only the first few terms of the summation are considered in practice.
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Figure 6.3: Comparison of the geometries adopted for diffusional modelling of xenon uptake in the lungs; from
the airspace across the alveolar septum, thickness d. The Patz et al and MOXE models consider solving the
diffusion equation with periodic boundary conditions in one dimension, x, created by identical alveolar airspaces
on either side of the septum. (i) the model of Patz et al does not distinguish between T/P and RBC compartments;
(ii) the model of Chang (MOXE) includes a tissue barrier term (δ) permitting separation of the T/P and RBC
compartments, in conjunction with the blood haematocrit (HCT ); (iii) the Ma˚nsson et al model also considers the
two dissolved 129Xe compartments individually, but with a circularly-symmetric geometry, with an alveolar radius
(RA) and tissue and capillary thicknesses LT and LC , respectively. In the first two models, blood flow is treated
orthogonal to and independent of diffusional gas exchange. In each case D denotes the diffusion coefficient of xenon,
in the airspace (D0, the xenon “self” diffusion coefficient), tissues (DT ), blood (DB) or combined dissolved-phase
(DD). Note: in the following discussions, D (instead of DD) is used to represent the dissolved-phase xenon
diffusion coefficient, which is fundamentally assumed to be the same for both tissues and blood in all three CSSR
models. In practice, these values are likely to be different but are not currently well-known; hence we designate
them with different symbols in this figure for completeness.
septum that is occupied with hyperpolarised 129Xe molecules after a diffusion time t is:
f(t) =
1
d
∫ d
x=0
ρ(x, t)dx = 1−
∑
n=odd
8
pi2n2
exp
(
−
[npi
d
]2
Dt
)
(6.2)
where ρ (x, t) is the dimensionless dissolved 129Xe magnetisation density in the septal slab (ρ (x, t) =
Md(x,t)
λMg
). In the CSSR experiment, the dissolved-phase 129Xe signal is measured after a diffusion time t
and compared with the gas signal at t = 0; as mentioned above, this ratio is denoted by the quantity F (t):
F (t) =
Md(t→∞)
Mg(t = 0)
f(t) = λ
Vd
Vg
f(t) =
λd
2
SA
Vg
f(t) (6.3)
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where Md(t → ∞) denotes the dissolved 129Xe magnetisation when the septal slab is saturated with
xenon, Mg(t = 0) denotes the gaseous
129Xe magnetisation at t = 0, Vd and Vg are the volumes of the
septal compartment and the airspace, respectively. The septal volume is defined to be the product of
septal thickness d, and half the alveolar surface area SA.
As a consequence of blood flow, a given portion of the capillary blood will reside in the gas exchange
region for times less than t. To quantify this effect, a simple model of plug flow can be adopted (see
Figure 6.3). The Patz et al model assumes that the capillary blood flow is orthogonal to, and independent
of, the diffusion of 129Xe. Furthermore, the entire capillary septal compartment is considered to flow
continuously in a perpendicular direction to the direction of gas exchange (i.e. the thin tissue barrier, δ
is ignored in the Patz et al model). The full solution for F (t), including a discretised treatment of blood
flow (see [138] for full details) can be written:
F (t) =
λd
2
SA
Vg
(
τ − t
τ
)
f
(
Dt/d2
)
+ λd
SA
Vg
[
t
τ
+
8d2
Dpi4
1
τ
g
(
Dt/d2
)]
(6.4)
where τ is the capillary transit time (the average length of time a RBC resides in the gas exchange
region) and f(q) and g(q) are functions of the dimensionless parameter q = Dt/d2 and are defined in the
following way:
f(q) =
[
1−
∑
n=odd
8
pi2n2
exp
(−qpi2n2)] (6.5)
g(q) =
[ ∑
n=odd
1
n4
{
exp
(−qpi2n2)− 1}] (6.6)
The model of xenon exchange (MOXE, developed by Chang [139]), is an extension of this methodology in
which the septum is separated into its parenchymal tissue and capillary components by the introduction
of the parameter δ, the tissue barrier thickness, and the haematocrit (HCT ). The relative contributions
from 129Xe in plasma and RBCs are distinguished by considering the distinct Ostwald solubilities of xenon
in these media (λPL and λRBC). Furthermore, the tissue and plasma contributions are combined (since
they induce the same NMR chemical shift for 129Xe and are indistinguishable at the B0 strengths mea-
sured to date). Blood flow is treated in an identical manner to that of the Patz et al model, however this
time, excluding the tissue barrier regions. Reproducing the result from [139] for the time-dependence of
the 129Xe T/P signal:
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(6.7)
STP (t) = b
[
2δ
d
− 8
pi2
∑
n=odd
1
n2
(
1− cos
(
npiδ
d
))
exp
(
−n
2t
T
)]
+ b (1− η)
{
2
[(
1− 2δ
d
)
t
τ
− 8T
pi2τ
∑
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1
n4
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npiδ
d
)(
1− exp
(
−n
2t
T
))]
+
(
1− t
τ
)[(
1− 2δ
d
)
− 8
pi2
∑
n=odd
1
n2
cos
(
npiδ
d
)
exp
(
−n
2t
T
)]}
where b = λd2
SA
Vg
, T = d
2
pi2D , the latter termed the ‘xenon exchange time constant’, and η denotes the
fraction of 129Xe in RBCs to 129Xe in blood as a whole. The parameter STP (t) is essentially equivalent
to F (t) minus the RBC contribution. Recasting the terms of Equation 6.7 within curly brackets as Sx(t),
the time-dependence of the 129Xe RBC signal can be written:
SRBC(t) = bηSx(t) (6.8)
Equations 6.7 and 6.8 are coupled, such that they can be simultaneously fitted to experimental data,
thereby constraining the fit parameters. From these equations, an estimate of the haematocrit, HCT can
be derived from the constant η and the Ostwald solubilities of xenon in plasma (λPL) and RBCs (λRBC):
HCT =
η
λRBC
η
λRBC
+ (1−η)λPL
(6.9)
Finally, Ma˚nsson et al [309] considered a circularly-symmetric geometry in order to solve the 129Xe septal
diffusion problem. In that work, the T/P and RBC signal dynamics were described by the same equation;
an exponential growth function on short timescales (where the observed signal dynamics are dominated
by diffusional exchange) and a linear increase on longer timescales (where perfusion governs the observed
signal):
S (t) = S0
(
1− exp
(
− t
TM
))
+ S1t (6.10)
where S0 is the y-intercept of S (t) at t = 0, if there was no exponential component; S1 is the linear
slope of S (t) at large t; and TM is the exponential time constant. These fitting parameters are determined
independently for the separate RBC and T/P components. For further details of the relation of these
parameters to physiologically meaningful quantities, we refer the reader to [309].
A number of interesting parameters related to lung physiology and microstructure can be derived from
the application of these models to 129Xe CSSR data. In particular, the alveolar septal thickness (ST),
RBC capillary transit time (CTT) and surface-area-to-volume ratio (S/V) were derived for each subject
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in this study. The results extracted from each model were compared in order to assess the suitability of
each for interpretation of 129Xe CSSR data. The accuracy of the model fit to the data was evaluated by
re-fitting each data-set with different “weightings” – i.e. applying the error function, weighted to specific
data points, to the residuals before calculating the sum of squares.
Furthermore, as a semi-quantitative measure of gas exchange efficiency, the ratio of RBC-to-T/P peak
integrals was determined from phase-corrected 129Xe CSSR spectra at a TR of 100 ms, consistent with
the recent work of Kaushik et al [171]. Lastly, statistical testing was performed using SPSS (IBM SPSS
Statistics, V19, Armonk, NY) in order to: (i) identify parameters of lung physiology that were signif-
icantly different between subject groups (by a two-tailed, one-way analysis of variance (ANOVA) test
with post-hoc contrast); (ii) determine significant correlations between parameters (Pearson’s correlation
coefficients).
DCE-MRI
For validation of the xenon RBC capillary transit times measured by 129Xe CSSR, two measures of
pulmonary-vascular output were determined from DCE-MRI: (i) the full-width at half-maximum (FWHM)
of the lung parenchymal signal enhancement and (ii) the pulmonary transit time. Patients were placed
in an 8-channel cardiac-array coil and a 0.05 mL.kg-1 dose of 1 mmol.mL-1 Gd-DPTA solution (Gadovist,
Schering, Leverkusen, DE) was injected with a power injector (Spectris, Medrad, Warrendale, PA) at a
rate of 4 mL.s-1 into the antecubital vein, followed by a 20 mL saline flush. A time-resolved 3D coronal
GRE sequence with: 2× phase acceleration and view sharing [44]; 24 slices of thickness 10 mm; band-
width = ±125 kHz; TE/TR = 0.8/2.3 ms; flip angle = 30◦; matrix, 200 × 80; 36 temporal phases at
an effective frame rate of 2 volumetric frames per second, was used to image the dynamics of the first
pass of gadolinium through the pulmonary vasculature. In order to calculate the pulmonary transit time
(PTT) from the time series of images, signal enhancement as a function of time was evaluated for regions
of interest (ROIs) placed in the left atrium and pulmonary artery [53, 319]. The PTT was calculated by
subtracting the time-to-peak signal of the pulmonary artery from that of the left atrium. For the FWHM
of the lung parenchymal enhancement, a ROI was placed on each lung and the FWHMs of the resulting
signal enhancement curves were averaged. Due to the positioning of the ROIs, both methods intrinsically
provided an estimation of the “whole-lung” gadolinium transit time for comparison to CSSR data.
6.3 Results
As part of a comprehensive pulmonary MRI protocol, hyperpolarised 3He MR imaging of lung ventilation,
and conventional structural 1H MRI of the thorax was performed for each recruited IPF and SSc patient.
Although no image analysis or quantification was done as a part of this thesis, these images provide good
background information about the prevalence of disease in these patients, and form a basis on which to
interpret the 129Xe CSSR data. Example images for subject I1 (see Table 6.1) are presented in Figure 6.5.
Predominantly peripheral and basal fibrosis is apparent on UTE and bSSFP images, and additional indi-
cations of impaired ventilation are present in similar spatial locations on the 3He images (as highlighted
by the patchy appearance of ventilation defects / regions of low signal intensity).
129Xe NMR spectra typically highlighted a dominant peak due to 129Xe dissolved in parenchymal tissues
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Figure 6.4: Contrast-enhanced signal as a func-
tion of time in the pulmonary artery (PA) and
left atrium (LA), for derivation of the mean
pulmonary transit time (PTT) (see also Fig-
ure 2.4). FWHM = full-width at half maxi-
mum. (Note: this is the FWHM of the signal-
time curve for a ROI placed at the position of
the pulmonary artery; in practice, for calcu-
lation of the FWHM of lung parenchymal en-
hancement, the signal intensity is significantly
lower.)
Figure 6.5: Representative hyperpolarised 3He and structural 1H MR images in an IPF patient. Example slices
from a) 3He ventilation imaging; b) ultra-short echo time (UTE) imaging; c) balanced steady-state free precession
(bSSFP) imaging. Additional structural 1H MR images from IPF patients are presented in Figure 2.1.
and blood plasma (T/P) with an accompanying smaller peak from 129Xe in RBCs, in both SSc and IPF
patients when compared with healthy volunteers. At short exchange times, 129Xe spectra from patients
exhibited almost no signal from RBCs, and only a moderate peak was observed at very long TRs (∼ 1
s) (see Figure 6.6, right panel). As illustrated in the left panel of Figure 6.6, 129Xe uptake curves indi-
cated that gas exchange from the alveoli to capillaries was impaired and delayed in both patient groups
compared with healthy volunteers. The exponential, diffusion-dominated part of the curve was visibly
prolonged in patients and the T/P component was observed to reach a greater value of F (TR), consistent
with the appearance of the individual spectra.
The apparent inhibition of gas exchange in patients suggested thickening of septal tissue, and this was
corroborated by fitting the 129Xe uptake curves with the models of Patz et al (Equations 6.4 to 6.6),
Ma˚nsson et al (Equation 6.10) and Chang (MOXE) (Equations 6.7 to 6.8). Each model exhibited a con-
siderably increased whole-lung alveolar ST in older healthy volunteers and patients with SSc, and an even
greater increase in IPF subjects, when compared to younger (< 50 years) volunteers (see Table 6.1 for a
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Figure 6.6: Left panel: Dynamics of 129Xe uptake into tissues and blood plasma (T/P), and RBCs, for: a) a
typical healthy volunteer; b) a patient with SSc; and c) a patient with IPF. Uptake curves, denoted by F (TR),
are displayed with corresponding MOXE model fits (solid black lines, Equations 6.7 to 6.8). Dashed lines indicate
increments in F (TR) of 0.005. Right panel: NMR spectra (moderately line-broadened and zero-filled to 128
points) of subjects from the same three groups, acquired at a TR of 1000 ms. The peaks due to 129Xe in RBCs,
T/P and the gaseous-phase (G) are clearly indicated.
summary of CSSR-derived parameters and pulmonary function test results). The ST values determined
from application of the MOXE model to 129Xe CSSR data are shown as a box plot in Figure 6.7. Using a
dissolved-phase 129Xe diffusion coefficient of D = 3.0× 10−6 cm2.s-1 [138], mean ST values derived from
this model were 10.0± 1.6 µm for healthy volunteers, 13.0± 1.5 µm for subjects with SSc and 17.2± 1.1
µm for those with IPF. Statistically significant differences between derived ST values for all three subject
groups were found upon fitting each of the three models of lung microstructure to hyperpolarised 129Xe
CSSR data. These values are summarised in Table 6.2, along with the P values expressing the statistical
significance.
A strong, positive correlation was identified between the CSSR-derived ST and the age of the healthy
volunteer cohorts (correlation statistics: r = 0.74, P = 0.015 using MOXE; r = 0.77, P = 0.010, Patz et
al; r = 0.75, P = 0.012, Ma˚nsson et al), as illustrated in Figure 6.8. This correlation was used to “correct”
for the effect of aging in volunteer and patient data; i.e. in attempt to show ST changes that were induced
by pathological processes only, and not age-related changes to lung microstructure. With age-correction,
a significant increase in ST in IPF patients was still observed (P < 0.05) for all models, however none of
the three models exhibited a significant difference in ST between volunteers and SSc subjects (P > 0.05).
The results of the age-correction analysis are presented in Table 6.2.
Furthermore, a statistically significant correlation was observed between the CSSR-derived ST values
and TL,CO. Results from fitting CSSR data with MOXE are displayed against %-predicted TL,CO in
Figure 6.9. Pearson’s correlation coefficients (r) and P values for ST versus %-predicted TL,CO were:
r = −0.90, P < 0.001 for data fitted with the Patz et al model; r = −0.91, P < 0.001, MOXE; r = −0.92,
P < 0.001, Ma˚nsson et al. The correlations against TL,CO in standard units (mmol/min/kPa, i.e. not
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Figure 6.7: Box plot of mean (whole-lung) alve-
olar septal thickness values for healthy volun-
teers and patients with SSc and IPF, as derived
from fitting the MOXE model to 129Xe CSSR
data.
Figure 6.8: Correlation between septal thick-
ness and age of healthy volunteers, with cor-
responding Pearson’s correlation coefficient (r)
and P value.
considering subject-wise predictions for height, age, sex) were: r = −0.85, P < 0.001 for data fitted with
the Patz et al model; r = −0.85, P < 0.001, MOXE; r = −0.86, P < 0.001, Ma˚nsson et al.
Complementary to the CSSR modelling results, the ratio of RBC-to-T/P peak integrals was found to be
significantly different between both SSc and IPF patients and healthy volunteers, although, unlike the ST
parameter, the ratio did not distinguish between the two patient groups. Mean values (P values) were:
0.42± 0.18 in healthy volunteers; 0.18± 0.04 in SSc subjects (P (HV-SSc) = 0.040) and 0.13± 0.04 in IPF
subjects (P (HV-IPF) = 0.009, P (SSc-IPF) > 0.05). Furthermore, the RBC-to-T/P ratio measurements
correlated well with ST values from all models (r = −0.74, P < 0.001, MOXE; r = −0.74, P < 0.001,
Patz et al; r = −0.77, P < 0.001, Ma˚nsson et al).
The mean CSSR CTT was: 2.2 ± 1.0 s, 2.5 ± 0.7 s, 2.5 ± 0.6 s (volunteers); 2.3 ± 0.8 s, 2.5 ± 0.9 s,
2.0 ± 0.5 s (SSc); 2.2 ± 0.2 s, 2.4 ± 0.2 s, 1.5 ± 0.1 s (IPF); respectively for the MOXE, Patz et al and
Ma˚nsson et al models. This parameter was not significantly different between subject groups (P > 0.05).
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Figure 6.9: Validation of 129Xe CSSR-derived
septal thickness values (from the MOXE model)
with the clinical gold-standard measure of pul-
monary function, the whole-lung transfer fac-
tor for carbon monoxide (TL,CO). The Pear-
son’s correlation coefficient (r) and correspond-
ing P value are shown. Error bars in ST were
estimated by re-fitting the data with different
weightings applied to the residuals before tak-
ing the sum of squares, as described in Sec-
tion 6.2. Note: %-predicted TL,CO represents
the measured TL,CO value as a percentage of
an expected value, based on subject height, sex,
age etc.
Group Mean ST Patz (µm) Mean ST MOXE (µm) Mean ST Ma˚nsson (µm)
Normal Age-corrected Normal Age-corrected Normal Age-corrected
HV 9.7± 1.5 8.3± 0.8 10.0± 1.6 8.5± 0.9 7.6± 0.9 6.7± 0.5
SSc 12.6± 1.6 10.4± 2.1 13.0± 1.5 10.7± 2.1 9.4± 0.5 8.0± 0.9
IPF 16.5± 0.9 12.2± 1.2 17.2± 1.1 12.7± 1.4 11.7± 0.9 9.3± 1.0
P (HV-SSc) 0.001∗ 0.274 0.010∗ 0.231 0.008∗ 0.125
P (SSc-IPF) 0.004∗ 0.388 0.004∗ 0.332 0.003∗ 0.238
P (HV-IPF) < 0.001∗∗ 0.009∗ < 0.001∗∗ 0.011∗ < 0.001∗∗ 0.020∗
Table 6.2: Summary of mean 129Xe CSSR-derived septal thickness (ST) values calculated using three models of lung
microstructure (Patz et al [138], Chang (MOXE) [139], Ma˚nsson et al, including values “corrected” for predicted
changes due to subject age. [309]). HV: healthy volunteers; SSc: systemic sclerosis patients; IPF: idiopathic
pulmonary fibrosis patients. ∗ indicates comparisons that are statistical significant at the level of P < 0.05, and
∗∗ indicates comparisons that are statistical significant at the level of P < 0.001.
The CTTs calculated from CSSR were not found to correlate significantly with the PTT or lung FWHM
as determined from DCE-MRI; the highest correlation coefficient was between the CTT (Patz et al) and
the lung FWHM (r = 0.34, P = 0.416).
The derived haematocrit from the MOXE and Ma˚nsson et al models was notably lower in IPF pa-
tients compared to healthy volunteers, with values of: 0.23±0.05 and 0.24±0.05 (volunteers); 0.17±0.04
and 0.15 ± 0.01 (SSc); 0.15 ± 0.01 and 0.11 ± 0.01 (IPF) for the two models, respectively. The HCT
was significantly different between healthy volunteers and IPF patients (MOXE) and between volunteers
and both patient groups (Ma˚nsson et al model) (P < 0.05). Finally, as extracted from the MOXE and
Patz et al models, the mean alveolar surface-area-to-volume ratio was: 135± 37 cm-1 and 128± 36 cm-1
(volunteers); 141± 53 cm-1 and 134± 51 cm-1 (SSc); 166± 53 cm-1 and 156± 51 cm-1 (IPF); respectively,
with P values of significance between groups > 0.05 in all cases.
6.4 Discussion & Conclusions
Clinical findings
Septal thickness values for healthy volunteers calculated from Patz et al and MOXE models agreed well
with previously-reported values derived from computerised morphometry of lung samples (∼ 10 µm for
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normals, see e.g. [320] and the literature review presented in Section 7.4). Thickening of alveolar septa in
IPF patients can be attributed to underlying fibrotic changes in lung microstructure that were confirmed
by CT scans, which each patient underwent as part of their routine clinical assessment. The significance
of apparent septal thickening in SSc subjects is clinically interesting and must be further assessed as these
patients had little discernible fibrosis on CT and no evidence of pulmonary hypertension (PH). If validated
histologically, septal thickening may help explain the reduced TL,CO frequently observed in patients with
SSc in the absence of evident PH and ILD. Nevertheless, since some patients were > 50 years old, the
measured thickening may be partially attributable to age-dependent changes in the septal structure, as
identified by the measured increase in ST of healthy volunteers with age. In future, with more healthy
volunteer data, it may be possible to derive a “%-predicted ST”, in accordance with the clinical standard
procedures for PFTs (i.e. in order to predict the ST for a particular healthy subject, depending on their
height, sex, age, etc.).
Of further potential clinical importance is the fact that the surface-area-to-volume ratio derived from
these CSSR models is not significantly different between subject groups. This finding might suggest that
the remodelling of the lung parenchyma due to fibrosis is not necessarily associated with emphysematous
processes. This result is assessed in relation to preliminary findings from 3He apparent diffusion coefficient
mapping MRI in Section 6.4.1. Finally, we re-iterate that the RBC-to-T/P ratios also exhibit significant
differences between subject groups. However, since this parameter is only a semi-quantitative measure-
ment of gas exchange that does not distinguish between diffusion- and perfusion-related components of the
129Xe uptake dynamics, it is not possible to derive clinically-relevant parameters of lung microstructure
from this method.
The demonstration of a distinct relation between whole-lung transfer factor for carbon monoxide, TL,CO,
and 129Xe CSSR-derived ST is the first time that the 129Xe CSSR technique has been cross-validated with
a clinically-accepted method ii and has important implications for clinical application of this technique.
For example, if adapted to enable acquisition of regionally-localised spectra (e.g. with receiver-coil arrays
or chemical shift imaging based approaches; the latter as postulated in Section 7.4.1), the CSSR method
could provide information about gas exchange that is not obtainable by standard pulmonary function
testing or CT techniques in ILD patients. However, it should be noted that the value of TL,CO is derived
from two measured quantities — the transfer rate of carbon monoxide across the pulmonary septum KCO,
and the alveolar volume, VA, as introduced in Section 3.1.3 — and therefore, in future work it may be
more appropriate to compare ST values to KCO only (since we recall that the ST is defined in terms of
the xenon exchange time constant, the xenon analogue of KCO for carbon monoxide). The VA is more
relevant for comparisons with the CSSR-derived S/V values, and, if VA is significantly altered in IPF or
SSc patients, it may cloud the interpretation of the measured relationship between TL,CO and ST.
The lack of correlation between 129Xe CSSR CTT values and DCE-MRI parameters suggests that the
CTT parameter is not sensitive to small changes in pulmonary-vascular output, or, that its meaning has
been obscured by the additional modelling parameters. In all cases, CTT values were significantly lower
than the corresponding DCE-MRI PTT values; however, this would be expected due to the different defi-
nitions of the parameters. The former describes the average time a RBC resides in the gas exchange region
iiSince the initial online publication of these results, comparable findings were reported by Qing et al [141] in a cohort of
healthy volunteers and COPD patients.
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(capillary bed), whilst the latter represents the complete transit time of a gadolinium contrast bolus from
the right heart, through the pulmonary-arterial system and lung gas exchange vasculature and back to the
left atrium through the pulmonary-venous system. Although the lung FWHM metric potentially provides
a closer representation of the CTT measurement, the mean MR signal from the lung ROIs was close to
the noise level (even with contrast enhancement) in many patients and thus it was difficult to accurately
estimate the FWHM; this may explain the observation of larger FWHM values than PTT values.
The HCT values derived from the MOXE and Ma˚nsson et al models were in general lower than results
obtained from patient blood samples. The CSSR-HCT was found to be reduced in patients with IPF
when compared with healthy volunteers (P < 0.05), although blood samples indicated relatively normal
values in those patients. As recently highlighted [140], the HCT in the narrow capillaries is reduced
(to values as low as 0.28) when compared to the whole-body HCT – due to the F˚ahraeus effect [321].
Although this may partially explain the low HCT values for healthy subjects, it does not indicate why the
CSSR-derived HCT of IPF patients should be further reduced. However, fixing the HCT to a plausible
value in the expected range (0.4-0.5) and repeating the fitting process, tends to yield increased ST values
for all subjects. Thus, the apparent reduced HCT values in patients may actually be a further artefact of
inhibited gas exchange / septal thickening and the complex, inter-dependent nature of the model parame-
ters. In fact, the HCT was found to correlate with the ST parameter for both models on the P < 0.01 level.
Modelling
Based upon the statistical testing, it could be argued that each of the three models assessed are useful
for quantification of lung microstructural changes in IPF and SSc. A visual comparison of the application
of each of the three models to 129Xe CSSR data from a single healthy volunteer is shown in the left
panel of Figure 6.10. It can be seen that each of the three models describes the data reasonably well;
the goodness-of-fit as determined from conventional R2 and χ2 statistics was typically better for MOXE
and Patz et al models than the Ma˚nsson et al model, because the latter fails to follow the middle section
of the uptake curves as accurately as the other two models, suggesting that it is not appropriate to only
consider a single exponential component of diffusive uptake. Also depicted in Figure 6.10 (right panel,
(ii)) are Bland-Altman plots highlighting the systematic differences between CSSR parameters extracted
from all three models. As expected due to the geometries employed, the Patz et al and MOXE models
were found to show similar characteristics, whereas the Ma˚nsson et al ST values were consistently lower
than those of the MOXE model, with an increased discrepancy in patients. Despite these systematic
differences, parameters extracted from all models correlated with each other to the significance level of
P < 0.01.
Since the MOXE model is an incremental extension of the Patz et al model, providing estimates of
additional parameters of lung physiology, it would seem to be the most up-to-date and logical model to
use in CSSR studies wherein the dissolved 129Xe resonances can be spectrally resolved. Despite this fact,
an increased number of inter-dependent fitting parameters may obscure their interpretation; for example,
in this study the tissue-barrier-to-septum ratio parameter ( δd , could not be compared between subject
groups due to the fact that in some cases, the parameter tended towards unrealistically low and even neg-
ative values. Hence in all fitting results shown, δd was restricted to lie within a range 0.05-0.30 (note, this
restriction had a negligible effect on the values of the other fitting parameters). Therefore, in future work,
it may be advantageous to reduce the complexity of the MOXE model, by constraining the fit parameters.
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To this end, with further data, we may be able to establish a link between the CTT parameter and DCE-
MRI data and could utilise this to yield prior knowledge about the CTT. Similarly, it may be possible to
estimate the true tissue-barrier-to-septum ratio from the RBC-to-T/P signal ratio measurements, which
provide a representation of the relative fractions of xenon in parenchymal tissues and blood. In combina-
tion with knowledge of the HCT (e.g. from blood samples) the MOXE fitting process could be reduced
to a 2- or 3-parameter problem, though some correction may be required to account for the F˚ahraeus effect.
Experimental limitations
Achievement of precise 90◦ excitations of dissolved-phase 129Xe magnetisation in vivo can be challenging,
as discussed in the following subsection. The design of the flexible transmit-receive coil used in this work
does not deliver a uniform flip angle across the whole of the lungs (∼ 16% variation overall; the ratio of
standard deviation to mean flip angle quoted in the caption of Figure 4.8). Of course, the delivered flip
angle is dependent upon the position of the flexible coil, and the loading realised by subjects which will
be of various shapes and sizes. The coil transmit inhomogeneity has important implications for CSSR
measurements. Since the acquired 129Xe spectra represent whole-lung averaged signals, the averaging
process takes into account not only the heterogeneity in gas exchange function across the lungs, but also
the spatial variation in delivered flip angle. Furthermore, we often observed elevated dissolved 129Xe
signal amplitudes at the start of the first TR sweep, which may be associated with B1 inhomogeneity and
hence imperfect dissolved 129Xe saturation. Indeed, the early data points may be affected not only by
the unknown time for which gas exchange can occur during inhalation, but also by 129Xe signal outside
the active region of the coil (this effect was not observed in subsequent TR sweeps). More homogeneous
transmitter coils (e.g. of birdcage design [322]) could be utilised; however these would typically be larger
and less power-efficient than flexible coils, necessitating increased RF powers to achieve complete satura-
tion of dissolved-phase 129Xe.
Aside: CSSR with incomplete saturation of dissolved-phase 129Xe
90◦ RF pulses are not readily achievable for 129Xe in the thorax due to a combination of factors, including:
the gyromagnetic ratio of 129Xe is almost four times smaller than that of 1H, meaning that the B1 field
strength required to achieve the same excitation flip angle is four times greater; RF amplifiers provided
for support of non-1H nuclei typically have a lower power output compared with 1H amplifiers. The
compromise solution presented in Section 6.2 is the use of binomial composite pulses, which can be highly
frequency-selective whilst maintaining a high power efficiency in terms of B1 performance
iii.
Nevertheless, some sites / systems may not have the capability for designing and implementing ar-
bitrary RF excitation pulses, and there may be no option for the use of higher-power broadband RF
amplifiers capable of delivering a high enough B1 field in the coil for such pulses. To this end, in this
subsection, a model of the expected in vivo dissolved-phase 129Xe magnetisation in a CSSR experiment
for excitation flip angles of less than 90◦ is presented. This derivation assumes a perfectly homogeneous
B1 field across the whole of the lungs.
iiiThe SAR associated with these binomial pulses at the flip repetition rates considered in this work is well within safe
limits, however rigorous SAR simulations should be carried out before utilising these pulses in a sequence with extremely
low repetition rate.
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Figure 6.10: (i) Comparison of the accuracy and applicability of the a) Patz et al, b) MOXE and c) Ma˚nsson et
al models in describing in vivo 129Xe CSSR data from a single healthy volunteer. Blue data points denote the
total dissolved 129Xe signal intensities, green the T/P component and red the RBC component. The model fits
are shown both with fit-weighting applied to the middle section of each curve (dashed lines), and in the absence
of any weighting (solid lines). (ii) Bland-Altman plots of the systematic differences in CSSR-derived parameters
(septal thickness (top), capillary transit time (centre) and surface-area-to-volume ratio (bottom)) between models,
in each case comparing the Patz et al and Ma˚nsson et al model results to those of the MOXE model.
From Equation 3.125 (see Section 3.2.6), it is known that the decay in signal of a hyperpolarised species
in a gradient-spoiled pulse sequence is dependent upon the excitation flip angle α, repetition time TR
and number of RF pulses n. By considering the propagation of magnetisation at different stages during
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the standard CSSR pulse sequence (see Figure 6.2), and using Equation 3.125 as a basis, a model of the
expected uptake of 129Xe gas into the bodily tissues and blood during a certain uptake time TR can
be derived. In the following, TR is considered to vary in an arbitrary fashion for each RF pulse, such
that TRn denotes the repetition time immediately following the nth RF pulse. This derivation considers
only the combined dissolved-phase 129Xe signal, i.e. not separating the signal into its constituent T/P
and blood components. Defining Mz(0),d and Mz(0),g as the dissolved and gaseous
129Xe longitudinal
magnetisations at time zero iv, we can write the following expressions for dissolved and gaseous 129Xe
longitudinal magnetisations after the first repetition time, TR1:
Mz(1),d = Mz(0),dcos(αd)exp
(
−TR1
T1,d
)
+Kgd (TR1)Mz(0),gexp
(
−TR0
T1,g
)
(6.11)
Mz(1),g = Mz(0),gcos(αg)exp
(
−TR1
T1,g
)
+Kdg (TR1)Mz(0),dexp
(
−TR0
T1,d
)
(6.12)
where, Kgd (TR1) and Kdg (TR1) describe the rate of transfer of
129Xe nuclei from the gaseous to
dissolved compartments (and vice-versa) respectively, during repetition time TR1. These terms are es-
sentially equivalent to F (t) in the Patz et al model, and its associated reverse process (i.e. the transfer
of 129Xe nuclei from the tissues and blood into the airspaces), respectively. The transverse magnetisation
of either dissolved or gaseous 129Xe can be calculated using:
Mxy(n) = sin(α)Mz(n−1) (6.13)
This model fundamentally assumes that just prior to the point of application of a RF pulse, the trans-
verse magnetisation of the dissolved 129Xe spins, Mxy(n−1),d = 0. This assumption is valid because all
magnetisation is spoiled at the end of each TR, and the dissolved-phase 129Xe T ∗2 is intrinsically short
(see Section 3.2.6). Furthermore, Mxy(n−1),g is considered to be negligible; the excitation flip angle for
gaseous 129Xe is typically very small, and additionally, any excited gaseous-phase 129Xe magnetisation
that exchanges during the TR will be dephased by the short T ∗2 associated with the dissolved-phase.
Extrapolating Equations 6.11 and 6.12 to an arbitrary number of RF pulses, n, the expression for the
dissolved-phase 129Xe longitudinal magnetisation immediately after pulse n, Mz(n),d, is:
(6.14)
Mz(n),d = Mz(n−1),dcos(αd)exp
(
−TRn
T1,d
)
+Kgd (TRn)Mz(n−1),gexp
(
−TRn−1
T1,g
)
≡ Sd (TRn+1)
sin (αd)
and, for the gaseous 129Xe longitudinal magnetisation, Mz(n),g:
ivTime zero is defined as the time immediately prior to the application of the first RF pulse. There will be an unknown
amount of gas exchange prior to the application of this pulse during inhalation of the bag and commencement of the scan.
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(6.15)
Mz(n),g = Mz(n−1),gcos(αg)exp
(
−TRn
T1,g
)
+Kdg (TRn)Mz(n−1),dexp
(
−TRn−1
T1,d
)
≡ Sg (TRn+1)
sin (αg)
where Sd (TRn) and Sg (TRn) are the dissolved and gaseous
129Xe MR signals measured in the CSSR
experiment (i.e. the signal intensities of each NMR peak). As expected, the dissolved 129Xe longitudinal
magnetisation is governed by both the residual (un-excited) dissolved 129Xe longitudinal magnetisation
due to a flip angle of less than 90◦, and the available longitudinal magnetisation from the gaseous-phase
129Xe at the start of the TR. These relations are recurrence relations, and hence must be solved simulta-
neously. We note that in the case of αd = 90
◦, the dissolved 129Xe magnetisation is solely determined by
the exchange term, and Mz(n),d ≡ Sd (TRn).
The flip angles αd and αg and spin-lattice relaxation times T1,d and T1,g are either known, can be
measured experimentally, or can be included as additional fitting parameters in the CSSR modelling pro-
cess; although the latter is impractical for reasons discussed in the previous subsection. Since Kgd (TRn)
is the analogue of the F (t) parameter from the Patz et al model, these recurrence relations should be
applicable for determining F (t) for any arbitrary combination of the flip angles αd and αg.
As yet, the applicability of these recurrence relationships to in vivo 129Xe CSSR data has not been prop-
erly assessed. Preliminary 129Xe CSSR data in one volunteer acquired at αd = 30, 50, 70, 90
◦ suggested
that the < 90◦ data can be retrospectively “corrected” such that the uptake curves from each acquisition
approximately overlaid each other (data not presented here). However, a thorough study involving many
subjects should be carried out before any conclusions about the accuracy of correcting CSSR data with
< 90◦ flip angles, and whether or not the CSSR fitting parameters are adequately preserved at different
values of αd.
Nevertheless, a more pragmatic and relatively straightforward, although costly, solution is to install a
higher-power broadband RF amplifier, which we have recently done in Sheffield. With a 4 kW amplifier
(double the power output of our previous amplifier), we can readily achieve 90◦ pulses in a short period
of time.
6.4.1 Future perspectives: Linking lung microstructural changes inferred
from 129Xe CSSR and 3He ADC mapping
This subsection provides brief details of an ongoing project related to 129Xe CSSR in our laboratory,
concerned with the relationship between microstructural changes in the alveoli measured by 129Xe CSSR
and 3He apparent diffusion coefficient (ADC) mapping in subjects with interstitial and obstructive lung
diseases.
ADC mapping MRI with 3He has demonstrated clinical utility for regional assessment of lung microstruc-
ture, and is sensitive to alterations in alveolar dimensions, particular in emphysematous disease (see e.g.
[101, 108] and Chapter 5 of this thesis). As demonstrated earlier, the 129Xe CSSR spectroscopy tech-
nique is a promising functional tool for pulmonary gas exchange assessment, sensitive to alterations in
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septal thickness in interstitial lung disease and COPD / emphysema. However, the relationship between
pathology-induced changes to alveolar airspace dimensions and septal wall dimensions measured from
these two techniques has not been explored in healthy volunteers or patient populations. Moreover, the
functional sensitivity of hyperpolarised 3He ADC mapping has not been investigated in subjects with ILD
to date.
The objectives of this work were to evaluate the feasibility of 3He ADC mapping and 129Xe CSSR in
patients with ILD and COPD / emphysema, and to appraise the relationship between derived parameters
of lung microstructure in order to better characterise the underlying microstructural behaviour in these
pathologies.
Subjects recruited for this study included: 10 healthy volunteers from the study presented in Section 6.2,
plus 10 additional volunteers (of mean age 42 ± 8 years); 4 patients with idiopathic pulmonary fibrosis
(from Section 6.2); 4 patients with systemic sclerosis (from Section 6.2), plus 4 additional SSc patients; 5
patients with COPD (described in more detail in the following chapter, see Section 7.2, and Table 7.1).
Note: MR-derived metrics of lung microstructure from COPD patients (in which multiple, repeated scans
were performed, see Section 7.2) were averaged to provide a single value for each patient and ensure
consistency of inter-group comparisons.
All patients underwent both 129Xe CSSR and diffusion-weighted 3He MRI, however, some volunteers
were recruited for specific scan types only; as a result, only 12 volunteers performed both scans. The
experimental methodology for 129Xe CSSR spectroscopy has been detailed in Sections 6.2 and 7.2. Ex-
perimental details of the 3He ADC mapping acquisition have been described in Section 5.2. Subjects
underwent pulmonary function tests including; TL,CO, FEV1 and FVC for comparison to MRI data.
Statistically-significant differences in parameters between subject groups were evaluated according to
a two-tailed analysis of variance (ANOVA) with post-hoc contrast, and the relationship between MR-
derived metrics and PFTs was assessed using Spearman’s correlation coefficient. It was hypothesised that
the fundamental differences in underlying microstructural response to disease between interstitial and ob-
structive pathologies would constrain the interpretation of an inter-group correlation between 129Xe CSSR
and 3He ADC values in all subjects. As such, subjects with IPF and SSc were considered separately from
subjects with COPD in the correlation analyses.
Figure 6.11: Representative single slice 3He ADC maps acquired from an IPF patient.
Example 3He ADC maps from a patient with IPF are depicted in Figure 6.11. This subject was observed
to have clear bullous emphysema in the apices of the lungs on accompanying CT scans, particularly in
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the anterior slices; this was further highlighted by regionally elevated 3He ADC values in those regions.
All other IPF and SSc patients did not exhibit co-existing emphysema in addition to their diagnosed
interstitial disease, hence this particular patient was excluded from the 129Xe CSSR versus 3He ADC
correlation analysis (red circled data-point in Figure 6.13).
Since 129Xe CSSR provides a global mean assessment of lung microstructure, it is appropriate to
compare the CSSR-derived septal thickness (ST) with the global mean 3He ADC. As has been presented
earlier in this chapter, the ST was found to be significantly larger in IPF patients and COPD patients as
compared with healthy volunteers. (Although the mean ST difference between healthy volunteers and SSc
patients was found to be significant in Section 6.3, the additional subjects included here have led to the
statistical significance being reduced above the P > 0.05 level.) In addition, global 3He ADC values were
elevated in all patient groups compared with healthy volunteers, at the P < 0.05 level. In both cases, SSc
patients exhibited the next-largest mean ST and ADC parameters after healthy volunteers, and, whilst
the ST was greatest in IPF patients, the ADC was greatest in COPD patients, reflecting the intrinsically
differing pathological action of these two diseases. Box plots illustrating the group-to-group differences in
129Xe CSSR-derived ST and 3He DW-MRI-derived global ADC are shown in Figure 6.12.
Figure 6.12: Comparison of global alveolar septal thickness values from 129Xe CSSR (a) and global mean 3He ADC
values (b) in healthy volunteers (HV), systemic sclerosis (SSc), idiopathic pulmonary fibrosis (IPF) and chronic
obstructive pulmonary disease (COPD) patients. Significant differences between groups are indicated by dashed
lines and corresponding P values.
The 129Xe CSSR ST and 3He ADC measurements therefore suggest that interstitial lung disease and
obstructive / emphysematous lung disease both impact adversely on gas exchange function and cause
enlargement of the alveolar airspaces. The correlation between 129Xe ST and 3He global ADC values is
shown in Figure 6.13, with separate linear regression lines plotted for healthy volunteers combined with
SSc and IPF patients, and healthy volunteers combined with COPD patients. This separate analysis is
necessitated by the opposite trend in greatest ST and ADC values in IPF and COPD patients, respectively
(as illustrated by Figure 6.12).
In order to further investigate the origin of the functional changes to the septum and the airspace in
these diseases, the two MR-derived metrics were compared to standard PFTs. 129Xe CSSR-derived septal
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thickness values correlated well with TL,CO and FVC metrics (r = −0.80, P < 0.001 and r = −0.55,
P = 0.003, respectively in all available subjects) but not with FEV1 (P > 0.05). Global mean
3He
ADC values exhibited strong correlations with TL,CO (r = −0.84, P < 0.001) and FEV1 (r = −0.92,
P < 0.001), but not FVC (P > 0.05). Other groups have reported strong correlations between 3He ADC
and TL,CO [85, 298], suggesting that the ADC measurement is inherently influenced by gas exchange
function. However, as considered in a previous subsection, the TL,CO is actually defined as the product
of the gas exchange rate KCO and the alveolar volume VA (see Equation 3.5). Thus, it is possible that
the correlations of 129Xe ST and 3He ADC with TL,CO are dominated by different components of TL,CO
(for example, KCO and VA, respectively).
Figure 6.13: Observed correlations between
global 3He ADC and 129Xe CSSR septal thick-
ness, including separate linear fits for ILD sub-
jects (small dashes) and COPD subjects (large
dashes), with corresponding Spearman’s corre-
lation coefficients (r) and P values. Red dashed
circle: IPF patient with established emphysema
that was excluded from correlation analysis due
to the conflicting pathological information con-
tained within the whole-lung average measure-
ments.
This project is ongoing; further investigations are required to fully explore the relationship between 129Xe
CSSR- and 3He DW-MRI-derived metrics of lung microstructure in order to determine the fundamental
disease mechanisms underpinning lung microstructural remodelling in ILD and COPD. In addition, as
presented in Chapter 5, the feasibility of using 129Xe DW-MRI to access the same microstructural in-
formation as 3He DW-MRI is currently being assessed. However, an important limitation of the current
129Xe CSSR method in comparison to hyperpolarised gas ADC mapping MRI is the lack of regional speci-
ficity afforded by whole-lung spectroscopy. This is particularly crucial in ILD and COPD patients where
regional disease heterogeneity is very common. This limitation is addressed in Section 7.4.1.
Conclusions
CSSR spectroscopy with hyperpolarised 129Xe is capable of detecting alterations in whole-lung structure-
function in interstitial and obstructive forms of lung disease, via the non-invasive measurement of alveolar
septal thickness. Statistically significant septal thickening has been detected in patients with IPF and
COPD, and also, preliminary evidence suggests some septal thickening in patients with SSc. Further data
may elucidate whether the 129Xe CSSR technique is sensitive to age-dependent changes in lung septal
structure. Previously established models of xenon uptake have been reviewed and each has been shown
to effectively distinguish between ILD subjects and healthy volunteers to a high level of statistical signifi-
cance. Additionally, the 129Xe CSSR technique has been compared for the first time against gold-standard
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clinical methods, including TL,CO and DCE-MRI. Ongoing work to reconcile the lung microstructural al-
terations in interstitial lung disease and COPD with 129Xe CSSR in conjunction with 3He ADC mapping
MRI has been presented. 129Xe CSSR shows considerable potential for application in a number of novel
studies to provide information not readily obtainable by CT or pulmonary function testing. In future, the
sensitivity of the technique to fibrosis treatment response, or early changes in ILD, should be assessed to
facilitate clinical application.
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Chapter 7
Reproducibility and methodological
considerations for implementation of
the 129Xe CSSR technique
7.1 Introduction
Previous studies with 129Xe CSSR in human subjects have been limited to small patient cohorts, and
the reproducibility of the technique has yet to be assessed. The reproducibility of MR-derived functional
measures is critical to determining their sensitivity and robustness for future clinical applications as a
quantitative outcome measure (see e.g. [323]). For example, though the efficacy of 3He apparent diffusion
coefficient mapping for characterisation of emphysema has been well-known for many years [101], the
reproducibility of the technique is key to facilitating increased application in a clinical setting [291, 292].
Similarly, 129Xe CSSR-derived measures of pulmonary gas exchange must be demonstrated to be suffi-
ciently reproducible before the sensitivity of the method to disease-related changes in lung structure and
function can be adequately assessed.
Building upon the initial experimental validation of the 129Xe CSSR technique presented in Chapter 6,
the purpose of this work was to evaluate the intra-subject reproducibility of 129Xe CSSR-derived quanti-
tative parameters of lung microstructure and function in COPD / emphysema patients and age-matched
healthy volunteers. Following on from the discussion in Section 6.4, some of the important considerations
for implementation of the CSSR method are evaluated by experimental measurements and reviews of
previous literature. In particular, the sensitivity of the technique to MR pulse sequence strategy and to
lung inflation state is examined by assessing the reproducibility of two existing implementations of the
CSSR sequence and performing CSSR experiments at different inflation levels in healthy volunteers, re-
spectively. Furthermore, the fundamental assumptions of the analytical models of CSSR data (introduced
in Section 6.2), and the current paucity of literature supporting the choice of xenon physico-chemical
constants required as a basis for these models, and the interpretation of the derived estimates of lung
microstructure, is discussed in detail. Finally, as a first step towards achieving spatial sensitivity with the
CSSR method, a means to obtain regionally-localised, dynamic CSSR data is presented by interleaving
the standard CSSR pulse sequence with phase encoding strategies as in chemical shift imaging (CSI), in
what we denote a “CSI-CSSR” acquisition.
Part of this chapter is based on the following publication: “Reproducibility of Quantitative Indices of Lung
Function and Microstructure from 129Xe Chemical Shift Saturation Recovery (CSSR) MR Spectroscopy”.
N. J. Stewart, F. C. Horn, G. Norquay, G. J. Collier, D. P. Yates, R. Lawson, H. Marshall, J. M. Wild.
Magnetic Resonance in Medicine, doi:10.1002/mrm.26310 (2016). Author contributions statement: study
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design, NJS, FCH, DPY, RL, HM, JMW; acquisition of data, NJS, FCH, GN, GJC, HM; analysis of data,
NJS; preparation of manuscript, NJS, FCH, GN, GJC, HM, JMW.
7.2 Methods
The reproducibility study was divided into two parts: (i) preliminary investigations of the reproducibility
and robustness of performance of two different pulse sequence implementations of the 129Xe CSSR method,
and quantification of the effect of lung inflation level on CSSR-derived lung microstructural parameters
in healthy volunteers; (ii) reproducibility measurements with one implementation of the CSSR sequence
at fixed inflation level in COPD patients and age-matched healthy volunteers.
Preliminary study (i): Five healthy volunteers (mean age ± standard deviation, 38 ± 14 years) with no
history of respiratory disease were recruited (subject demographics shown in Table 7.1). To examine the
reproducibility of two different implementations of the CSSR sequence existing in the literature, each
subject was scanned on three separate days over a period of 1-3 weeks using the same scanner and ex-
perimental set-up as in Section 6.2. The two implementations of the 129Xe CSSR sequence are hereafter
defined as the “multi-sweep” and “multi-sat” sequences for the purpose of this preliminary study (see
Figure 7.1). The “multi-sweep” sequence is the exact sequence described in Section 6.2, employing the
use of single saturation pulses to destroy the magnetisation of 129Xe dissolved in T/P and RBCs, followed
by a variable inter-pulse wait period (repetition time, TR), during which alveolar-capillary gas exchange
occurs and polarised 129Xe gas diffuses into the T/P and RBC compartments. Multiple repeats of the
“TR sweep” are acquired and averaged, as discussed earlier. Sequence parameters were identical to those
described in Section 6.2.
The “multi-sat” sequence, as detailed in [140, 141], employs multiple saturation pulses prior to each
variable wait period and involves no averaging. This sequence was implemented with the following pa-
rameters: RF pulse and bandwidth as for the multi-sweep case; 128 sampling points (increased relative
to the multi-sweep implementation because the minimum achievable exchange time is not limited by the
read-out duration in the multi-sat sequence); 21 TR values from 20-1000 ms.
In each case, a gas dose of 350-400 mL xenon (86% 129Xe, polarised to ∼ 25% using the “upgraded”
polarisation system described in Section 4.4.1), balanced to 1 L with nitrogen, was inhaled from a Tedlar
bag from functional residual capacity (FRC) prior to a 10-15 second breath-hold. CSSR data were fitted
with the model of Chang (MOXE) [139], using a xenon diffusion coefficient in the dissolved-phase of
D = 3.0 × 10−6 cm2.s-1 and an Ostwald solubility coefficient of xenon in tissue of 0.1 [138], to estimate
whole-lung alveolar septal thickness (ST) and surface-area-to-volume ratio (S/V).
In order to investigate the change in CSSR-derived parameters with lung inflation level, multi-sweep CSSR
data were acquired at three different lung inflation levels from three healthy volunteers (24(M), 28(M)
and 31(M) in Table 7.1). Sequence parameters and acquisition strategy were as above. The following
inflation levels were attained prior to breath-hold and data acquisition: 1) forced exhalation to residual
volume (RV), followed by inhalation of the 1 L xenon-nitrogen mixture; 2) exhalation to FRC, followed by
a 1 L inhalation; 3) exhalation to FRC, followed by inhalation of the 1 L dose and additional inhalation
of room air to reach total lung capacity (TLC).
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Figure 7.1: Schematic representation of the two implementations of the 129Xe CSSR pulse sequence used in this
work: A) 90◦ RF saturation pulses separated by a variable wait period (equivalent to the inter-pulse repetition
time, TR); whole acquisition repeated three times (“multi-sweep” CSSR as in Figure 6.2). B) Multiple RF
saturation pulses with a short inter-pulse delay, followed by a variable wait period; whole time-series acquired
once (“multi-sat” CSSR). C) Typical time-series of 129Xe NMR spectra acquired using the multi-sweep sequence,
normalised to the gas peak. T/P: 129Xe dissolved in tissues and blood plasma; RBC: 129Xe in red blood cells.
Reproducibility measurements (ii): Nine healthy volunteers (59± 8 years) with no history of respiratory
disease, and five patients with COPD (67 ± 6 years) were recruited (see Table 7.1). To assess the short-
and long-term reproducibilities of 129Xe CSSR, COPD patients were scanned on four occasions; twice on
the first day, once the following day, and once two weeks later. Volunteers were scanned in three separate
sessions on the same day, between which they were repositioned. In all cases, the multi-sweep sequence
was employed, with parameters as above and a xenon dosage of 300-350 mL.
For comparison with MR measurements, conventional pulmonary function tests (PFTs) were performed by
all subjects (see Table 7.1), including forced expiratory volume in one second (FEV1) and forced vital ca-
pacity (FVC) manoeuvres. In addition, the transfer factor of carbon monoxide (TL,CO) test was performed
by COPD patients to provide a standard metric of pulmonary gas exchange. For the two healthy volunteer
cohorts, PFT data were acquired on only one occasion since the variability of spirometry is well-known in
healthy subjects [299], whilst for COPD patients, PFT data were obtained on each of the three scan dates.
To evaluate the reproducibility of each CSSR-derived functional parameter, the intra-subject standard
deviation and coefficient of variation (CV; the ratio of the standard deviation (SD) to the mean value,
expressed as a percentage) was calculated. A mixed model, repeated measures analysis of variance test
was performed for each parameter to determine the significance of any time-dependent variations, accord-
ing to the F-value (analogous to a conventional statistical t-value) and P value of statistical significance.
Reproducibility data are presented as mean, SD and CV values and modified Bland-Altman plots [324]
with CV on the y axis. An equivalent analysis was carried out for PFT measurements where applicable.
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7.3 Results
In one participant from the age-matched healthy volunteer cohort (62(M) in Table 7.1), the signal-to-noise
ratios (SNRs) of spectra obtained from one scan were insufficient to accurately fit the data and derive
meaningful estimates of alveolar ST and S/V. Additionally, another participant from this group (59(F))
was unable to maintain breath-hold for the duration of one scan. Hence, only two data-points were used
for reproducibility analysis in these subjects. For two COPD patients (64(F) and 67(F)), data were only
successfully acquired once on the first day of scanning, and in a third patient (71(M)), spectral SNR was
insufficient in one scan from the first day; thus, only three of four proposed acquisitions were available for
reproducibility analysis in these patients.
Preliminary study (i): Mean ST values in the five healthy volunteers derived from multi-sweep and multi-
sat sequences were 11.5± 0.9 µm and 12.6± 1.2 µm, and the corresponding mean CV values of ST were
4.1 ± 1.3% and 10.0 ± 7.4%, respectively. Mean S/V values derived from the multi-sweep and multi-sat
sequences were 228 ± 49 cm-1 and 195 ± 46 cm-1, and the corresponding mean CV values of S/V were
25.1 ± 7.8% and 23.7 ± 13.2%, respectively. Figure 7.2 depicts Bland-Altman plots of the intra- and
inter-subject variations of ST and S/V parameters derived from the two sequences. (The intra-subject
variability (reproducibility) is represented by the CV axis.)
Figure 7.2: Preliminary investigation of the reproducibility of parameters derived from the two different imple-
mentations of the 129Xe CSSR sequence, as assessed in five healthy volunteers. The coefficient of variation (CV) of
CSSR-derived septal thickness (ST) and surface-area-to-volume ratio (S/V) values are plotted on Bland-Altman
charts in A) and B), respectively. Solid lines represent the mean CV and dashed lines denote ±2 standard devia-
tions from the mean CV.
Mean ST values from the three healthy volunteers were similar at inflation levels of RV + 1 L (11.0± 0.1
µm) and FRC + 1 L (11.3 ± 0.5 µm), whilst the ST was significantly reduced (P < 0.001) at TLC
(7.6± 0.5 µm) when compared with both RV + 1 L and FRC + 1 L, as shown in Figure 7.3A. S/V values
exhibited a decreasing trend with inflation level (Figure 7.3B), with a significance of P = 0.057 between
TLC (115± 16 cm-1) and RV + 1 L (253± 66 cm-1) (S/V at FRC + 1 L was 200± 62 cm-1).
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Figure 7.3: Mean 129Xe CSSR-derived A): alveolar septal thickness (ST) and B): alveolar surface-area-to-volume
ratio (S/V) measurements as a function of lung inflation level in three healthy volunteers. RV: residual volume;
FRC: functional residual capacity; TLC: total lung capacity.
Reproducibility measurements (ii): The average of the mean ST in COPD patients (14.0 ± 2.7 µm) was
elevated when compared to age-matched healthy volunteers (11.6± 1.0 µm) (P < 0.05). Additionally, ev-
idence of a reduced S/V ratio in COPD patients (117±60 cm-1) when compared with volunteers (194±70
cm-1) was observed (P = 0.055). The mixed model analyses showed no significant changes in ST or
S/V as a function of scan time-point, with F = 1.32, P = 0.294 and F = 2.48, P = 0.116 for healthy
volunteers; F = 2.08, P = 0.156 and F = 0.27, P = 0.845 for COPD subjects, concerning ST and S/V,
respectively. CV values of ST were < 8% and < 13% in volunteers and COPD patients, with a mean ±
standard deviation of 3.9±1.9% and 6.0±4.5%, respectively (see Figure 7.4A, C). CV values of S/V were
< 28% and < 50% in volunteers and COPD patients, with a mean ± standard deviation of 14.1 ± 8.0%
and 18.0± 19.3% (see Figure 7.4B, D).
Average FEV1 and FEV1/FVC measurements were significantly reduced in COPD patients when com-
pared to volunteers (P < 0.001) (see Table 7.1). In these patients, the mean CV values associated with
pulmonary function tests were: 4.2± 1.5% for FEV1; 2.4± 1.1% for FEV1/FVC; 8.8± 4.8% for TL,CO.
7.4 Discussion & Conclusions
The observation of improved reproducibility (lower CV) of ST for the multi-sweep when compared to the
multi-sat implementation of 129Xe CSSR may be a result of the reduction in variance of fitted data points
arising from the multiple-averaging process. Nevertheless, upon separate analysis of the individual TR
sweeps of the multi-sweep data-sets presented in Figure 7.2, no clear difference in mean CV of ST or S/V
values derived from each of the sweeps — when compared with the multi-sweep average — was observed,
other than the CV of ST of the first sweep being slightly higher than that of the other two sweeps (mean
CV of ST = 4.1± 1.3% for all sweeps, 5.5± 1.3% for sweep 1, 3.5± 2.4% for sweep 2, 3.7± 1.5% for sweep
3, as summarised in Table 7.2). We suspect that the minor increase in CV for the first sweep could have
resulted from the fact that this sweep is associated with the highest SNR data-points, and is thus more
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Figure 7.4: Reproducibility of 129Xe CSSR-derived alveolar septal thickness (ST) and surface-area-to-volume ratio
(S/V) values in COPD patients and age-matched healthy volunteers. A) and B): ST and SV values in healthy
volunteers (mean age = 59±8 years). C) and D): ST and SV values in COPD patients (mean age = 67±6 years).
Solid lines represent the mean CV and dashed lines denote ±2 standard deviations from the mean CV.
sensitive to subtle changes in the shape of the uptake curve between scans. The latter two sweeps have
lower SNR, and hence the fitting process results in a curve that approximates a noisier data-set, such
that subtle changes between repeated scans may be less apparent. Additionally, it is worth noting that
the mean CV for the multi-sat sequence is strongly influenced by an outlying data-point with a CV of
ST of 22.7%, resulting from an anomalous ST value in one of the three repeated scans for that subject.
In the absence of this outlying data-point, the mean CV between the two CSSR implementations would
be considerably closer. Previously, multiple saturation pulses have been required to completely destroy
the dissolved-phase 129Xe magnetisation in human subjects [138, 140, 141]. However, the utilisation of a
custom binomial-composite pulse design permits highly effective saturation of magnetisation with a single
pulse [317]. The observation that the CV of S/V is similar between the two sequence implementations
implies that the saturation process itself is reproducible, since the S/V is most strongly influenced by the
early time-points of the CSSR experiment, where incomplete saturation could cause significant effects. In
light of the apparent improved reproducibility of ST, the multi-sweep implementation was employed for
subsequent experiments inflation-level and reproducibility experiments.
Xenon is perfusion limited (see Section 3.1.3) and, at all time-points during an in vivo 129Xe CSSR exper-
iment, it is assumed that the pulmonary capillaries are essentially saturated by xenon. Thus, we would
not expect the xenon exchange dynamics to change significantly between subsequent sweeps of a multi-
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TR sweep Mean ST Mean CV SD CV of Mean S/V Mean CV SD CV of
(µm) of ST (%) ST (%) (cm-1) of S/V (%) S/V (%)
Average 11.50 4.13 1.26 228.5 25.1 7.8
(all sweeps)
Sweep 1 11.36 5.47 1.29 230.0 25.3 7.7
Sweep 2 11.63 3.53 2.40 225.8 25.6 6.9
Sweep 3 11.58 3.69 1.48 226.6 25.1 8.0
Average 11.63 3.30 1.63 225.6 25.4 7.5
(2 & 3)
Multi-sat 12.55 10.0 7.4 194.6 23.7 13.2
(from paper)
Table 7.2: Reproducibility of derived ST and S/V parameters from individual sweeps of the multi-sweep CSSR
experiment (method comparison study).
sweep CSSR experiment; in fact, it is an important assumption of the method that no change in exchange
dynamics occurs over the entire course of the breath-hold. In addition, it is assumed that alterations to
associated physiological parameters during the breath-hold (such as capillary oxygen saturation and heart
rate) would influence the observed gas exchange behaviour to a negligible degree.
In this study we noticed no clear changes in subject heart rate over the course of the 15 second breath-
hold (as recorded by pulse oximetry). However, if the heart rate was seen to change over the breath-hold,
it may be expected that the rate of extraction of xenon from the capillary bed would be altered, and
thus the slope of the perfusion-dominated section of the CSSR uptake curve could be different in the final
sweep compared with the first sweep, for example.
In terms of oxygen saturation changes: as stated above, xenon is perfusion limited. Oxygen on the
other hand exhibits a mixture of diffusion-limited and perfusion-limited behaviour, particularly in subjects
with pathology. It is not thought that the oxygen and xenon binding sites in human deoxy-haemoglobin
are the same [262, 325]. However, it may be possible that oxygen acts as an allosteric inhibitor on xenon,
such that as the haemoglobin changes conformation (from oxy to deoxy-haemoglobin), the binding sites
for xenon and the affinity of the molecule for binding xenon may change. Therefore, it is possible that
if the oxygen saturation of the blood were to change considerably during the breath-hold, there may be
an alteration of the rate of xenon uptake into the RBCs. However, the principle of the CSSR experiment
assumes that the dissolved-phase is already saturated with xenon before starting the experiment – i.e.
that the concentration of xenon in the dissolved-phase is roughly constant during the breath-hold, and
hence even if this process occurred, its effect should be negligible.
The measured decrease in S/V and ST with lung inflation level can be explained by the expansion of
the alveoli and stretching of the lung tissue at high inflation levels, respectively [326]. A reduction in
CSSR-derived S/V has been previously reported with lung inflation level [248], and, although a change
in CSSR-derived ST with inflation level has not been reported, recent observations of a decline in the
ratio of 129Xe T/P- or RBC-to-gas-phase resonances with increasing inflation level [141, 171] indicate a
reduced contribution of the dissolved 129Xe MR signal at higher inflation levels due to the lower volume
fraction of the dissolved compartment.
Despite our observations, the interpretation of this data must be carefully considered in terms of the
meaning of the different inflation levels. Although some recent 129Xe CSSR studies in humans have used
the same approach as that described here to achieve a desired inflation level of FRC + 1 L prior to data
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acquisition [140], others have employed a procedure of quantifying the subject’s TLC prior to MRI, and
modifying the inhaled gas dose for each subject in order to achieve an inflation level that equates to a
specific fraction of that subject’s TLC [138, 141]. The second procedure ensures that the lungs are at
an equivalent level of relative inflation in each subject, which should correspond to a comparable alveo-
lar geometry. On the other hand, the inflation level of FRC + 1 L employed in this work may equate
to a different fraction of each subject’s TLC. In future work, it may be better practice to calculate an
inhaled gas dose such that the inflation level is proportionate between subjects (e.g. 50% TLC), making
comparisons between subjects more meaningful in terms of viable gas exchange surface. In addition, it
may be beneficial to instruct subjects to exhale to RV rather than FRC in all cases prior to inhaling a
xenon gas dose, in order to improve the validity of comparisons between different inflation levels. In the
current work, whilst the inflation levels of FRC + 1 L and TLC were achieved from an initial state of
FRC, the RV + 1 L level was reached from RV, and hence the xenon mixing may have been affected by
the differences in residual gas in the lungs prior to inhalation of the xenon dose. On the other hand, it
could be argued that the procedure for achieving the RV + 1 L and FRC + 1 L inflation levels should
remain as described in Section 7.2 but the TLC level should be achieved by inhaling air up until TLC −
1 L and then inhaling the 1 L xenon dose afterwards. This alternative method ensures that the xenon
dose is always the final amount of gas breathed in for each of the three inflation levels.
Assuming that the calculated variation in ST and S/V with lung inflation level cannot be fully ex-
plained by inter-subject differences in relative lung inflation level, this observation is an important consid-
eration for future experimental 129Xe CSSR studies; in that, it is crucial to carefully instruct the subject
to ensure that the desired inflation level is achieved and that breath-hold is effectively maintained. It
might be expected that patients would better-tolerate breath-holds at higher inflation levels than FRC
+ 1 L. Furthermore, we might also expect the reproducibility of derived ST and S/V metrics at TLC
to be improved compared with FRC + 1 L, because TLC represents an extreme limit of lung inflation
level, which should be easier to achieve for the patient (whilst the patients’ perception of FRC may vary
between scans). However, appropriate reproducibility tests must be carried out at TLC before routine
129Xe CSSR studies are possible at this inflation level.
The mean ST and S/V values derived in this work are comparable to estimates obtained from alternative
methods: ST ∼ 10µm from histological methods [327] including computerised morphometry [320, 328];
S/V in healthy volunteers ∼ 250 cm-1 from histological methods [329] and 200-240 cm-1 from hyperpo-
larised 3He diffusion-weighted MRI [103] (both these articles also reported a reduced S/V of ∼ 50− 150
cm-1 in a range of patients with severe to mild emphysema). In addition, our results are of the same order
as those reported in recent 129Xe CSSR studies with human subjects [138, 140, 141]. However, a direct
comparison of the absolute ST and S/V values in this work and other 129Xe CSSR studies in humans
requires careful consideration of any discrepancies in the data acquisition and analysis approaches in those
works, as discussed below. A thorough review of example literature references for ST and S/V values and
a detailed explanation of the challenges in directly comparing our values to those of other 129Xe CSSR
studies in humans is provided later in this section.
It is important to consider that the data presented in this study can be analysed using models other
than MOXE (see e.g. Section 6.4 and [138, 145, 309]). In Section 6.4, small differences in CSSR-derived
lung microstructural parameters resulting from some of these models were highlighted. Furthermore, in
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addition to discrepancies in data analysis procedure, most human studies with 129Xe CSSR to date have
been performed with slightly different assumptions about the value of critical physical parameters [138–
141], such as the diffusion coefficient and Ostwald solubility of xenon in tissue, which have a significant
bearing on the absolute derived ST and S/V estimates, respectively. A review of the approaches and
assumptions considered in each of these works is presented in the next subsection.
The mean intra-subject standard deviation of CSSR-derived ST values of age-matched healthy volunteers
(0.46 ± 0.21 µm)measured in this study is much less than the difference in mean ST between healthy
subjects and IPF patients (∼ 7µm) as quantified in Section 6.3 (mean healthy subject ST = 10.0 ± 1.6
µm; mean IPF patient ST = 17.2 ± 1.1 µm for the MOXE model), and also less than the 2.4 µm mean
difference between healthy subjects and COPD patients as presented in Section 7.3. In addition, the
Bland-Altman plots in Figure 7.4 illustrate that the CV of ST does not appear to change with the mean
value. These factors, coupled with the generally low CV values from volunteers and COPD patients (< 8%
and < 13%, respectively), provide substantive evidence that the CSSR-derived ST is a reproducible pa-
rameter. The CV of ST was comparable to that of PFT metrics of gas exchange; mean CV values in
COPD patients were comparable to reported long-term variability of TL,CO (9% [301]), whilst the CV in
healthy volunteers was of a similar magnitude to that of same-session variability of TL,CO [300].
On the other hand, mean CV values of S/V were above the target value for reproducibility of TL,CO. This
constrains the interpretation of apparent trends of reduced S/V in COPD patients and changes with lung
inflation level. The S/V parameter is derived from the early time-points of the CSSR experiment, where
dissolved 129Xe signal-to-noise ratio is lowest [307]. In addition, it would be expected that incomplete
saturation of magnetisation would adversely affect the derived S/V more-so than the ST, because the lat-
ter is predominantly influenced by later time-points. Furthermore, the complexity of the model of xenon
exchange [139] and its multiple interdependent fitting parameters may lead to inaccurate estimates of S/V
(whilst by definition of the model, it could be expected that ST values would be less influenced by these
interdependencies). A combination of these factors may explain the relatively poor S/V reproducibility.
A further limitation of the reproducibility of the CSSR-derived S/V in patients is the outlying data-
point (from subject 67(F)), with 49% CV. This subject exhibited a lower ST than all subjects, and whilst
FEV1 and FEV1/FVC were < 50% of the predicted value, TL,CO was 98.1%-predicted; comparable to
that of healthy subjects. Further study with larger patient populations and stricter lung inflation level
control is necessary to identify these outliers and further validate the S/V reproducibility.
For both ST and S/V metrics, the intra-subject reproducibility was noticeably worse in COPD patients
than healthy volunteers, despite similar results obtained from the mixed model analysis. This may be
at least partially explained by the fact that patients were scanned on multiple days, whilst volunteers
were scanned on a single day. Due to poor-quality or failed scans on the first day of the protocol, there
was insufficient data available to accurately separate COPD patient reproducibility data into same-day or
multi-day reproducibility data; hence CV values for these patients are dominated by inter-day variations.
Additionally, it is worth considering that the reproducibility of the 129Xe CSSR measurement is dependent
on a variety of factors, including fluctuations in 129Xe polarisation, reproducibility of lung inflation level,
and successful maintenance of breath-hold for the scan duration; the latter two factors depend heavily on
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the subject. Patients may have difficulty in inhaling the complete contents of the Tedlar bag, and/or may
be less effective in maintaining breath-hold for the scan duration. It is possible to circumvent breath-hold
failure in the third sweep by analysing data from the first or second sweeps only. However, factors such
as lung inflation level are challenging to control, and it is prudent to carefully instruct the patient on the
exact details of the protocol and perform training scans with bags of air prior to the CSSR scan itself, in
a similar manner to the repeated procedure employed for pulmonary function testing [330].
Review of literature values of xenon diffusion constants and solubilities used
in 129Xe CSSR studies with human subjects
In the existing analytical diffusion models for estimating lung microstructural parameters from 129Xe
CSSR data [138, 139, 145, 309], the estimate of septal thickness is directly proportional to the square
root of the xenon diffusion coefficient (D) in human lung parenchymal tissue and blood (see the rela-
tionship between the CSSR-fitted xenon exchange time constant (T ), D and d in Equation 6.7), and
the estimate of surface-area-to-volume ratio is inversely related to the septal thickness and the xenon
solubility in the lung parenchyma (λ). This review summarises the discrepancies in the choice of values
adopted for the xenon diffusion constant and solubility in previous 129Xe CSSR studies in human subjects.
The effect of diffusion coefficient (D)
The diffusion coefficient in human lung tissue used in the present work (including both the studies de-
scribed in Section 6.2 and 7.2) was D = 3.0× 10−6 cm2.s-1, which was taken from the work of Patz et al
[138, 248]. The value quoted by Patz et al were assumed to be valid, however, on further inspection, we
noticed that Patz et al cited Sta Maria and Eckmann [331] as the origin of this value. In Table 1 of [331],
estimated diffusivities of xenon in water, blood, and brain tissue of 1.55×10−5 cm2.s-1, 1.35×10−5 cm2.s-1
and 5.4×10−6 cm2.s-1, respectively, are quoted, which were estimated using the methods described in the
appendix of that article. The closest value that we can find to 3.0 × 10−6 cm2.s-1 in [331] is 3.8 × 10−6
cm2.s-1, which is stated as the diffusion coefficient for xenon in rat liver tissue, originally taken from [332].
Thus, we are unsure of the exact origin of the 3.0 × 10−6 cm2.s-1 estimate in [138, 248]; it may be that
Patz et al applied some of the methods described in [331] to calculate a diffusivity for xenon in lung tissue,
or the value may arise from inaccurate rounding of the value from [332].
Other previous 129Xe CSSR studies in humans [139–141] have quoted a value of the total dissolved-phase
xenon diffusion coefficient of D = 3.3 × 10−6 cm2.s-1. In addition, this value has been adopted in other
(non-CSSR-based) 129Xe dissolved-phase MRI studies in humans, e.g. Dregely et al [152] and Cleveland
et al [144]. Each of these articles cites a study by Ruppert et al [265] as the source of this value.
Although this value has been accepted in a number of different studies, we believe that the origins of
this value and its applicability to human lung tissue should be considered. Ruppert et al [265] derived
this value from a 129Xe CSSR-type experiment in rabbits; by fitting the total dissolved-phase 129Xe signal
intensity as a function of time post saturation of dissolved-phase 129Xe magnetisation, and assuming a
value for the whole-lung average septal thickness in rabbits in order to derive D. (This is essentially the
reverse of what has been done in most standard 129Xe CSSR experiments, which is to assume a dissolved-
phase xenon diffusion coefficient in order to calculate a septal thickness.)
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A key limitation of the validity of this value as the “standard” for D is that it was derived by assuming
a global mean septal thickness value in rabbits rather than measuring the ST by other means. Ruppert
et al quote a value of 5.5 µm as the average “membrane thickness” which they use to calculate D, citing
Kovar et al [333] for this value. In fact, this value is not quoted explicitly in [333], so we must assume
that Ruppert et al derived it from Figure 3c of [333], which depicts measurements of alveolar septal wall
thickness as a function of rabbit age. Unfortunately, Ruppert et al do not specify the age of the rabbits
used in their study, so it is not possible to verify that the assumed value of alveolar septal thickness is
indeed determinable from this figure; instead, we must observe Figure 3c of [333] and infer that the age of
rabbits in Ruppert et al’s study was approximately 20 weeks. (It is worth noting that Figure 3c of [333]
has considerable uncertainty associated with the wall thickness values (e.g. error bars ∼ 0.5µm).)
Ruppert et al [265] do state that there is a wide range of existing literature values for the xenon dif-
fusion coefficient in different tissues and species, although in actuality, the extent of relevant literature is
quite limited. Ruppert et al cite [334] as a reference that summarises relevant values of the xenon diffusion
coefficient in dog and sheep tissue samples, in addition to human blood plasma. Reproducing the values
in that article (measured at 37◦C): in water, D ∼ 1.9 × 10−5 cm2.s-1; in blood serum D = 1.61 × 10−5
cm2.s-1 and in blood plasma D = 1.51 × 10−5 cm2.s-1; in sheep liver D = 2.9 × 10−6 cm2.s-1; in dog
muscle, D = 6.8 × 10−6 cm2.s-1. Thus, it may indeed be expected that there is a wide range of xenon
diffusion coefficients in different tissue types of varying compositions and functions.
On a related note, it cannot be assumed that the value of D in blood plasma is identical to that
of whole blood – the presence of red blood cells would be expected to cause a significant alteration of
xenon’s diffusion properties in whole blood. Hence, even if we assume that the diffusion coefficient of
xenon in blood plasma and lung parenchyma is the same, it is difficult to infer an average value of the
xenon diffusion coefficient in lung tissues and whole blood from the above studies, and moreover, it is
likely not appropriate to assume that the diffusion coefficient is the same in tissues and whole blood; an
assumption which currently underpins the 129Xe CSSR experiment.
Fundamentally, although Ruppert et al’s (D = 3.3×10−6 cm2.s-1) value appears to be the most commonly
used to date, it is founded upon several key assumptions:
i) the age of the rabbits in [265], ii) the accuracy of the mean thickness values in [333], iii) the translata-
bility of the situation in rabbit lungs to that in humans, iv) the equality of the diffusion coefficient in lung
tissue and whole blood.
For completeness, point ii) can be reviewed further, because importantly, if the assumed tissue thick-
ness value in [265] was slightly different, the value of D would be altered to a non-negligible degree. There
is a paucity of literature reference values for rabbit septal tissue thickness, although as an example, here
we quote two values that suggest that the mean septal thicknesses could indeed be different to the values
reported in [333]: (i) in the same sub-species of rabbits, Mataloun et al [335] determined a mean value of
9.6± 2.5 µm in 17 control rabbits on a normal diet and room air at 7 days old, which is larger than the
value quoted in [333] (approximately 7.5 µm) for rabbits of the same age; (ii) also for the same breed of
rabbits, we can estimate the septal thickness from Birks et al [336] by using the mean radius of curvature
of capillaries and blood-gas barrier thickness reported in that work – if we assume that the septal thickness
is ≈ (2× capillary radius) + (2× blood-gas barrier thickness), we obtain (2× 3.63) + (2× 0.54) ≈ 8.34
µm. (However, unfortunately the age of the rabbits tested in [336] was not provided and hence this value
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cannot be directly compared with those in [333].)
Finally, although not reporting measurements from human subjects, Ma˚nsson et al [309], who presented
one of the first models with which to analyse 129Xe CSSR data, used a significantly different value of D
(1× 10−5 cm2.s-1) in their study with lipopolysaccaride-treated rats. This value is sourced from a confer-
ence abstract by Wolber et al [264], in which it is stated that this is the measured diffusion coefficient of
xenon in plasma, in vitro. Although Ruppert et al’s value was derived at 37◦C, there is no mention of the
temperature at which the diffusion coefficient of 1× 10−5 cm2.s-1 was derived in Wolber et al’s abstract.
From [264], we are led to assume that the methods used were the same as those in a previous paper by
that group [263], in which values for the xenon diffusion coefficient in water were obtained at 25◦C. Thus,
we can conclude that the value of 1×10−5 cm2.s-1 used in [309] is likely less appropriate for use in human
129Xe CSSR studies than D = 3.3× 10−6 cm2.s-1.
In spite of the above discrepancies between studies, we can conclude that the value of D = 3.3 × 10−6
cm2.s-1 from Ruppert et al [265] seems to have been generally accepted by the dissolved 129Xe MRI field,
and going forward it may be appropriate to utilise this value until a better estimate becomes available,
for example, from new experimental measurements. However, the limitations placed on the validity of
this value should be considered in future dissolved-phase 129Xe NMR studies, and further work should be
done in attempt to determine accurate estimates for the value of D in human lung tissue.
The effect of solubility coefficient (λ)
There is also some inconsistency in the choice of literature values of xenon solubility in different dissolved-
phase compartments (including lung tissue) used in CSSR analysis. For example, Chang et al [140] used
a solubility of xenon in lung tissue of λ = 0.2, citing [241], whilst Patz et al [138, 248] used a solubility of
xenon in lung tissue of 0.1, citing [233]. The value of xenon solubility in lung tissue used by Qing et al
[141] is not quoted in their paper.
Upon attempting to confirm the source of the values used by Chang et al, we cannot find a quotation
of the xenon solubility in (any form of) tissue in [241]. Furthermore, in Chang’s earlier article [139],
[241] is also cited, however it appears that [333] might also be cited for a value of xenon solubility in
tissue (see Figure 4 caption of [139]). There is no mention of a tissue solubility in [333]. Thus, we are
unsure as to Chang’s motivations and evidence for using a xenon tissue solubility of 0.2, but we note that
the discussion of [139] states “the value we used here (λ = 0.2) was only a highly crude approximation.
Approximations of the same nature apply to a few other parameters including the diffusion coefficient D
of dissolved xenon.”
Although there seems to be “no universally agreed value for λ” (another quote from [139]), we might
speculate that Patz et al’s estimate of 0.1 is more appropriate than Chang’s approximation of 0.2. Eger
and Larson [233] (cited by Patz et al [138, 248]) quote values of the xenon water/gas partition coefficient
(which is equivalent to the Ostwald solubility of xenon in water if the gas is assumed to be at a pressure
of 1 atmosphere) of approximately 0.1 at 37◦C. Although [233] refers to unpublished data for the source
of this value, we assume that Patz et al considered that parenchymal tissue is predominantly comprised
of water, and thus that the value of 0.1 could be directly translated to that of lung tissue.
Further support for using a value of 0.1 is provided by other (non-CSSR) studies in the dissolved
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129Xe MRI field; for example Dregely et al [152], who stated that the Ostwald solubility of xenon in
tissue is approximately equivalent to the blood-gas partition coefficient, which is quoted as ∼ 0.1, citing
[337], a study which reported a value of 0.115 for the blood-gas partition coefficient of xenon at 37◦C. In
addition, it is worth noting that Cleveland et al [144] cited Weathersby and Homer [135] as a reference
providing values for the solubility of xenon in various tissues. In [135], a summary of xenon Ostwald
solubilities and partition coefficients in different media is presented, and, whilst this article does not ex-
plicitly report a value of the xenon Ostwald solubility in lung tissue, we can take the quoted values of
Ostwald solubility in water and blood plasma as a guideline, which suggest a value in the range 0.09−0.11.
Finally, we review the previously-used values of the Ostwald solubility of xenon in plasma and red blood
cells (RBCs); information which is integral to separating the contribution of the T/P and RBC signals
and deriving the pulmonary haematocrit according to Equation 6.9. In Chang et al [139, 140], values of
0.091 and 0.19 are used for the xenon solubility in plasma and RBCs, respectively, citing [241] (which
requires the assumption that the plasma and RBCs are saturated with air at 37◦C). Although we accept
the methodology of [241] as valid, we note that it may be more appropriate to use values from Chen et al
[244] instead; 0.0939 and 0.271 for xenon solubility in plasma and RBCs, respectively. These values are
more up-to-date than those of [241], were determined in a thorough, systematic manner for a number of
experimental conditions, and have been adopted previously by other groups in the hyperpolarised 129Xe
MRI field, e.g. [144].
A summary of the above discussion is presented in Table 7.3. In conclusion, although well-accepted es-
timates of D and λ exist, increased dissemination of results is still required to ensure that all groups in
the hyperpolarised 129Xe MR field adopt the same values, in order to simplify inter-study comparisons.
Additionally, further work is needed to obtain more accurate estimates of these parameters. For example,
xenon diffusion coefficients in isolated ex vivo tissue and blood samples should be measured, for example
by echo train-based diffusion NMR techniques [263], to investigate the differences in D between lung
parenchyma and blood. Moreover, the xenon diffusion coefficient and Ostwald solubility should be better
characterised in diseased tissue samples in order to identify potential changes induced by structural re-
modelling / fibrosis.
Paper D (cm2.s-1) λ λPL λRBC Fitting Model
Patz et al [138, 248] 3.0× 10−6 0.1 N/A N/A Patz et al (to combined
dissolved-phase 129Xe peak)
Chang et al [140] 3.3× 10−6 0.2 0.091 0.19 Chang (MOXE)
Qing et al [141] 3.3× 10−6 N/S N/A N/A Patz et al (to T/P peak only)
Study in Section 6.2 3.0× 10−6 0.1
(N/S)
0.091
(N/S)
0.19
(N/S)
Chang (MOXE), Patz et al (to
combined peaks) and Ma˚nsson
et al
Present study (Section 7.2) 3.0× 10−6 0.1 N/A N/A Chang (MOXE)
Most up-to-date / widely-
used literature value [+
source]
3.3 × 10−6
[265]
0.1
[337]
0.0939
[244]
0.271
[244]
N/A
Table 7.3: Summary of values of literature constants employed in 129Xe CSSR studies in human subjects to date.
N/A: not applicable; N/S: not specified.
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Review of literature values of 129Xe CSSR-derived septal thickness and surface-
area-to-volume ratio in previous studies involving human subjects
In light of the discrepancies in the values of literature constants between previous 129Xe CSSR studies
as discussed above, the validity of comparing 129Xe CSSR-derived septal thickness and surface-area-to-
volume ratio values between different studies is somewhat limited. Firstly, this review introduces values of
septal thickness and surface-area-to-volume ratio in human subjects determined from methods other than
129Xe CSSR. Secondly, we discuss the 129Xe CSSR-derived septal thickness and surface-area-to-volume
ratio values reported in previous 129Xe CSSR studies in human subjects, and the appropriateness of
comparisons between different studies. The following review comprises references for the morphological
parameters of human lungs only – there are a number of studies that report ST and S/V in animal lungs,
however we do not believe that these values are directly translatable to humans (see e.g. [338]).
(i) ST and S/V values derived from other (histological) methods:
A limited number of references are available that quote alveolar septal thickness values in human subjects
(where the septal thickness has the same meaning as the parameter derived from 129Xe CSSR):
Gil et al [320] reported septal thickness measurements by interactive computerised morphometry of
formalin-instilled single human autopsy lung samples (using an intercept-based method with real-time
video of samples). Assessing a range of values from a number of measurements and various experimental
procedures, the septal thickness measurements presented in [320] tend to lie between 8.5 and 11 µm.
Kohlhase and Maxeiner [328] used the methods demonstrated in [320] to assess septal thickness in
elderly subjects with senile emphysema (aged 71-88 years) who had died either by drowning or cardiac
complications. (Note: subjects with serious pathological findings were excluded.) Mean septal thickness
values were found to be 10.5 µm and 11.1 µm; 11.3 µm and 11.3 µm in the left and right lungs of drowned
and non-drowned subjects, respectively.
Gla¨ser et al [327] obtained lung specimens from subjects who had died some time after a heart trans-
plantation. (Note, patients had no pulmonary complications, and a mean age of 52 ± 14 years.) The
average septal wall thickness for 73 patients was 9.9±4.2 µm, although it is worth noting that the authors
of [327] suggest that these values are increased compared with what they would consider to be “healthy
control” values.
Although the range and standard deviation of literature values for septal thickness is quite large, it can
concluded from the above that values of the order of 10 µm should be expected in normal subjects. We
may then anticipate that younger subjects would exhibit a lower mean septal thickness, and older or
diseased subjects would exhibit higher values.
In the present study, we have reported a mean ST in healthy volunteers (mean age 59 years) of 11.6±1.0
µm and 14.0 ± 2.7 µm in COPD patients, the former of which are comparable to ST values in elderly
subjects reported in [328]. However, it should be noted that comparison of in vivo measured ST values
with those derived from histological methods is not ideal, because any post-mortem histological analysis
will be susceptible to structural changes induced by the treatment procedure (e.g. formalin instillation).
We were unable to find any literature values of septal thickness determined by methods other than
129Xe CSSR in subjects with lung disease, with which to compare with our values obtained in COPD
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subjects. We discuss our values in relation to other 129Xe CSSR studies in humans in the second part of
this review.
The extent of literature reporting surface-area-to-volume ratio in humans is slightly broader. Here, we
note two methods by which S/V can be measured:
The work of Coxson et al [329] stands out as a commonly-referenced report for S/V values determined
from fixed human histology samples. Coxson et al reported S/V values of 256 ± 24 cm2.mL-1 in lungs
extracted from healthy control subjects, 165±23 cm2.mL-1 in the lungs of mild emphysema patients, and
43± 6 cm2.mL-1 in the lungs of severe emphysema patients. (Note: 1 cm2.mL-1 ≡ 1 cm-1.)
Also, the alveolar S/V can be estimated from diffusion-weighted MRI of 3He or 129Xe in the gaseous-
phase, subject to the constraints of the measured diffusion regime. An example of the derivation of S/V
values from 3He diffusion-weighted MRI data is described by Yablonskiy et al [103], who reported the
following range of results for healthy volunteers and emphysema patients: S/V = 200−240 cm-1 in healthy
control subjects, 100− 140 cm-1 in mild emphysema patients, 50− 55 cm-1 in severe emphysema patients.
In the present study, we calculated mean S/V values in healthy volunteers and COPD patients of 194±70
cm-1 and 117± 60 cm-1, respectively, which are of a similar order to those reported in [103, 329]. We can
therefore postulate that our COPD patient data reflects a S/V value of somewhere between that expected
for mild and severe emphysema based on [103, 329]. However, the pulmonary function test results in
Table 7.1 suggest that emphysema was quite severe in all patients except 67(F).
(ii) ST and S/V from previous 129Xe CSSR studies in humans (considering each study individually):
Qing et al [141] reported median septal thickness values as follows: 7.1 ± 0.9 µm in healthy subjects;
11.9 ± 3.7 µm in COPD patients. In comparison with the values from our study, quoted in (i) above,
Qing et al’s values are lower in both subject groups. However there are a number of reasons why a direct
comparison of our values with those of [141] is challenging.
Firstly, the mean age of subjects was substantially larger in our study (mean age 59 years) compared
with [141] (mean age 26 years). As shown in Section 6.3, we believe that there is a non-negligible increase
in septal thickness with age.
Secondly, Qing et al used the model of Patz et al [138] to fit CSSR data, rather than MOXE (used
in our study). Figure 6.10 clearly shows some slight systematic differences in the absolute values of ST
derived using the two models, with a minor bias towards larger values from MOXE. Moreover, Qing et
al fitted the Patz et al model to the tissue-plasma (T/P) peak signal only, rather than the combined
dissolved-phase signal. As the Patz et al model was designed for use at low field strengths where the two
dissolved-phase 129Xe peaks could not be distinguished, the total dissolved-phase signal intensities should
be fitted with that model to derive a total septal thickness. We postulate that fitting to only the T/P
signal could lead to a slight underestimation of the ST.
Thirdly, the mean values in [141] are quoted at TLC, whilst all our measurements have been conducted
at FRC + 1 L. If we compare Qing et al’s values with the values derived at TLC in our lung inflation level
experiments, the agreement between healthy volunteer data is significantly improved. Although Qing et
al did not observe a statistically-significant difference in ST values measured at TLC and 50% FVC or
RV, we have found a significant difference between values derived at RV + 1 L and TLC, and FRC + 1
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L and TLC, as already presented in Section 7.3.
Finally, Qing et al used a different value of xenon diffusion coefficient in lung tissue to that used in
our work, as discussed in the previous subsection. Qing et al do not reference any literature values of ST
for comparison with their derived values.
Chang et al [140] reported a mean ST value of 9.2± 6.5 µm in healthy volunteers with a mean age of 33.7
years, including results from scans at both 1.5 T and 3 T. Chang [139] did not report fitting results for
ST from a human data-set, but instead quoted a value of the “xenon exchange time” of 83±7.5 ms in one
“previously-published data-set”. This corresponds to a ST value of 16.4 µm, assuming D = 3.3 × 10−6
cm2.s-1 (used in [140]). However, because of the discrepancy in the derived S/V values from human data-
sets in [139] and [140] as mentioned below, we do not believe that it is valid to compare our data with
that presented in [139].
The mean ST values in our work are comparable to those in [140], though slightly larger, as might be
expected since the mean age of subjects was higher in our study. However, even though the same analysis
model was used in our work and [140], we note that Chang et al used different values for the diffusion
coefficient and Ostwald solubility in lung tissue.
Chang et al [140] compared their ST values to a literature value of 10 µm, citing [320], the results of
which are discussed above.
Patz et al [138] reported mean septal thickness values (see Figure 6 of [138]) of approximately 12.5 µm in
normal subjects, and 16.5 µm and 22 µm in two patients with interstitial lung disease (we have estimated
these values by reading the bar chart in Figure 6). In an earlier paper, [248], Patz et al only presented
S/V findings and not ST findings.
Although we have employed the MOXE approach for our CSSR data analysis, the values quoted in
[138] may be the most appropriate from other human 129Xe CSSR studies for comparison with our results,
because we used the same values of the fundamental constants (xenon diffusion coefficient and solubility
in lung tissue) as that work. As mentioned above, we have observed marginally higher septal thickness
values with MOXE as compared to the model of Patz et al; mean difference ≈ 0.5 µm (see Figure 6.10).
Although the values taken from elderly healthy volunteers in our study are only slightly different to those
presented by Patz et al, we are unsure of the age of the subjects in that study; however, we might assume
that it is less than that of our reproducibility cohort (see e.g. Table 1 of [248] for supporting evidence for
this assumption).
Finally, as discussed in Section 7.4 and below, whilst we have adopted the same approach as Chang
et al [140] for achievement of a given inflation level prior to acquiring 129Xe CSSR data, Patz et al used a
different procedure; in their work, a number of distinct lung volumes relative to TLC were used, which,
as we have shown, might severely impact the derived ST value. Thus, the validity of comparing absolute
values between different subjects at different relative inflation levels is limited.
Patz et al [138] did not compare their derived ST results with any literature values from other methods.
Qing et al did not present S/V measurements from CSSR.
Chang [139] derived a S/V value of 404 cm-1 by fitting a previously-published 129Xe CSSR data-set using
MOXE. However, it appears that this value was obtained by assuming that a septal thickness value from
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rabbits of 5 µm (cited as originating from [333]) is applicable to human data. Given that Chang et al
present significantly lower S/V values in their later paper [140], we may assume that the value of 404 cm-1
is not appropriate for comparison with our work.
Chang et al [140] reported a mean S/V of 210± 50 cm-1 in healthy subjects with a mean age of 33.7
years, which appears to have been derived from the actual measured septal thickness values (rather than
the assumed ST of 5 µm as in [139]). This S/V value is similar to our study measurements (194 ± 70
cm-1 in healthy volunteers). However, we must re-iterate the point that we used a slightly different value
of the xenon diffusion coefficient in tissue to that of Chang et al, and crucially, Chang et al employed
an Ostwald solubility of xenon in tissues which was a factor of 2 higher than the value we used. (Note:
the value we employed is arguably more well-established and supported by literature than that used by
Chang et al, as discussed in the previous subsection.) Thus, it may not be appropriate to compare our
values of S/V with those in [140].
Chang et al [140] compared their inferred values of S/V to those reported in [329], stating that their
values are comparable to those of that study in normal subjects.
In [139], two different literature values of S/V are quoted: a value of 250 cm-1, citing [329], is used to
support Chang’s initial computational simulations of the CSSR signal; however, later in the article, when
Chang presents the results of a CSSR data-set from a healthy volunteer, a literature value of 450 cm-1 is
quoted instead, the origin of which is unclear to the reader.
Patz et al [138, 248] reported S/V values at different relative lung volumes between 0.25 and 1 × TLC
in each subject. We believe that it would be most appropriate to compare our values of S/V with those
measured by Patz et al [138, 248] at volumes of 50% TLC (∼ 120 cm-1 in both papers). Nevertheless,
in our current work, the % of TLC represented by our chosen inhalation strategy of FRC + 1 L means
that the relative inflation level varies between subjects and could correspond to values in a wider range
(e.g. 30% to 70% of TLC). Due to the observation of changes in S/V as a function of lung inflation level
presented in our current manuscript (and indeed in Patz et al [138, 248]), the validity of comparison of
absolute values of S/V between our work and that of Patz et al is limited.
Patz et al compared their inferred values of S/V to those reported in [329], stating that their values
are ∼ 40% lower than those in [329].
7.4.1 Future perspectives: Chemical shift imaging (CSI)-CSSR
Like Section 6.4.1, this subsection provides initial results of an ongoing project related to 129Xe CSSR
in our laboratory, concerning the development of a means to acquire spatially-localised 129Xe CSSR data
with an interleaved, phase-encoded CSSR sequence.
129Xe CSSR provides a means of assessment of whole-lung average functional changes, allowing estima-
tion of the mean alveolar septal thickness and surface-area-to-volume ratio. However, most lung diseases
present in a spatially heterogeneous manner; for example, idiopathic pulmonary fibrosis is typically most
severe at the base and periphery of the lungs (see e.g. [339] and Figure 6.1). Furthermore, there are well-
known gravitational effects in the supine lungs, in terms of tissue density [1] and ventilation-perfusion
ratio (V/Q) [340]. Thus, a method for spatial localisation of the dissolved-phase 129Xe signal is required
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in order to permit regional estimation of lung microstructural parameters.
Whilst Dixon- [145, 148] or “IDEAL”-based chemical shift imaging (CSI) [146, 147] approaches al-
low the regional depiction of the chemically-distinct resonances of 129Xe dissolved in T/P and RBC
compartments, the imaging data is only associated with a single exchange time (TR), such that only
semi-quantitative information about gas exchange dynamics and function can be derived. In addition,
though the development of multiple exchange time xenon polarisation transfer contrast (MXTC) tech-
niques has permitted regional evaluation of the dynamics of gas exchange for derivation of quantitative
maps of parameters related to ST and S/V [152, 153], XTC-based methods do not enable distinction of
the signals arising from the T/P and RBC components, and thus do not enable separate assessment of
diffusion and perfusion contributions to gas exchange. The relative advantages and disadvantages of each
approach are summarised in Table 7.4 and Figure 7.5.
The necessity for multiple repetition times in 129Xe CSSR constrains the spatial resolution achiev-
able within a single breath-hold. Thus, the simultaneous acquisition of regional, spectrally-selective
and dynamic/temporal information about gas exchange is challenging, and in practice a compromise
is required. Although spiral IDEAL techniques have been recently demonstrated for the acquisition of
spatially-localised CSSR uptake curves in rats [341, 342], this involved a multiple-scan approach which is
unfeasible for single breath-hold acquisitions in humans at present.
Technique Advantages Disadvantages
CSSR Spectral & dynamic; No regional localisation
(dynamic spectroscopy) allows estimation of lung structure
(M)XTC Regional (& dynamic) No spectral selectivity
IDEAL / Dixon CSI Regional & spectral No dynamic information;
semi-quantitative
Table 7.4: Advantages and disadvantages of currently-adopted 129Xe MRI methods for studying gas exchange.
Figure 7.5: Summary of the types of information offered by 129Xe MRI methods for studying gas exchange.
The purpose of this preliminary study was to implement a free induction decay CSI method with multiple
spectral acquisitions at different CSSR exchange times for each phase encoding step (which we denote
“CSI-CSSR”), in order to study the regional variation in gas exchange dynamics from anterior to poste-
rior, whilst preserving spectral-selectivity of the T/P and RBC components.
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A FID-based CSI sequence with a variable repetition time (TR) CSSR acquisition for each phase en-
code was programmed as shown in Figure 7.6, utilising binomial-composite RF pulses for saturation of
dissolved-phase 129Xe (as introduced in Section 6.2). Two healthy subjects were scanned using the same
experimental set-up as detailed in previous sections of this thesis. Enriched xenon gas was delivered to
subjects in 1 L doses of either 100% hyperpolarised xenon or 50:50 xenon-nitrogen mixtures. Subjects
were scanned on two occasions, with one-dimensional phase encoding applied in the right-left (R-L) and
anterior-posterior (A-P) anatomical directions.
Figure 7.6: Interleaved CSI-CSSR pulse sequence, as implemented in this work. For each CSI phase encoding
step (PE), 90◦ binomial-composite RF pulses were used to saturate the dissolved-phase 129Xe magnetisation and
generate FIDs at multiple different inter-pulse delay times (TR values) in order to sensitise the MR acquisition to
xenon uptake dynamics for each pixel.
The number of exchange times (TRs) and phase encodes was optimised according to: the available reser-
voir of gaseous 129Xe magnetisation; the minimum number of TR points required to achieve satisfactory
fitting of CSSR uptake curves with diffusion models; and the feasible length of a breath-hold.
In order to assess the first requirement, the decay of gaseous-phase 129Xe signal as a function of RF
pulse number was evaluated at a fixed repetition time TR = 30 ms ( T1 and  maximum TR used in
129Xe CSSR). For reference, a Tedlar bag with a 3% hyperpolarised 129Xe gas mixture (balanced with N2
and 4He) was placed in the transmit-receive RF coil (loaded) and subjected to 90◦ RF pulses centred on
the dissolved-phase 129Xe frequency (and separated by spoiler gradients and TR = 30 ms). By fitting the
decay in gaseous 129Xe signal according to Equation 3.125, the equivalent flip angle for gaseous 129Xe (for
a 90◦ dissolved 129Xe excitation) was found to be 0.85◦. The same experiment was performed in three
different subjects after inhalation of hyperpolarised 129Xe gas. In this case, the rate of decay was found
to be equivalent to that produced by a flip angle of ∼ 10◦ in each subject. This more rapid decay can be
attributed to depletion of the gaseous 129Xe reservoir by transfer into the dissolved-phase and saturation
by the 90◦ RF pulse. As illustrated in Figure 7.7A, this implies that the gaseous 129Xe magnetisation will
be almost completely diminished after ∼ 150-200 RF pulses with TR = 30 ms.
A previously-acquired 129Xe CSSR data-set from a healthy volunteer was analysed in order to inves-
tigate the effects of reducing the number of temporal data-points sampled during the CSSR uptake curve
on the quality of the fit. This was done by fitting the Patz et al model to the combined dissolved-phase
129Xe data after reducing the number of data-points by a factor of 2, 3 and 4, compared to the initial
number of 25 (as in Section 6.2). As shown in Figure 7.7B, significant discrepancies in the fit quality were
only observed when the number of data-points was decreased by 4× compared with the original number,
whilst 2- and 3-fold reductions caused little change in the shape of the curve. ST values derived from
the model fitting were 1%, 5% and 19% different to the original values for 2-, 3- and 4-fold reductions,
respectively. Hence, 8 TR values were chosen for the CSI-CSSR acquisition, equating to an approximately
3-fold reduction in the sampling density of the CSSR uptake curve as compared with Section 6.2.
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Preliminary CSI-CSSR data acquired with 8 or 12 phase encoding samples indicated a non-negligible
leakage of signal into neighbouring phase encodes due to insufficient sampling density. However, since
it was desired that the maximum number of RF pulses did not exceed 200, a compromise of 16 phase
encoding steps was chosen. Thus, the total number of RF pulses was 8× 16 = 128. To limit the sequence
duration to that of a realistic breath-hold time (∼ 15 sec), it was practically unfeasible to acquire data
associated with a TR of 1 s, or even 500 ms; hence, a maximum TR of 320 ms was selected to provide
some information about pulmonary perfusion. The minimum TR was 20 ms. Additional sequence pa-
rameters were as follows: field-of-view of 26 cm (36 cm) in the A-P (R-L) direction; each phase encode
corresponded to ∼ 16 (22.5) mm; 128 spectral points were sampled over a bandwidth of 12 kHz.
Figure 7.7: Pulse sequence design considerations for 129Xe CSI-CSSR. A) Off-resonant excitation and depolarisa-
tion of 129Xe gas signal in a Tedlar bag (orange) and in vivo (pink) upon 90◦ excitation of dissolved 129Xe. B)
Alteration of the quality of the Patz et al model fit to 129Xe CSSR data as the number of data points is reduced
to a fraction of the original number (25 points).
In the R-L direction, the dissolved and gaseous 129Xe signal intensities were found to be symmetrically
distributed about the trachea at all repetition times, suggesting that there was little R-L variation in
ventilation, tissue density, or perfusion. (Spikes in the F (t) parameter in the middle phase encodes were
manually excluded; these were attributable to the relatively large gaseous 129Xe signal in the trachea
compared with the dissolved 129Xe signal.) An example CSI-CSSR data-set with phase encoding in the
R-L direction is shown in Figure 7.8.
CSSR uptake curves associated with each phase encoded region were analysed with the model of Patz
et al. In the regions associated with the centres of each lung, the derived septal thickness values were
≤ 13% of previous whole-lung CSSR data in healthy volunteers (see Section 6.3). However, in the extreme
right and left locations, the SNR was insufficient to yield high quality data fitting, and as such, meaningful
estimates of lung microstructural parameters were not possible in these regions.
Figure 7.9 depicts typical results acquired from one subject in the A-P orientation, highlighting elevated
signal from both gaseous and dissolved 129Xe in the posterior regions. At TR values of greater than
50 ms, the total dissolved 129Xe signal from the most posterior regions was greater than that from the
anterior regions. Figure 7.9B shows example 129Xe CSSR uptake curves from two posterior positions,
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Figure 7.8: A) CSSR data as a function of (CSI-encoded) position in the right-left direction for a healthy subject.
B) Example fits to tissue/plasma (T/P) and RBC data for phase encode steps 6 and 11.
fitted with the model of Patz et al, which display a good agreement between the model fit and the data.
However, the SNR associated with the dissolved and gaseous 129Xe signal in the anterior regions was low,
constraining the fit quality. As such, reliable estimates of fit parameters, and hence a meaningful estimate
of the variation in those parameters as a function of A-P position, could not be derived.
Nevertheless, though ventilation, perfusion and surface-area-to-volume ratio would be expected to dif-
fer, we would not necessarily expect to observe an A-P variation in alveolar septal thickness in healthy
normal subjects. In order to validate the CSI-CSSR results against a standard clinical observation, the
ratio of the integrated signal intensities of gaseous and RBC-dissolved 129Xe at the longest TR value (320
ms) were calculated for each phase encoding step to provide a surrogate measurement of the ventilation-
perfusion ratio (see Figure 7.9C). These findings indicated a marked increase in the signal intensity ratio
in the most anterior locations compared with posterior locations, in agreement with previously-published
imaging measurements [143] (note: in [143], the dissolved-phase 129Xe signal was not separated into its
constituent components).
The prospect of multiple-interleaved CSI encoding for acquisition of 129Xe CSSR uptake curves in two
or three dimensions in a single breath-hold is desirable, and although challenging, could be realised in
future by sparse encoding methods in both the spatial and temporal domains. For example, it may be
feasible to apply a compressed sensing type reconstruction (see Section 4.5) and utilise the shape of the
129Xe CSSR uptake curve from global spectroscopic measurements as prior knowledge to constrain the
CS reconstruction (in a similar manner to previous measurements wherein anatomical co-registered 1H
MRI data has been used as prior knowledge in the reconstruction of 3He ventilation images [343]).
There are a number of clinically interesting possibilities for studying regional gas exchange dynamics
with CSI-CSSR in future work. In particular, the technique may be applied in its current implementation
to measure superior-inferior differences in alveolar septal thickness in fibrotic lung disease with a basal
predominance. Additionally, further investigations of gravitational (anterior-posterior) changes in other
CSSR-derived lung functional parameters, e.g. perfusion and S/V, are possible.
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Figure 7.9: CSI-CSSR validation in the
anterior-posterior (A-P) direction. A) 129Xe
spectra acquired from a healthy subject at a
TR of 100 ms, as a function of A-P position
(planning shown on anatomical 1H image in the
inset). B) Example 129Xe CSSR uptake curves
from two posterior sections of the lung (phase
encode numbers 5 and 6 in A)), fitted with the
model of Patz et al. C) A-P position depen-
dence of signal from gaseous (green) and RBC-
dissolved (red) 129Xe at the longest TR of 320
ms, and the corresponding ratio of gas/RBC
signal (a surrogate of the ventilation perfusion
ratio, “V/Q”, plotted in purple). In A) and C),
each position step represents an extent of ∼ 16
mm.
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Conclusions
The 129Xe CSSR technique has been demonstrated to be a reproducible method for the non-invasive
quantification of alveolar septal thickness in COPD patients and age-matched healthy volunteers. The
reproducibility of the derived ST has been found to be of a similar order to session-to-session variability
of conventional pulmonary function tests. Furthermore, the associated mean intra-subject standard devi-
ations of ST were observed to be substantially less than the difference in ST between healthy volunteers
and COPD or IPF patients. At present, the CSSR-derived alveolar surface-area-to-volume ratio is not
sufficiently reproducible for consideration as a robust clinical biomarker. The limitations of the technique
— in terms of fundamental assumptions of the diffusion modelling approach, and the lack of established
literature references for the assessment of alveolar septal thickness in humans — have been discussed in
detail. In addition, preliminary steps towards regional localisation of 129Xe CSSR data have been taken
by employing a CSI-based approach. If some of the factors constraining the clinical applicability of the
technique can be overcome, 129Xe CSSR may mature into a beneficial means of early diagnosis and lon-
gitudinal assessment in lung diseases characterised by gas exchange limitation.
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Chapter 8
Finite element modelling of 129Xe
diffusive gas exchange NMR in the
human alveolar-capillary bed
8.1 Introduction
The suitability of hyperpolarised 129Xe as a NMR probe of pulmonary gas exchange function has been
thoroughly described in Chapters 2, 3 and 6. In particular, the CSSR spectroscopy method has been
introduced as a means of assessment of the temporal dynamics of diffusive exchange of xenon from the
alveoli to the capillaries during a single breath-hold of inhaled hyperpolarised 129Xe [138, 248]. 129Xe
CSSR data can be modelled using analytical solutions of the one-dimensional diffusion equation in or-
der to obtain quantitative information about gas exchange, including estimates of lung microstructural
dimensions [138–140, 309]. This has enabled evaluation of alveolar septal thickening in patients with
interstitial lung disease and chronic obstructive pulmonary disease (see Chapter 6 and e.g. [138, 141]).
The technique has potential clinical impact in interstitial and gas exchange pathologies for which there is
no universally-accepted gold-standard metric of gas exchange assessment at present [344].
The most widely-employed analytical model of xenon diffusional exchange in the lungs for interpreting
129Xe CSSR data was developed by considering a simplified 1D description of the acinar regions of the
lungs as alveolar spaces separated by septal (interstitial) tissue [138, 248]. This (Patz et al) model was
subsequently extended by dividing the interstitial region into tissue and capillary compartments [139] in
order to utilise the MR signals arising from the discrete dissolved-phase 129Xe resonances that can be
spectrally resolved at sufficiently high B0 field strengths. Inherent to these approaches is the assumption
that the septal thickness separating the alveoli and capillaries is uniform throughout the lungs.
In addition, a 1D radially-symmetric geometry comprising spherical alveoli sheathed by a uniform
tissue layer has been considered in order to formulate a comparable model with similar assumptions [309].
In attempt to validate the applicability of these analytical models, preliminary finite difference simulations
have been implemented to model 129Xe diffusive exchange in a geometry comprising a single alveolus and
a capillary region; however, this model also assumed homogeneity of septal tissue [345]. Fundamentally,
these approaches do not utilise realistic representations of the lung microstructure to account for the
heterogeneity in alveolar geometry and tissue or capillary thickness that is present in normal lungs [346]
and crucially, is accentuated in many lung diseases (see e.g. [347] and example whole-lung and micro-CT
images of the lungs of normal subjects and patients with IPF depicted in Figure 6.1 of Section 6.1). Ad-
ditionally, the efficacy of most analytical methods is constrained by a high number of interrelated fitting
parameters that may obscure the quantitative interpretation of metrics of gas exchange and microstructure
so-derived (see Section 6.4). Thus, realistic geometrical representations of the alveoli, septa and capillary
networks should help to advance the current models of 129Xe diffusional exchange in the human lungs and
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strengthen the interpretation of quantitative information about lung microstructure derived from in vivo
129Xe NMR.
In this chapter, 129Xe diffusive exchange between the alveoli and pulmonary capillaries is simulated via
finite element analysis, adopting a similar methodology to that previously presented for simulating hyper-
polarised gas diffusion MR [348–351]. A number of geometrical approaches are employed, including 3D
cylindrical geometries of the pulmonary capillaries (as an initial model system for validation of numerical
simulations), and realistic 2D and 3D “image-based” geometries of the alveolar microstructure, derived
from histological sections and volumetric µ-CT data of normal human lungs and the lungs of patients
with ILD. The implications of these simulations for the analysis of 129Xe CSSR data and the future de-
velopment of associated analytical models of lung microstructure are discussed.
This chapter is based on the following publication: “Finite Element Modeling of 129Xe Diffusive Gas
Exchange NMR in the Human Alveoli”. N. J. Stewart, J. Parra-Robles, J. M. Wild. Journal of Mag-
netic Resonance, doi:10.1002/mrm.26279 (2016). Author contributions statement: study design, NJS,
JMW; acquisition of data, NJS, JPR; analysis of data, NJS; preparation of manuscript, NJS, JMW.
8.2 Methods
Background theory
Although it has been already explained in the previous chapter, this paragraph briefly reviews the for-
mulation of gas exchange “contrast” in 129Xe NMR experiments, which is enabled by the fact that the
magnetisation of hyperpolarised 129Xe is non-renewable and can be manipulated by RF pulses. Upon
inhalation, xenon rapidly saturates the pulmonary capillaries and its overall concentration in the capillary
bed is limited by capillary perfusion. However, the application of spectrally-selective RF saturation pulses
that destroy the longitudinal magnetisation of dissolved-phase 129Xe, whilst preserving the polarisation
of 129Xe gas in the alveolar spaces, permits the measurement of diffusive exchange of 129Xe from the
alveoli to the capillaries [171]. The application of 90◦ RF pulses effectively “resets” the dissolved-phase
129Xe magnetisation to zero such that the increase in signal during a given NMR repetition time (TR) is
governed by the amount of dissolved-phase 129Xe magnetisation that is replenished by diffusive exchange
with polarised 129Xe from the reservoir of gaseous-phase 129Xe (in the alveoli) within that time period.
The CSSR measurement involves sampling the dissolved-phase 129Xe magnetisation at various delay times
(TRs) after the application of selective 90◦ pulses at the dissolved-phase 129Xe resonance frequency (see
Section 6.2 for further information). As such, the dynamics of gas exchange, i.e. a measure of the uptake
of 129Xe concentration in the parenchyma and capillaries as a function of time, can be derived, which
provides information about “diffusion limitation”; the extent to which a particular disease process (e.g.
inflammation or fibrosis) impairs the diffusional exchange of xenon into the capillaries.
Unlike the measurement of hyperpolarised gas ADC values, because diffusion sensitisation is achieved
by RF pulses which modulate the longitudinal magnetisation, rather than magnetic field gradients (which
modulate the phase of the transverse signal), the dissolved-phase 129Xe magnetisation does not require
treatment with the Bloch-Torrey equation. Assuming perfect B1 and B0 field homogeneities, and there-
fore fully on-resonance 90◦ excitations of the dissolved-phase 129Xe magnetisation in a CSSR experiment,
the transport of 129Xe magnetisation into and within the parenchymal tissue and pulmonary capillaries
180
is governed by the diffusion-convection equation, such that the magnetisation, Md, can be treated equiv-
alently to a concentration:
∂Md
∂t
=∇ · (D∇Md − vMd) + S (8.1)
where D is the diffusion coefficient of xenon, which differs by many orders of magnitude in the alveolar
airspace (D0 = 0.14 cm
2.s-1 [226]) and in the dissolved-phase (Dt, here assumed to be 3.3
−6 cm2.s-1
[265], and see Section 7.4) and S represents any additional “sources” or “sinks” of magnetisation. In the
following simulations, blood flow in the lungs is assumed to be well-approximated by plug flow [352], thus,
the velocity vector, v, has constant magnitude in the capillaries, and is zero in the parenchymal tissue.
Boundary conditions
Diffusion-weighted MRI of 129Xe in the alveolar airspaces assumes that xenon gas atoms reflect (i.e.
“bounce-off”) the alveolar walls rather than transferring into the dissolved-phase; it is this restriction of
diffusional motion at the alveolar boundaries that forms the basis of hyperpolarised gas ADC mapping as
a probe of alveolar spatial length-scale. This assumption is substantiated by the fact that only a small
fraction (∼ 2%) of the total 129Xe MR signal is constituted by xenon dissolved in the pulmonary tissues
and blood (as mentioned in the previous chapter, this arises from the relatively low Ostwald solubility of
xenon in tissue and the fact that the volume of the pulmonary tissues and blood is a small fraction of the
airspace volume).
However, when simulating the diffusion of xenon in both gaseous- and dissolved-phases, the permeation
of xenon atoms through the alveolar walls must be considered. Due to the large difference in diffusion
coefficient between xenon in the airspace and tissue compartments, and the relatively low Ostwald sol-
ubility, the boundary between these two phases is an example of a so-called “stiff” boundary, wherein
the xenon concentration exhibits a discontinuity at the boundary itself. In finite element analysis, these
discontinuities can be accounted for by applying “stiff” boundary conditions, defined as follows (see e.g.
[353]):
(−D∇M2 −M2v) = vSS (K21M1 −M2) (8.2)
where Mi represents the magnetisation in region i, nˆ is the unit vector perpendicular to the bound-
ary between the two regions, Kij is the partition coefficient for the j
th medium with respect to the ith
medium (equivalent to the ratio of the Ostwald solubility in medium j to that in medium i) and vSS is
the “stiff-spring” velocity, a non-physical velocity, the value of which is somewhat arbitrary, but must be
sufficiently large to allow a continuous 129Xe flux across the boundaries between the two media, and to
permit the concentration (magnetisation) differences in the brackets in Equation 8.2 to approach zero [354].
Here, preliminary investigations were conducted by simulating the diffusion of 129Xe in the airspaces and
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dissolved-phase using stiff boundary conditions as applied to 2D histological samples (the implementation
and results of which are described below and depicted in Figure 8.4). However, the use of these boundary
conditions results in a constantly depleting supply of gaseous 129Xe, and the rate of diffusive uptake of
129Xe depends heavily upon the surface-perimeter-to-area ratio of the alveoli (i.e. the size of the gaseous
129Xe reservoir) contained in the 2D image. As such, this approach does not account for the full 3D extent
of the alveolar ducts and sacs. Therefore, in all subsequent simulations, the magnetisation of 129Xe in the
gaseous-phase was considered to be constant — in order to represent an infinite reservoir of 129Xe — by
applying the Dirichlet boundary condition at the boundary between phases that the 129Xe magnetisation
was fixed to a constant, non-zero value. Importantly, this infinite gas reservoir approach is consistent with
the assumptions of the CSSR methodology, in which the dissolved-phase 129Xe magnetisation from each
acquisition is normalised with respect to the gaseous-phase 129Xe magnetisation to account for sources of
gaseous 129Xe signal decay and to treat the 129Xe gas as a constant reservoir supplying hyperpolarised
129Xe to the dissolved-phase.
Geometrical approaches
The 1D model adopted by Patz et al [138] to develop analytical solutions for the dissolved-phase 129Xe
signals in a 129Xe CSSR experiment is illustrated in Figure 8.1a. Figure 8.1b shows the Patz et al model
applied to a CSSR data-set from a normal subject (same subject as in Figure 6.10 of the previous chapter),
reiterating that this analytical approach provides a high quality fit of typical in vivo CSSR data. This
three compartment model, comprising a single dissolved-phase 129Xe compartment (septum) separating
two adjacent alveoli was extended in [139] in order to divide the septal compartment into two tissue layers
with a capillary segment in the middle. This extension is also depicted in Figure 8.1a. A similar one-
dimensional analytical solution has been developed by Ma˚nsson et al [309] adopting a radially-symmetric
capillary model. The fundamental assumption of these models is that the proposed geometrical situation
is replicated in a homogeneous manner across the whole of the lungs, and that the alveolar septal thickness
is uniform, which is clearly not the case, as illustrated in Figure 6.1 of Section 6.1.
Figure 8.1: Schematics of the design of uniform models of 129Xe gas exchange, with example 129Xe CSSR data.
a) One-dimensional geometrical picture of gas exchange employed in [138, 139] to derive analytical expressions for
the 129Xe CSSR signal. b) Typical 129Xe CSSR data from a normal subject (see also Figure 6.10), fitted with the
equation of Patz et al [138]. c) Design of the uniform, 3D radially-symmetric septal capillary model for numerical
simulations of 129Xe diffusive uptake. The cylindrical model is divided into two regions, one in which gas exchange
is permitted to occur (un-hatched), and one in which it is not permitted to occur (hatched). [V = ventilation; D
= diffusion; Q = perfusion; d = septal thickness; δ = tissue layer thickness; lG and lC represent the gas exchange
region length and total capillary length, respectively.]
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(i) To expand upon these one-dimensional pictures, in this work, a three-dimensional model of a septal
compartment was developed by considering a cylindrical capillary surrounded by a cylindrical lumen shell
of tissue, as illustrated in Figure 8.1c.
As described in Section 6.2, 129Xe CSSR experiments involve the acquisition of spectroscopic data at
a range of time-points from tens of milliseconds to ∼ seconds. The early time-points are predominantly
governed by diffusive uptake of 129Xe into the pulmonary tissues and the capillary bed, whilst at time-
points & 100 milliseconds, significant additional increases in dissolved 129Xe signal can be observed due
to the detection of dissolved 129Xe down-stream from the gas exchange region in the pulmonary venous
system. If signal could only be detected from the region of the lungs where gas exchange occurs, then the
signal would be expected to saturate at a time-point related to the size of the capillary septa. However,
because the 129Xe lung RF coil excites all of the lungs and not just the alveolar-capillary gas exchange
region i, and the T1 relaxation time of
129Xe in the blood is sufficient to preserve signal over many seconds
[246, 255], additional dissolved 129Xe signal can be detected from 129Xe in the bloodstream that has been
carried out of the gas exchange region of the lungs; this leads to an approximately linearly increasing
signal at later time-points (see Figure 8.1b). In order to account for the detection of post-capillary bed
signal within the cylindrical model developed here, the cylinder was composed of two equal sections, one
as described above (with a tissue layer and constant source of alveolar xenon), and one in which the tissue
layer and gas source were removed (hatched region in Figure 8.1c), to represent a blood-carrying region
whose only source of 129Xe signal was that transported from the first section of the cylinder by perfusion.
The signal detected in a CSSR experiment is constituted by the total integrated 129Xe magnetisation in
both regions of the cylinder.
The outer perimeter of the tissue layer was assumed to be in contact with gaseous-phase 129Xe (in
the alveoli). The diameter of the capillary was chosen based upon previous 129Xe CSSR observations
as d = 10 µm (see Section 7.4), and the tissue layer thickness was permitted to be a free parameter in
the simulations, with values ranging from δ = 0.2-1.0 µm [140]. A Dirichlet boundary condition was
implemented at the outer surface of the tissue layer in order to represent a constant source of 129Xe from
the gaseous-phase (i.e. ensuring that the cylinder was entirely encompassed by alveoli). The total length
of the cylindrical capillary model was determined from estimates of pulmonary blood flow and red blood
cell transit time (the latter being the average length of time required for a RBC to traverse through
the pulmonary capillary, i.e. the gas exchange region). Taking an approximate value of blood (plasma)
velocity in the capillaries as vb ≈ 0.5 mm.s-1 [355], assuming plug flow as discussed above and an average
RBC transit time of τ ≈ 1.0 s [356], leads to a gas exchange region length (lG) of 0.5 mm. This value is
identical to that assumed in [355] for the length of a single capillary. For simplicity, here, the two halves
of the cylindrical model were chosen to have the same length, such that the total length of the cylinder
(lC) was 1 mm. However, it is worth noting that in principle, the second (post-capillary) section of the
model could be chosen to be longer than 0.5 mm, to represent the fact that the T1 of
129Xe dissolved in
blood is > 1 s [255]. Nevertheless, the length of this region only needs to satisfy the requirement of being
≥ the distance that blood can travel in the typical CSSR measurement period (i.e. ∼ RBC transit time),
since there is no mechanism by which 129Xe can be detected further down-stream than this.
iIn reality, the pulmonary vessels and capillaries are regionally inter-mingled and not spatially discrete on the length-scale
of MR experiments.
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This idealised cylindrical model provides a testing platform for exploring the effects of different geometri-
cal and physical parameters on the resulting 129Xe diffusive uptake behaviour. The influence of different
disease-induced microstructural changes upon 129Xe CSSR data can be investigated by varying the fol-
lowing parameters in a certain manner: septal thickness and tissue thickness, d and δ, can be increased,
e.g. for simulating interstitial lung disease; blood flow velocity, vb, can be altered, e.g. for pulmonary
hypertension applications; dissolved-phase xenon diffusion coefficient, D, can be modified for diseases in
which the tissue structure is remodelled, e.g. fibrotic disease.
(ii) Though the above cylindrical model is a natural 3D extension of the 1D analytical models that pro-
vides equivalent information about gas exchange dynamics, and offers a relatively straightforward means
of exploring the effect of different 129Xe CSSR fitting parameters on in vivo data, it still requires the
assumption of a homogeneous septal geometry across the lungs, which is not representative of the genuine
situation (see e.g. Figure 6.1 of Section 6.1). As proposed by Miller et al [350] for simulating the diffusion
of hyperpolarised 3He in the alveolar airspaces, a more accurate representation of the alveolar geometry
can be obtained by using high resolution histological images. Following the method described in [350],
here, 2D histological sections of the alveoli of normal subjects and patients with usual interstitial pneu-
monia (UIP; the most common form of interstitial lung disease) were segmented — by thresholding and
manually revising the resulting segmentations using ScanIP software (Simpleware Ltd., Exeter, UK) —
in order to separate the alveoli from the capillaries and thus create two-dimensional models of the alveo-
lar septa (i.e. the “dissolved-phase”). In order to simulate homogeneous tissue thickening and generate
comparative models to those derived from UIP histology samples, alveolar septa segmented from normal
lung histology samples were artificially-dilated using ball-shaped structuring elements of different sizes
between R = 10 and 20 pixels. In other words, circles of radius R pixels were placed on each pixel of the
septal region, and allowed to overlap such that the edges of the septa were expanded whilst the center of
the septa were preserved. The total physical extent of each histology section used was 0.87 mm × 0.65
mm, with an isotropic pixel dimension of 0.68 µm.
This approach is limited by the fact that it does not permit distinction of the tissue and blood
compartments, because they cannot be easily separated using standard histological staining techniques.
Furthermore, because the histological samples are two-dimensional, and only comprise alveoli from within
the acinar region, the contribution of blood flow and post-capillary bed signal cannot be easily incorpo-
rated into the finite element analysis model. Thus, the geometrical situation is directly comparable to
the analytical model of Patz et al [138] for the case of static capillary blood, but with the inclusion of
geometrical heterogeneity.
We acknowledge the provision of histology samples from Dr William Wallace at the University of
Edinburgh.
(iii) In order to implement flowing capillary blood and simulate the effect of post-capillary bed dissolved
129Xe signal for a model with non-uniform septa, models (i) and (ii) were combined. The histology-based
models described in (ii) were smoothed and “extruded” into three dimensions; effectively, the model was
replicated in a direction perpendicular to the plane of the original image. The resulting 3D model was
designed to have the same length as the cylindrical model in (i) (1.0 mm) in the direction of the extru-
sion, and was divided equally into two regions in the same manner as in that model. As a result, the
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model comprised one region in which gas exchange was permitted by considering the magnetisation at
the boundaries of the dissolved-phase compartments to be constant, and a second “post-capillary” region
in which no gas exchange was permitted. The entire dissolved-phase region was considered to flow with
a constant velocity along the direction of the extrusion (i.e. perpendicular to the plane of the original
histological image), as described in (i).
The process of segmentation, meshing and extrusion of 2D histological sections to generate 2D and
3D finite element models is illustrated in Figure 8.2.
Figure 8.2: Procedure for generation of 2D and 3D finite element models based on lung histology samples. a)
Example histology section taken from the lungs of a patient with usual interstitial pneumonia (UIP). Dimensions:
0.87 mm (width) × 0.65 mm (height). b) Magnified view of the resulting 2D mesh in the section of the histology
sample highlighted by the black box. c) Resulting 3D extrusion and coarser mesh created by smoothing and
extruding the original 2D geometry by 1 mm along the axis perpendicular to the original 2D plane. This 3D
geometry is divided into a 0.5 mm region in which gas exchange is permitted and a 0.5 mm region in which no
gas exchange is permitted.
(iv) In order to derive a truly representative three-dimensional model of the alveoli (without extrusion
of 2D images), sections of volumetric µ-CT images obtained ex vivo from the lungs of normal subjects
and patients with IPF were segmented (see [357] for example µ-CT data). Thresholding was applied to
the input volumetric images to derive a 3D model of the alveolar septa (dissolved-phase), and subsequent
amendment of the model was performed by utilising filters to: (a) “fill in” small gaps in the model, (b)
remove “islands” (sections of the model with a volume of less than a certain number of pixels cubed), (c)
smooth the resulting model with a Gaussian function. The physical extent of the µ-CT volumes used was
1.68 mm or 1.26 mm in each dimension with isotropic pixel sizes of 8.39 µm or 16.79 µm for normal or
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IPF lung samples, respectively. An illustration of the process of converting the volumetric µ-CT images
into a 3D model of the alveolar septa is presented in Figure 8.3.
This approach provides a representative 3D model of a section of the alveolar tissue and capillary
(dissolved-phase) network. However, the spatial resolution of the µ-CT images used here is significantly
lower than that of the histological images, meaning that the number of pixels comprising each septal
wall is reduced. Additionally, the implementation of plug flow is not readily achievable with this model,
because the model does not provide a means of delineating blood vessels external to the gas exchange
region.
We acknowledge the provision of µ-CT samples from Dr Bart Vanaudenaerde and Dr John McDonough
of Catholic University Leuven.
Figure 8.3: Procedure for generation of 3D models of alveolar septa based on volumetric µ-CT images. a)
Volumetric stack of µ-CT slices of part of the lungs of a normal subject (slice thickness ≡ in-plane pixel size
= 8.39 µm). From this volume, a smaller volume (blue) is extracted that is approximately representative of
the overall volume. b) Example slices segmented for the alveolar septa (blue). The selected volume in a) is
segmented by thresholding and using morphological filters to fill-in gaps, remove small islands, and smooth the
resulting model, as described in the main text. c) Render of the resulting 3D model of the alveolar septal network,
generated after manually checking the segmentation in b) in each slice.
Further details of finite element analysis
FEM simulations of 129Xe diffusion and blood flow (using Equation 8.1 with S = 0) for each of the four
aforementioned models were performed on two desktop PCs (4-core Intel®Corei7, 3.2 GHz processor,
32 GB RAM; XMA Ltd, St Albans, UK; and 6-core Intel®Xeon®E5-1650 v2, 3.5 GHz processor, 32 GB
RAM, Dell, Round Rock, TX), using COMSOL Multiphysics software (versions 4.4 and 5.0; Burlington,
MA). The velocity term vb was set to zero in the tissue compartments of model (i) and the dissolved-phase
compartments of models (ii) and (iv), whilst it was permitted to be non-zero in the capillary compartments
of model (i) and in all the dissolved-phase compartments of model (iii). In all cases, simulations were per-
formed with an initial 129Xe magnetisation in the tissue and capillary compartments of zero (representing
the initial saturation of dissolved-phase 129Xe magnetisation in CSSR), and with boundary conditions as
described below. The uptake of 129Xe into the dissolved-phase was initially probed by running simulations
from t = 0 to t = 1.0 s, with a time-step ∆t = 0.001 s. Based on this preliminary data, simulations were
repeated for until a longer time-point if required; a time-step of ∆t = 0.01 s was employed for simulations
with an end time of > 5 s. For particularly long and computationally-intensive simulations involving
three-dimensional geometries, a variable time-step was employed, with ∆t taking values between 0.001 s
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(for t < 1.0 s) and 1.0 s (for t > 10 s). Following completion of the FEM simulations, the total dissolved-
phase 129Xe signal was computed by integrating the magnetisation across the entire model-space at each
time-point. Specific details for each individual model are described below.
(i) To initialise the simulations, the magnetisation of 129Xe in the tissue and capillary compartments was
set to zero at all spatial locations. As mentioned before, a Dirichlet boundary condition was implemented
at the outer boundary of the tissue lumen layer in order to enforce a constant supply of xenon from
the alveoli to the dissolved-phase at all time-points. Stiff boundary conditions were implemented at the
interface between the tissue and capillary regions, where the rate of diffusive exchange depends on the
xenon partition coefficient between the two compartments. The blood velocity was permitted to be a vari-
able of the simulations, taking values between 0 and 0.5 mm.s-1 [355]. Prior to commencing simulations,
tetrahedral meshes of the entire geometry were generated in COMSOL.
(ii) Initially, finite element meshes were created for both the airspace (gaseous-) and dissolved-phase
129Xe compartments, and diffusion was simulated using stiff boundary conditions at the interface between
the two compartments, with the initial conditions that all gaseous 129Xe possessed a magnetisation of 1
and all dissolved 129Xe had a magnetisation of 0. However, as discussed earlier, the finite extent of the
airspaces in the 2D histology sections leads to a depletion of the reservoir of xenon for diffusive exchange
(see Figure 8.4). Thus, rather than adopting that approach, all simulations were carried out using an
effectively infinite reservoir of gaseous xenon, by implementing a Dirichlet boundary condition of constant
magnetisation at the boundary between gaseous and dissolved xenon compartments. Therefore, mixing of
129Xe gas of differing longitudinal magnetisation levels by Brownian diffusion within the alveolar airspaces
was not simulated.
Prior to commencing simulations, tetrahedral meshes of the entire geometry were generated in COM-
SOL. Potential meshing errors arising from inadequate size and number of mesh elements when meshing
small regions were circumvented by removing islands (regions of the model comprising less than a thresh-
old number of pixels) prior to meshing.
(iii) Prior to extruding the 2D histological images into three dimensions, a coarse version of the 2D model
was generated by removing structures with a total area less than a certain threshold number of pixels
(dependent on the exact model, but of the order of tens of pixels) and by specifying the minimum distance
between adjacent edge elements to be substantially larger than that of the 2D models. This reduced the
memory requirements for the 3D model when running in the COMSOL graphical user interface. As with
model (ii), diffusion of 129Xe gas in the alveolar airspaces was ignored, and a Dirichlet boundary condi-
tion was implemented at the boundaries of the alveolar septa to enforce a constant source of xenon to the
dissolved-phase. Tetrahedral meshes of the entire geometry were generated in COMSOL.
(iv) In order to reduce memory requirements of the COMSOL graphical user interface, finite element
meshes comprising tetrahedral elements were generated using the ScanIP +FE module prior to COM-
SOL import. As above, Dirichlet boundary conditions were implemented at the borders of the alveolar
septa to enforce a constant reservoir of xenon to the dissolved-phase.
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Figure 8.4: Preliminary investigations of the effects of a non-constant gaseous 129Xe reservoir in the alveoli on
finite element simulations in 2D histological samples. Distribution of dissolved-phase (a) and gaseous-phase (b)
129Xe in a normal histological sample after t = 0.75 s. c) and d) represent equivalent results obtained from a UIP
histological sample (denoted UIP #1 in Figures 8.6 and 8.8). In both cases, simulations were initialised with all
gaseous-phase 129Xe magnetisation equal to one and all dissolved-phase 129Xe magnetisation equal to zero. Unlike
in subsequent simulations, the gaseous-phase 129Xe magnetisation was not fixed at one, and was instead allowed
to decrease due to diffusive exchange into the dissolved-phase (i.e. “non-constant gas reservoir”). e) Integrated
dissolved 129Xe signal in the two cases (without (w/o) replenishment of the gas reservoir), compared with results
obtained from simulations which included a replenishment of the gas reservoir (w). The latter (w) results are
presented in full in Figures 8.6 and 8.8. The dissolved-phase 129Xe signal is normalised by that at infinite diffusion
time for no blood flow.
8.3 Results
(i) The simulated distribution of 129Xe magnetisation in the uniform 3D cylindrical pulmonary septum
model is shown (at different time-points between 5 ms and 330 ms) in the left panel of Figure 8.5. It can be
observed that the thin tissue layer (δ = 0.5 µm in the case shown) was saturated with 129Xe from the alve-
olar reservoir after ∼ 10 ms, whilst the xenon in the capillary region was still heterogeneously distributed
after 130 ms of exchange. The right panel of Figure 8.5 shows the 129Xe CSSR uptake curves, portraying
the dissolved 129Xe signal as a function of time, generated by integrating the total dissolved-phase 129Xe
magnetisation over the entire geometry for each time-point, for two different values of δ and vb. The
introduction of non-zero blood velocity leads to an increase in signal at time-points greater than ∼ 100
ms, in comparison to the case of zero blood velocity in which a plateau is reached after ∼ 300 ms. The
increase in signal at later time-points reflects the detection of 129Xe down-stream from the gas exchange
region, as measured in vivo via CSSR experiments. The change in tissue layer thickness δ did not induce
an obvious difference in uptake behaviour for the case of zero blood flow; in fact, the two curves at δ = 0.4
µm, vb = 0 mm.s
-1 and δ = 2.0 µm, vb = 0 mm.s
-1 appear to overlap in Figure 8.5 (right). However, for
the case of non-zero blood flow, a marked difference in the rate of uptake and total signal achieved was
observed at the different values of δ. As expected, reductions in the dissolved-phase diffusion coefficient
D (and/or increases in the total septal thickness d) manifested as longer saturation times (data not shown).
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Figure 8.5: Validation of the uniform 3D cylindrical septum model (model (i)). Left: Depiction of the distribution
of 129Xe in the cylindrical model at selected time-points. These images are magnified views of the section of the
cylinder where the gas exchange region (bottom half) and no gas exchange region (top half) intersect. Right: Sim-
ulated 129Xe CSSR signal (integral of magnetisation over the entire 3D geometry as a function of time, normalised
by that at infinite diffusion time for no blood flow) for two different values of tissue thickness (δ) and blood flow
velocity (vb). In each case, the Ostwald solubility of the tissue compartment was specified as 0.09 and that of the
blood was specified as 0.20 [241].
(ii) Figure 8.6 shows the results of finite element simulations of 2D histological samples obtained from the
lungs of normal subjects and patients with UIP. The normal histology sample exhibited rapid saturation of
the tissue and capillaries with 129Xe in a similar manner to that observed for the cylindrical septum model
(i), but with subtle differences in the shape of the curve of uptake dynamics arising from averaging over
many unequal septal thickness values. The effect of uniform thickening of alveolar septa by dilation of the
model with ball-shaped structural elements is depicted in Figure 8.6B) and C). As expected, artificially-
thickened septa required a progressively longer time for the dissolved-phase to completely saturate with
increasing degrees of dilation. Simulated uptake curves for the 2D UIP histology samples are depicted
in Figure 8.6D) and E), and magnified views of selected sections of the samples (specifically illustrating
the 129Xe distribution at t = 0.03 s) are shown in panel F). The shapes of these curves appeared quali-
tatively different to those of the artificially-thickened normal samples. Additionally, when plotted on an
x-axis of time raised to the power of 12 [248], whilst the normal and artificially-thickened normal uptake
curves exhibited clear linear regions (in agreement with that reported in [248]), the UIP early time-point
data exhibited a comparable initial slope to that of the artificially-thickened normal sample (with struc-
turing element size 10 pixels), but relatively quickly deviated from a linear relationship. Although the
two UIP histology sections shown in Figure 8.6 were obtained from spatially distinct regions of the lung,
and appeared qualitatively different in the snapshots at different time-points, the integrated signal (up-
take) curves (normalised by the dissolved-phase 129Xe magnetisation at infinite diffusion time for no blood
flow) exhibited comparable time-dependent behaviour, both when plotted against t and plotted against t
1
2 .
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Figure 8.6: 2D FEM simulations in normal, artificially-thickened (AT) normal, and UIP histology samples. A) =
normal histology section; B) = section in A) with alveolar septa thickened by a ball-shaped structuring element
of 10 pixels in size; C) = section in A) thickened by a 20 pixel structuring element; D) = example UIP histology
section; E) = second example UIP section (obtained from a different region of the lung). (In all cases, pixel size
= 0.68 µm, and blood is static, i.e. vb = 0 mm.s
-1.) Left panels: snapshot images of the distribution of 129Xe in the
histology sections at different time-points after initialisation of the simulation. Top right panel: total integrated
dissolved 129Xe signal for each case, representing the predicted CSSR uptake curves. The dissolved-phase 129Xe
signal is normalised by that at infinite diffusion time for no blood flow. Magnified views of selected regions of the
UIP sections (dashed black boxes) at t = 0.03 s are shown in the bottom right of the figure, panel F).
(iii) A snapshot of the 129Xe distribution at 0.75 s after commencement of simulations for the 3D model
based on an extruded normal histology sample (with non-zero blood flow) is presented in Figure 8.7.
The dark red appearance of the boundaries of the alveolar septa reflects the Dirichlet boundary con-
dition of a constant source of 129Xe magnetisation from the airspace (by definition of the model, the
boundaries were observed to be dark red at all time-points). However, at the near-edges of the septa,
the effect of perfusion is highlighted by the low magnetisation values (blue), which result from blood
flow transporting 129Xe away from those regions. Simulated 129Xe CSSR uptake curves, derived from all
3D histology-based geometries, are shown in Figure 8.8a. These uptake dynamics were comparable to
the results of the 3D cylindrical model, and qualitatively similar to in vivo CSSR data (see Chapter 6).
Discrepancies in the 129Xe diffusive exchange behaviour of models based on normal and UIP histology
samples were most significant at early time-points (< 200 ms), indicating that the 0-200 ms behaviour
was governed by diffusion, whilst the > 200 ms behaviour was more strongly influenced by perfusion
190
Figure 8.7: Distribution of xenon after t = 0.75
s in a 3D model extrusion of a histological sec-
tion obtained from normal lungs. Blood veloc-
ity, vb = 0.33 mm.s
-1 along the axis indicated
by the red arrow.
effects (as expected by definition of plug flow; see Section 8.2). The slope of the perfusion-dominated re-
gion, derived by linear regression analysis, correlated significantly with the blood velocity, vb, as expected.
Figure 8.8: a) Integrated dissolved 129Xe magnetisation as a function of time for 3D extrusion models derived
from one normal (N) and two UIP (U1, U2) histology samples. In each case, the static case (no blood flow)
is compared with the case of blood flow along the axis of extrusion (vb = 0.33 mm.s
-1). The signal has been
normalised with respect to the dissolved-phase 129Xe signal at infinite diffusion time for no blood flow resulting
from the corresponding 2D simulations. b) Simulated normal and UIP 129Xe uptake curves for vb = 0.33 mm.s
-1
from a) fitted with the 1D analytical model of Patz et al.
(iv) An illustration of the 3D mesh resulting from the segmentation process, and the simulated xenon
distribution after t = 0.33 s in a geometry derived from volumetric µ-CT data of normal lungs is shown
in Figure 8.9a) and b), respectively. Note: the outer surface of the alveolar tissue was saturated at all
time-points by definition of the Dirichlet boundary condition. Figure 8.9c) highlights the significantly
increased saturation time associated with a geometry derived from a 3D µ-CT volume of IPF lungs com-
pared with that of normal lungs. The saturation time in both cases was longer than that observed for the
2D or 3D histological samples.
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Figure 8.9: 3D FEM simulations for a geometry derived from a section of a 3D µ-CT volume obtained from the
lungs of a normal subject. a) Side view of the 3D finite element mesh developed for this image volume. b) Simulated
distribution of 129Xe in the dissolved-phase after t = 0.33 s. Note: the dark red appearance of the boundaries of
the alveolar septa reflects the Dirichlet boundary condition of a constant source of 129Xe magnetisation from the
airspace (by definition of the model, the boundaries were observed to be dark red at all time-points). c) Integrated
dissolved 129Xe magnetisation as a function of time for geometries derived from µ-CT volumes of normal and IPF
lungs. (Inset: magnified view of the t = 0 s to t = 0.75 s region.) The dissolved-phase 129Xe signal is normalised
by that at infinite diffusion time for no blood flow.
8.4 Discussion & Conclusions
This work presents, to our knowledge, the first implementation of a finite element based numerical sim-
ulation framework for analysis of 129Xe diffusive exchange in the alveoli and evaluation of the impact
of different lung microstructural and physio-chemical parameters on the expected NMR signal behaviour
of dissolved 129Xe. In this section, the limitations and implications of the several modelling approaches
introduced here are discussed.
Validity and assumptions of geometrical approaches
Of the four geometrical approaches adopted for finite element simulations of 129Xe diffusive exchange
in the lungs, no one single model is able to completely fulfil the criteria of accounting for heterogeneity
in tissue and capillary thicknesses, whilst still permitting distinction of the 129Xe signals arising from
parenchymal tissues and blood plasma as compared with red blood cells. The 3D cylindrical capillary
model allows for distinction of the contributions of tissue and blood compartments, but requires assump-
tions about the pulmonary haematocrit in order to separate the plasma and RBC signal contributions,
and does not account for heterogeneity of septal geometry; whilst the image-based models provide an
adequate geometrical representation of the heterogeneity of the alveolar geometry, but do not allow the
separation of contributions from different septal compartments.
Nevertheless, to date, the primary outcome metric of the 129Xe CSSR experiment that has been
presented with most clinical relevance is the whole-lung septal thickness (see e.g. [138, 140, 141] and
Section 6.3), which can be derived by treating the entire dissolved-phase as a single compartment [138].
In Sections 6.3 and 6.4, it has been shown that septal thickness values derived from analytical models
that treat the dissolved-phase as single or multiple compartments are comparable, with a mean difference
in derived ST values of < 10% between the two implementations. Thus, though there are considerable
opportunities for improvement of our geometrical models (as suggested below), we can conclude that our
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numerical simulation results can be compared qualitatively with in vivo clinical 129Xe CSSR data in their
present state.
However, it is challenging to directly and quantitatively compare in vivo 129Xe CSSR measurements with
our simulated data. Full validation of our simulations would require in vivo CSSR of a subject, followed
by extraction of a sample of lung tissue and ex vivo CSSR of that sample, further followed by micro-CT
and/or histological analysis for generation of finite element geometries. This is an involved procedure, and
is highly susceptible to the heterogeneity of the alveolar septa across the lungs, particularly in subjects
with lung disease, and is a topic of further work in our laboratory.
As a first step towards semi-quantitative comparison of our simulated data with previous in vivo CSSR
data, an existing analytical model of 129Xe diffusive uptake was utilised to fit the simulated 129Xe uptake
curves from 3D histological samples and evaluate the derived fitting parameters, namely the alveolar septal
thickness. The analytical model presented by Patz et al [138] was chosen for this purpose because it treats
the dissolved-phase as a single compartment, and therefore it is appropriate for use with the 3D histolog-
ical models wherein the tissue and capillary regions cannot be distinguished. In addition, this model has
previously been found to be robust in a number of 129Xe CSSR studies involving human subjects (see e.g.
[138, 248] and Chapter 6). Fitting the Patz et al model to the simulated signal-time curve (Figure 8.8b,
vb = 0.33 mm.s
-1) for the 3D normal histology model resulted in a mean septal thickness value of 8.8 µm.
In order to validate this value, the septal thickness was also estimated from the original 2D histological
image by drawing (∼ 60) perpendicular lines on the image across different regions of the septa. The mean
septal thickness in the histology section was found to be 9.8±6.3 µm by this method, which is comparable
to that derived from fitting the associated uptake curve. In addition, both these septal thickness values
are in good agreement with values derived from previous in vivo 129Xe CSSR measurements in healthy
human volunteers [138, 140, 141, 248] (and Chapters 6 and 7), which suggest that a value of ∼ 10 µm is
representative of normal lung.
Septal thickness values derived from fitting 3D UIP histology-based models with the analytical model
of Patz et al (Figure 8.8b) were 21.4 µm and 17.2 µm for the two samples (UIP #1 and UIP #2 respec-
tively). These values were significantly lower than the values determined from the original histological
images by the line drawing approach (30-40 lines per image resulted in septal thickness values of 62.7±33.5
µm and 79.2 ± 47.1 µm, respectively). However, the fitted-simulated values were in approximate agree-
ment with values reported in the literature for subjects with interstitial lung disease: 15-22 µm [138];
∼ 17 µm (Chapter 6). Discrepancies between in vivo measured values and values obtained from the line
drawing approach may be explained by disease heterogeneity; i.e. the fact that the histological samples
of UIP lungs were taken from heavily diseased regions of lungs, whilst in reality, UIP lungs are comprised
of a mixture of healthy and diseased regions that are distributed heterogeneously (see Figure 6.1 of Sec-
tion 6.1). However, the differences between the UIP septal thicknesses derived from the fitted-simulated
data and the line drawing method are considerable. These differences could result from the fact that the
blood flow acts as a “heat-sink” to extract 129Xe from the gas exchange region and create / maintain a
concentration gradient to allow a more rapid uptake of 129Xe in the gas exchange region. This increased
rate of uptake would then lead to a lower estimated septal thickness. It is likely that this same process
contributes to the in vivo measured septal thicknesses being lower than the values derived by line drawing.
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One of the principal limitations of the 2D and 3D image-based models is that the resulting geometries
reflect the situation in only a relatively small part of the lungs, from which the samples were obtained.
Due to the highly heterogeneous nature of the alveolar geometry, particularly so in patients with intersti-
tial lung disease (see again Figure 6.1 of Section 6.1), histological images acquired from different regions
of the lungs could result in considerably altered apparent 129Xe CSSR uptake behaviour. Therefore, our
current models are biased to provide information about a specific region of the lung parenchyma, whilst
the 129Xe CSSR measurement involves acquisition of spectra from the whole of the lungs, corresponding
to a global average of the alveolar microstructure. Hence, a better representation of 129Xe CSSR data
could be obtained by simulations using a geometry derived from the entire lung volume, for example
using 3D volumetric µ-CT images. However, this geometry would be extremely complex and simulations
would be practically unfeasible in reasonable timescales on a desktop PC. Furthermore, the resolution of
the µ-CT images used in this work is relatively low compared with that of histology images, limiting the
number of pixels comprising the dissolved-phase 129Xe regions. If the µ-CT resolution could be improved,
finer capillary structures could be identified, and an increased mesh density could be used, allowing for
better implementation of the initial saturation conditions at t = 0 s ii. Nevertheless, increased image
resolution would in-turn lead to additional computational complexity. An alternative solution would be
to obtain histological samples from specific regions of the lungs to compare with spectral time-series data
associated with a comparable spatial location (i.e. obtained by applying additional phase encoding to the
CSSR sequence, see e.g. Section 7.4.1).
As mentioned above, the UIP histological samples simulated herein exhibited considerably longer 129Xe
saturation times and hence increased diffusive exchange limitation compared with that observed in IPF
patients previously studied with 129Xe CSSR (see Section 6.3). This may be partially explained by the
highly heterogeneous distribution of tissue fibrosis in IPF lungs; i.e. if the histological samples used in
this work were purposely obtained from severely diseased sections of the lungs, the gas exchange process
would be expected to be adversely affected to a greater degree than in a whole-lung CSSR measurement
that involves averaging over diseased (i.e. structurally altered) and relatively healthy (i.e. not structurally
altered) regions of the lungs. Furthermore, histological samples were obtained post-mortem; as such, it
may be supposed that they would represent a more severe stage of disease when compared with in vivo
129Xe MR data obtained from live patients. In an ideal situation, histological samples obtained from
lung biopsies of ILD patients on, or close to, the date of 129Xe CSSR scanning could be used for direct
comparison of simulation results to in vivo data.
Following on from this, it is prudent to discuss the validity of artificial thickening of the alveolar septa of
normal histological samples as a means of simulating the effects of interstitial lung disease. As highlighted
by the differences in the “static” (2D, no blood flow) uptake curves when comparing UIP samples and
artificially-thickened normal samples (Figure 8.6), it is apparent that the derived gas exchange dynam-
ics are significantly disparate. The histological samples obtained from normal lungs exhibit noticeably
more homogeneity of septal thickness after dilation than those from UIP lungs, which show a wide range
of airspace and capillary sizes. The artificial thickening process was found to increase the mean septal
iiIn the present simulations, the integrated dissolved-phase 129Xe signal is not precisely zero at t = 0 since the pixels
at the borders of the dissolved-phase are non-zero (due to contact with the gaseous-phase). Improved resolution of the
dissolved-phase 129Xe compartments would lead to an initial dissolved-phase 129Xe signal that was closer to zero.
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thickness of the histological sample in a linear manner, as quantified by the line drawing method: normal
sample, 9.8 ± 6.3 µm; sample dilated by structuring elements of 10 pixels in size, 28.0 ± 7.3 µm; sample
dilated by structuring elements of 20 pixels in size, 48.9 ± 8.3 µm. This was also reflected in the time
taken for the 129Xe signal in each geometry to saturate (since the saturation time is directly proportional
to the square of the septal thickness [138, 139]). Fitting the Patz et al model to the simulated uptake
curves derived from normal and artificially-thickened normal samples (data in Figure 8.6) yielded septal
thickness estimates of: normal sample, 9.7 µm; sample dilated by structuring elements of 10 pixels in size,
30.2 µm; sample dilated by structuring elements of 20 pixels in size, 52.3 µm. These values are in good
agreement with the values calculated using the line drawing method, and further support the uniform
thickening induced by the artificial thickening procedure – i.e. that dilation by a structuring element of
10 pixels in size leads to an increase in septal thickness by ∼ 20 µm on average. This is not unexpected
when the original pixel size is 0.67 µm and the structuring element is ball shaped with a radius equal to
either 10 or 20 pixels.
As discussed above, the steep initial section of the 129Xe uptake curve of the UIP samples (and non-
linear behaviour when plotted against t
1
2 ) can be attributed to the presence of numerous small structures
that are saturated on a rapid timescale; these structures were less prominent in artificially-thickened sam-
ples. It is also noticeable from observations of the UIP sections that the sizes and shapes of the alveolar
airspaces are dissimilar to those of the normal lung sections. These two factors in combination imply
that the effects of an alteration to the surface-area-to-volume ratio in addition to the effects of changes
in septal thickness may be entwined when fitting the 129Xe uptake dynamics from UIP patients with
the aforementioned analytical CSSR models. In future work, it may be beneficial to explore alternative
means of artificially thickening the septa of normal histological samples in a more heterogeneous manner,
for example by adopting a spatially-random variation in the size of the structuring elements employed for
the dilation process.
A final assumption employed herein is that the blood flow in the lungs is well-approximated by linear
(plug) flow. Plug flow was assumed previously in the development of the analytical models for simplicity
reasons, and here we have adopted the same assumptions for consistency. However, in practice, pulmonary
capillary blood flow is weakly pulsatile in nature, and a recent report suggested that oscillations in the
129Xe RBC peak intensity of up to ∼ 20% of the magnitude of the peak can be observed by in vivo NMR
spectroscopy methods as a result of the pulsatile blood flow in the capillaries [358]. In our simulations
based on 2D and 3D image segmentations, we have considered only a single dissolved-phase 129Xe com-
partment consisting of lung parenchymal tissue along with plasma and RBCs, thus the pulsatile nature
of blood flow would be expected to have a less significant impact on the resulting signal dynamics. We
would expect that the oscillatory amplitude of the total dissolved-phase MR signal measured in a 129Xe
CSSR experiment would be much less than 20%, and would cause negligible alterations to the derived
uptake curve. Therefore, we believe that it is reasonable to assume that blood flow is constant. However,
in future work, more complex models of pulmonary blood flow may be implemented relatively straight-
forwardly within the existing simulation framework.
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Relevance and implications of finite element simulations
The fact that alterations of multiple lung microstructural and physical parameters, such as the septal
thickness, air-blood barrier thickness and diffusion coefficient, can present as only subtle changes to the
shape of the observed 129Xe uptake dynamics implies that clinically-relevant differences in these parame-
ters may be difficult to uniquely identify from 129Xe CSSR data. Furthermore, under certain experimental
conditions, differences in alveolar surface-area-to-volume ratio could be challenging to distinguish from
alterations to the tissue geometry or diffusion coefficient.
Thus, in future 129Xe NMR spectroscopy and imaging experiments sensitised to diffusive exchange of
xenon in the lungs, care must be taken as to the choice of the acquisition timing post-saturation of the
dissolved 129Xe magnetisation with a spectrally-selective 90◦ RF pulse. If a 90◦ pulse is used with a fixed
repetition time, then the repetition time should be chosen such that it represents a time-point correspond-
ing to the regime where the dissolved 129Xe signal is predominantly governed by diffusive uptake rather
than perfusion. In addition, for future 129Xe CSSR experiments, in which a number of exchange times are
probed in order to measure the dynamics of the uptake process, we may postulate that the total number
of acquired data-points could be reduced by minimising the number of points in the perfusion-dominated
region of the curve. In other words, because we have verified that the simulated uptake behaviour after
∼ 200 ms exhibits an approximately linear response as a function of time governed by the pulmonary
blood flow, only one or two data-points need to be collected in this region, which should help to reduce
scan times and facilitate CSSR spectroscopic imaging applications wherein spatial information could be
encoded in addition to temporal and spectral information (see e.g. Section 7.4.1 and [341]). As indicated
in Figure 8.8, it is critical to acquire a sufficient number of data-points to accurately resolve the short
timescale (< 200 ms) behaviour in order to quantify differences in diffusive exchange efficiency between
disease states; as can be seen in this figure, the rate of change of the uptake curves of normal and diseased
lungs after ∼ 200 ms is very similar (because the prescribed blood flow dynamics were equivalent), whilst
the short timescale data exhibits significant discrepancies between the normal and the two UIP examples.
Thus, to accurately distinguish the different rates of diffusive uptake, acquisition of short timescale data
at multiple time-points is necessary.
Due to the relative complexity of the finite element simulations in comparison to calculation of analytical
solutions of 129Xe CSSR data, it is impractical to replace typically-employed rapid analytical curve-fitting
processes with a least squares optimisation that incorporates a series of time-consuming finite element
simulations. However, we propose that the numerical simulations introduced here may be used to validate
/ verify the analytical solutions, for example, in order to aid decision making about which physical or
microstructural parameters may have led to an observed change in the dissolved 129Xe signal behaviour.
Unfortunately, due to the multitude of factors contributing to the measured signal, as discussed above,
the interpretation of the analytical models may be obscured without numerical validation. Furthermore,
by simulating the dissolved 129Xe MR signal for a number of different histology and µ-CT sections from
subjects with different forms of lung disease, it may be possible to generate a “library” of data pertain-
ing to the gas exchange behaviour of different disease subtypes and co-pathologies. It may therefore be
possible to compare in vivo and simulated data from these subgroups of patients in order to identify and
explain subtle alterations to the uptake dynamics.
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The numerical simulations performed in this work highlight the importance of considering a representative
geometrical picture of the alveolar-parenchymal substrate when investigating 129Xe diffusive uptake via
NMR methods. Our findings may be used to improve the existing analytical models of 129Xe diffusive
uptake, for example by introducing an additional parameter to quantify the heterogeneity in alveolar sep-
tal dimensions. However, the high number of fitting parameters involved in the current analytical models
means that the robustness of these models may be approaching the limits of clinical suitability. Thus, it
is especially advantageous to maintain a flexible numerical solution to the diffusion problem for validating
the results of the analytical models.
The methods introduced here can relatively easily be extended to simulate the ADC of 129Xe in the
airspaces, and to quantify to what extent the ADC measurement could be influenced by diffusive exchange
of 129Xe between the gaseous- and dissolved-phase compartments. To date, it has been assumed that de-
rived 129Xe ADC values are negligibly affected by the exchange process because only ∼ 2% of the total
inhaled 129Xe is taken up into the dissolved-phase, but the validity of this assumption has not been fully
explored. Using the approaches described here and elsewhere [348], an end goal of this project would be
to generate a full 3D model of the alveolar and airway network and to model the time-course of inhalation,
distribution and uptake of 129Xe, allowing simultaneous prediction of the 129Xe ADC in the alveoli and
lung microstructural parameters from CSSR spectroscopy. It can be envisaged that representative models
of blood flow in the capillary network could be added to the model, accounting for its pulsatile behaviour
in order to examine the implications for in vivo NMR experiments [358]. However, it is important to con-
sider that this model would require a means of estimating the contribution from xenon situated outside
the gas exchange region to the total dissolved 129Xe signal.
Furthermore, in future experiments, the developed models could be better related to actual in vivo
129Xe spectroscopy data by replacing the absolute magnetisation (employed here as a surrogate for con-
centration) with the complex form of the measured transverse magnetisation, and conditions could be
established to account for the difference in Larmor frequency by applying a different magnetisation phase
in the different chemical compartments. This approach would be valid for geometries in which it is pos-
sible to accurately separate the parenchymal tissues and blood, and as such, would require distinction
of the plasma and red blood cells by visual methods or by making assumptions about the pulmonary
haematocrit. Similarly, the gaseous-phase and the dissolved-phases could be isolated by the phase of the
magnetisation, such that the 129Xe magnetisation could be more easily simulated in a full 3D model of
the alveolar airspace and capillaries, as discussed above.
Conclusions
A model system for simulating the effect of lung microstructural and physical parameters on 129Xe dif-
fusive exchange NMR of the lungs has been developed by implementing a uniform 3D cylindrical model
of the alveolar septal compartment. Finite element simulations of 129Xe diffusion have been carried out
using this geometry and realistic 2D and 3D geometries of the alveoli derived from histology and micro-CT
images of normal and diseased lungs. This work has implications for future MR imaging and spectroscopy
studies with dissolved 129Xe in the lungs, in terms of choice of acquisition timing parameters, and in partic-
ular, to improve the accuracy of modelling of lung microstructure and gas exchange from 129Xe NMR data.
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Chapter 9
Summary and further work
This thesis has been primarily concerned with the development and experimental validation of MR meth-
ods for the study of lung function with hyperpolarised 129Xe. This summary chapter reviews the findings
of each experimental chapter of this thesis, and summarises the proposed future directions of research in
each related area, including some examples of ongoing work. The co-authors of this chapter are: M. R.
Rao, G. Norquay and J. M. Wild. Author contributions statement: study design, NJS, MRR, GN, JMW;
acquisition of data, NJS, MRR, GN; analysis of data, NJS, MRR; drafting of chapter, NJS, JMW.
The initial impact and historical predominance of clinical studies with both hyperpolarised 3He and 129Xe
gas MRI has been realised through direct imaging of pulmonary ventilation, and mapping of the apparent
diffusion coefficient of the gases in the alveolar airspaces. Chapter 4 reports on the optimisation and
experimental validation of a 3D steady-state free precession acquisition strategy for high quality lung ven-
tilation imaging with 129Xe, with the goal of improving image SNR to overcome the limitations imposed by
the relatively lower gyromagnetic ratio of 129Xe compared with 3He. A method for numerical simulation of
the 3D bSSFP signal, including the sensitivity to B0 and B1 inhomogeneities, has been demonstrated and
utilised to derive the optimum imaging parameters for 129Xe lung imaging. This approach has been em-
ployed to acquire high SNR images with relatively cheap and readily-available naturally-abundant xenon.
In combination with the development of compressed sensing techniques for attainment of clinically-feasible
breath-hold times, this work indicates the potential of 129Xe for replacing 3He in routine ventilation imag-
ing applications, and opens up the possibility of relatively inexpensive longitudinal screening of patients
with lung disease without the use of ionising radiation. It is worth noting that the numerical optimisation
method and 3D bSSFP pulse sequence is readily applicable to other nuclei, and in fact, variations on
the sequence described in Section 4.3.2 are now used routinely in our group for ventilation imaging with
hyperpolarised 3He in addition to 129Xe.
Chapter 5 presents the results of a preliminary study in which two proposed biomarkers of lung
function derived from hyperpolarised gas ventilation imaging and ADC mapping with 3He and 129Xe —
namely the ventilated volume percentage of the lung and the global mean ADC — are quantitatively
compared in healthy subjects, and patients with lung cancer and COPD. Of particular interest, the find-
ings highlight the excellent reproducibility of derived VV% and ADC metrics in a patient cohort, and
demonstrate that 129Xe provides almost equivalent functional information to 3He on the whole-lung level.
In future work, the relationship between ventilation and ADC data derived from the two gases will be
investigated more thoroughly on a regional (slice-by-slice) basis, to appraise the relative sensitivity to
spatially-heterogeneous disease. Additionally, whilst the study involving COPD patients has now been
completed, recruitment of patients with lung cancer is ongoing, and further data from supplementary
cohorts of patients should be collected in order to strengthen the argument for 129Xe being adopted as a
more economically-viable alternative to 3He for these applications.
In Chapters 6, 7 and 8, an implementation of the 129Xe chemical shift saturation recovery MR spec-
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troscopy method for assessment of pulmonary gas exchange dynamics, an experimental validation and a
review of the methodological considerations of the technique, and a finite element modelling framework
for further validation and exploration of the limitations of the technique, are presented respectively. A
preliminary study in patients with SSc and IPF has been carried out to validate the applicability of
the CSSR technique for quantification of pathological alterations to lung microstructural parameters, in
particular, the thickness of the alveolar septum. The CSSR-derived septal thickness has been shown to
be reproducible in COPD patients and healthy volunteers, and indicates the utility of the method as a
complementary functional assessment tool to conventional pulmonary function tests. The applicability
of analytical models of gas diffusion in the lung parenchyma and capillaries for estimation of lung mi-
crostructural parameters has been evaluated, and a numerical solution to the diffusion equation has been
implemented in order to investigate the effects of crucial physico-chemical parameters on diffusive gas
exchange in the lungs. Gas exchange simulations have been performed using 2D and 3D image-based
models which account for the effects of heterogeneity of lung disease, for the purpose of appraising the
robustness of 129Xe CSSR data and permitting better classification of gas exchange behaviour in terms of
its underlying causes. These methods exhibit promise for non-invasive quantification of lung microstruc-
tural remodelling in lung diseases characterised by gas exchange limitation. Future work will focus on
the realisation of acquisition of regional, dynamic information about gas exchange, with selectivity of the
signal from 129Xe dissolved in lung tissue and plasma, and RBCs, in a single breath-hold. In addition,
further development of geometrical models for numerical simulations of diffusion in the alveolar airspaces,
gas exchange, and perfusion in the capillaries in a full three-dimensional network should enable simulta-
neous prediction of 129Xe ADC mapping and dynamic spectroscopic data.
In light of the successful identification of septal thickening in patients with IPF by 129Xe CSSR, a
further study is already underway in our group with the principal aim of assessing longitudinal changes in
MR-derived metrics (including 129Xe CSSR-derived septal thickness, and 3He ventilation volume percent-
age and ADC) in IPF patients at baseline, 6 months and 12 months. The sensitivity of these metrics to
early IPF is being investigated by conducting the baseline scans as close as possible to the date of initial
diagnosis of the condition. Furthermore, by carrying out two baseline scans on the same scan date, the
reproducibility of these metrics in the IPF cohort is under evaluation.
A focus of current experimental work is to establish ultra-short TE pulse sequence acquisition and re-
construction strategies for imaging of dissolved-phase 129Xe in the human lungs for regional evaluation of
pulmonary gas exchange. Dixon- [148] and IDEAL-based [147] techniques with radial encoding schemes
have been previously demonstrated elsewhere in order to overcome the limitations imposed by the short
T ∗2 relaxation times and intrinsically low signal associated with dissolved-phase
129Xe in vivo. In com-
bination with existing 129Xe CSSR and high-resolution spectroscopic approaches (see e.g. [171]), these
methods have the potential to form a comprehensive dissolved 129Xe MR protocol for the evaluation of
multiple aspects of pulmonary gas exchange function.
Preliminary work has been undertaken to design and implement 2D and 3D radial encoding strategies
with spectrally-selective radiofrequency excitations of dissolved- and gaseous-phase 129Xe. An example
data-set from an isotropic 3D radial acquisition with interleaved excitation of dissolved and gaseous 129Xe
in a single breath-hold is shown in Figure 9.1. These initial images clearly depict the challenges associated
with imaging 129Xe in the dissolved-phase as compared with the gaseous-phase (in terms of image SNR);
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however, the quality of obtained dissolved-phase 129Xe images should be sufficient for the acquisition of
distinct images from the two dissolved-phase compartments in the near future.
Figure 9.1: 3D radial interleaved acquisition of dissolved- and gaseous-phase 129Xe images from the lungs of
a healthy volunteer. Top: coronally-reconstructed gaseous-phase 129Xe images (flip angle ∼ 0.5◦). Bottom:
coronally-reconstructed dissolved-phase 129Xe images (flip angle ∼ 18◦). Effective voxel size 12.5 mm3 in both
cases.
One application of 3D (UTE) radial imaging — when used in combination with Dixon or IDEAL CSI for
separation of MR signals arising from 129Xe dissolved in T/P and RBC compartments — is the improved
visualisation of gas exchange impairment and semi-quantitative assessment of ventilation-perfusion match-
ing, which is particularly of interest in co-pathologies that cause both diffusion and perfusion limitation,
for example interstitial lung disease and co-existing pulmonary hypertension.
In addition, work is in progress to optimise acquisition strategies for visualising the distribution of
cerebral perfusion via hyperpolarised 129Xe MRI of the brain. In previous work by our group, traditional
2D spoiled gradient echo sequences have been used to obtain preliminary images of 129Xe dissolved in
the grey matter in vivo after inhalation by human subjects [359]. However, in light of the low T ∗2 of
dissolved-phase 129Xe in vivo, ultra-short echo time radial encoding may offer the possibility of improved
image SNR. To this end, work is underway to implement and optimise 2D radial acquisition techniques
for human brain imaging. Preliminary 2D radial images of 129Xe dissolved in a healthy human brain in
the axial and sagittal orientations are depicted in Figure 9.2.
In conclusion, the promise of 129Xe as an alternative to 3He, and for additional functional studies of the
lung that are unfeasible with 3He, is considerable. It is hoped that the work presented in this thesis will
add to the extensive literature demonstrating the potential of 129Xe MRI techniques, and ultimately, aid
in their clinical translation.
As a final note, it has been briefly mentioned in Chapters 2 and 4 that our group has recently received
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Figure 9.2: 2D radial images of 129Xe dissolved in the human brain. a) Axial image. b) Sagittal image overlaid on
a low resolution 1H image (acquired with the 129Xe brain coil in situ). In both cases, the in-plane pixel dimension
was 7.5 mm and the slice thickness was either 18 cm (sagittal) or 20 cm (axial). Images were acquired 15 seconds
after inhalation of ≈ 1 L of pure isotopically-enriched xenon.
a licence for patients to be referred for hyperpolarised gas scans by clinicians. This licence applies to both
3He and 129Xe and represents a vital step towards translation of the technique for diagnostic purposes in a
clinical setting. The initial intake of referred patients has been extremely promising, with a current referral
frequency of approximately one patient per week. These patients typically undergo a 3D bSSFP imaging
sequence for assessment of lung ventilation, and ADC mapping and other more specialised techniques can
be requested by the clinician. Although the initial successes of the award of this licence are exciting for
the hyperpolarised gas MRI field, a more widespread dissemination of the advantages and possibilities
of the techniques is still required to facilitate increased interest from additional centres throughout the UK.
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